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Summary  
Epigenetic processes include the establishment, maintenance and coordinated 
change of DNA and histone modifications to shape chromatin structure across cell 
divisions without affecting the DNA sequence. This thesis addresses the regulation 
of DNA methylation with particular focus on the interplay between epigenetic factors 
DNMT1 and UHRF1, their role during development and disease as well as 
technology advancements in genome editing and transcriptomics towards better 
understanding of chromatin biology. 
The field of epigenetics increasingly relies on genome editing and genome-wide 
transcriptomic analyses as key technologies to study and understand the regulation 
of individual genes, their protein products as well as systemic effects on gene 
expression. During my PhD, I co-established a multifunctional integrase (MIN) tag 
for rapid and versatile genome engineering. Based on CRISPR/Cas mediated 
manipulation, this approach enables efficient generation of multiple isogenic cell 
lines to study gene function under physiological conditions. Moreover, I participated 
in a comprehensive study comparing different library preparation methods for 
single-cell transcriptomic analyses.  
The main study of this thesis focuses on mutations in the TS domain of DNMT1 that 
are linked to a neurodegenerative disease called HSAN1E. Here, we characterized 
two disease related mutations with functional complementation assays in mouse 
embryonic stem cells. We showed that these mutations impair both interaction with 
UHRF1 and DNMT1 heterochromatin association resulting in decreased methylation 
levels. The next objective of this work was to investigate UHRF1-mediated 
modifications and their functional interplay with DNMT1 regulating DNA methylation. 
We identified H3K18 as a novel ubiquitination target of UHRF1. H3K18ub is 
essential for DNMT1 targeting and function. Consequently, we identified a ubiquitin 
interacting motif (UIM) within the TS domain of DNMT1, responsible for binding 
H3K18ub.  
Finally, with UHRF1 and UHRF2 single knockout ESCs, we assayed for differential 
ubiquitination using mass spectrometry and identified novel non-histone 
ubiquitination targets. We show that UHRF1 ubiquitinates PAF15 at Lys 15 and Lys 
24 and thereby promotes its binding to PCNA during late s phase.  
Together my findings indicate a novel functional aspect of UHRF1 in regulating DNA 
methylation via H3K18ub and suggest a non-epigenetic role in DNA damage 
response. Despite sequence and domain similarity of UHRF1 and UHRF2, my 
results suggest that UHRF1/2 are involved in different cellular pathways, arguing for 
non-redundant functions. 
Summary 
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Zusammenfassung 
Epigenetische Prozesse umfassen die Etablierung, Aufrechterhaltung und 
koordinierte Veränderung von DNA- und Histon-Modifikationen. Desweiteren 
beeinflussen sie die Chromatinstruktur während des Zellzyklus, ohne dass die DNS-
Sequenz verändert wird. Diese Doktorarbeit beschäftigt sich mit den molekularen 
Mechanismen der DNS-Methylierung mit besonderem Fokus auf dem funktionellen 
Zusammenspiel der epigenetischen Faktoren DNMT1 und UHRF1 und ihrer 
Funktion in der embryonalen Entwicklung. Desweiteren werden technologische 
Fortschritte in der Genommanipulation und Transkriptomanalyse zum besseren 
Verständnis der Chromatinbiologie beschrieben.  
Das Feld der Epigenetik setzt zunehmend auf Genommanipulation und genomweite 
Transkriptomanalysen als Schlüsseltechnologien, um die Regulation einzelner 
Gene, ihre Proteinprodukte sowie systemische Effekte auf das zelluläre 
Transkriptom zu untersuchen und zu verstehen. Während meiner Promotion habe 
ich das multifunctional integrase (MIN) tag System für eine schnelle und vielseitige 
Genommanipulation mitetabliert. Basierend auf CRISPR/Cas-vermittelten 
Manipulationen ermöglicht dieser Ansatz eine effiziente Generierung von isogenen 
Zelllinien, um individuelle Gene unter physiologischen Bedingungen zu 
untersuchen. Darüber hinaus habe ich an einer umfassenden Studie teilgenommen, 
in deren Rahmen verschiedene Verfahren der Einzelzell-Transkriptomanalyse 
verglichen wurden. 
Die Hauptstudie dieser Arbeit konzentriert sich auf Mutationen in der TS-Domäne 
von DNMT1, die mit einer neurodegenerativen Erkrankung namens HSAN1E 
assoziiert sind. Hier haben wir zwei krankheitsbezogene Mutationen mit 
Komplementierungsexperimenten in embryonalen Stammzellen charakterisiert. Wir 
haben gezeigt, dass diese Mutationen sowohl die Bindung von DNMT1 an 
Heterochromatin als auch die Interaktion mit UHRF1 beeinträchtigen, was zu einem 
verringerten Methylierungslevel führt. 
Das nächste Ziel dieser Arbeit war es, UHRF1-vermittelte posttranslationale 
Modifikationen und deren Einfluss auf die Regulation von DNMT1 zu untersuchen. 
Wir identifizierten H3K18 als eine neue Histonubiquitinierungsstelle, die von UHRF1 
ubiquitiniert wird. H3K18ub ist essentiell für die Funktion von DNMT1. In der Folge 
haben wir ein ubiquitin interacting motif (UIM) innerhalb der TS-Domäne von 
DNMT1 identifiziert, das für die Bindung von H3K18ub verantwortlich ist. 
Schließlich wurden embryonale UHRF1- und UHRF2-knockout Stammzellen auf 
differenzielle Ubiquitinierung mittels Massenspektrometrie untersucht und neue 
Zusammenfassung 
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Ubiquitinierungssubstrate identifiziert. Wir zeigen, dass UHRF1 PAF15 ubiquitiniert 
und damit die Bindung von PAF15 an PCNA in der späten S-Phase fördert. 
Die Ergebnisse dieser Arbeit zeigen einen neuen funktionellen Aspekt von UHRF1 
bei der Regulation der DNS-Methylierung über H3K18ub und deuten auf eine 
Funktion bei der Reparatur von DNS-Schäden hin. Trotz der Ähnlichkeit von 
Sequenz und Domänenstruktur von UHRF1 und UHRF2 deuten die Ergebnisse 
darauf hin, dass UHRF1/2 an verschiedenen zellulären Prozessen beteiligt sind und 
unterschiedliche Funktionen haben. 
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1 Introduction 
1.1 Epigenetic regulation 
Although almost all cells of a multicellular organism are genetically 
homogeneous, they are structurally and functionally heterogeneous and give 
rise to multiple tissues (Bird 2002). To explain how different cellular morphology 
and function can arise from the totipotent zygote during development, the 
epigenome provides a superordinate layer of information (Waddington 1957; 
Jaenisch and Bird 2003). Central to the definition of epigenetics is the 
knowledge that genes carry regulatory information beyond their nucleotide 
sequences. Epigenetic mechanisms are either dynamic during early embryonic 
development or relatively stable, capable of being passed onto daughter cells 
(Smith and Meissner 2013). In higher order chromatin, epigenetic information is 
mediated by DNA and histone modifications and further histone variants and 
nucleosome positioning as well as RNA-mediated gene silencing (Figure 1). 
These mechanisms function in a highly complex regulatory system and 
deregulation leads to genomic instability and promotes tumorigenesis 
(Goldberg, Allis, and Bernstein 2007; Choi and Jong-Soo 2013). It has become 
clear that significant crosstalk exists between epigenetic modifications and 
pathways, which are connected in various combinations with each other that 
manifolds the complexity of epigenetic regulation (Reik 2007; Ponting, Oliver, 
and Reik 2009; Bannister and Kouzarides 2011). As DNA and histone 
modifications are the most prominent and well-studied epigenetic marks, they 
will be introduced in the next chapters. 
Figure 1. Epigenetic mechanisms. Gene expression is regulated by the crosstalk between 
DNA methylation and posttranslational histone modifications. The replacement of canonical 
histone proteins by histone variants and nucleosome remodeling can additionally alter the 
accessibility of chromatin. Further, non-coding RNAs contribute to epigenetic regulation. 
Introduction 
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1.2 Chromatin structure and histone modifications     
The basic level of chromatin compaction in eukaryotic cells consist of DNA 
wrapped around a histone octamer forming nucleosomes that are folded into 
higher-order chromatin fibres (Luger and Richmond 1998; Kornberg and Lorch 
1999). Two copies of histones H2A, H2B, H3, and H4 pairwise interact to form 
the barrel-shaped histone particle called histone octamer (Woodcock and 
Ghosh 2010). To further compact chromatin, a linker histone called H1 localizes 
near the DNA entry-exit sites of the core particle (Figure 2) (Thoma, Koller, and 
Klug 1979). Histones possess a globular structure, but also harbor a 20-35 
amino acid long N-terminal unstructured peptide that protrudes from the surface 
of the nucleosome called histone tail (Luger et al. 1997). All histones can be 
posttranslationally modified, and the sites of modification are mainly on the 
histone tails.  
 
 
 
Figure 2. The nucleosome. 147 bp of 
DNA is wrapped around the histone 
octamer that consists of two histone H3, 
H4 and two heterodimers H2A and H2B. 
The linker histone H1 is stabilizing the 
nucleosome and is further compacting the 
chromatin. Shown are also histone tails 
protruding from H3 and H4. 
 
 
 
 
 
So called ‘writers’ set modification marks such as acetylation, phosphorylation, 
ubiquitination, sumoylation, ADP ribosylation, deimination, proline isomerization 
as well as different degrees of methylation (Kouzarides 2007). Additionally, 
unmethylated, monomethylated but not di-methylated arginines can be 
converted to citrulline by deimination (Cuthbert et al. 2004). 
The most abundant posttranslational modifications (PTMs) are set by different 
groups of writers including kinases, histone acetyltransferases (HATs) and 
histone methyltransferases (HMTs), which play important roles in development. 
Mutation or misregulation of writers is associated with genetic disorders as well 
as various cancers (T. Zhang, Cooper, and Brockdorff 2015). 
  Introduction 
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Histones carrying certain PTMs are recognized by ‘reader’ modules that bind 
their target (Kouzarides 2007; Taverna et al. 2007). Methylated, acetylated, 
phosphorylated histones are recognized by chromo-like domains of the Royal 
family, bromodomains and a domain within 14-3-3 proteins, respectively. By 
reading the histone PTMs, either the binding protein itself or in cooperation with 
associated complexes initiate functional pathways. Histone PTMs can be stable 
or dynamic as they can be removed by the catalytic activity of erasers like 
histone deacetylases (HDACs), deubiquitinases (DUBs) and demethylases 
(Kouzarides 2007). 
Histone PTMs influence gene expression by modulating chromatin structure. 
There are two suggested models for the mode-of-action of histone PTMs. First, 
by modifying the electrostatic charge of the histone, PTMs may induce a change 
in chromatin organization and state of condensation and thus regulate the 
accessibility for non-histone proteins to chromatin. One such modification is 
histone acetylation, which was the first PTM shown to correlate with gene 
expression (Allfrey, Faulkner, and Mirsky 1964). Acetylation neutralizes the 
positively charged lysine (K) residues of the histone N-terminus, weakening 
histone-DNA and internucleosome contacts and thereby reducing chromatin 
compaction. Together, this causes the nucleosomes to unfold and thereby 
enables the binding of the transcription machinery (Workman and Kingston 
1998; Zentner and Henikoff 2013). Second, histone modifications influence gene 
expression by recruitment of regulatory factors that bind histone PTMs directly 
(Strahl and Allis 2000). For example, the bromodomains of several proteins 
involved in transcriptional activation bind to acetylated lysines of histone H3 and 
H4 (Jacobson et al. 2000). Histone modifications can also lead to the 
recruitment of DNA methyltransferases and thereby lead to DNA methylation and 
transcriptional repression (Tachibana et al. 2008). Trimethylated histone H3 on 
K9 (H3K9me3), a predominant mark for heterochromatin (Lachner et al. 2001), 
can be bound by the chromodomain of heterochromatin protein 1 (HP1), which 
can lead to repression of transcription (Danzer and Wallrath 2004). 
Moreover, histone marks can regulate each other, giving rise to a dynamic 
epigenetic crosstalk. The presence of one modification can promote or inhibit 
the occurrence of one or more subsequent modifications on the same histone 
molecule, or between different histone molecules and across nucleosomes. 
Depending on the combination of histone PTMs, the functional output leading to 
activation or repression of the underlying gene can differ (Latham and Dent 
2007; Strahl and Allis 2000). In the next chapter distinct patterns of histone 
marks associated with active and repressed transcriptional states will be 
introduced (Figure 3).  
Introduction 
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Figure 3. Histone posttranslational 
modif ications of active and 
repressed genes. (A) PTMs found in 
promoters, transcriptional start sites and 
gene bodies of active genes are shown. 
(B) PTMs found in promoters of 
repressed genes are shown. Modified 
from (T. Zhang, Cooper, and Brockdorff 
2015).  
 
 
 
 
   
1.2.1 Histone modifications associated with transcriptional activity 
Actively transcribed genes are usually found in euchromatic regions and are 
characterized by an array or combination of PTMs on histone tails (Figure 3A, B). 
Active enhancers are marked by H3K4me1 and H3K27ac and promoters as well 
as transcriptional start sites (TSS) of active genes are marked by a high density 
of H3K4me3 as well as H3 and H4 acetylation (Deckert and Struhl 2001; Liang et 
al. 2004; Barrera et al. 2008; Creyghton et al. 2010). The distribution of 
H3K4me3 is highly coupled to regions of CpG- and GC-dense DNA, so called 
CpG islands (CGI) that are found in 50–70% of all promoters (Deaton and Bird 
2011). All CGI promoters are marked with H3K4me3, and high levels of 
H3K4me3 correlated with high gene expression (Barski et al. 2007; Guenther et 
al. 2007). The gene bodies of euchromatic genes are enriched in H3 and H4 
acetylation (Myers et al. 2001), H3K79me3 (Ng et al. 2003), and H2BK120ub1 
(Batta et al. 2011; Ng, Dole, and Struhl 2003), as well as increasing H3K36me3 
levels towards the 3’ end (Pokholok et al. 2005; Neri et al. 2017). Chromatin 
marks associated with active genes can positively reinforce each other through 
various positive feedback mechanisms. In mammals, one example is the co-
accumulation of H3K4me3 and H2BK120ub1 on gene bodies, as the knockdown 
of the H2BK120ub1-specific E3-ligases RNF20/40 lead to global reduction of 
H3K4me3 (J. Kim, Hake, and Roeder 2005).    
  Introduction 
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1.2.2 Histone modifications associated with transcriptional repression   
Repressed genes are usually found in heterochromatic regions and are 
characterized by a combination of PTMs on histone tails, for example 
methylation of residues K27 and K9 of H3 and the ubiquitination of H2A on K119 
(Figure 3). H3K27me3 and H2AK119ub1 are associated with the formation of 
facultative heterochromatin, which is competent to interconvert between active 
and inactive states depending on the spatiotemporal context. H3K9me2/3 has 
important roles in the formation of constitutive heterochromatin, which is largely 
transcriptionally inert except for early developmental and pathological situations 
(Smith and Meissner 2013; T. Zhang, Cooper, and Brockdorff 2015). The 
methylation of H3K27 is set by Polycomb Repressive Complex 2 (PRC2), which 
consists of five subunits, EZH2 (enhancer of zeste homolog 2), EED (Embryonic 
Ectoderm Development), SUZ12 (suppressor of zeste 12 protein homolog), and 
the histone binding proteins RBBP4 and RBBP7 (Kuzmichev et al. 2002). 
Different states of methylation of H3K27, mono-, di-, and trimethylated, can all be 
set be PRC2 and have different biological functions. H3K27me1/2 is enriched on 
gene bodies and is associated with gene activation whereas H3K27me3 is 
associated with gene repression (Morey and Helin 2010; Ferrari et al. 2014). The 
monoubiquitination of H2AK119ub1 is set by RING1B, a subunit of Polycomb 
Repressive Complex 1 (PRC1) (Bhaumik, Smith, and Shilatifard 2007). 
Interestingly, both PRC1 and PRC2 together with their associated chromatin 
modification co-localize at many genomic regions, like promoters of 
developmentally regulated genes (Ku et al. 2008). The exact mode-of-action of 
PRC1 and PRC2 and their hierarchical recruitment model is still under 
investigation (Tavares et al. 2012; Schoeftner et al. 2006; L. Wang et al. 2004; 
Ren, Vincenz, and Kerppola 2008; Blackledge et al. 2014; Cooper et al. 2014; 
Kalb et al. 2014).  
Interestingly, CGI promoters linked to developmental and lineage-specific genes 
in embryonic stem cells (ESCs), harbor the repressive H3K27me3 as well as the 
active H3K4me3 mark. This PTMs combination is called bivalency and it is 
suggested that it renders genes poised for immediate activation upon 
differentiation (Bernstein et al. 2006; Azuara et al. 2006). 
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1.3 DNA methylation  
 
DNA methylation is among the best-studied epigenetic marks and was the first 
epigenetic mark found to correlate with gene expression. Methylated 
mammalian promoters are thought to lead to transcriptional repression either by 
inhibiting transcription factors to bind or by further compacting the chromatin. 
DNA methylation is highly conserved among different species such as most 
plants, animals as well as fungi and is essential for mammalian development 
(Smith and Meissner 2013). In mammals, DNA methylation occurs predominantly 
at the C5 position of cytosine in a symmetrical CpG dinucleotide context 
resulting in 5-methylcytosine (5mC), however, low non-CpG methylation levels in 
a CpA and CpT context were described in ESCs and are also prevalent in 
oocytes and neurons (Patil, Ward, and Hesson 2014). In Drosophila 
melanogaster, DNA methylation was mainly found in a CpT and in plants 
additionally in a CpA and CpC context (Bird 2002; Law and Jacobsen 2010).   
In the human genome, 60-80% of the roughly 28 million CpGs are generally 
methylated. Less than 10% of CpGs occur in CGIs, are usually hypomethylated 
and associated with TSSs of housekeeping and development associated genes 
(Smith and Meissner 2013). A small subset of the CGIs gains methylation during 
development leading to a stable transcriptional repression.  
However, DNA methylation is also found in transcriptionally active gene bodies 
and at exon–intron boundaries, where it was suggested to regulate co-
transcriptional splicing and to inhibit spurious transcription initiation (Wolf et al. 
1984; Laurent et al. 2010; Maunakea et al. 2013; Neri et al. 2017). 
1.3.1 Setting DNA methylation        
The enzymes responsible for the addition of the methyl group to cytosines 
belong to the protein family of DNA methyltransferases (DNMTs). In vertebrates, 
different DNMT members have been described, which harbor a catalytically 
active C-terminal domain. All of them contain a highly conserved catalytic 
domain, which includes 10 sequence motives that are also found in prokaryotic 
cytosine-C5 DNA methyltransferases (Figure 4A) (Goll and Bestor 2005; Qin, 
Leonhardt, and Pichler 2011). 
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Reaction mechanism 
All catalytically active DNMTs share a common reaction mechanism, 
requiring S-adenosyl-L-methionine (SAM) as a methyl-donor. In the first step of 
the methylation reaction, DNMTs bind to the DNA and flip out the target base. 
Subsequently, they form a covalent complex by a conserved cysteine 
nucleophile with the C6 position of cytosine. This results in the activation of the 
C5 atom and the methyl group is transferred from the cofactor SAM, which 
serves as the common cellular methyl group donor. In the last reaction step, the 
covalent bond is resolved by β-elimination and the enzyme released from the 
DNA  (Figure 4B) (X. Cheng and Blumenthal 2008).  
     
 
Figure 4. Domain structure of DNMTs and the methylation reaction of the 
mammalian DNMT family. (A) Schematic outline of the domain architecture of mammalian 
DNMTs in comparison to the prokaryotic DNMT, M.HhaI. All DNMTs except DNMT3L harbor a 
catalytically active C-terminal domain. DMAP1: a DNA methyltransferase associated protein 1 
(DMAP1)-binding domain; PBD: PCNA binding domain; TS: Targeting sequence; CXXC: zinc 
finger domain; BAH: Bromo-adjacent homology domain; PWWP: Pro-Trp-Trp-Pro motif containing 
Introduction 
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domain; PHD: plant homeodomain. Modified from (Rottach, Leonhardt, and Spada 2009; Qin, 
Leonhardt, and Pichler 2011). (B) Methylation reaction of the DNMT family. After the formation of 
a covalent complex of the DNMTs with the C6 position of the cytosine (C), the methyl group is 
transferred from the cofactor SAM to the C5 position of the cytosine, leaving the demethylated 
cofactor S-adenosyl-L-homocystein (SAH). DNMTs are released by β-elimination. Modified from 
(Goll and Bestor 2005).  
 
 
The DNMT3 family and DNMT2  
Upon differentiation, many pluripotency associated genes such as Oct4 (also 
known as Pou5f1) have to be silenced by epigenetic marks to ensure correct 
differentiation (Feldman et al. 2006). DNA methylation represents the final step in 
gene repression after histone PTMs on already transiently silenced loci thereby 
finalizing the epigenetic status of silent chromatin (Bird 2002).  
DNMT3A and DNMT3B show catalytic activity on unmethylated DNA and 
are responsible for establishing de novo methylation during embryogenesis and 
gametogenesis. In ESCs and germ cells, DNMT3A and DNMT3B are highly 
expressed, while in differentiated cells and tissues they are downregulated 
(Daisuke Watanabe et al. 2002). In DNMT3A/DNMT3B double-knockout ESCs, 
methylation of imprinted regions is not affected, while newly introduced retroviral 
elements remain hypomethylated (Okano et al. 1999; Kaneda et al. 2004). 
In vivo studies of either DNMT3A- or DNMT3B- knockout mice demonstrate that 
DNMT3B has an essential role during early developmental stages, while 
DNMT3A is important for methylation in later development. DNMT3A-/- mice die 
four weeks after birth and DNMT3B-/- mice display several developmental 
defects and are not viable, indicating that DNMT3B has an essential function 
during early development, whereas DNMT3A is important for methylation in later 
developmental stages (Okano et al. 1999).  
Mutations in the DNMT3A or DNMT3B genes are associated with human 
diseases. Patients with mutations in DNMT3B suffer from the rare 
immunodeficiency, centromere instability and facial abnormalities (ICF) 
syndrome and are characterized by DNA hypomethylation of CpG sites in 
pericentromeric satellite regions as well as on the inactive X chromosome 
(Hansen et al. 1999; Bourc’his et al. 1999). Mutations in the functional domains 
of human DNMT3A cause overgrowth syndromes, intellectual disabilities and 
facial dysmorphism. None of the overgrowth-associated mutations seem to 
affect DNA binding ability of DNMT3A. Instead, their positions within the 
DNMT3A domains suggest that recognition of unmethylated H3K4, 
intramolecular interactions within DNMT3A and histone binding is disturbed and 
thereby de novo methylation is impaired (Tatton-Brown et al. 2014). 
  Introduction 
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Both DNMT3A and DNMT3B have a long regulatory N-terminal domain (NTD) 
fused to a catalytic C-terminal domain (CTD). The NTD contains a Pro-Trp-Trp-
Pro (PWWP) domain that enhances methyltransferase activity by binding 
H3K36me3 and thus is targeted to heterochromatin (Fuks et al. 2001; Ge et al. 
2004; Dhayalan et al. 2010). Interaction with multiple chromatin-associated 
proteins, such as heterochromatin protein (HP1), histone deacetylase 1 
(HDAC1) and histone methyltransferase SUV39H1 is mediated by the cysteine-
rich plant homeodomain (PHD) (Fuks et al. 2001, 2003). 
One member of the DNMT family, DNMT3L, lacks methylation activity but 
cooperates with DNMT3A and DNMT3B and stimulates their methylation activity 
(Chedin, Lieber, and Hsieh 2002; Gowher et al. 2005). DNMT3L regulates 
methylation at gene bodies of housekeeping genes positively and at bivalent 
promoters negatively (Neri et al. 2013) and acts downstream of the piRNA 
pathway (Aravin et al. 2008; Bourc’his and Bestor 2004). The inactivation of 
DNMT3L results in hypomethylation and reactivation of retrotransposons, meiotic 
failure and male sterility (Zamudio and Bourc’his 2010). 
Recently, an additional de novo DNMT enzyme was discovered: DNMT3C, 
which evolved via a duplication event of DNMT3B in rodent genomes and is 
responsible for methylating promoters of evolutionarily young retrotransposons 
to ensure male fertility of mice (Barau et al. 2016). Remarkably, DNMT3C shares 
70% identity with DNMT3B, while DNMT3A and DNMT3B are 46% identical.  
TRDMT1 (also known as DNMT2) comprises only a catalytic domain, is involved 
in methylation of cytoplasmic tRNAAsp and shows very weak DNA 
methyltransferase activity (Hermann, Schmitt, and Jeltsch 2003; Goll et al. 2006). 
However, TRDMT1 may be responsible for rare cytosine methylation at 
sequence contexts other than CpG (Kunert et al. 2003; Borsatti and Mandrioli 
2004).  
 
DNMT1 
The maintenance of tissue-specific DNA methylation patterns to future cell 
generations is mediated by DNMT1 after each cycle of replication (Bird 2002; 
Smith and Meissner 2013). DNMT1 is essential for development as a catalytic 
DNMT1 mutation in mouse embryos results in hypomethylation, delayed 
development and lethality during gestation (E. Li, Bestor, and Jaenisch 1992). 
Reduction of DNMT1 expression in mice to 10% of wildtype (wt) level is 
compatible with viability but results in genome-wide hypomethylation and 
chromosomal instability leading to severe T-cell lymphomas (Gaudet et al. 
2003). In contrast to the CTD of DNMT3A and DNMT3B, the CTD of DNMT1 
Introduction 
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alone is not sufficient for methylation activity but requires a large part of the NTD 
(Margot et al. 2000; Anton and Bultmann 2017). 
The very N-terminus of DNMT1 has a DNA methyltransferase associated 
protein 1 (DMAP1)-binding domain that binds HDAC2 and mediates the 
interaction of the transcriptional repressor DMAP1 with DNMT1 (Rountree, 
Bachman, and Baylin 2000). In late S phase, DNMT1 co-localizes and interacts 
with HDAC2 as well as HDAC1 coupling histone deacetylation activity with DNA 
methylation at replicating heterochromatin (Fuks et al. 2000; Rountree, 
Bachman, and Baylin 2000). 
DNMT1 localization to sites of DNA replication is mediated by the PCNA 
binding domain (PBD) in early to mid S phase, while the targeting sequence (TS) 
domain mediates heterochromatin binding during late S and G2 (Leonhardt et 
al. 1992; Chuang et al. 1997; Easwaran et al. 2004). In addition, DNMT1 harbors 
a CXXC type zinc finger domain (CXXC) that binds unmethylated CpG sites 
(Fatemi et al. 2001; Pradhan et al. 2008; Frauer et al. 2011). Interestingly, 
structural insights find an inhibitory role of the CXXC-bromo adjacent homology 
domain 1 (BAH1) linker, which inhibits binding and de novo methylation of 
unmethylated CpG sites during maintenance methylation. This inhibitory 
mechanism is mediated by the complex of unmodified DNA with the CXXC-
BAH1 linker, which blocks the access of CTD to the target CpG site (J. Song et 
al. 2011).  
The two BAH domains are involved in several protein-protein interactions such 
as with HP1β and ubiquitin-specific processing protease 7 (USP7) (Fuks et al. 
2003; Du et al. 2010; Qin, Leonhardt, and Spada 2011). 
The NTD and the CTD are fused by a linker that contains several lysyl-glycyl 
dipeptide repeats ((KG)7) providing a flexible region between the two domains of 
DNMT1. The CTD of DNMT1 contains all ten conserved motifs for the methyl 
group transfer but the intramolecular interactions with the NTD are essential for 
allosteric activation and methylation activity (Margot et al. 2000; Fatemi et al. 
2001; Takeshita et al. 2011).  
DNMT1 is not only subjected to protein interactions but also to multiple 
PTMs, which contribute to proper regulation of DNA methylation and DNMT1 
stability (Qin, Leonhardt, and Pichler 2011). Throughout the cell cycle, the 
stability, abundance and catalytic activity in vivo of DNMT1 is controlled by 
ubiquitination and acetylation as well as by phosphorylation with subsequent 
methylation (B. Lee and Muller 2009; Du et al. 2010; Estève et al. 2011; Felle et 
al. 2011; Qin, Leonhardt, and Pichler 2011). Long non-coding RNAs have also 
been shown to regulate DNMT1 activity (Di Ruscio et al. 2013). 
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Taken together, DNMT1 is regulated in a highly complex manner by PTMs and 
intramolecular protein interactions. Besides intramolecular protein-protein 
binding, also intermolecular protein interactions serve as a prerequisite for 
DNMT1 activation, which have to be overcome by conformational changes 
before the methylation reaction can occur.  
The interaction of DNMT1 with Ubiquitin-like, containing PHD and RING finger 
domains 1 (UHRF1, also known as 95 kDa mouse nuclear protein (Np95)) 
releases the TS domain and enables catalytic activity of the CTD (Bashtrykov, 
Jankevicius, et al. 2014). Therefore, UHRF1 has emerged as an essential 
cofactor for maintenance DNA methylation.  
 
  
UHRF protein family 
UHRF1 binds, flips out hemimethylated DNA and recruits DNMT1 to its substrate 
sites (Arita et al. 2008; Avvakumov et al. 2008; Bostick et al. 2007; Hashimoto et 
al. 2008). Consistently, UHRF1 deficient embryos phenocopy the DNA 
hypomethylation and early embryonic lethality of DNMT1­ knockout embryos, 
indicating that the multi-domain protein UHRF1 (Figure 5) is a key factor in 
maintenance methylation (Sharif et al. 2007). The SRA domain of UHRF1 
mediates the direct interaction with DNMT1 and is essential for allosteric 
activation of DNMT1, which enables binding of substrate DNA to the CTD 
(Syeda et al. 2011; Takeshita et al. 2011; Bashtrykov, Rajavelu, et al. 2014; 
Berkyurek et al. 2014). In addition to hemimethylated DNA, UHRF1 binds to 
methylated H3K9 via its tandem Tudor domain (TTD) (Citterio et al. 2004; 
Karagianni et al. 2008; Rottach et al. 2010). Via its plant homeodomain (PHD), 
which was previously implicated in transcriptional regulation and 
heterochromatin organization, UHRF1 was shown to bind the unmodified N-
terminus of histone H3 and via its SRA domain target DNMT1 to hemimethylated 
sites (Papait et al. 2007; Rajakumara et al. 2011).  
Crystal structures of the linked TTD–PHD bound to H3K9me3 peptides revealed 
that UHRF1 can simultaneously bind the unmodified H3 N-terminus and 
H3K9me3 on a single histone H3 tail through this cooperative recognition 
module (J. Cheng et al. 2013). However, the accessibility of the different histone 
H3-binding domains is allosterically regulated by binding of phosphatidylinositol 
5-phosphate (PI5P) to a polybasic site in a linker region of UHRF1 between the 
SRA and RING domain. PI5P controls access to the TTD and PHD domain and 
so the interaction with unmodified H3 or H3K9me3, respectively, which might 
influence UHRF1 heterochromatin localization and function (Gelato et al. 2014). 
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In addition, UHRF1 harbors a RING domain that regulates DNMT stability 
together with USP7 and ubiquitinates histone tails (Citterio et al. 2004). However, 
the exact specificity of the RING domain is still under investigation. 
Taken together, the cooperative binding of hemimethylated DNA and repressive 
histone marks by UHRF1 targets DNMT1 to newly synthesized DNA in 
heterochromatin after replication (X. Liu et al. 2013). Furthermore, UHRF1 was 
shown to interact with DNMT3A, DNMT3B and several histone-modifying 
enzymes like HDAC1 or the histone methyltransferase G9A (Achour et al. 2008; 
J. K. Kim et al. 2009; Meilinger et al. 2009).  
Besides epigenetic regulation, UHRF1 is also involved in a variety of processes 
ranging from DNA damage response to DNA replication (Fujimori et al. 1998; 
Muto 2002; Uemura et al. 2000).  
     
 
 
 
Figure 5. The UHRF family structure. The UHRF family harbors ubiquitin-like (Ubl) domain, 
a tandem Tudor domain (TTD), a plant homeodomain (PHD), a SET and RING-associated (SRA) 
domain and a really interesting new gene (RING) domain. Homology between UHRF1 and its 
paralogue UHRF2 are indicated. Numbers indicate the length of the murine proteins in amino 
acids.    
  
The paralogue UHRF2 shares a high domain structure similarity with UHRF1 
(Figure 5) (Bronner et al. 2007). Interestingly, both genes are expressed in 
opposite patterns. UHRF1 is highly expressed in undifferentiated cells, whereas 
UHRF2 is upregulated during differentiation and highly expressed in somatic 
cells especially neuronal cells. Although both UHRF1 and UHRF2 interact with 
DNMT1, UHRF2 cannot target DNMT1 to pericentric heterochromatin (PCH) in S 
phase and ectopic expression of UHRF2 in UHRF1-/- ESCs did not restore DNA 
methylation levels arguing for non-redundant functions (Pichler et al. 2011; J. 
Zhang et al. 2011; R. Chen et al. 2017). Recently however, both UHRF1 and 
UHRF2 were shown to be negative regulators of DNA de novo methylation by 
DNMT3A by functioning as E3 ligases promoting DNMT3A ubiquitination and 
thereby subsequent degradation (Jia et al. 2016). Very recently, it was shown 
that UHRF2 knockout mice are viable as well as fertile and exhibit no DNA 
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methylation defect. Except a partial reduction in spatial memory acquisition and 
retention, no gross developmental defect was observed (R. Chen et al. 2017).  
In combination with binding to H3K9me3 mediated by the TTD, UHRF2 displays 
a preference for hemimethylated DNA. The localization and in vivo binding 
characteristics of UHRF2 were described to require an intact TTD and depend 
on H3K9me3 recognition but not on DNA methylation (Pichler et al. 2011). 
Interestingly, UHRF2 has 3-fold higher binding affinity to 5-
hydroxymethylcytosine (5hmC) than 5mC and is a specific binder of 5hmC in 
neuronal progenitor cells (NPCs) (Spruijt et al. 2013; Zhou et al. 2014). Further, 
UHRF2 is recruited to 5hmC by the zinc finger protein 618 (ZNF618) indicating 
that ZNF618 might be important for the function of UHRF2 as a specific 5hmC 
reader in vivo (Y. Liu et al. 2016). UHRF2 interacts with DNMT3A and DNMT3B, 
HDAC1, G9a and H3K9me3 (Pichler et al. 2011; J. Zhang et al. 2011).  
Besides epigenetic regulation, UHRF2 represents a nodal point in the cell cycle 
network as it interacts with cell cycle proteins including cyclins, cyclin-
dependent kinases, retinoblastoma 1 protein (RB1), tumor protein p53, and 
PCNA (Mori et al. 2011, 2012). Taken together, UHRF2 might be a link between 
the epigenetic network and cell cycle regulation.  
 
1.3.2 DNA modification dynamics during development  
DNA methylation was thought to be a stable epigenetic mark due to its chemical 
nature, but dynamic changes of DNA methylation can be observed during early 
development (Figure 6). The maternal genome gradually loses DNA methylation 
during subsequent cell divisions as the oocyte-specific isoform of DNMT1 
(DNMT1o) is actively excluded from the nucleus (passive dilution) (Cardoso and 
Leonhardt 1999). However, imprinted genes are excluded from passive dilution 
and are only demethylated in primordial germ cells (PGCs) (Monk, Boubelik, and 
Lehnert 1987; Howlett and Reik 1991). In contrast, active DNA demethylation 
occurs in sperm-derived paternal pronuclei genome-wide before the two 
pronuclei merge (Mayer et al. 2000). Imprinting control regions such as the H19 
promoter, IAP retrotransposons and centromeric as well as pericentromeric 
regions avoid active DNA demethylation in the paternal genome (Olek and 
Walter 1997; Rougier et al. 1998; Lane et al. 2003).  
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Figure 6. DNA modif ication dynamics during development. Shortly after fertilization, 
the paternal genome undergoes rapid genome-wide active demethylation, whereas the maternal 
genome stays at its methylated state. During the following first cell divisions, DNA methylation in 
the maternal genome is diluted by passive demethylation in the absence of DNMT1. Modified 
from (H. Wu and Zhang 2014). 
 
Although, active DNA demethylation was already described 1982, the 
contributing enzymes have not been identified until recently (Gjerset and Martin 
1982; Tahiliani et al. 2009). The responsible enzymes were first described in a 
different biological context: as a fusion partner of the MLL gene in acute myeloid 
leukemia (AML) in a t(10;11)q(22;23) translocation event (TET: ten-eleven-
translocation) (Lorsbach et al. 2003). The family of TET proteins (TET1, TET2 and 
TET3) converts 5mC to 5hmC, 5-formylcytosine (5fC) and 5-carboxylcytosine 
(5caC). The higher oxidized cytosine variants, 5fC and 5caC, can be excised by 
the Thymine-DNA glycosylase (TDG) (He et al. 2011; Maiti and Drohat 2011). 
This process is thought to be an intermediate step of active DNA demethylation 
(Tahiliani et al. 2009; Kriaucionis and Heintz 2009). Loss of genome-wide 
paternal DNA methylation concurs with a rapid increase in 5hmC, 5fC and 5caC, 
suggesting that TET-mediated 5mC oxidation contributes to active 
demethylation (Inoue and Zhang 2011; Iqbal et al. 2011).  
The epigenetic mechanisms in early development are of great interest to the 
scientific field and are still under investigation and great debate. The 
accumulation of 5hmC on the paternal DNA has been mainly attributed to the 
activity of TET3, the only TET member present at this stage (Gu et al. 2011; Iqbal 
et al. 2011; Wossidlo et al. 2011).  
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Figure 7. Init ial loss of paternal 5mC is independent of TET3. In this model, the initial 
loss of DNA methylation might be due to base-excision repair (BER) and TET3 protects newly 
hypomethylated sequences from accumulating new DNA methylation. Modified from (Amouroux 
et al. 2016). 
 
Recently however, it was shown that ablation of maternal TET3 did not affect 
early loss of paternal 5mC observed in zygotes. A new model was proposed, in 
which the initial loss of paternal 5mC does not require 5hmC formation as 
genetic ablation of TET3, impedes 5hmC accumulation in zygotes without 
affecting the early loss of paternal 5mC (Figure 7). Instead, the initial loss of 5mC 
might be due the activity of base-excision repair (BER) pathway (Hajkova et al. 
2010; Santos et al. 2013). Further, 5hmC accumulation is dependent on the 
activity of zygotic DNMT3A and DNMT1, documenting a role for TET3-driven 
hydroxylation in protecting the newly acquired hypomethylated state from de 
novo DNA methylation (Amouroux et al. 2016). 
After the fusion of paternal and the maternal pronuclei, genome-wide 5hmC, 5fC 
and 5caC in sperm-derived and 5mC in oocyte-derived chromosomes are lost 
by passive dilution (Inoue and Zhang 2011). However, sequences such as 
maternally derived methylated CpG-rich regions, including maternal imprinting 
control regions (ICRs) stay partially or even fully methylated mediated by DNMT1 
and DNMT3A (Smallwood et al. 2011; Smith et al. 2012; Xiajun Li et al. 2008). 
The regulation of TET expression is dependent on developmental stage and cell 
type indicating distinct functions of the different members (Szwagierczak et al. 
2010; H. Wu and Zhang 2014). The ICM of the blastocyst harbors pluripotent 
ESCs that express TET1 and TET2 at relatively high levels. Although both 
proteins are dispensable for ESC maintenance, they are important for 
differentiation into defined lineages (Koh et al. 2011).  
TET1 or TET2 mutant mice are viable, while TET1/TET2 double-knockout 
mice die perinatally with severe developmental defects, suggesting a role of 
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TET1 and TET2 in regulating embryonic development. TET3 might be partially 
compensating functions of TET1 and TET2, as some of the double-mutant 
embryos survived to normal and fertile adult mice (Dawlaty et al. 2011, 2013). 
Consistent with the important function of TET3 in early embryonic development, 
TET3 knockout mice die perinatally (Gu et al. 2011). In brain and other somatic 
tissues, TET enzymes are expressed, indicating that DNA methylation might be 
more dynamic as previously thought (H. Wu and Zhang 2014). Interestingly, 
there is growing evidence for 5hmC to be a stable epigenetic mark rather than 
only an intermediate in the process of active demethylation. Recently, specific 
5hmC readers in different tissues were identified that might be involved in 
different regulatory processes (Spruijt et al. 2013). Furthermore, TET1 is involved 
in keeping promoters and enhancers of highly expressed genes as well as CpG 
islands hypomethylated to enable rapid gene activation upon differentiation 
(Ficz et al. 2011; Neri et al. 2015).  
In summary, the epigenetic reprogramming in the early embryo is a 
complex process regulated by a dynamic interplay between active DNA 
demethylation, de novo DNA methylation and TET mediated 5mC hydroxylation. 
Although, many processes are understood, further studies will be necessary to 
investigate locus-specific modification changes and key factors involved in this 
process. 
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1.4 DNA modifications in neurogenesis and neurodegeneration  
During embryonic and adult neurogenesis, neuronal stem cells follow a precise 
path of differentiation and give rise to functional neurons at various 
developmental stages. This process is highly regulated by epigenetic factors 
that encompass histone modifications, non-coding regulatory RNAs and DNA 
modifications. In the next chapter the function of dynamic DNA modifications in 
embryonic and adult neurogenesis as well as neurodegeneration will be 
introduced. 
 
1.4.1 DNA modification dynamics during embryonic and adult neurogenesis 
During early embryonic development and throughout life, neurogenesis gives 
rise to functional neurons from neuronal stem cells (NSCs) and progenitor cells 
(NPCs), which are located in the subgranular zone (SGZ) of the dentate gyrus in 
the hippocampus and the subventricular zone (SVZ) of the lateral ventricle in the 
adult brain (Ma et al. 2010). Epigenetic mechanisms interplay in a spatially and 
temporally regulated manner to regulate this highly complex process (Figure 8) 
(Santos-Reboucas and Pimentel 2007). 
 
 
 
 
Figure 8. Embryonic and adult 
neurogenesis. Expression of epigenetic 
factors and levels of DNA modifications 
during embryonic and adult neurogenesis. 
Data from (Ehrlich et al. 1982; Goto et al. 
1994; D. Watanabe, Uchiyama, and 
Hanaoka 2006; Ito et al. 2010; 
Szwagierczak et al. 2010; Szulwach et al. 
2011; Wen et al. 2014; Zhiqin Wang et al. 
2016).  
 
 
 
 
 
 
 
 
DNMT1 is highly expressed in the embryonic and adult brain especially in 
postmitotic neurons (Goto et al. 1994). Consistently, DNA methylation by DNMT1 
is essential for brain development and neuronal maturation (Fan et al. 2001). 
Interestingly, neurons have high levels of DNA methylation (Ehrlich et al. 1982) 
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and the majority of the DNMT1 is localized in the cytoplasm and enzymatically 
active (Inano et al. 2000) hinting at other functions of DNMT1 besides DNA 
methylation. Depletion of DNMT1 in neurons is not fatal, but it was suggested 
that restoration of DNA methylation after BER of G-T mismatches is mediated by 
DNMT1 (Brooks, Marietta, and Goldman 1996). 
The de novo methyltransferases show an opposite expression profile with a 
transition from DNMT3B to DNMT3A expression during neuronal development. 
DNMT3B regulates early embryogenesis and is highly expressed in NPCs, while 
DNMT3A is highly expressed postnatally decreasing towards adulthood and was 
further shown to establish tissue-specific methylation patterns in neurons 
(Daisuke Watanabe et al. 2002, 2004; Feng et al. 2005; D. Watanabe, Uchiyama, 
and Hanaoka 2006). 
DNMT3A influences the neuronal and glial cell differentiation of embryonic NSC 
in vitro as ESCs depleted of DNMT3A differentiate into astrocytes and 
oligodendrocytes and show other defects such as hypomethylation and a higher 
proliferation rate (Z. Wu et al. 2012). Furthermore, DNA methylation patterns set 
by DNMT3A on intergenic regions and gene bodies antagonize PcG mediated 
repression of neurogenic genes and thereby maintaining an active chromatin 
state of genes that are important for development (H. Wu et al. 2010).  
The paralogue DNMT3B has a role in regulating the timing of embryonic neural 
differentiation and maturation as RNAi mediated DNMT3B knockdown 
experiments in human ESCs showed premature maturation, neural and neural 
crest marker expression (Martins-Taylor et al. 2012). 
Interestingly, in brain tissues like cortex and hippocampus, 5hmC abundance is 
among the highest in comparison to other tissues (Szwagierczak et al. 2010) 
pointing towards a possible functional importance of this DNA modification in 
neuronal development and activity. The 5hmC levels increase during neuronal 
differentiation and all TET enzymes are expressed in the brain with TET2 and 
TET3 showing the highest levels (Figure 8) (Ito et al. 2010; Szwagierczak et al. 
2010; C.-X. Song et al. 2011; Szulwach et al. 2011; Wen et al. 2014). 
Interestingly, 5hmC is not enriched at enhancers but associates preferentially 
with gene bodies of activated neuronal function-related genes. Within these 
genes, 5hmC is accompanied by loss of H3K27me3. Loss of function of TET2/3 
and gain of function of EZH2 leads to defects in neuronal differentiation, 
suggesting that formation of 5hmC and loss of H3K27me3 cooperate to promote 
brain development (Hahn et al. 2013). 
TET3 has been associated with fear extinction learning by triggering a 
redistribution and accumulation of 5hmC, which is required for rapid behavioral 
adaptation (Xiang Li et al. 2014). Although, TET1 knockout mice are viable (see 
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1.3.2), spatial learning and memory is affected in these animals. Further, several 
genes of NSCs are hypermethylated and thus silenced indicating an important 
role of TET1 in differentiating NPCs to neurons (R.-R. Zhang et al. 2013).  
In summary, the DNMT and TET family carry out diverse functions in regulating 
specific aspects of neurogenesis. The deregulation of epigenetic modifications 
as DNA methylation is associated with neurodegenerative diseases and will be 
introduced in the next part. 
 
 
1.4.2 DNA methylation and neurodegenerative diseases 
Human diseases have been associated with alterations in epigenetic 
mechanisms including cancer, syndromes associated with chromosomal 
instability, imprinting and neurodegenerative disorders as well as mental 
retardation. In contrast to the genetic information, epigenetic marks are 
reversible, which makes them a possible target for disease treatment (Santos-
Reboucas and Pimentel 2007; Pogribny and Beland 2009). 
Given the critical functions of DNMTs mentioned in the previous section, it is not 
surprising that misregulation of DNA methylation was described to be involved in 
the pathophysiology of neurodegenerative disorders (Zhao, Deng, and Gage 
2008; Braun and Jessberger 2014). In several studies, neurological disorders 
were described to be caused by mutations within DNMTs (Table 1). 
 
Table 1. DNMT family members and related neurological diseases or defects  
Gene  Molecular defect Related disease/ phenotype References 
DNMT1 N-terminal TS 
domain mutations; 
heterozygous 
 
C-terminal TS 
domain mutations; 
heterozygous 
 
Hereditary sensory and 
autonomic neuropathy type 1 
(HSAN1E);  
 
Autosomal dominant 
cerebellar ataxia, deafness, 
and narcolepsy (ADCA-DN) 
(Klein et al. 
2011; 
Winkelmann et 
al. 2012) 
DNMT3A DNMT3A functional 
mutations/ deletions 
Acquisition of developmental 
mental defects; impaired 
postnatal neurogenesis 
(Nguyen et al. 
2007; H. Wu et 
al. 2010; Yao 
and Jin 2014) 
DNMT3B DNMT3B functional 
mutations; usually 
heterozygous in 
catalytic domain 
The immunodeficiency, 
centromere instability, facial 
anomalies (ICF) syndrome 
(Hansen et al. 
1999; G. L. Xu 
et al. 1999; 
Robertson 
2005) 
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To date, DNMT3A has not been associated with neuronal diseases, although 
mice depleted of functional DNMT3A in the central nervous system (CNS) die 
prematurely due to developmental defects such as hypoactivity and defective 
motor coordination (Nguyen et al. 2007). Further, DNMT3A deletion leads to a 
postnatal neurogenesis defect in both the SVZ and SGZ as significantly fewer 
terminally differentiated neurons arise from DNMT3A-/- NSCs indicating that 
DNMT3A regulates postnatal neurogenesis (H. Wu et al. 2010). 
Polymorphic mutations in the de novo methyltransferase DNMT3B are 
associated with a syndrome called immunodeficiency, centromere instability, 
and facial anomalies (ICF) (Hansen et al. 1999; G. L. Xu et al. 1999). These 
patients suffer from immunodeficiency, which results from a significant reduction 
of at least two immunoglobulin isotypes. Further, ICF patients show 
hypomethylation and decondensation of pericentromeric heterochromatin on 
chromosomes 1, 16 and 9 in mitogen stimulated B cells or lymphoblastoid cell 
lines (Robertson 2005).  
Heterozygous DNMT1 mutations causing DNA hypomethylation in patients 
suffering from hereditary sensory and autonomic neuropathy type 1E (HSAN1E) 
or autosomal dominant cerebellar ataxia deafness and narcolepsy (ADCA-DN) 
have been reported by several medical studies. Clinical manifestations of 
HSAN1E and ADCA-DN include a broad phenotypic spectrum with sensory 
impairment, hearing loss and dementia as hallmarks of the disease (Baets et al. 
2015). In particular, HSAN1E is characterized by late onset neurologic disorders 
of the CNS and the peripheral nervous system (PNS) that manifest in progressive 
degeneration predominantly of sensory and autonomic neurons (Klein et al. 
2013). Notably, all mutations described to date affect the TS domain in the 
regulatory part of DNMT1 (Klein et al. 2011; Winkelmann et al. 2012; Pedroso et 
al. 2013; Yuan et al. 2013; Moghadam et al. 2014; Z. Sun et al. 2014; Baets et al. 
2015), raising the question how simple amino acid exchanges outside the 
catalytic domain of DNMT1 may lead to global hypomethylation and late onset 
neurodegenerative diseases. The pathophysiological trajectories underlying 
these neurological disorder caused by DNMT1 mutations remain mostly 
unknown. 
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1.5 New advances in genome engineering techniques 
 
To gain insights into the function of a gene a widely used approach remains 
targeted disruption and the subsequent assay for cellular defects in living cells. 
Genome editing enables functional studies of genetic variation in biology and 
disease, and holds a great potential for clinical applications. Zinc-Finger 
Nucleases (ZFNs) and Transcription Activator-Like Effector Nucleases (TALENs) 
have been developed to facilitate the modification of endogenous genomic 
sequences (Miller et al. 2007; Hockemeyer et al. 2011). However, the 
applicability of these technologies is limited and laborious, as for each target 
site a new complex nuclease needs to be designed.  
Recently, a powerful tool to edit genomes of diverse organisms 
revolutionized the genome engineering field by providing an easy and fast 
method. This approach utilizes the CRISPR (clustered regularly interspaced 
short palindromic repeats)/Cas system, which was initially discovery as an 
adaptive immune system in bacteria. In general, the CRISPR-associated protein 
9 (Cas9) is an RNA-guided DNA endonuclease that can be recruited to sites in 
the genome by editing the guide RNA (gRNA) sequence (Figure 9) (Haurwitz et 
al. 2010; Mali, Esvelt, and Church 2013). The gRNA mediates the specificity of 
Cas9 in the genome by binding 20 bp within the target sequence and thereby 
recruits endonuclease Cas9, which in turn introduces a DNA double strand 
break (DSB).  
 
Figure 9. The Cas9-gRNA 
RNA-guided nuclease 
complex for eukaryotic 
genome engineering. Target 
recognition and cleavage 
require a 20 bp sequence 
complementary to the genomic 
target sequence and presence 
of the appropriate NGG PAM 
(orange) sequence. Modified 
from (Mali, Esvelt, and Church 
2013). 
 
DSBs are either repaired by highly efficient yet error-prone non-homologous end 
joining (NHEJ) or by inefficient homology directed repair (HDR). While NHEJ is a 
useful tool for gene knockout generation, it is not desirable for precise 
modification of the genome. In contrast, HDR allows targeted manipulation of the 
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genome, but competes with highly active NHEJ (Capecchi 2005). Although this 
approach has improved the generation of gene disruptions in diverse 
organisms, off-target effects have to be considered (Kuscu et al. 2014).  
In addition to the CRISPR/Cas9 system, phage-derived serine integrases, in 
particular BXB1, were used as novel genome engineering tools as they are 
unidirectional and highly efficient site-specific recombinases (Z. Xu et al. 2013). 
In general, the serine integrases induce the recombination of a phage 
attachment sites (attP) and bacterial attachment sites (attB) (Brown et al. 2011), 
which can facilitate in-frame insertions of desired sequences such as 
prefabricated functional cassettes. 
In this study, we aim to combine the advantages of both CRISPR/Cas and 
unidirectional integrases into one fast, widely applicable and flexible method.  
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1.6 New advances in transcriptome analysis  
 
As described before (1.5), targeted gene disruption by CRISPR/Cas-based 
approaches and the subsequent assay for cellular defects in living cells is used 
to investigate gene function. The function of the desired gene disruption on 
transcriptional regulation, can be investigated by RNA sequencing (RNA-seq), a 
genome-wide quantification of mRNA transcripts.  
The appreciation for cell-to-cell variability and the ability to profile the 
transcriptome of individual cells, has transformed the characterization of cell 
types, differentiation states and rare cellular phenotypes, revealing exciting 
biological and medical insights (Sandberg 2014; Kolodziejczyk et al. 2015; 
Ebinger et al. 2016). 
A wide variety of single cell RNA-sequencing (scRNA-seq) methods, such as 
Smart-seq, automated microfluidic platform from Fluidigm (C1 platform) and 
CEL-seq, have been established (Hashimshony et al. 2012; Ramsköld et al. 
2012; Picelli et al. 2013). Therefore, it is important to compare different 
parameters, in order to choose the best method for a given question. Some 
strengths and weaknesses concerning monetary costs, sensitivity, accuracy and 
coverage of different methods are already known (Hashimshony et al. 2012; A. 
R. Wu et al. 2014). However, a thorough and systematic comparison of relevant 
parameters across scRNA-seq methods is still lacking.  
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1.7 Aims of this work  
The main questions addressed in this PhD thesis revolve around the functional 
and regulatory interplay between epigenetic key factors DNMT1 and UHRF1, its 
role during development and disease as well as technology advancements in 
genome editing and transcriptomics towards a better understanding of 
chromatin biology. 
DNMT1 TS domain mutations are linked to a neurodegenerative disease called 
HSAN1E, however, the underlying molecular dysfunctions remained elusive. 
Here, I aimed at characterizing two disease related mutations in mouse DNMT1 
(P496Y and Y500C) with respect to their impact on catalytic activity, UHRF1 
interaction, subnuclear localization, protein stability and neuronal progenitor 
differentiation. 
Although, it is well established that UHRF1 is essential for maintenance DNA 
methylation, defined functions of distinct regulatory domains remained unknown. 
Therefore, the next objective of this work was to investigate UHRF1-mediated 
modifications and their functional interplay with DNMT1, regulating DNA 
methylation. Besides chromatin binding domains, UHRF1 carries a RING domain 
that ubiquitinates histones. With proteomic analysis, we aimed at identifying 
novel, site-specific histone ubiquitination set by UHRF1. As the identified 
UHRF1-dependent H3 ubiquitination was essential for DNMT1 targeting and 
function, I participated in further analyzing the underlying regulatory 
mechanisms and regions in DNMT1 responsible for ubiquitinated histone 
binding.  
To further study the E3 ligase function of UHRF1 and UHRF2, I co-established a 
multifunctional integrase (MIN) tag for rapid and versatile genome engineering. 
The MIN tag serves as a genetic entry site for functional as well as knockout 
modules. Based on CRISPR/Cas mediated manipulation, this approach enables 
efficient generation of multiple isogenic cell lines to study gene function under 
physiological conditions or gene depletion.  
Further, I was interested in non-histone ubiquitination targets of UHRF1 and 
UHRF2. Using the MIN tag strategy, I established ESCs depleted of either 
UHRF1 or UHRF2 and assayed for differential ubiquitination in living cells with 
mass spectrometry. To exclude redundancy between the two paralogues 
UHRF1 and UHRF2, which are highly similar in both sequence and structure, I 
compared the ubiquitome of UHRF1 and UHRF2 knockout cells and screened 
for novel ubiquitination targets.  
New next-generation technologies to profile the transcriptome of individual cells 
now enable researchers to investigate exciting biological and medical 
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questions. In the cancer evolution field, cell-to-cell variability is of special interest 
as it is a major driver of cancer evolution, progression, and emergence of drug 
resistance. To investigate cell heterogeneity, a wide variety of scRNA-seq 
methods have been established. In this project, I participated in comparing 
different library preparation methods, in order to systematically compare 
parameters across scRNA-seq methods. 
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2 Results  
2.1 DNMT1 mutations found in HSAN1E patients affect interaction with 
UHRF1 and neuronal differentiation 
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dependent recruitment of DNMT1 is mediated by the PCNA-binding domain (PBD) and the targeting sequence (TS) within the
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autonomic neuropathies with dementia and hearing loss (HSANIE) and autosomal dominant cerebellar ataxia deafness and
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complementation assays in mouse embryonic stem cells, we showed that DNMT1 mutations P496Y and Y500C identified in
HSANIE patients not only impair DNMT1 heterochromatin association, but also UHRF1 interaction resulting in hypomethyla-
tion. Similar DNA methylation defects were observed when DNMT1 interacting domains in UHRF1, the UBL and the SRA do-
main, were deleted. With cell-based assays, we could show that HSANIE associated mutations perturb DNMT1 heterochroma-
tin association and catalytic complex formation at methylation sites and decrease protein stability in late S and G2 phase. To
investigate the neuronal phenotype of HSANIE mutations, we performed DNMT1 rescue assays and could show that cells ex-
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sights into the molecular basis of DNMT1 dysfunction in HSANIE patients and emphasize the importance of the TS domain in
the regulation of DNA methylation in pluripotent and differentiating cells.
‡
Present address: BioMedical Center (BMC), Department of Molecular Biology, Ludwig-Maximilians-Universit€at München, Grobhaderner Str. 9, 82152
Planegg-Martinsried, Germany.
¶Present address: Microcoat Biotechnologie GmbH, Am Neuland 3, 82347 Bernried am Starnberger See, Germany.
§Present address: Definiens AG, Bernhard-Wicki-Str. 5, 80636 München, Germany.
||Present address: Max Planck Institute of Neurobiology, Am Klopferspitz 18, 82152 Martinsried, Germany.
†
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.
Received: December 21, 2016. Revised: February 7, 2017. Accepted: February 9, 2017
VC The Author 2017. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
For commercial re-use, please contact journals.permissions@oup.com
1522
Human Molecular Genetics, 2017, Vol. 26, No. 8 1522–1534
doi: 10.1093/hmg/ddx057
Advance Access Publication Date: 3 March 2017
Original Article
Introduction
Epigenetic mechanisms are crucial for the regulation of gene ex-
pression during embryonic development and cell differenti-
ation. Tissue-specific DNA methylation patterns are established
during embryogenesis by the de novo DNA methyltransferases
DNMT3A and DNMT3B, whereas the propagation of these marks
to future somatic cell generations is based on the maintenance
DNA methyltransferase 1 (DNMT1) (1–5). The catalytic activity
of DNMT1 is attributed to its C-terminal domain (CTD), however
enzyme regulation, targeting and activation are mediated by
the N-terminal domain (NTD) harboring distinct subdomains
(6). During S phase DNMT1 localization at sites of DNA replica-
tion is mediated by the PCNA-binding domain (PBD) while het-
erochromatin binding during late S and G2 is mediated by the
targeting sequence (TS) domain, both of which contribute to
proper maintenance of DNA methylation patterns (7–9).
A key factor in the regulation of DNMT1 is Ubiquitin-like, con-
taining PHD and RING finger domains 1 (UHRF1, also known as
95 kDa mouse nuclear protein (Np95)). By binding to hemimethy-
lated DNA via its SET and RING associated (SRA) domain (10–14),
UHRF1 targets DNMT1 to its substrate sites (10). In addition,
UHRF1 binds to methylated H3K9 via its tandem Tudor domain
(TTD) and to H3R2 via its plant homeodomain (PHD) (15–18).
By cooperative binding of repressive H3K9me3 marks and
hemimethylated DNA, UHRF1 targets DNMT1 to newly synthe-
sized DNA in heterochromatin after replication (19). In addition,
the UHRF1 RING domain ubiquitinates H3 tails on K18 (K23 in
Xenopus), which is specifically recognized by the ubiquitin
interacting motif (UIM) in the TS domain of DNMT1 and
required for DNA methylation (20,21). Besides intermolecular
protein–protein binding, also intramolecular protein inter-
actions serve as a prerequisite for DNMT1 activation. Firstly, in
complex with unmethylated DNA, the linker between the zinc
finger (CXXC) domain and the bromo-adjacent homology do-
main 1 (BAH1) blocks the access of DNA to the catalytic center
(22). Secondly, the crystal structure of DNMT1 reveals that, in
absence of DNA, the TS domain is inserted in the DNA-binding
pocket of the CTD thereby inhibiting enzymatic activity (23).
These two autoinhibitory mechanisms have to be overcome by
structural changes before the methylation reaction can occur.
Interaction of UHRF1 with DNMT1 releases the TS domain and
enables catalytic activity of the CTD (24).
In addition to enzyme targeting and activation, protein stabil-
ity also contributes to the regulation of maintenance DNA methy-
lation. Stability and abundance of DNMT1 during the cell cycle is
governed by UHRF1 dependent ubiquitination and deubiquitina-
tion by the ubiquitin specific peptidase 7 (USP7, also known as
herpes virus associated ubiquitin specific protease (HAUSP))
which protects against proteasomal degradation (25,26). While
Tip60 mediated acetylation promotes ubiquitination by UHRF1
and thereby marks DNMT1 for proteasomal degradation, the cor-
responding deacetylation by histone deacetylase 1 (HDAC1) con-
tributes to the stabilization of DNMT1 (25,26).
Despite its well-known replication-coupled function as main-
tenance DNA methyltransferase in proliferating cells, DNMT1 is
highly expressed in embryonic and adult postmitotic neurons, es-
pecially in the central nervous system (CNS) (27,28). Remarkably,
DNA methylation is required in adult neurogenesis and its misre-
gulation was described to be involved in the pathophysiology of
neurodegenerative disorders (29,30). Several medical studies have
reported heterozygous DNMT1 mutations causing DNA hypome-
thylation in patients suffering from hereditary sensory and auto-
nomic neuropathy type IE (HSANIE, OMIM 614116) or autosomal
dominant cerebellar ataxia deafness and narcolepsy (ADCA-DN,
OMIM 604121). Strikingly, all causative mutations described to
date affect a genomic region in DNMT1, which codes for the TS
domain (31–38). Clinical manifestations of HSANIE and ADCA-DN
include a broad phenotypic spectrum with sensory impairment,
hearing loss and dementia as hallmarks of the disease (38). In
particular, HSANIE is characterized by late onset neurologic dis-
orders of the CNS and the peripheral nervous system that mani-
fest in progressive degeneration predominantly of sensory and
autonomic neurons (39). However, the pathophysiological trajec-
tories underlying these neurological disorders caused by DNMT1
mutations remain mostly unknown.
In this study, we investigate the effect of DNMT1 mutations
identified in HSANIE patients on the function of the TS domain
in embryonic stem cells and neuronal progenitor cell differenti-
ation. With functional complementation assays, we show that
HSANIE associated mutations in mouse DNMT1 disrupt binding
of UHRF1 and lead to defects in maintenance DNA methylation.
We show that the TS point mutations affect the association
with late replicating chromatin, catalytic complex formation at
methylation sites and cell cycle dependent protein stability.
Importantly, ESCs expressing HSANIE mutants fail to differ-
entiate into the neuronal lineage and are prone to undergo
apoptosis. These results emphasize the importance of the com-
plex interplay of UHRF1 with the TS domain in regulating
DNMT1 function and DNA methylation in neurogenesis.
Results
Deletions and TS domain mutations found in HSANIE
patients affect DNMT1 activity in vivo
Although the catalytic activity of DNMT1 resides in its CTD, the
NTD of the enzyme is indispensable for proper maintenance DNA
methylation (6). Within the NTD the TS domain spans from amino
acid 309 to 628 in mouse isoform 2 and is highly conserved among
different species (Fig. 1). To map regions required for methylation
activity, we generated a systematic set of DNMT1 deletion con-
structs and performed rescue experiments expressing the deletion
constructs in Dnmt1"/" mouse embryonic stem cells (ESCs). Site
specific DNA methylation analysis revealed that not only the re-
gions between amino acid (aa) 356 to 404 and 458 to 500 (21), but
also regions from 496 to 573 are functionally relevant to maintain
methylation patterns at pericentromeric heterochromatin (Fig. 2A,
shown in dark blue). DNMT1 either lacking the flexible, less con-
served N-terminal region of the TS domain (aa 309 to 355), or the C-
terminal region of the TS domain (aa 579 to 595) was able to restore
methylation at major satellite repeats (Fig. 2A, shown in light blue).
Interestingly, mutations of two highly conserved amino acids
in the TS domain (Fig. 1B) were linked to a neurodegenerative
disease described as HSANIE (31,39). As the HSANIE associated
mutations are located within a functionally relevant central re-
gion of the TS domain (Fig. 2A), we investigated the DNA methy-
lation activity of GFP-DNMT1 harboring HSANIE mutations. To
this end, we cloned HSANIE associated mutations P496Y
(human: D490E.P491Y) and Y500C (human: Y495C) in mouse
DNMT1 expression constructs and reintroduced the mutant pro-
teins in Dnmt1"/" ESCs (Supplementary Material, Fig. S6). In line
with previous findings (31), we found that transiently and stably
expressed mutated DNMT1 is unable to rescue DNA methylation
levels in vivo (Fig. 2B, Supplementary Material, Fig. S1A and S1C).
Methylation levels at imprinted and unmethylated H19 pro-
moter remained unchanged (Supplementary Material, Fig. S1B).
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To investigate a potential targeting defect of DNMT1 harboring
HSANIE associated mutations, we made use of a DNA methyl-
transferase trapping assay in living cells. In this assay, the cyto-
sine analogue 5-aza-20-deoxycytidine (5-aza-dC) is incorporated
into DNA during replication and forms an irreversible covalent
complex with the active methyltransferase at the C6 position of
the cytosine residue thereby immobilizing the catalytically active
enzyme at DNA replication foci (40). Trapping was measured by
fluorescence recovery after photobleaching (FRAP). We found that
DNMT1 harboring HSANIE mutations can be trapped, but exhibit a
larger mobile fraction than DNMT1 wild-type (wt) indicating a
lower targeting to substrate sites in living cells (Fig. 2C). In
summary, we could show that the TS domain of DNMT1 is essen-
tial for maintenance DNA methylation. Deletions in the TS do-
main between amino acid 356 to 573 as well as point mutations
found in HSANIE patients lead to decreased methylation activity
in vivo.
Functional relevance of UHRF1 domains on the
regulation of DNMT1 enzymatic activity
UHRF1 is required for maintaining DNA methylation patterns
after replication by direct interaction with DNMT1 (10). To eluci-
date which protein domains are involved in the interaction of
Figure 1. Domain structure of mouse DNMT1 and conservation of the TS domain among different species. (A) Domain structure of GFP-DNA methyltransferase 1 (DNMT1) with
illustration of deletions and HSANIE associated point mutations in the targeting sequence (TS) domain. The large regulatory N-terminal domain (NTD) of DNMT1 is comprised of
a DNA methyltransferase associated protein 1 (DMAP1)-binding domain, a proliferating cell nuclear antigen (PCNA)-binding domain (PBD), the TS domain harboring a ubiquitin
interacting motif (UIM (21)), a zinc finger (CXXC) domain, two bromo-adjacent homology (BAH1 and BAH2) domains and a catalytically active C-terminal domain (CTD). (B)
Primary sequence alignment of TS domains from different species. The secondary structure of the mouse TS domain is indicated (PDB: 3AV4 (23)). Highly conserved residues are
shaded black. Deleted regions are indicated by blue rectangles and hereditary sensory and autonomic neuropathy type IE (HSANIE) associated point mutations by red arrows.
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DNMT1 and UHRF1 (Fig. 3A), we generated a systematic set of
constructs of the NTD and CTD of DNMT1 as well as single do-
mains of UHRF1 and performed a binding assay. We used a
semi-quantitative fluorescence protein–protein interaction
assay, in which GFP-tagged proteins are immobilized on a GFP-
multiTrap plate, incubated with RFP/Ch-tagged proteins and
binding ratios are determined by fluorescence readout (41).
Mapping studies on UHRF1 showed that the SRA domain inter-
acted with DNMT1 (Fig. 3C). In terms of DNMT1, the TS medi-
ated the binding to UHRF1 (Fig. 3B). To analyze domain
contribution to the TS domain interaction in the UHRF1 protein
context, we tested the binding of Ch-TS to UHRF1-GFP single do-
main deletions (Fig. 3D). We generated constructs with single
domain deletions of UHRF1 and found that deletions of the
TTD, the PHD and the RING domain had little to no effect on the
interaction, whereas deletions of the UBL and the SRA domain
reduced the binding of Ch-TS to UHRF1-GFP indicating that the
TS domain of DNMT1 can interact with two domains of UHRF1,
the UBL and the SRA domain of UHRF1 (Fig. 3F). In our experi-
mental set-up, the UBL domain alone, however, did not interact
with DNMT1 suggesting a cooperative binding mode involving
the UBL and SRA domain of UHRF1.
To examine which domains of UHRF1 are functionally rele-
vant for regulation of DNMT1 enzymatic activity, we
investigated the ability of UHRF1 single domain deletions in
mediating DNA methylation in vivo. All Uhrf1"/" ESC lines stably
expressing UHRF1-GFP with single domain deletions displayed
low methylation levels suggesting a DNMT1 recruitment defect
(Fig. 3E). Consequently, we investigated the dependence of
DNMT1 subnuclear localization on UHRF1 domains. In the wt
UHRF1-GFP cell line, DNMT1 showed late S phase-specific het-
erochromatin association that was abolished in all single do-
main UHRF1 deletion cell lines displaying diffuse nuclear
localization of DNMT1 comparable to Uhrf1"/" ESCs
(Supplementary Material, Figs S3 and S4). In conclusion, all
UHRF1 domains are required for recruitment of DNMT1 for
maintenance DNA methylation.
HSANIE associated mutations in TS domain of DNMT1
affect the interaction with UHRF1 and lead to
dissociation from heterochromatin
As HSANIE associated mutations in the TS domain of DNMT1
lead to hypomethylation at pericentric heterochromatin and
the TS mediates the interaction with UHRF1, we investigated
the effects of HSANIE mutations on UHRF1 interaction. With
coimmunoprecipitation experiments, we found that mutated
TS was defective in binding UHRF1 (Fig. 4A), which was
Figure 2. TS domain deletions and HSANIE associated mutations affect the DNA methylation activity of DNMT1 in vivo. (A and B) Site-specific DNA methylation analysis
at major satellite repeats of mouse Dnmt1"/" ESCs expressing transiently GFP-DNMT1 wild-type (wt) and deletions (A) or HSANIE associated point mutant constructs
(B). DNA methylation levels of untransfected Dnmt1"/" ESCs are displayed for comparison. Shown are mean values 6 standard deviations (SDs) from two to six (A) or
(B) three independent biological replicates (average from eight CpG sites, respectively). (B) Two-sample t-tests were performed that assume equal variances. Asterisks
represent significant differences: *P<0.05, **P< 0.001. (C) Quantitative evaluation of FRAP data showing mean curves. Error bars represent standard deviations. FRAP of
S-phase mouse embryonic fibroblasts (n¼5) expressing GFP-DNMT1 and GFP-DNMT1 harboring HSANIE mutations without drug treatment (upper panel) and after
treatment with 30 mM 5-aza-dC for 30 min (lower panel).
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Figure 3. DNMT1 TS domain interaction with UHRF1 is necessary for DNA methylation. (A) Schematic outline of DNMT1 and the ubiquitin-like, containing PHD and
RING finger domains 1 (UHRF1) expression constructs used for protein–protein interaction mapping studies. UHRF1 harbors an ubiquitin-like domain (UBL) followed by
a tandem Tudor domain (TTD), a plant homeodomain (PHD), a SET and RING associated (SRA) domain and a really interesting new gene (RING) domain. (B) Mapping
and relative quantification of the interaction GFP-DNMT1 with Ch-UHRF1 by fluorescence protein–protein interaction assay in vitro. Ratios of Ch-UHRF1 over GFP fusion
proteins are shown as mean values 6 standard error of the mean (SEM) of three to six biological replicates. (C) Mapping and relative quantification of the interaction
GFP-UHRF1 with RFP-DNMT1 by fluorescence protein–protein interaction assay in vitro. Ratios of RFP-DNMT1 over GFP fusion proteins are shown as mean
values 6 SEM of three biological replicates normalized to the binding ratio of the GFP-UHRF1 full length protein. (D) Schematic outline of different UHRF1-GFP single do-
main deletion (D) constructs used for rescue experiments. (E) Local methylation analysis at major satellite repeats. CpG methylation levels in Uhrf1"/" ESCs stably ex-
pressing UHRF1-GFP wt or single domain deletions were analyzed. DNA methylation levels of untransfected Uhrf1"/" ESCs are shown for comparison. Values represent
means from eight CpG sites. (F) Coimmunoprecipitation of UHRF1-GFP wt and single domain deletion mutants and Ch-TS. GFP and Ch fusion constructs were coex-
pressed in HEK293T cells and cell lysates were used for immunoprecipitation with the GFP-Trap. Bound fractions were detected by immunoblotting with anti-GFP and
anti-Ch antibodies. GFP was used as negative control. I¼ Input, B¼Bound.
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confirmed by a semiquantitative fluorescence protein–protein
interaction assay (Fig. 4B). Expression of GFP-TS in ESCs re-
vealed that while the TS domain was tightly associated with
heterochromatin in wt cells, enrichment of the TS domain at
chromocenters was lost and the signal was diffusely distributed
in the nucleus in UHRF1 depleted cells (Uhrf1"/") (Fig. 4C). A
similar delocalization was found in UHRF1 binding deficient TS
domain mutants (Fig. 4D, Supplementary Material, Fig. S5). With
half nucleus FRAP we investigated the mobility of TS domain fu-
sions in MEFs and found that HSANIE mutations caused fast
protein mobility indicating chromatin binding defects (Fig. 4E).
Notably, the interaction of DNMT1 with the replication protein
PCNA was not altered by the HSANIE mutations arguing against
severe misfolding of the mutant proteins (Supplementary
Figure 4. HSANIE associated point mutations in the TS domain reduce the interaction of DNMT1 with UHRF1. (A) Coimmunoprecipitation of GFP-TS wt, P496Y, Y500C
and P496Y.Y500C mutant constructs and Ch-UHRF1. GFP and Ch fusion constructs were coexpressed in HEK293T cells and cell lysates were used for immunoprecipita-
tion with the GFP-Trap. Bound fractions were analyzed by immunoblotting with anti-GFP and anti-Ch antibodies. GFP was used as negative control. I¼ Input,
B¼Bound. (B) Fluorescence protein–protein interaction assay of the GFP-DNMT1 NTD with Ch-UHRF1. After one-step purification of the GFP-DNMT1 NTD wt and mu-
tant constructs in a GFP-multiTrap plate, the binding of Ch-UHRF1 expressed in HEK293T cells was determined by fluorescence readout. GFP and RFP were used as
negative control. Shown are mean relative binding ratios 6 SEM of Ch-UHRF1 or RFP over GFP fusion proteins from four to six biological replicates. Two-sample t-tests
were performed that assume equal variances. Significance compared to the relative binding ratio of GFP-DNMT1 NTD wt are indicated: *P<0.05, **P<0.001.
(C) Confocal midsections of fixed mouse ESCs (wt, Uhrf1"/") transiently expressing GFP-TS and DNA was counterstained with DAPI. In the merged image, DAPI is de-
picted in magenta. Scale bar 10 mm; enlargements: 3-times magnification, scale bar 2 mm. (D) Confocal midsections of fixed MEF cells transfected with GFP-TS wt or
GFP-TS Y500C and P496Y.Y500C constructs. In the merged image, GFP-TS is depicted in red and DAPI in magenta. Scale bar 5 mm; enlargements: 3-times magnification,
scale bar 1 mm. (E) Protein mobility of GFP-TS wt and HSANIE associated GFP-TS Y500C and P497Y.Y500C mutants in living MEF cells (n¼ 13) determined by half nucleus
fluorescent recovery after photobleaching (FRAP) analysis. Curves represent mean 6 SEM.
1527Human Molecular Genetics, 2017, Vol. 26, No. 8 |
Material, Fig. S2). In conclusion, our findings suggest that the TS
domain is crucial for mediating the interaction of DNMT1 with
UHRF1 and that this interaction is affected by the HSANIE asso-
ciated mutations located in this region.
The destabilization of HSANIE associated GFP-DNMT1
TS mutants is cell cycle-dependent
As the TS domain is essential for late S phase-specific localiza-
tion and mobility of DNMT1 (42), we tested the effect of HSANIE
mutations on subcellular localization of GFP-DNMT1 on a single
cell level throughout the cell cycle. We imaged living cells coex-
pressing GFP-DNMT1 wt or GFP-DNMT1 P496Y.Y500C with RFP-
PCNA as a cell cycle marker. While the localization in early to
mid S phase was comparable to wt, the GFP signal of mutant
DNMT1 dropped when cells entered late S phase. In addition,
the double point mutant displayed only weak late S phase-
specific association with heterochromatin and did not display
the characteristic, prolonged TS domain mediated heterochro-
matin association in G2 (Fig. 5A). Interestingly, the signal of
GFP-DNMT1 P496Y.Y500C recovered in G1 phase indicating a
cell cycle dependency of this defect (Fig. 5B). To investigate a po-
tential stability defect of mutant DNMT1, we performed cyclo-
heximide experiments, which showed that GFP-DNMT1
abundance and stability was reduced by the HSANIE mutations
(P496Y, Y500C or P496Y.Y500C) (Supplementary Material, Fig.
S6). These results provide evidence for a cell cycle-dependent
destabilization of GFP-DNMT1 harboring HSANIE mutations be-
ginning in late S phase that might be caused by insufficient tar-
geting to late replicating heterochromatin.
Figure 5. The destabilization of the DNMT1 HSANIE associated mutations is cell cycle dependent. (A and B) Spinning disk confocal midsections of MEF cells transiently
coexpressing GFP-DNMT1 wt or P496Y.Y500C mutant and RFP-PCNA as a cell cycle marker. (A) Selected frames from live cell series are shown of GFP-DNMT1 wt (left
panel) and GFP-DNMT1 P496Y.Y500C (right panel). Cells were tracked starting from early S until G2 phase. In the merged image, RFP-PCNA is depicted in magenta.
(B) Live cell series of MEF cells shown in (A) transiently coexpressing GFP-DNMT1 wt (upper panel) or P496Y.Y500C (lower panel). Starting from very late S phase (wt) or
mid S phase (P496Y.Y500C) images were taken every 200 min. White represents the highest and black the lowest intensity. Scale bar 5 mm.
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HSANIE associated point mutations affect neuronal
progenitor differentiation
As HSANIE associated mutations in DNMT1 lead to a neuronal
restricted phenotype in HSANIE patients (31), we investigated
the potential of cells expressing DNMT1 with HSANIE associated
mutations to differentiate into the neuronal lineage. During
neuronal progenitor cell (NPC) differentiation (Fig. 6A), we
examined cell viability of wt, Dnmt1"/" and different ESC lines
carrying HSANIE associated mutations (Supplementary
Material, Fig. S7). In the pluripotent state and on day 8 of differ-
entiation (Supplementary Material, Fig. S8), wt, Dnmt1"/" and
mutant cell lines exhibited a similar viability degree. Strikingly,
young neuronal progenitors generated from Dnmt1"/" cells, as
well as stably expressing GFP-DNMT1 Y500C and double mu-
tants P496Y.Y500C did not fully develop into differentiated
NPCs, but instead were prone to undergo apoptosis 2 h after dis-
sociation from cellular aggregates (Fig. 6B). Furthermore, we
compared mRNA expression levels in NPCs of pluripotency
gene Oct4 and Brachyury, Gata6 and Nestin for early mesodermal,
primitive endodermal and ectodermal lineage, respectively.
GFP-DNMT1 Y500C and double mutant P496Y.Y500C NPCs had
lower expression levels of developmental marker Nestin, a
marker for neuronal progenitor differentiation and elevated ex-
pression levels of pluripotency marker Oct4 indicating an un-
completed differentiation in NPCs (Fig. 6C). The results
highlight the importance of proper DNMT1 function during
neurogenesis and indicate that the limited differentiation po-
tential of DNMT1 deficient cells cannot be rescued by DNMT1
harboring HSANIE associated mutations.
Discussion
For long, DNA methylation has been regarded as a stable epi-
genetic mark set by the de novo DNA methyltransferases
DNMT3A and DNMT3B during development and maintained
after each round of DNA replication by DNMT1 (1–5). This sim-
ple view of DNA methylation, however, cannot explain why
DNMT1 is expressed and required in postmitotic cells (27,28).
Despite or because of the central and ubiquitous role in DNA
methylation only very few human diseases were linked to het-
erozygous DNMT1 mutations that are mostly restricted to the
TS domain within the regulatory NTD of DNMT1 (43). So far, two
neurodegenerative diseases HSANIE and ADCA-DN have been
linked to mutations in the TS domain of DNMT1 (31,32) but the
underlying molecular mechanism remained elusive.
To investigate how simple amino acid exchanges outside
the catalytic domain of DNMT1 may lead to global hypomethy-
lation and neurodegenerative diseases, we transferred these
mutations to a controlled ESC differentiation system and
assayed for cellular defects. As UHRF1 plays a central role in the
regulation of DNMT1, we first investigated whether the HSANIE
mutations affect this interaction. Our coimmunoprecipitation
experiments and deletion analyses show an interaction of the
TS domain with the SRA domain of UHRF1, which is consistent
with previous yeast two-hybrid screens (44). Interestingly, the
HSANIE mutations are located within this part of the TS domain
and indeed weaken this protein–protein interaction. We could
demonstrate that mutated DNMT1 showed weaker association
with heterochromatin in late S phase and failed to maintain
DNA methylation in ESC, which is consistent with the previous
Figure 6. HSANIE associated point mutations in the TS domain show different survival rate and differentiation potential during neuronal progenitor differentiation.
(A) Mouse embryonic stem cells are differentiated into young neuronal progenitor cells (NPCs). Scale bar: 200 mm. (B) Flow cytometric analysis of alive, early apoptotic,
late apoptotic and necrotic cells. Two hours after dissociation of cellular aggregates, young neuronal progenitors were analyzed using Annexin V and propidium iodide
staining. Bar graphs represent mean values 6 standard deviation (SD) from two to three biological replicates. (C) RNA expression profiles of NPCs in biological dupli-
cates (wt) or triplicates (P496Y, Y500C, P496Y.Y500C) of pluripotency factor Oct4, lineage specific markers Brachyury, Gata6 and Nestin for mesodermal, endodermal and
ectodermal lineage, respectively. All ddCt values are normalized to wt Oct4 expression.
1529Human Molecular Genetics, 2017, Vol. 26, No. 8 |
observation that UHRF1 is required for recruitment of DNMT1
(10). The interaction of UHRF1 with DNMT1 was also shown to
be essential for allosteric activation of the enzyme to enable
binding of substrate DNA to the CTD (23,24,45–47). The weak-
ened interaction could explain the reduced activity of mutated
DNMT1 pull-downs in vitro (31) and fits well with our observa-
tion that DNMT1 harboring HSANIE mutations are impaired in
catalytic complex formation as measured with our trapping
assay in living cells. In addition to defects in enzyme activation
and targeting, we show that HSANIE mutations also cause pro-
teasomal degradation of DNMT1 in late S and G2 phase, likely
as a result of failed heterochromatin binding, which is consist-
ent with previous studies (31). Similar protein destabilization
was shown for chromatin unbound DNMT3A and DNMT3B
(48,49).
Besides harboring a binding site for UHRF1, the TS domain of
DNMT1 also contains a UIM that recognizes H3K18 ubiquiti-
nated by UHRF1 (21). Although this UIM is well separated in pri-
mary and tertiary structure from the sites mutated in HSANIE
patients, allosteric interference with H3K18ub binding cannot
be ruled out. In addition to UHRF1 and histone binding, DNMT1
is subjected to further protein interactions and multiple post-
translational modifications, which likely contribute to proper
regulation of DNA methylation (50). Several of these inter-
actions may not be absolutely required but may enhance local
or global efficiency and thereby contribute to the fine tuning
DNMT1 activity as we found for the interaction with PCNA,
which 2-fold enhances DNMT1 efficiency in living cells (51,52).
While it is unclear which of these interactions are affected by
the HSANIE mutations in different cell types, we could clearly
show that ESCs carrying these mutations are impaired in neur-
onal differentiation and prone to apoptosis.
Curiously, although HSANIE TS domain mutations are pre-
sent in all patient tissues, they mostly affect the neuronal lin-
eage causing both central and peripheral neurodegeneration.
Although it is not clear yet how dynamic the changes in DNA
methylation could be in postmitotic neurons, the turnover and
change of DNA methylation has emerged as one possible modu-
lator of neuronal plasticity in response to external or internal
stimuli (53–55). This fits with the observation that neuronal tis-
sues are characterized by strong expression of ten-eleven trans-
location (TET) genes and high hmC levels (56–59). Therefore,
DNA modification might be more dynamic in postmitotic neu-
rons than previously thought so that even small changes in pro-
tein–protein interactions and activity might unbalance the
equilibrium of DNA modifications. But it remains unclear why
neuronal tissues are specifically affected by these DNMT1 muta-
tions in HSANIE patients.
In summary, we show that HSANIE mutations affect DNMT1
interaction with the essential cofactor UHRF1, cause cell cycle
dependent degradation of DNMT1 and impair neuronal differ-
entiation. These data add to our understanding of the role and
regulation of DNMT1 during differentiation and help to under-
stand DNMT1 dysfunction and hypomethylation in the patho-
genesis of this neurodegenerative disease.
Materials and Methods
Mammalian expression constructs and antibodies
Mouse fusion constructs were generated using enhanced green
fluorescent protein (GFP), monomeric red fluorescent protein
(RFP) or monomeric cherry (Ch). The expression constructs
for RFP-DNMT1, GFP-DNMT1 wt, GFP-DNMT1D356-404, GFP-
DNMT1D458-500, GFP-NTD, Ch-TS, GFP-DNMT1 (1-308), GFP-TS,
GFP-DNMT1 (629-1110) and GFP-CTD have been described previ-
ously (9,21,26,40,60,61). GFP-DNMT1 deletion and HSANIE point
mutants as well as UHRF1-GFP deletion expression constructs
were derived from the corresponding wt constructs by overlap
extension PCR (62). The GFP-UHRF1, UHRF1-GFP, Ch-UHRF1 and
GFP-UHRF1 single domain constructs have been reported before
(17,51,63,64). GFP, RFP and RFP-PCNA have been reported before
(9,25,65,66). All constructs were verified by DNA sequencing.
The following monoclonal antibodies were used for immuno-
blotting: rat anti-RFP/Ch (5F8, Chromotek; (67), rat anti-GFP
(3H9, Chromotek). In dependence on the expected intensity of
the signals, secondary antibodies either conjugated to horserad-
ish peroxidase (HRP) (anti-rat (Dianova)) or conjugated to fluor-
escent dyes (anti-rat Alexa Fluor 488, Alexa Fluor 594 or Alexa
Fluor 647 (Invitrogen)) were applied. For detection of HRP-
conjugated antibodies an ECL Plus reagent (GE Healthcare,
Thermo Scientific) was used.
Cell culture, transfection and immunofluorescence
staining
HEK293T cells were cultured in Dulbecco’s modified Eagle me-
dium supplemented with 10% fetal bovine serum and 50 mg/ml
gentamicin. MEF cells were cultured in Dulbecco’s modified
Eagle medium supplemented with 15% fetal bovine serum, non-
essential amino acids, 2 mM L-glutamine, 0.1 mM b-mercaptoe-
thanol (Gibco-BRL), 100 U/ml penicillin and 100 mg/ml strepto-
mycin (PAA Laboratories GmbH). Mouse ESCs were cultured as
published (51) with the exception that the medium was supple-
mented with 2i inhibitors (1 mM MEK inhibitor PD and 3 mM GSK-
3 inhibitor CHIR) (2i, Axon Medchem) (63). To analyze the DNA
methylation level in stably expressing UHRF1-GFP ESC lines, we
cultured the cell lines in medium supplemented with 1,000 U/
ml recombinant mouse leukemia inhibitory factor LIF
(Millipore). Mouse J1 Dnmt1"/" ESCs are homozygous for the c
null allele and have been described before (65). Mouse E14 wt
and Uhrf1"/" cells (M. Muto and H. Koseki) as well as J1 triple
knockout cells (Masaki Okano) have been reported previously
(68). HEK293T cells were transfected with polyethylenimine
(Sigma). Mouse ESCs and MEF cells were transfected with
Lipofectamin (Invitrogen). Fixation, DAPI counterstaining and
image acquisition cells was performed as described before (17).
Live cell microscopy, DNA methyltransferase trapping
assay and fluorescence after photobleaching analysis
Live cell imaging and the trapping assay were performed as
described previously (40,42). Briefly, mouse embryonic fibro-
blasts stably expressing RFP-PCNA were seeded on multi-well
imaging slides (ibidi) and transfected using Lipofectamine 3000
(Life Technologies) following the manufacturer’s protocol.
Trapping assay was performed on an Ultraview-Vox spinning
disk system (Perkin-Elmer) equipped with an EMCCD camera
(Hamamatsu, Japan) a microirradiation system, and an environ-
mental chamber kept at 37 $C with 5% CO2, using a 63X 1.4 NA
Plan-Apochromat oil-immersion objective (Zeiss). Imaging was
performed with 488 nm and 561 nm solid-state laser diodes,
using minimal gain and 2%2 camera binning for a final pixel
size of 220 nm. Cells in late S-phase were visually identified for
photobleaching experiments. For each photobleaching experi-
ment, three pre-bleach images were acquired, before using the
microirradiation system with the 488 nm laser to photobleach a
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small area (<1 mm). After bleaching, images were acquired for
both fluorophores every 10 s for up to 5 min.
Data extraction and FRAP normalization was performed in
Fiji. Briefly, images were background subtracted and registered
to correct for xy drift and cell motion artifacts. ROIs correspond-
ing to the bleached area and to the entire nucleus were manu-
ally selected, and mean fluorescence intensities were extracted
for each timepoint. From these raw intensities, two normaliza-
tion steps were performed. First each data point was normal-
ized to its corresponding average pre-bleach intensity, and then
each data point from the bleached area was normalized to the
total nuclear fluorescence at its corresponding timepoint to cor-
rect for acquisition photobleaching. Normalized recovery data
was then imported into R (69).
Generation of stable ESC lines and DNA methylation
analysis
Forty-eight hours after transfection with GFP tagged constructs,
GFP positive ESCs were separated using a fluorescence activated
cell sorting (FACS) Aria II instrument (Becton Dikinson) and the
cells were subsequently grown in selective medium containing
10 mg/ml blasticidin (GFP-DNMT1 cell lines) or normal medium
(UHRF1-GFP cell lines). After expansion, cells were again FACS
sorted one or two more times until at least 90% of the popula-
tion was GFP positive. Furthermore, the GFP-DNMT1 cell lines
were single cell sorted and clones with low expression levels
were chosen for further analysis. The GFP-DNMT1 ESC line has
been reported before (26). Genomic DNA isolation, bisulfite con-
version, Primer sets and PCR conditions were described before
(61,70). All PCR products were analyzed by pyrosequencing
(Varionostic).
Neuronal progenitor cell (NPC) differentiation
The differentiation of pluripotent ESCs into NPCs was based on
a protocol described before (71).
Analysis of cell viability
In order to analyze cell viability, we stained apoptotic cells with
annexin V and necrotic cells with propidium iodide. To test the
efficiency of the staining, apoptosis was induced by treatment
of the cells with 5 mM staurosporine for 2 h (‘apoptotic control’)
(Supplementary Material, Fig. S8). For the staining 200,000 cells
were resuspended in 100 ml annexin binding buffer (100 mM
HEPES pH 7.4, 140 mM NaCl, 2.5 mM CaCl2). Cells were stained
with 5 ml Alexa Fluor 350 conjugated annexin V (Thermo Fisher)
for 15 min at room temperature protected from light. 400 ml
annexin binding buffer were added and necrotic cells were
stained by addition of 20 lg/ml propidium iodide solution
(Sigma Aldrich) shortly before analysis by flow cytometry using
a FACS Aria II instrument (Becton Dickinson). Quantification of
alive, necrotic, early and late apoptotic cells was performed
using the single cell analysis software FlowJo.
RNA isolation, cDNA synthesis and real-time PCR
Total RNA was isolated from cells using a nucleospin triprep kit
(Macherey-Nagel). 500 ng of total RNA was reverse transcribed
with a high-capacity cDNA reverse transcription kit (Applied
Biosystems) according to the manufacturer’s instructions. Real-
time PCR was conducted using LightCyclerVR 480 SYBR Green I
Master on a LightCyclerVR 480 Instrument II (Roche). PCR effi-
ciency and primer pair specificity was examined using a stand-
ard curve of serially diluted cDNA and melting curve,
respectively. After normalization to the transcript level of glyc-
eraldehyde phosphate dehydrogenase, data were analyzed
based on the 2-DDCT method (72). A detailed list of primers
used in the real-time PCR is shown in Supplementary Material,
Table S1.
Protein–protein interaction assay and
coimmunoprecipitation
For protein–protein interaction assays and coimmunoprecipita-
tion GFP and RFP or Ch fusion constructs were expressed in
HEK293T cells and 2 days after transfection cells were harvested
in ice cold PBS. Cell pellets from one to two 10 cm dishes were
lysed in 200 ml lysis buffer (20 mM Tris–HCl pH 7.5, 150 mM NaCl,
0.5 mM EDTA, 0.1 mM MgCl2, 0.1% NP-40, 1%protease inhibitor,
2 mM PMSF, 1 mg/ml DNaseI (AppliChem)) and a protein–protein
interaction assay in GFP-multiTrap plates (Chromotek) was
performed as described (41) with the following adaptations: GFP
extracts were equalized to a concentration of 60 nM in immuno-
precipitation buffer (20 mM Tris–HCl pH 7.5, 150 mM NaCl,
0.5 mM EDTA) prior to one step purification in blocked (3% milk)
GFP-multiTrap plates. After stringent washing (wash buffer;
20 mM Tris–HCl pH 7.5, 300 mM NaCl, 0.5 mM EDTA), purified
GFP fusion proteins were incubated with crude protein extracts
of RFP or Ch fusion proteins at a concentration of 1.1 to 2.1 mM
diluted in IP buffer (excess of amount RFP or Ch fusion proteins
in relation to GFP fusions: 18–35 times). Bound fractions were
quantified by fluorescence intensity measurements with a
Tecan Infinite M1000 plate reader (Tecan). For coimmunopreci-
pitation assays, the GFP and RFP or Ch fusion constructs were
coexpressed in HEK293T cells, protein extracts were equalized
and depending on the expression amounts of 5–30 pmol GFP-
fusion protein were applied for the coimmunoprecipitation
with the GFP-Trap (Chromotek). Note that the plasmid amount
of GFP fusion construct and RFP fusion constructs used for
transfection was adapted in a way to have at least a 3-fold ex-
cess of the molar RFP or Ch fusion protein amount in relation to
GFP fusions. Bound fractions were firstly detected by fluores-
cence intensity measurements and secondly by immunoblot-
ting using specific antibodies.
Statistical Analysis
Results were depicted as mean values 6 standard deviations
(SDs) or as mean values 6 standard errors of the mean (SEM)
from the number of biological replicates indicated in the corres-
ponding figure legend. The difference between two mean values
was analyzed by Student’s t-test and was considered as statis-
tically significant in case of P< 0.05 (*) and highly significant for
P< 0.001 (**).
Sequence Alignments
Alignments were prepared using ClustalW2 (73) and ESPript
(74).
Supplementary Material
Supplementary Material is available at HMG online.
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was supported by the China Scholarship Council (CSC). Funding
to pay the Open Access publication charges for this article was
provided by the Deutsche Forschungsgemeinschaft [grant num-
ber SFB1064/A17 to H.L].
References
1. Bird, A. (2002) DNA methylation patterns and epigenetic
memory. Genes Dev., 16, 6–21.
2. Goll, M.G. and Bestor, T.H. (2005) Eukaryotic cytosine meth-
yltransferases. Annu. Rev. Biochem., 74, 481–514.
3. Cheng, X. and Blumenthal, R.M. (2008) Mammalian DNA
methyltransferases: a structural perspective. Structure, 16,
341–350.
4. Law, J.A. and Jacobsen, S.E. (2010) Establishing, maintaining
and modifying DNA methylation patterns in plants and ani-
mals. Nat. Rev. Genet., 11, 204–220.
5. Smith, Z.D. and Meissner, A. (2013) DNA methylation: roles
in mammalian development. Nat. Rev. Genet., 14, 204–220.
6. Margot, J.B., Aguirre-Arteta, A.M., Di Giacco, B.V., Pradhan,
S., Roberts, R.J., Cardoso, M.C. and Leonhardt, H. (2000)
Structure and function of the mouse DNA methyltransferase
gene: Dnmt1 shows a tripartite structure. J. Mol. Biol., 297,
293–300.
7. Leonhardt, H., Page, A.W., Weier, H.U. and Bestor, T.H.
(1992) A targeting sequence directs DNA methyltransfer-
ase to sites of DNA replication in mammalian nuclei. Cell,
71, 865–873.
8. Chuang, L.S., Ian, H.I., Koh, T.W., Ng, H.H., Xu, G. and Li, B.F.
(1997) Human DNA-(cytosine-5) methyltransferase-PCNA
complex as a target for p21WAF1. Science, 277, 1996–2000.
9. Easwaran, H.P., Schermelleh, L., Leonhardt, H. and Cardoso,
M.C. (2004) Replication-independent chromatin loading of
Dnmt1 during G2 and M phases. EMBO Rep., 5, 1181–1186.
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Supplementary materials and methods 
Mammalian expression constructs and antibodies 
The construct GFP-DNMT1 ∆PBD has been reported previously (1). For immunofluorescent stainings of 
endogenous proteins, the monoclonal rat anti-DNMT1 antibody 5A10 (2) and a polyclonal rabbit anti-UHRF1 
antibody were used (3). The following monoclonal antibodies were used for immunoblotting: rabbit anti-H3 
(Abcam), rabbit anti-UHRF1 (3), and mouse anti β-Actin (Sigma) and rat anti-DNMT1 14F6 (4). As secondary 
antibodies an anti-rabbit Alexa Fluor 488 or anti-rat Alexa Fluor 594 were applied (Invitrogen). In dependence 
on the expected intensity of the signals, secondary antibodies either conjugated to horseradish peroxidase (HRP) 
(anti-rat (Dianova)) or conjugated to fluorescent dyes (anti-rat Alexa Fluor 488 or Alexa Fluor 647 (Invitrogen)) 
were applied. For detection of HRP-conjugated antibodies an ECL Plus reagent (GE Healthcare, Thermo 
Scientific) was used. 
 
Cycloheximide assay and preparation of protein extracts 
Mouse ESCs were plated at equal densities three hours before cycloheximide (CHX) (0.03 mg/ml, Sigma-
Aldrich) and MG132 (5 µM, Cell Signaling) treatment. DMSO served as mock control. Cell pellets were lysed in 
lysis buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM MgCl2, 0.5% NP40, 0.3 U/µl Benzonase (Sigma-
Aldrich), 2 mM PMSF and protease inhibitor mix M (SERVA)) and lysates were equalized to the overall protein 
concentration using the Pierce™ 660nm Protein Assay Reagent (ThermoFisher). Protein levels were detected by 
immunoblotting with specific antibodies against DNMT1 (14F6) (4), UHRF1 (3), β-Actin (Sigma) and H3 
(Abcam) and quantified using the ImageJ gel analysis tool. 
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Supplementary figures and legends 
 
Figure S1. HSANIE associated DNMT1 TS mutants cannot restore the local methylation level at the skeletal α-
actin promoter. (A and B) Site-specific DNA methylation in mouse Dnmt1-/- ESCs after reintroducing GFP-
DNMT1 wt or P496Y and Y500C as well as P496Y.Y500C of (A) the skeletal α-actin and (B) the H19a 
5	
	
promoter. Bar graphs represent mean values ± s.d. from three biological replicates (average from 13 or 6 CpG 
sites, respectively) and two-sample t-tests were performed that assume equal variances. Statistical significance 
compared to the methylation level of GFP-DNMT1 wt is indicated: *P<0.02, **P<0.0002. (C) CpG methylation 
levels at the major satellite repeats and the skeletal α-actin promoter of mouse Dnmt1-/- ESCs stably expressing 
GFP-DNMT1 wt or HSANIE associated point mutants were analyzed. Shown are mean values from two 
different single cell clones, respectively.  
 
 
Figure S2. HSANIE associated point mutations in the DNMT1 TS domain do not affect the interaction with the 
replication protein PCNA. Coimmunoprecipitation of GFP-DNMT1 wt, P496Y, Y500C or P496Y.Y500C and 
RFP-PCNA. GFP and RFP fusion constructs were coexpressed in HEK293T cells and cell lysates were used for 
immunoprecipitation with the GFP-Trap. Bound fractions were analyzed by immunoblotting with anti-GFP and 
anti-RFP antibodies. GFP-DNMT1 lacking the PCNA-binding domain (PBD) served as a negative control. I = 
Input, B = Bound. 
 
Figure S3. DNMT1 shows a diffuse nuclear pattern in Uhrf1-/- ESCs. Confocal midsections of fixed mouse E14 
wt and Uhrf1-/- ESCs. Endogenous DNMT1 and UHRF1 were immunostained with specific antibodies and 
6	
	
chromatin was counterstained with DAPI. In the merged image, DAPI is depicted in magenta and DNMT1 in 
green. Scale bar 10 µm. 
 
Figure S4. DNMT1 shows a diffuse pattern in Uhrf1-/- ESCs stably expressing GFP-UHRF1 single domain 
deletion mutants. Confocal midsections of fixed mouse E14 Uhrf1-/- ESCs stably expressing UHRF1-GFP wt or 
single domain deletion mutant proteins. Endogenous DNMT1 was immunostained with a specific antibody and 
chromatin was counterstained with DAPI. In the merged image, DAPI is depicted in magenta. Scale bar 10 µm. 
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Figure S5. GFP-DNMT1 TS mutations lead to decreased association with heterochromatin. Localization of 
GFP-DNMT1 wt and HSANIE associated mutants P496Y, Y500C and P496Y.Y500C stably expressed in J1 
Dnmt1-/- ESCs. DAPI was used for chromatin counterstaining. In the merged image, DAPI is depicted in 
magenta. Scale bar 5 µm.      
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Figure S6. HSANIE associated mutations in the TS domain decrease protein stability of DNMT1. (A and B) 
Cycloheximide (CHX) and MG132 assay in Dnmt1-/- ESCs stably expressing GFP-DNMT1 wt or P496Y and 
Y500C as well as P496Y.Y500C. Cells were treated with 0.03 mg/ml CHX or in addition with 30 µM MG132 
for 5 h. Treatment with DMSO served as mock control. After harvesting, expression levels of GFP-DNMT1 and 
endogenous UHRF1 were analyzed by immunoblotting with specific antibodies and by quantification using the 
ImageJ gel analysis tool. β-Actin and H3 staining was used to normalize protein expression levels of DNMT1 
and UHRF1. (A) Shown is one representative blot of three independent experiments. For immunoblotting, we 
used specific antibodies for DNMT1, UHRF1, β-Actin and H3. (B) Quantification of the relative protein 
9	
	
stability. Ratios of the relative protein expression 5 h after CHX treatment over the relative expression in the 
mock control (DMSO treatment) were calculated. Shown are mean values ± SEM of three biological replicates 
relative to the loading controls (left panel). Dependence of GFP-DNMT1 wt and HSANIE mutants expression on 
proteasomal degradation (right panel). Ratios of the relative protein expression 5 h after CHX+MG132 treatment 
over the relative expression after 5 h of CHX treatment were calculated. Ratios > 1 illustrate that protein 
abundance is higher in the combinatorial treatment (CHX+MG132) when compared to the treatment with CHX 
suggesting a dependence of protein stability on the proteasomal pathway. Shown are mean values ± SEM of 
three biological replicates relative to the loading controls. 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S7. GFP-DNMT1 wt and HSANIE associated point mutations in the TS domain of DNMT1 show 
different expression levels. Expression levels of GFP-DNMT1 and endogenous UHRF1 were analyzed by 
immunoblotting with specific antibodies and by quantification of the resulting signals using the ImageJ gel 
10	
	
analysis tool. Equal loading was confirmed by β-Actin and H3 staining and was used to normalize protein 
expression levels of DNMT1 and UHRF1. (A) Shown are the different expression levels of GFP-DNMT1 wt, 
P496Y, Y500C, and P496Y.Y500C via western blot analysis. For immunoblotting, we used specific antibodies 
for DNMT1, UHRF1, β-Actin and H3. (B) Quantification of protein levels. Signals were quantified with ImageJ. 
For the neuronal progenitor differentiation, embryonic stem cell clones with different expression levels of GFP-
DNMT1 were chosen (clones shown in black). 
 
 
 
Figure S8. Cell Viability. Flow cytometric analysis of alive, early apoptotic, late apoptotic and necrotic cells in 
embryonic stem cells (A) and dissociated cellular aggregates on day 8 of differentiation (B). Apoptosis was 
induced by treatment of cells with staurosporine (“apoptotic control”).  
 
 
Supplementary table 
Table S1. List of primers used for real-time quantitative PCR. 
Target gene Primer sequence 
Forward 
Primer sequence 
Reverse 
Gata6 CAAAAGCTTGCTCCGGTAACA GGTCGCTTGTGTAGAAGGAGAAG 
Gapdh CATGGCCTTCCGTGTTCCTA CTTCACCACCTTCTTGATGTCATC 
Brachyury CTCCAACCTATGCGGACAATTC ATGACTCACAGGCAGCATGCT 
Nestin ACTCTGCTGGAGGCTGAAACT CAAGGAAATGCAGCTTCAGCTT 
Oct4 TCACCCTGGGCGTTCTCTT GGCCGCAGCTTACACATGTT 
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2.2 DNA methylation requires a DNMT1 ubiquitin interacting motif (UIM) 
and histone ubiquitination 
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XLWLQ OLNH FRQWDLQLQJ3+'DQG5,1*¿QJHU GRPDLQV
e8+5),f*>,Da,/@]*,Q*FRQWUDVW*WR*8+5)D-*WKH*LQWHUDFWLRQ*
RI*8+5),*ZLWK*'107,*ZDV*IRXQG*WR*EH*6*SKDVHaGHSHQa
GHQW*>,A@]
8+5),-*DOVR*NQRZQ*DV*13dA*ePRXVHf*RU*,&%3d[*eKXa
PDQf-*KDV*EHHQ* UHSRUWHG*DV* D* FUXFLDO* FRIDFWRU* IRU*PDLQa
WHQDQFH*'1$*PHWK\ODWLRQ]*0LFH* ODFNLQJ*8+5),* VKRZ*
D*VLPLODU*SKHQRW\SH*DV*'QPW!*QXOO*e'QPW!ííf*PLFH*WKDW*
PDQLIHVWV* LQ*JHQRPLF*'1$*K\SRPHWK\ODWLRQ*DQG*GHYHOa
RSPHQWDO*DUUHVW*DW*HPEU\RQLF*GD\*d]A*>,Ga,O@]*7KH*65$*
GRPDLQ*RI*8+5),*SUHIHUHQWLDOO\*ELQGV*WR*KHPLPHWK\ODWa
HG*'1$* UHVXOWLQJ* IURP* VHPLFRQVHUYDWLYH*'1$* UHSOLFDa
WLRQ*DQG* LV-* WKHUHIRUH-* WKRXJKW* WR*SOD\*DQ* LPSRUWDQW* UROH*
LQ* ORDGLQJ*'107,*RQWR*QHZO\* V\QWKHVL]HG*'1$*VXEa
VWUDWHV* >,G-*,M-*,daDD@]*7KH*KHWHURFKURPDWLQ*DVVRFLDWLRQ*
RI*8+5),*LV*DOVR*PHGLDWHG*E\*WKH*WDQGHP*7XGRU*GRPDLQ*
77'ZKLFKIRUPVDQDURPDWLFFDJHIRUVSHFL¿FELQGa
LQJ*RI*KLVWRQH*+.*WDLOV*FRQWDLQLQJ*D*WULPHWK\ODWHG*O\VLQH*
d* e+..dPH.f* UHVLGXH* >DDaDA@]*7KH*SODQW*KRPHRGRPDLQ*
e3+'f*ZDV*UHSRUWHG*WR*DFW*LQ*FRPELQDWLRQ*ZLWK*WKH*77'*
WR* UHDG* WKH*+..dPH.*PDUN* >DG@* DQG* WR* FRQWULEXWH* WR*
ODUJHaVFDOH*UHRUJDQL]DWLRQ*RI*SHULFHQWURPHULF*KHWHURFKURa
PDWLQ*>DM@]*,Q*DGGLWLRQ-*8+5),*KDUERUV*D*UHDOO\*LQWHUHVWa
LQJ*QHZ*JHQH*e5,1*f*GRPDLQ*HQGRZHG*ZLWK*XELTXLWLQ*(.*
OLJDVH*DFWLYLW\*LQ*YLWUR-*ZKLFK*LV*UHTXLUHG*IRU*JURZWK*UHJa
XODWLRQ*RI* WXPRU* FHOOV* >D/-* DO@]*7KH*XELTXLWLQDWLRQ* VWDWH*
DQG*VWDELOLW\*RI*'107,*LV*FRQWUROOHG*E\*8+5),*DQG*WKH*
XELTXLWLQVSHFL¿FSURWHDVH863>@8+5)RYHUa
H[SUHVVLRQ*OHDGV*WR*'1$*K\SRPHWK\ODWLRQ*E\*WKH*GHVWDa
ELOL]DWLRQ* DQG*GHORFDOL]DWLRQ*RI*'107,* >.,@]*%HVLGHV*
LWV*UROH*LQ*PDUNLQJ*'107,*IRU*SURWHDVRPDO*GHJUDGDWLRQ-*
8+5),*DOVR*H[HUWV*LWV*XELTXLWLQ*(.*OLJDVH*DFWLYLW\*RQ*KLVa
WRQH*VXEVWUDWHV*>D/-*DA@]
$*UHFHQW*VWXG\*GHVFULEHV*UHSOLFDWLRQaGHSHQGHQW*+..D.*
XELTXLWLQDWLRQ*E\*8+5),* LQ*;HQRSXV* H[WUDFWV* >.D@]*
.QRFNGRZQ*DQG* UHVFXH* H[SHULPHQWV* LQ*+H/D* FHOOV*
VKRZHG*WKDW*65$*GRPDLQaPHGLDWHG*'1$*ELQGLQJ*DV*ZHOO*
DV*5,1**GRPDLQaGHSHQGHQW*(.*XELTXLWLQ* OLJDVH*DFWLYLW\*
RI*8+5),*DUH*UHTXLUHG*IRU*+.*XELTXLWLQDWLRQ]*([SUHVVLRQ*
RI*WKH*65$*DQG*5,1**GRPDLQ*PXWDQWV*LQ*8KUI!íí*PRXVH*
FHOOV*FRXOG*QHLWKHU* UHVWRUH*'107,*UHSOLFDWLRQ* WDUJHWLQJ*
QRU*'1$*PHWK\ODWLRQ*OHYHOV]*$*GHOHWLRQ*RI*ODUJH*SDUWV*RI*
WKH*'107,*76*GRPDLQ*DEROLVKHG*ELQGLQJ*WR*XELTXLWLQDWa
HG*+..D.*LQ*YLWUR-*EXW*HIIHFWV*RQ*HQ]\PDWLF*DFWLYLW\*ZHUH*
QRW*LQYHVWLJDWHG]*,Q*SDUWLFXODU-*WKH*VWUXFWXUH*DQG*IXQFWLRQ*
RI*WKH*UDWKHU*ODUJH*76*GRPDLQ*ZLWK*LWV*PXOWLSOH*UROHV*DQG*
LQWHUDFWLRQVUHPDLQWREHFODUL¿HG
,Q* WKLV* VWXG\-*ZH*HOXFLGDWH* WKH* FRPSOH[* LQWHUSOD\*EHa
WZHHQ*8+5),*DQG*'107,]*:KLOH*ZH* FRXOG* FRQILUP*
WKH*JHQHUDO*UROH*RI*8+5),*LQ*UHFUXLWLQJ*'107,*WR*VXEa
VWUDWH*VLWHV*E\*GLUHFW* LQWHUDFWLRQ-*ZH*IRXQG*WKDW*'107,*
WDUJHWLQJ*DQG*DFWLYLWLHV*DUH*HVVHQWLDOO\*FRQWUROOHG*E\*VSHa
FLILF* ELQGLQJ* WR* KLVWRQH* WDLOV* XELTXLWLQDWHG*E\*8+5),]*
:H*JHQHUDWHG*GHILQHG*PXWDWLRQV* LQ* GLIIHUHQW*8+5),*
GRPDLQV* WKDW* UHWDLQHG*65$*GRPDLQaPHGLDWHG*ELQGLQJ*
WR* KHPLPHWK\ODWHG*'1$*VXEVWUDWH* VLWHV-*77'aPHGLDWHG*
UHFRJQLWLRQ*RI*+..dPH.* DQG*ELQGLQJ*RI*'107,-*EXW*
GLG*QRW*DOORZ*PDLQWHQDQFH*'1$*PHWK\ODWLRQ]*:H*FRXOG*
VKRZWKDWELQGLQJWRXQPRGL¿HG+5YLDWKH3+'DQG
XELTXLWLQDWLRQ*RI*+..,O*YLD* WKH*5,1**GRPDLQ* DUH* UHa
TXLUHG*IRU*8+5),*WR*PHGLDWH*PDLQWHQDQFH*'1$*PHWK\Oa
DWLRQ,QWXUQZHLGHQWL¿HGDXELTXLWLQLQWHUDFWLQJPRWLI
e8,0f*LQ*WKH*76*GRPDLQ*RI*'107,*WKDW*UHDGV*WKLV*XELTa
XLWLQ*PDUN*DQG*LV*VWULFWO\*UHTXLUHG*IRU*PDLQWHQDQFH*'1$*
PHWK\ODWLRQ* LQ* YLYR]*7KHVH* UHVXOWV* VKRZ* WKH*PDQLIROG*
UHJXODWRU\*PHFKDQLVPV*FRQWUROOLQJ*'107,*DFWLYLW\*DQG*
LOOXVWUDWH* WKH*PXOWLIDFHWHG* LQWHUSOD\*EHWZHHQ*'1$*DQG*
KLVWRQHPRGL¿FDWLRQV
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TXHQFH*DOLJQPHQW*RI*76*GRPDLQV*IURP*KLJKHU*HXNDU\RWHV*
DQG* D* FRQVHUYHG* FRUH* UHJLRQ*RI* WKH*GRPDLQ*ZDV* FKRVHQ*
IRU*PXWDWLRQDO*DQDO\VLV*e6XSSOHPHQWDU\*LQIRUPDWLRQ-*)LJa
XUH*6,$f]*,Q*FRQWUDVW*WR**)3a'107,*ZW-**)3a'107,*
¨*GLG* QRW* FRaORFDOL]H*ZLWK* FKHUU\* e&Kfa8+5),*
DQG*VKRZHG*D*GLVSHUVHG*GLVWULEXWLRQ*LQ*WKH*QXFOHXV*e)LJXUH*
,&f-* VXJJHVWLQJ* WKDW* WKH* LQWHUDFWLRQ*ZLWK*8+5),* LV* HVa
VHQWLDO*IRU*VXEQXFOHDU*ORFDOL]DWLRQ*RI*'107,]
1H[W-*ZH* LQYHVWLJDWHG* WKH* UROH* RI*8+5),* LQWHUDFWLRQ*
IRU*WKH*FDWDO\WLF*IXQFWLRQ*RI*'107,]*1RWDEO\-**)3a'1a
07¨ WKDW GLGQRW LQWHUDFWZLWK8+5)ZDV
DEOH* WR* IXOO\*PHWK\ODWH*KHPLPHWK\ODWHG*'1$*VXEVWUDWHV*
LQ* YLWUR* e6XSSOHPHQWDU\* LQIRUPDWLRQ-*)LJXUH*6,&f]*7R*
WHVW*WKH*'1$*PHWK\ODWLRQ*DFWLYLW\*RI*WKLV*GHOHWLRQ*PXWDQW*
LQ*YLYR-*ZH*PDGH*XVH*RI* D* WUDSSLQJ*DVVD\]* ,Q* WKLV* DVVD\-*
WKHF\WRVLQHDQDORJXHD]DƍGHR[\F\WLGLQHD]DG&
IRUPV* DQ* LUUHYHUVLEOH* FRYDOHQW* FRPSOH[*ZLWK* WKH*PHWKa
\OWUDQVIHUDVH* DW* WKH*&G*SRVLWLRQ*RI* WKH* F\WRVLQH* UHVLGXH*
ZKHQ* LQFRUSRUDWHG* LQWR*'1$*GXULQJ* UHSOLFDWLRQ* WKHUHE\*
WUDSSLQJ* WKH* HQ]\PH*DW*'1$* UHSOLFDWLRQ* IRFL]*7UDSSHG*
'107,*IUDFWLRQV*LQFUHDVH*RYHU*WLPH*DQG*DOORZ*PRQLWRUa
LQJ*WKH*DFWLYLW\aGHSHQGHQW*DFFXPXODWLRQ*RI*'107,*DW*LWV*
WDUJHW*VLWHV*>..@]*,Q*(6&V*VWDEO\*H[SUHVVLQJ**)3a'107,*
ZW-* IRFL*RI* LPPRELOL]HG*SURWHLQ*HPHUJHG*DOUHDG\*ZLWKLQ*
D[*PLQ*e)LJXUH*,'-*OHIW*SDQHOf]*,Q*FRQWUDVW-**)3a'107,*
¨*ZDV*QRW*HQULFKHG*DW*UHSOLFDWLRQ*IRFL*HYHQ*DIWHU*
,,[*PLQ-*LQGLFDWLQJ*WKDW*WKH*GHOHWLRQ*PXWDQW*LV*XQDEOH*WR*
PHWK\ODWH*QHZO\* UHSOLFDWHG*'1$* LQ* OLYLQJ* FHOOV* e)LJXUH*
,'-*ULJKW*SDQHOf]*7R*SXUVXH*WKLV*LGHD-*ZH*IXUWKHU*DQDO\]HG*
VLWHVSHFL¿F'1$PHWK\ODWLRQOHYHOVRIVWDEOH*)3'1a
07ZW DQG¨(6& OLQHV 6XSSOHPHQWDU\ LQa
IRUPDWLRQ-*)LJXUH*6,%f]**)3a'107,*FRXOG* UHVWRUH*
ORFDO*'1$*PHWK\ODWLRQ* DW* WKH*PDMRU* VDWHOOLWH* UHSHDWV* LQ*
'QPW!íí(6&V* OHDGLQJ* WR* DQ* DYHUDJH*PHWK\ODWLRQ* OHYHO*
RI*GDl*WKDW*LV*FRPSDUDEOH*WR*WKH*OHYHO*RI*WKH*ZW*FHOO*OLQH*
H[SUHVVLQJ* WKH* HQGRJHQRXV*SURWHLQ* eM/l-*)LJXUH*,(-*
OHIW SDQHO ,Q FRQWUDVW WKH'107PXWDQWGH¿FLHQW LQ
8+5),*ELQGLQJ*ZDV*XQDEOH* WR* UHHVWDEOLVK* ORFDO*'1$*
PHWK\ODWLRQ*SDWWHUQV* UHVXOWLQJ* LQ* GHFUHDVHG* OHYHOV* DW*
WKH*PDMRU* VDWHOOLWH* UHSHDWV* eDYHUDJH*,dlf* VLPLODU* WR* WKH*
'QPW!íí*FRQWURO*FHOO*OLQH*eDYHUDJH*,Olf]*&RQVLVWHQWO\-*D*
VLPLODUGHIHFWRI*)3'107¨LQ'1$PHWKa
\ODWLRQ*DFWLYLW\*ZDV*REVHUYHG*DW*WKH*VLQJOHaFRS\*VHTXHQFH*
RI*WKH*VNHOHWDOĮDFWLQ*SURPRWHU*e)LJXUH*,(-*ULJKW*SDQHOf]*
)XUWKHUPRUH-* VLPLODU* UHVXOWV*ZHUH*REWDLQHG* IURP*'1$*
PHWK\ODWLRQ* DQDO\VHV* DW* WKH*PLQRU* VDWHOOLWH* UHSHDWV* DQG*
WKH*'QPW!R SURPRWHU FRQ¿UPLQJ WKDW VWDEOH H[SUHVVLRQ
RI*)3'107¨FRXOGQRWUHVWRUH'1$PHWKa
\ODWLRQ* LQ*D*'QPW!íí*FHOO* OLQH* e6XSSOHPHQWDU\* LQIRUPDa
WLRQ-*)LJXUH*6,'f]
,Q* VXPPDU\-*ZH*SURYLGH* VWURQJ* HYLGHQFH* WKDW* WKH*
*)3'107¨PXWDQW GHILFLHQW LQ8+5)
ELQGLQJ-*HYHQ* WKRXJK*DEOH* WR*PHWK\ODWH*'1$*VXEVWUDWHV*
LQ* YLWUR-* FDQQRW* UHVWRUH*'1$*PHWK\ODWLRQ*SDWWHUQV* LQ*
'QPW!íí*(6&V]*7KHVH* ILQGLQJV* VXJJHVW* WKDW* WKH* LQWHUa
DFWLRQ*RI*'107,*ZLWK*8+5),* LV* UHTXLUHG* WR*PDLQWDLQ*
'1$*PHWK\ODWLRQ*LQ*YLYR]
7KH*3+'*DQG*5,1**GRPDLQ*RI*8+5)!*DUH*HVVHQWLDO*IRU*
PDLQWHQDQFH*'1$*PHWK\ODWLRQ
&RRSHUDWLYH*ELQGLQJ*RI* WKH*8+5),*77'* WR*GLa* DQG*
WULPHWK\ODWHG*KLVWRQH*+..d*DQG*RI* WKH*65$*GRPDLQ* WR*
KHPLPHWK\ODWHG*'1$*ZDV*GHVFULEHG* DV* D* SUHUHTXLVLWH*
IRU*WDUJHWLQJ*'107,*WR*LWV*VXEVWUDWH*DQG*IRU*VXEVHTXHQW*
'1$*PHWK\ODWLRQ* >./@]**LYHQ* WKH* UHJXODWRU\* LPSDFW* RI*
WKHVH*WZR*GRPDLQV-*ZH*ZHUH*LQWHUHVWHG*LQ*KRZ*WKH*3+'*
DQG*5,1**GRPDLQ*RI*8+5),*PD\*IXQFWLRQDOO\*FRQWULEa
XWH* WR*PDLQWHQDQFH*'1$*PHWK\ODWLRQ*E\*'107,]*7R*
WKLV*HQG-*ZH*LQWURGXFHG*SRLQW*PXWDWLRQV*LQ*WKH*3+'*DQG*
5,1**GRPDLQ* e8+5),a*)3*+./G**DQG*8+5),a*)3*
+M.[$-*UHVSHFWLYHO\f*WKDW*DUH*H[SHFWHG*WR*SUHYHQW*FRRUGLa
QDWLRQRI]LQFLRQVE\]LQF¿QJHUPRWLIV)LJXUH$DQG
6XSSOHPHQWDU\*LQIRUPDWLRQ-*)LJXUH*6D$f]*&RQVHTXHQWO\-*
WKHPXWDWLRQ LQ WKH5,1*GRPDLQ VLJQL¿FDQWO\ UHGXFHG
WKH*(.*XELTXLWLQ*OLJDVH*DFWLYLW\*RI*8+5),* LQ*YLYR*e6XSa
SOHPHQWDU\*LQIRUPDWLRQ-*)LJXUH*6D&*DQG*6D'f]*1RWDEO\-*
WKH*SUHIHUHQFH*RI*8+5),a*)3*IRU*KHPLPHWK\ODWHG*'1$*
ZDV*QRW* LPSDLUHG*E\* WKH*3+'*DQG*5,1**GRPDLQ*PXWDa
WLRQV*e6XSSOHPHQWDU\*LQIRUPDWLRQ-*)LJXUH*6D%f]
)LUVW-*ZH* WHVWHG*ZKHWKHU* WKH*SRLQW*PXWDWLRQV* LQ* WKH*
3+'*DQG*5,1**GRPDLQ* LQIOXHQFH* WKH* LQWHUDFWLRQ*RI*
8+5),*ZLWK*'107,]*8+5),a*)3*ZW* DV*ZHOO* DV*
8+5),a*)3*+./G**DQG*8+5),a*)3*+M.[$* VWLOO*
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5)3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WHUDFWLRQ*ZLWK*'107,*GLUHFWO\*e)LJXUH*D%f]*,Q*DGGLWLRQ-*
WKH XQDOWHUHG LQWHUDFWLRQVZHUH FRQ¿UPHGE\ DÀXRUHVa
FHQW* WKUHHaK\EULG*DVVD\* >.A-*.G@]* ,Q* WKLV*DVVD\-*8+5),a
*)3* IXVLRQ* FRQVWUXFWV*ZHUH*XVHG* DV* EDLWV* E\* WHWKHULQJ*
WKHP* WR* D* ODF* RSHUDWRU* eODF2f* DUUD\*SUHVHQW* LQ* EDE\*
KDPVWHU*NLGQH\*e%+.f*FHOOV*WKDW*VLPXOWDQHRXVO\*H[SUHVV*
5)3a'107,*DV*D*SUH\]*$FFXPXODWLRQ*RI*5)3a'107,*
DW* WKH* ODF2*VSRW*HQULFKHG*IRU*8+5),a*)3*ZW-*8+5),a
*)3*+./G**RU*8+5),a*)3*+M.[$*FOHDUO\* GHPRQa
VWUDWHV*WKDW*WKH*PXWDQW*SURWHLQV*ZHUH*VWLOO*DEOH*WR*LQWHUDFW*
ZLWK*'107,*LQ*YLYR*e)LJXUH*D&f]
,Q*RUGHU* WR* SHUIRUP* IXQFWLRQDO* VWXGLHV* RQ* WKH*3+'*
DQG*5,1**GRPDLQ*PXWDQWV-*ZH* VWDEO\* H[SUHVVHG**)3a
WDJJHG*8+5),*ZW-*8+5),*+./G**RU*8+5),*+M.[$*LQ*
8KUI!í^í*(6&V]*6LPLODU*WR*ZW-*DOVR*8+5),a*)3*+./G**
DQG*8+5),a*)3*+M.[$* VKRZHG* IRFDO* HQULFKPHQW* DW*
KHWHURFKURPDWLQ* e)LJXUH*D'-* ILUVW* SDQHO* DQG*6XSSOHa
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DOWKRXJK*QRW*DIIHFWLQJ*8+5),*KHWHURFKURPDWLQ*ORFDOL]Da
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VKRZHG*UHGXFHG*XELTXLWLQDWLRQ*OHYHOV* LQGLFDWLQJ*WKDW* WKH*
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$QDOPRVWFRPSOHWHVHULHVRIEDQGIXOO\SURGXFWLRQVJHQHUDWHG
E\&,'IUDJPHQWDWLRQZHUHGHWHFWDEOHSURYLGLQJDKLJKFRQ¿GHQFH
LQLWVFRUUHFW LGHQWL¿FDWLRQDQGORFDOL]DWLRQRIWKHXELTXLWLQPRGL¿@
FDWLRQ,QVHWPDVVFKDUJHDQGPHDVXUHPHQWHUURUGHWHUPLQDWLRQ
RI WKH+SHSWLGHV.**.3U LQ WKH(ZW VDPSOH
'LVSOD\HGLVWKHLVRWRSLFGLVWULEXWLRQRIWKH+SHSWLGHIURPZKLFK
WKH!PDVV! WR! FKDUJH! UDWLR! DPC] WKH FKDUJH  DQG WKHPRQRL@
VRWRSLFPDVV YDOXH PZHUHGHULYHGǻP GLIIHUHQFHEHWZHHQ
WKHH[SHFWHGDQGWKHPHDVXUHGPDVVHV5UHVROXWLRQRIWKH06
PHDVXUHPHQWA! :%= ,GHQWLILFDWLRQRI+SHSWLGHV FDUU\LQJ
XELTXLWLQDWLRQ**DW.DQGDFHW\ODWLRQ$FDW.E\/&06
06DVLQ$:&;$'=4XDQWL¿FDWLRQRI+SHSWLGHVFDUU\LQJ
XELTXLWLQDWLRQXEDW.DQGDQXQPRGL¿HGXQRUDFHW\ODWHGDF
.UHVLGXHIURP(ZWDQG(8KUI0íCíVDPSOHV([WUDFWHGLRQ
FKURPDWRJUDPVRIWKHLRQVFRUUHVSRQGLQJWRWKHSHSWLGHVRILQWHU@
HVWZHUHXVHGIRUWKHTXDQWL¿FDWLRQ7KHVLJQDOVZHUHQRUPDOL]HG
DJDLQVWWKHWRWDODPRXQWRIDQDO\]HG+SURWHLQV
WKH8,0 ǻ RU FRQWDLQLQJ VXEVWLWXWLRQVRI WKH
UHOHYDQW*DQG*FRQVHUYHG*DPLQR*DFLGV* LQ* WKH*PRWLI* WR*DODa
QLQH* e'.O,$a(.OD$a6.dD$-*'.O,$a(.OD$a0.OA$a
6.dD$a'.dA$-*)LJXUH*A$*DQG*6XSSOHPHQWDU\* LQIRUPDa
WLRQ-*)LJXUH*6G$f*VKRZHG*D*GHIHFW*LQ*WKH*DVVRFLDWLRQ*ZLWK*
XELTXLWLQDWHG*KLVWRQH*+.* DQG*XELTXLWLQDWHG*+D$.,,d*
e)LJXUH*A%-* A&*DQG*6XSSOHPHQWDU\* LQIRUPDWLRQ-*)LJXUH*
6G%a6G'f]*7R*IXUWKHU*HOXFLGDWH*8,0aGHSHQGHQW*XELTXLWLa
QDWHGKLVWRQHELQGLQJZHTXDQWL¿HGPRGL¿HG+
SHSWLGHV*ERXQG*E\**)3a'107,*ZW*RU*WKH*8,0*PXWDQWV*
E\*PDVV* VSHFWURPHWU\]*:KHUHDV*+.*KLVWRQH*SHSWLGHV*
XELTXLWLQDWHGDW.DQGDFHW\ODWHGRUXQPRGL¿HGDW.
FRaLPPXQRSUHFLSLWDWHG*ZLWK**)3a'107,*ZW-*RQO\*OLWWOH*
WR*QR*XELTXLWLQDWHG*SHSWLGH*VLJQDOV*ZHUH*GHWHFWHG*IRU*WKH*
8,0PXWDQWV )LJXUH$%*)3'107¨
GHIHFWLYH* LQ*8+5),*LQWHUDFWLRQ*e)LJXUH*,%f*VKRZHG*UHa
GXFHG*e)LJXUH*G%f*RU*XQGHWHFWDEOH*e)LJXUH*A%-*A&f*ELQGa
LQJ* WR*XELTXLWLQDWHG*+.*DQG*+D$]*7KLV*GHOHWLRQ* ORFDWHG*
LQ* D*76*GRPDLQ* UHJLRQ*&aWHUPLQDO* RI* WKH*8,0*PLJKW*
DIIHFW*WKH*LQWHJULW\*DQG*IXQFWLRQDOLW\*RI*WKH*PRWLI*UHVSRQa
VLEOH*IRU*XELTXLWLQ*ELQGLQJ]*7KHUHIRUH-*ZH*FDQQRW*UXOH*RXW*
WKDW*DSDUW*IURP*GLVUXSWHG*8+5),*ELQGLQJ*DOVR*GHIHFWV*LQ*
WKH*DVVRFLDWLRQ*ZLWK*XELTXLWLQDWHG*KLVWRQHV*FRQWULEXWHG*WR*
WKH*REVHUYHG*FKDQJHV*LQ*VXEQXFOHDU*GLVWULEXWLRQ*DQG*SURa
WHLQIXQFWLRQRI*)3'107¨)LJXUH&(
%HVLGHV*D*GHFUHDVHG*ELQGLQJ* WR*XELTXLWLQDWHG*+.-* WKH*
76*GRPDLQ*SRLQW* DQG*GHOHWLRQ*PXWDQWV* H[KLELWHG* DQ* LQa
FUHDVHG*ELQGLQJ* WR*+.*RU* FRUH* KLVWRQHV* FRPSDUHG*ZLWK*
*)3'107ZW )LJXUH%7KHUHIRUH VSHFL¿FELQGa
LQJ*RI*'107,* WR*XELTXLWLQDWHG*+.*YLD* LWV*8,0*PLJKW*
SUHYHQW* WKH* HQ]\PH* IURP* VWDEOH* FKURPDWLQ* DVVRFLDWLRQ*
DQG*WKHUHE\*IDFLOLWDWH*'1$*PHWK\ODWLRQ]
7R* FODULI\* WKH* IXQFWLRQDO* UROH* RI* WKH*8,0* LQ*PDLQWHa
QDQFH*'1$*PHWK\ODWLRQ* LQ* YLYR-*ZH*SHUIRUPHG* D* IXQFa
WLRQDO* FRPSOHPHQWDWLRQ* DVVD\* LQ*'QPW!íí*(6&* OLQHV*
WUDQVLHQWO\* H[SUHVVLQJ**)3a'107,*ZW-**)3a'107,*
¨*)3'107'$($6$RU
*)3a'107,*'.O,$a(.OD$a0.OA$a6.dD$a'.dA$]*
/RFDO*'1$*PHWK\ODWLRQ* DQDO\VHV* DW* WKH*PDMRU* VDWHOOLWH*
UHSHDWV*DQG*WKHVNHOHWDOĮDFWLQ*SURPRWHU*VKRZHG*WKDW*WKH*
8,0*PXWDQWV*ZHUH*QRW* DEOH* WR* UHHVWDEOLVK*'1$*PHWKa
\ODWLRQ*SDWWHUQV* e)LJXUH*G&f]**)3a'107,*ZW* UHVWRUHG*
'1$*PHWK\ODWLRQ* DW* WKH*PDMRU* VDWHOOLWH* UHSHDWV* WR*/Ol]*
%\* FRPSDULVRQ-* WKH*8,0*GHOHWLRQ* DQG*SRLQW*PXWDQWV*
ZHUH*QRW* DEOH* WR* UHVFXH* UHVXOWLQJ* LQ* ORZ*DYHUDJH*PHWKa
\ODWLRQ* OHYHOV* RI* D[l* WR*D.l*FRPSDUDEOH* WR* XQWUDQVa
IHFWHG*'QPW!íí*(6&V* e,Alf]*6LPLODU* UHVXOWV*ZHUH* DOVR*
REVHUYHG* DW* WKH*PLQRU* VDWHOOLWH* UHSHDWV* DQG* WKH*'QPW!R*
SURPRWHU*e6XSSOHPHQWDU\*LQIRUPDWLRQ-*)LJXUH*6M$f]
*LYHQ* WKDW* WKH**)3a'107,*76*8,0*GHOHWLRQ* DQG*
SRLQW*PXWDQWV*ZHUH* DEOH* WR* LQWHUDFW*ZLWK*&Ka8+5),*
e6XSSOHPHQWDU\* LQIRUPDWLRQ-*)LJXUH*6M%f-*ZH*ZHUH* LQa
:HLKXD(4LQ(HW#DO<
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)LJXUH$F7KH76GRPDLQRI'107KDUERUVDXELTXLWLQLQWHUDFWLQJPRWLI8,0WKDWLVHVVHQWLDOIRUELQGLQJWRXELTXLWLQDWHG+
DQG+$:$=$6FKHPDWLFRXWOLQHRIWKH8,0LQWKH76GRPDLQRI'107DQGLQGLFDWLRQRIWKH8,0GHOHWLRQ¨DQG
WKHSRLQWPXWDWLRQV '$($6$DQG'$($0$6$'$$SHSWLGH VHTXHQFHRI'107HQ@
FRPSDVVLQJDPLQRDFLGZDVDOLJQHGZLWKSHSWLGHVHTXHQFHVRISURWHLQVSUHYLRXVO\NQRZQWRFRQWDLQ8,0V,GHQWLFDO
DPLQRDFLGVDUHKLJKOLJKWHGLQEODFNKLJKO\VLPLODUDPLQRDFLGVDUHIUDPHGLQEODFN7KHVHFRQGDU\VWUXFWXUHRIWKH'107
UHJLRQSGE(3=>@KDUERULQJWKH8,0LVGLVSOD\HGRQWRSRIWKHVHTXHQFHDOLJQPHQWJHQHUDWHGXVLQJ(63ULSW>@A!7KH!
FRQVHQVXVVHTXHQFHIRUVLQJOHVLGHG8,0V>@LVVKRZQEHORZ7KH8,0VZHUHIRXQGE\VFDQQLQJWKHSURWHLQSULPDU\VH@
TXHQFHVDJDLQVWDFROOHFWLRQRIPRWLIVLQ([3$6\3URVLWH3XWDWLYHVXEJURXSVRI8,0VDUHLQGLFDWHGRQWKHOHIW$:%=8ELTXLWL@
QDWHGKLVWRQH+ELQGLQJDVVD\$IWHUH[WUDFWLRQRIKLVWRQHVIURP+(.7FHOOVWKHH[WUDFWVZHUHLQFXEDWHGZLWK*)3'1@
07ZWRUPXWDQWV LPPRELOL]HGRQ WKH*)37UDSDQG WKHERXQG IUDFWLRQVZHUHDQDO\]HGE\ZHVWHUQEORWWLQJZLWKVSHFL¿F
DQWL+DQGDQWL*)3DQWLERGLHV*)3ZDVXVHGDVQHJDWLYHFRQWURO,LQSXW%ERXQG:&=8ELTXLWLQDWHGKLVWRQH+$ELQGLQJ
DVVD\DVLQ%%RXQGIUDFWLRQVZHUHDQDO\]HGE\ZHVWHUQEORWWLQJZLWKVSHFL¿FDQWL+$.XEDQGDQWL*)3DQWLERGLHV
$QDO\VHVRIWKHDQWL+$.XEDQWLERG\VSHFL¿FLW\DQGRISHSWLGHVLVRODWHGIURPWKHFRUUHVSRQGLQJEDQGDUHVKRZQLQ6XS@
SOHPHQWDU\LQIRUPDWLRQ)LJXUH6&DQG6'+$XEPRQRXELTXLWLQDWHG+$+$XEGLXELTXLWLQDWHG+$
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'1$(PHWK\ODWLRQ(UHTXLUHV('1076(XELTXLWLQ(LQWHUDFWLQJ(PRWLIQSJ
&HOO(5HVHDUFK(_(ZZZ<QDWXUH<FRPCFU
WKH*77'-*3+'*DQG*65$*GRPDLQ* DQG*GHIHFWV* LQ* DQ\*RI*
WKHVH* WKUHH*GRPDLQV* OHDG* WR*GHFUHDVHG*'1$*PHWK\ODWLRQ*
E\*'107,* >./-* /A-* /G@]*$FFRUGLQJO\-* LW*ZDV*SRVWXODWHG*
WKDW*8+5),* UHDGV* DQG*ELQGV* UHSUHVVLYH*KLVWRQH*PDUNV*
DQG*KHPLPHWK\ODWHG*'1$*DQG*YLD* GLUHFW* SURWHLQaSURWHLQ*
LQWHUDFWLRQ*UHFUXLWV*'107,*IRU*PDLQWHQDQFH*'1$*PHWKa
\ODWLRQ]
'HIHFWV* RI* D*5,1**GRPDLQ*PXWDQW* e&M,.$-*&A,A$*
DQG*&M,G$f* LQ* UHVWRULQJ*XELTXLWLQDWHG*+.* LQ*+H/D*FHOOV*
DIWHU* NQRFNGRZQ*RI* KXPDQ*'107,*DQG*8+5),*KDYH*
SUHYLRXVO\*EHHQ* UHSRUWHG* >.D@]*:H* IRXQG* WKDW* WKH*5,1**
GRPDLQ-*WKRXJK*QRW*GLUHFWO\*LQYROYHG*LQ*8+5),*FKURPDa
WLQ*ELQGLQJ*RU*LQWHUDFWLRQ*ZLWK*'107,-*LV* LQGLVSHQVDEOH*
IRU*'1$*PHWK\ODWLRQ*E\*'107,]*5HPDUNDEO\-*D*8+5),*
5,1**GRPDLQ*PXWDQW*e+M.[$f*ZLWK*GLPLQLVKHG*XELTXLWLQ*
(.* OLJDVH* DFWLYLW\* e6XSSOHPHQWDU\* LQIRUPDWLRQ-*)LJXUH*
6D&*DQG*6D'f*WKDW*FRXOG*VWLOO*ELQG*'107,*e)LJXUH*D%f-*
KHPLPHWK\ODWHG*'1$*DQG*.d*WULPHWK\ODWHG*+.*SHSWLGHV*
LQ* YLWUR* e)LJXUH*.'*DQG*6XSSOHPHQWDU\* LQIRUPDWLRQ-*
)LJXUH*6D%f* DQG* FKURPRFHQWHUV* LQ* YLYR* e6XSSOHPHQWDU\*
LQIRUPDWLRQ-*)LJXUH*6D(f-*QRQHWKHOHVV*IDLOHG*LQ*UHFUXLWLQJ*
'107,*WR* UHSOLFDWLRQ*VLWHV* e)LJXUH*D'*DQG*6XSSOHPHQa
WDU\LQIRUPDWLRQ)LJXUH6)7KHVH¿QGLQJVVXJJHVWWKDW
'107,*UHFUXLWPHQW* WR* UHSOLFDWLRQ*IRUNV* LV*QRW*EDVHG*RQ*
GLUHFW*LQWHUDFWLRQ*ZLWK*8+5),-*EXW*RQ*WKH*FDWDO\WLF*DFWLYa
LW\*RI*WKH*5,1**GRPDLQ]*3UHYLRXVO\-*WKH*5,1**GRPDLQ*RI*
8+5),*KDV*EHHQ* UHSRUWHG* WR*KDYH*DQ*DXWRXELTXLWLQDWLRQ*
DFWLYLW\* >DO@* DQG-* LQ* DGGLWLRQ-* WR* XELTXLWLQDWH*'107,*
>Dd-* .[@* DQG*KLVWRQH* VXEVWUDWHV* >D/-* DA@]*$* UHFHQW* VWXG\*
GHVFULEHV* WKDW* XELTXLWLQDWLRQ*RI*+.*E\*8+5),*SURYLGHV*
GRFNLQJ* VLWHV* IRU*'107,*RQ* FKURPDWLQ* DQG* WKXV* FRXa
SOHV*PDLQWHQDQFH*'1$*PHWK\ODWLRQ*DQG*UHSOLFDWLRQ*>.D@]*
:KLOHZHFRXOGFRQ¿UPWKHHVVHQWLDOUROHRI8+5)ZH
REWDLQHG*QHZ* LQVLJKWV* LQWR* WKH*FRPSOH[* IXQFWLRQDO* LQWHUa
SOD\*RI*8+5),*DQG*'107,*GRPDLQV]
)LUVW-* LQ* FRQWUDVW* WR* XELTXLWLQDWLRQ* DW*.D.* LQ*;HQRSXV*
HJJH[WUDFWV>@RXUPDVVVSHFWURPHWU\UHVXOWVLGHQWL¿HG
+..,O*DV*XELTXLWLQDWLRQ*WDUJHW*RI*8+5),*LQ*PDPPDOLDQ*
FHOOV* e)LJXUH*/$-* /%*DQG*6XSSOHPHQWDU\* LQIRUPDWLRQ-*
)LJXUH*6A$f]*%\*PXWDWLRQDO*DQDO\VLV*LQ*+(.*Dd.7*FHOOV-*
ZH* IRXQG* WKDW* LQ* DEVHQFH*RI*.,O-* WKH*PXWDWHG**)3a
WDJJHG*+.*PLJKW*EH*XELTXLWLQDWHG*DW*.D.*e6XSSOHPHQWDU\*
LQIRUPDWLRQ-*)LJXUH*6A%f]*+RZHYHU-*E\* VHPLTXDQWLWDWLYH*
DQDO\VLV* RI* HQGRJHQRXV*XELTXLWLQDWHG*+.*SHSWLGHV* LQ*ZW*
YHUVXV*8KUI!íí*PRXVH*(6&V*XVLQJ*PDVV* VSHFWURPHWU\-*
ZHFOHDUO\VKRZWKHVSHFL¿FLW\RI.XELTXLWLQDWLRQE\
8+5),*DQG* LWV* UHGXFWLRQ*E\*8+5),*GHSOHWLRQ* e)LJXUH*
/&-* /'f]*6HFRQG-* LQ* WKH*SUHYLRXV* VWXG\-* D* GHOHWLRQ*RI*
DPLQR DFLGVZLWKLQ WKH'10776GRPDLQ ¨
/DAf* FDXVHG* D* ORVV* RI* KLVWRQH*ELQGLQJ* LQ* YLWUR* >.D@]*7KH*
76*GRPDLQ*LV-*KRZHYHU-*LQYROYHG*LQ*PXOWLSOH*LQWHUDFWLRQV*
DQG* UHTXLUHG* IRU* SURSHU* IROGLQJ-* VWDELOLW\* DQG* DFWLYLW\*RI*
'107,]*7KH*LQFRPSOHWH*VWUXFWXUDO*LQIRUPDWLRQ*LQGLFDWHV*
WHUHVWHGLQKRZWKH8,0LQ'107KDVDQLQÀXHQFHRQ
WKH* VXEQXFOHDU* ORFDOL]DWLRQ*RI* WKH*SURWHLQ]* ,PPXQRVWDLQa
LQJRI UHSOLFDWLQJ'1$ZLWK D VSHFL¿F DQWL3&1$DQWLa
ERG\* LQGLFDWHG* WKDW**)3a'107,*ZW*ZDV* HQULFKHG* DW*6*
SKDVHVSHFL¿FUHSOLFDWLRQIRFLZKLOH*)3'107¨
/[/-**)3a'107,*'.O,$a(.OD$a6.dD$*DQG**)3a'1a
07,*'.O,$a(.OD$a0.OA$a6.dD$a'.dA$* VKRZHG*
RQO\*ZHDN*DVVRFLDWLRQ*ZLWK*WKH*3&1$aVWDLQHG*UHSOLFDWLRQ*
VLWHV*HVSHFLDOO\* LQ* ODWH*6*SKDVH* e6XSSOHPHQWDU\* LQIRUPDa
WLRQ-*)LJXUH*6Of]*7R* DQDO\]H* WKH*8,0aGHSHQGHQW* HQULFKa
PHQW*RI*'107,*DW* ODWHaUHSOLFDWLQJ*KHWHURFKURPDWLQ-*ZH*
TXDQWL¿HGPHDQÀXRUHVFHQFHLQWHQVLWLHVDWFKURPRFHQWHUV
FRPSDUHG*ZLWK*WKH*QXFOHRSODVPLF*UHJLRQ*e)LJXUH*M$f]*,Q*
ODWH6SKDVH(6DQGPRXVHHPEU\RQLF¿EUREODVWV0()
FHOOV-**)3a'107,*ZW* ORFDOL]HG* DW* FKURPRFHQWHUV-*
ZKHUHDV* WKH*8,0*PXWDWLRQV* DEROLVKHG*KHWHURFKURPDWLQ*
HQULFKPHQW* e)LJXUH*M%*DQG*M&f]*7KHVH* UHVXOWV* FOHDUO\*
GHPRQVWUDWH*WKH*NH\*UROH*RI*WKH*8,0*LQ*'107,*WDUJHWLQJ*
YLD*XELTXLWLQDWHG*KLVWRQH*+.*ELQGLQJ*DQG*IRU*PDLQWHQDQFH*
'1$*PHWK\ODWLRQ*LQ*PDPPDOLDQ*FHOOV]
'LVFXVVLRQ
'1$*PHWK\ODWLRQ* LV* DQ* LPSRUWDQW* HSLJHQHWLF*PRGLILa
FDWLRQ* UHJXODWLQJ*JHQH* H[SUHVVLRQ* LQ* GHYHORSPHQW* DQG*
GLVHDVH]*$*NH\*TXHVWLRQ* LV* KRZ*PHWK\ODWLRQ*PDUNV* DUH*
VHW-*PDLQWDLQHG* DQG* UHPRYHG]*$FFRUGLQJ* WR*SUHYLRXV*
PRGHOV-*'1$*PHWK\ODWLRQ*PDUNV*DUH* VHW*E\* WKH*GH*QRYR*
PHWK\OWUDQVIHUDVHV*'107.$*DQG*'107.%*GXULQJ*
GHYHORSPHQW* DQG*PDLQWDLQHG*E\* WKH*PDLQWHQDQFH*'1$*
PHWK\OWUDQVIHUDVH*'107,* WKDW* VSHFLILFDOO\* UHFRJQL]HV*
DQGPRGL¿HVKHPLPHWK\ODWHG'1$VXEVWUDWHV+RZHYHU
WKH*SUHIHUHQFH*RI*'107,*IRU*KHPLPHWK\ODWHG*'1$*PHDa
VXUHG*LQ*YLWUR*>@LVQRWVXI¿FLHQWWRH[SODLQHI¿FLHQW
PDLQWHQDQFH*RI*'1$*PHWK\ODWLRQ*SDWWHUQV* RYHU*PDQ\*
FHOO* GLYLVLRQ* F\FOHV* LQ* YLYRB*7KH* LQWHUDFWLRQ*RI*'107,*
ZLWK*WKH*UHSOLFDWLRQ*SURWHLQ*3&1$*ZDV*VKRZQ*WR*HQKDQFH*
PDLQWHQDQFH*'1$*PHWK\ODWLRQ*E\*D*IDFWRU*RI*WZR-*EXW*QRW*
WR* EH* HVVHQWLDO* >G-* M@]* ,Q* FRQWUDVW-* WKH* LQWHUDFWLQJ* IDFWRU*
8+5),* UHFUXLWLQJ* DQG* DOORVWHULFDOO\* DFWLYDWLQJ*'107,*
LV*HVVHQWLDO*IRU*'1$*PHWK\ODWLRQ*>,/-*,G-*,M-*//@B*,Q*WKLV*
VWXG\-*ZH*KDYH*QRZ*GLVVHFWHG*WKH*GLVWLQFW*UROH*RI*GLIIHUHQW*
8+5),*DQG*'107,*GRPDLQV*LQ*GLUHFWLQJ*'1$*PHWK\ODa
WLRQ]
,Q*OLQH*ZLWK*SUHYLRXV*VWXGLHV-*ZH*VKRZ*WKDW-*DOEHLW*EHa
LQJ*ZHDN-*WKH*76*GRPDLQaPHGLDWHG*LQWHUDFWLRQ*RI*'107,*
ZLWK*WKH*65$*GRPDLQ*RI*8+5),*LV*UHTXLUHG*IRU*WDUJHWLQJ*
DQG* IXQFWLRQ*RI*'107,* LQ* YLYR]*$FFRUGLQJO\-* WUXQFDWHG*
'107¨GH¿FLHQWLQ8+5)ELQGLQJVKRZHG
ZHDNHU* DVVRFLDWLRQ*ZLWK* FKURPRFHQWHUV* LQ* ODWH*6*SKDVH*
PRXVH¿EUREODVWV>@DQGIDLOHGWRPDLQWDLQ'1$PHWK\Oa
DWLRQ*LQ*(6&*e)LJXUH*,f]
+HWHURFKURPDWLQ*ELQGLQJ*RI*8+5),* LV*PHGLDWHG*E\*
:HLKXD(4LQ(HW#DO<
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)LJXUH$G7KH'1078,0 LV UHTXLUHG IRUXELTXLWLQDWHG+.ELQGLQJDQG IRU'1$PHWK\ODWLRQ$ :$=$8ELTXLWLQDWHGKLVWRQH
ELQGLQJH[SHULPHQWVXVLQJ*)3'107ZWRU8,0PXWDQWVDVZHOODVWKH¨PXWDQWGH¿FLHQWLQELQGLQJWR8+5)
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WHLQVZHUHYLVXDOL]HGE\&RRPDVVLHVWDLQLQJDQGWKHIUDFWLRQVKLJKOLJKWHGE\EODFNUHFWDQJOHVZHUHDQDO\]HGE\PDVVVSHF@
WURPHWU\*)3ZDVXVHGDVQHJDWLYHFRQWURO:%=$4XDQWL¿FDWLRQRI+SHSWLGHVFDUU\LQJXELTXLWLQDWLRQXEDW.DQG
DQDFHW\ODWHG DFRUXQPRGL¿HG XQ. UHVLGXH IURPKLVWRQHELQGLQJH[SHULPHQWVKRZQ LQ $([WUDFWHG LRQFKURPDWR@
JUDPVRIWKHLRQVFRUUHVSRQGLQJWRWKHSHSWLGHVRILQWHUHVWZHUHXVHGIRUTXDQWL¿FDWLRQ+.XE.DFPC] 
SSP+.XE.XQPC] SSP$:&=/RFDO'1$PHWK\ODWLRQDQDO\VHVRI-'QPW0íCí(6&VH[SUHVVLQJ
*)3'107ZWRU¨DQG8,0SRLQWPXWDQWV&S*PHWK\ODWLRQOHYHOVDWWKHPDMRUVDWHOOLWHUHSHDWVDQGWKHVNHOHWDO*
Į,DFWLQSURPRWHUZHUHDQDO\]HGE\ELVXO¿WHWUHDWPHQWRIJHQRPLF'1$3&5DPSOL¿FDWLRQDQGGLUHFWS\URVHTXHQFLQJ0HWK@
\ODWLRQOHYHOVRIXQWUDQVIHFWHG-'QPW0ííFHOOVDUHVKRZQIRUFRPSDULVRQ0HDQYDOXHV6'IURPWKUHHWRIRXUELRORJLFDO
UHSOLFDWHVZHUHFDOFXODWHGUHVSHFWLYHO\
64
'1$(PHWK\ODWLRQ(UHTXLUHV('1076(XELTXLWLQ(LQWHUDFWLQJ(PRWLIQSJ
&HOO(5HVHDUFK(_(ZZZ<QDWXUH<FRPCFU
GLIIHUHQW*76*GRPDLQ* FRQIRUPDWLRQV* DQG* D* UROH* LQ* DXWRa
LQKLELWLRQ*RI* WKH*&'-*EXW* GRHV*QRW* SURYLGH* DQ\* IXUWKHU*
PHFKDQLVWLF* LQVLJKWV* >,[-* ,,-* /M@]*:LWK*ELRLQIRUPDWLFV*
DQGPXWDWLRQDODQDO\VHVZH LGHQWL¿HGDFRQVHUYHG8,0
ORFDWHG* LQ* WKH*76*GRPDLQ*RI*'107,*eDPLQR*DFLGV*.O,a
.dAf*WKDW*PHGLDWHV*WKH*UHFRJQLWLRQ*RI*XELTXLWLQDWHG*+.*LQ*
YLWUR* e)LJXUH*A-*G$-*G%*DQG*6XSSOHPHQWDU\* LQIRUPDWLRQ-*
)LJXUH*6G%f]*/RFDOL]DWLRQ* DQG* DFWLYLW\* DQDO\VHV*ZLWK*
VSHFL¿FPXWDQWVLQ*YLYR*FOHDUO\*LQGLFDWHG*WKDW*WKH*8,0*LV*
UHTXLUHG*IRU*'107,*VXEQXFOHDU*GLVWULEXWLRQ*DQG*PDLQWHa
QDQFH*'1$*PHWK\ODWLRQ*e)LJXUHV*G&-*M*DQG*6XSSOHPHQa
WDU\*LQIRUPDWLRQ-*)LJXUH*6M$*DQG*6Of]
/DVW-*ZH*FRXOG*VKRZ*WKDW*EHVLGHV*KHPLPHWK\ODWHG*'1$*
ELQGLQJ*E\* WKH*65$*GRPDLQ* >.D@-*8+5),*3+'*ELQGLQJ*
WR*+.5D*LV*DOVR*UHTXLUHG*IRU*+.*XELTXLWLQDWLRQ*DQG*VXEVHa
TXHQW*'1$*PHWK\ODWLRQ* e)LJXUH*D(* DQG*.%f]*7KHUHIRUH-*
ZH*SURSRVH* WKDW* FRRSHUDWLYH* FKURPDWLQ*ELQGLQJ*RI* WKH*
77'-* WKH*3+'*DQG* WKH*65$*GRPDLQ* FRQVWLWXWHV* D* SUHa
UHTXLVLWH* IRU*+..,O*XELTXLWLQDWLRQ]*7KHVH*XELTXLWLQDWHG*
KLVWRQH*WDLOV*DUH*UHFRJQL]HG*E\*WKH*8,0*DQG*WKXV*PHGLDWH*
'107,*FKURPDWLQ*ELQGLQJ]*7KHUHE\-*8+5),*DFWV* DV* D*
UHDGHU* DQG*ZULWHU* RI* KLVWRQH*PDUNV* DQG*YLD* UHFUXLWPHQW*
RI*'107,*G\QDPLFDOO\* OLQNV*'1$*DQG*KLVWRQH*PRGLa
¿FDWLRQSDWKZD\V%DVHGRQ WKHVH UHVXOWVZHSURSRVH D
XELTXLWLQDWLRQaGHSHQGHQW*FKURPDWLQ*WDUJHWLQJ*PHFKDQLVP*
IRU*'107,*WKDW*LV*HVVHQWLDO*IRU*PDLQWHQDQFH*'1$*PHWKa
\ODWLRQ* DIWHU* UHSOLFDWLRQ* e)LJXUH*O$f]*7KH* LGHQWLILFDWLRQ*
DQG*IXQFWLRQDO*FKDUDFWHUL]DWLRQ*RI*D*8,0*LQ*'107,*QRW*
RQO\*FKDQJHV*RXU*YLHZ*RI*PDLQWHQDQFH*'1$*PHWK\ODWLRQ-*
EXW* DOVR*RSHQV*QHZ*SHUVSHFWLYHV* IRU* WKH* LQYROYHPHQW* RI*
'107,*LQ*RWKHU*UHSUHVVLYH*HSLJHQHWLF*SDWKZD\V*e)LJXUH*
O%f]
%HVLGHV* DVVRFLDWLRQ*ZLWK*XELTXLWLQDWHG*+.-*ZH* IRXQG*
WKDW*'107,*DOVR*ELQGV*XELTXLWLQDWHG*+D$.,,d*e)LJXUH*
A&*DQG*6XSSOHPHQWDU\* LQIRUPDWLRQ-*)LJXUH*6G&-*6G'f]*
&RQVLVWHQWO\-*'107,*ZDV*UHFHQWO\*GHWHFWHG*DPRQJ*SURa
WHLQV*ELQGLQJ* WR*+D$*XELTXLWLQDWHG*DW*.,,O* LQ*'URVRSKG
LOD-*FRUUHVSRQGLQJ* WR*.,,d* LQ*PDPPDOV* >/O@]*+D$.,,d*
XELTXLWLQDWLRQ* LV* FDWDO\]HG*E\*5,1*,$^,%-* WZR*FRPSRa
QHQWV*RI*WKH*3RO\FRPE*UHSUHVVLYH*FRPSOH[*,*e35&,f-*DQG*
SOD\V*DQ*LPSRUWDQW*UROH*LQ*UHJXODWLQJ*JHQH*H[SUHVVLRQ*>/d@]*
6LPLODU* WR*8+5),aGHSHQGHQW*+.*XELTXLWLQDWLRQ-*+D$*
XELTXLWLQDWLRQ*E\*5,1*,$^,%*PLJKW* DOVR* FRQWULEXWH* WR*
'1$*PHWK\ODWLRQ]*:H*VSHFXODWH*WKDW*8,0aPHGLDWHG*ELQGa
LQJ*RI*'107,* WR*XELTXLWLQDWHG*+D$.,,d*PLJKW* GLUHFW*
'107,* WR*XQa* RU* KHPLPHWK\ODWHG* VLWHV* GHSHQGHQW* RQ*
35&,*XELTXLWLQDWLRQ*DFWLYLW\*e)LJXUH*O%-*OHIW*KDOIf]
35&,aGHSHQGHQW*+D$*XELTXLWLQDWLRQ* IXUWKHU* OHDGV* WR*
35&D* UHFUXLWPHQW* DQG* VXEVHTXHQW*+..DM*PHWK\ODWLRQ*
>A[@]*(QKDQFHU* RI*=HVWH* KRPRORJ*D* e(=+Df-* D* FRPSRa
QHQW* RI*35&D-*ZULWHV*PHWK\ODWHG*+..DM*DQG* LQWHUDFWV*
ZLWK*'107V]*7KLV*LQWHUDFWLRQ*ZDV*VKRZQ*WR*EH*UHTXLUHG*
IRU*'1$*PHWK\ODWLRQ*RI*(=+D* WDUJHW* SURPRWHUV* >A,@]*
'107,*GHSOHWLRQ* LQ* GLIIHUHQWLDWHG* FHOOV* DIIHFWV*+D$*
XELTXLWLQDWLRQaGHSHQGHQW*35&D* UHFUXLWPHQW* DW* SHULFHQa
WURPHULF* KHWHURFKURPDWLQ* >AD@]*7KXV-*8,0*ELQGLQJ* WR*
XELTXLWLQDWHG*+D$*LV*OLNHO\*'1$*UHSOLFDWLRQ*LQGHSHQGHQW*
DQG*'107,*PLJKW*IXQFWLRQ*DV*DGDSWRU*SURWHLQ*PHGLDWLQJ*
35&D*UHFUXLWPHQW*DQG* UHSUHVVLYH*3RO\FRPE*GRPDLQ* IRUa
PDWLRQ]
%HVLGHV* UHFUXLWLQJ*'107,* WR* VSHFLILF* VLWHV* RQ* FKURa
PDWLQ-* WKH*8,0*FRXOG* DOVR*SOD\* D* UROH* LQ* WKH* DOORVWHULF*
DFWLYDWLRQ*RI*WKH*HQ]\PH]*7KH*8,0*LV*ORFDWHG*ZLWKLQ*WKH*
76*GRPDLQ*RI*'107,*WKDW*KDG*EHHQ*VKRZQ* WR*ELQG* WKH*
&'*DQG* WKHUHE\* LQKLELW* FDWDO\WLF* DFWLYLW\* >,[-* ,,@]* ,W* LV*
WHPSWLQJ* WR* VSHFXODWH* WKDW* FRPSHWLWLYH*8,0*ELQGLQJ* WR*
XELTXLWLQDWHG*KLVWRQH*WDLOV*GLVSODFHV*WKH*76*GRPDLQ*IURP*
WKH*'1$*ELQGLQJ*SRFNHW*DQG*DEROLVKHV*DXWRLQKLELWLRQ*RI*
'107,]
*LYHQ* WKH* HPHUJLQJ* UROH* RI* XELTXLWLQDWLRQ* LQ*'1$*
PHWK\ODWLRQ-* LW* LV* LQWHUHVWLQJ*WR*QRWLFH*WKDW*XELTXLWLQDWLRQ*
LV D KLJKO\G\QDPLFSRVWWUDQVODWLRQDOPRGL¿FDWLRQ WKDW
FDQ*EH* UHYHUVHG*E\*XELTXLWLQaVSHFLILF* SURWHDVHV* e863Vf]*
7KH*8+5),a'107,*FRPSOH[*KDV*EHHQ*UHSRUWHG*WR*FRQa
WDLQ*863M*WKDW*GHXELTXLWLQDWHV*DQG*VWDELOL]HV*'107,*>Dd-*
.[@]*7KXV-*863M*PLJKW*LQ*DGGLWLRQ*PRGXODWH*WKH*XELTXLWLa
QDWLRQ*VWDWXV*RI*KLVWRQH*+.*DQG*WKHUHE\*UHJXODWH*'107,*
DVVRFLDWLRQ*ZLWK*FKURPDWLQ]*$Q*DOWHUQDWLYH*SDWKZD\*FRQa
WUROOLQJ*'107,*FKURPDWLQ* DVVRFLDWLRQ* FRXOG* LQYROYH*
WKH* UHFHQWO\* GHVFULEHG* FKURPDWLQ* DFHW\ODWLRQ*RI*+..,O*
DQG*.D.* >A.-* A/@]*$FHW\ODWHG*+..,O* LV* HQULFKHG* DW* WKH*
WUDQVFULSWLRQDO*VWDUW*VLWHV*RI*DFWLYH*DQG*SRLVHG*JHQHV*>AA@]*
7KXV-*+..,O*DFHW\ODWLRQ*PLJKW*FRXQWHUDFW*XELTXLWLQDWLRQ*
DQG*WKHUHE\*SUHYHQW*ELQGLQJ*DQG*VLOHQFLQJ*RI*DFWLYH*JHQHV*
E\*'107,]*7KH*G\QDPLF*LQWHUSOD\*RI*XELTXLWLQDWLRQ*DQG*
DFHW\ODWLRQ*RI*+..,O*OLNHO\*FRQWUROV*'107,*FKURPDWLQ*
ELQGLQJ*DQG* WKHUHE\*GLUHFWV*PHWK\ODWLRQ*DFWLYLW\]*6WXGLHV*
RI*8+5),*DQG*'107,*FRPSOH[* FRPSRVLWLRQ* LQ*GLIIHUa
HQW*FHOO*F\FOH*SKDVHV*DQG*FHOO*W\SHV*VKRXOG*SURYLGH*IXUWKHU*
LQVLJKWVLQWRWKH¿QHWXQLQJRI'107DFWLYLW\LQ*YLYR]
*LYHQ*WKH*FRPSOH[*UROH*RI*WKH*ODUJH*76*GRPDLQ*RQ*WKH*
RQH*KDQG*DQG* WKH* VFDUFH* VWUXFWXUDO* DQG*PHFKDQLVWLF*GDWD*
RQ* WKH*RWKHU* KDQG-* RXU* LGHQWLILFDWLRQ*RI* D*ZHOO* GHILQHG*
8,0*SURYLGHV* D* FRQFUHWH* EDVLV* IRU* IXQFWLRQDO* LQVLJKWV]*
8ELTXLWLQELQGLQJSURWHLQVZLWKGH¿QHG8,0VKDYHEHHQ
GHVFULEHG* LQ*YDULRXV* FHOOXODU*SURFHVVHV* OLNH-* H]J]-* VRUWLQJ*
RI* XELTXLWLQDWHG*PHPEUDQH*SURWHLQV* IRU* O\VRVRPDO* GHJa
UDGDWLRQ]*7KH* FU\VWDO* VWUXFWXUH* RI* WKH* VLJQDO* WUDQVGXFLQJ*
DGDSWRU*PROHFXOH* ,* e67$0,f* >AG@* VXJJHVWV* WKDW* WKUHH*
FHQWUDO* DPLQR* DFLGV* LQ* WKH*8,0-*/,MG-*$,Md* DQG*6,O.*
IRUP*D*K\GURSKRELF* LQWHUIDFH* IRU*XELTXLWLQ*ELQGLQJ* >AM@]*
6LPLODU*WR*WKH*8,0*LQ*67$0,-*WKH*8,0*LQ*'107,*DOVR*
KDUERUV* D* FRQVHUYHG*K\GURSKRELF* DPLQR* DFLG*0.OA* DQG*
6ÀDQNHGE\QHJDWLYHO\FKDUJHGDPLQRDFLGV '
(.OD*DQG*'.dAf-*ZKLFK*ZH* IRXQG* WR*EH*HVVHQWLDO* LQ*RXU*
DQDO\VHV*e)LJXUHV*A-*G*DQG*Mf]*'LIIHUHQW*IURP*RWKHU*8,0V-*
:HLKXD(4LQ(HW#DO<
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)LJXUH$H*)3'1078,0PXWDQWVVKRZDGHFUHDVHGDVVRFLDWLRQZLWK3&1$VWDLQHGUHSOLFDWLRQVLWHVLQODWH6SKDVHFRP@
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5HSOLFDWLQJ'1$ZDVVWDLQHGZLWKDVSHFL¿FDQWL3&1$DQWLERG\DQGFKURPDWLQZDVFRXQWHUVWDLQHGZLWK'$3,5HSOLFDWLRQ
IRFLPDVNVUHGPDWFK WKHHQULFKPHQWRI*)3'107ZW LQ ODWH6SKDVHZKHUHDV WKH8,0PXWDQWVGRQRWVKRZD IRFDO
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7KHQX@
FOHDUPDVNRXWOLQHGLQEOXHZDVEDVHGRQWKH'$3,VWDLQLQJZKHUHDVWKHUHSOLFDWLRQIRFLPDVNVRXWOLQHGLQUHGZHUHEDVHG
RQWKH3&1$VWDLQLQJ%RWKPDVNVZHUHVXSHULPSRVHGRQWKH*)3FKDQQHOV7KH*)3'107VLJQDOLQVLGHWKHUHGPDVNV
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'1$(PHWK\ODWLRQ(UHTXLUHV('1076(XELTXLWLQ(LQWHUDFWLQJ(PRWLIQSJ
&HOO(5HVHDUFK(_(ZZZ<QDWXUH<FRPCFU
)LJXUH$I2YHUYLHZRILQWHUDFWLRQVDQGPRGL¿FDWLRQVFRQWUROOLQJ'107DFWLYLW\$8+5)LVHQULFKHGDW+WDLOVDVDUHVXOW
RI WKH3+'PHGLDWHGELQGLQJ WR+5 WKH77'PHGLDWHGELQGLQJ WRPHWK\ODWHG+.DQG UHFRJQLWLRQRIKHPLPHWK\ODWHG
&S*VLWHVYLDWKH65$GRPDLQ%\LQWHUDFWLRQRIWKH65$GRPDLQZLWKWKH76GRPDLQ'107LVGLUHFWO\UHFUXLWHGWRLWVWDUJHW
VLWHV8+5)FKURPDWLQELQGLQJYLDLWV77'3+'DQG65$GRPDLQLVDSUHUHTXLVLWHIRUVXEVHTXHQW+XELTXLWLQDWLRQE\WKH
5,1*GRPDLQ7KH8,0RI'107ELQGVWR+WDLOVXELTXLWLQDWHGDW.E\8+5)DQGLVHVVHQWLDOIRU'107WDUJHWLQJDQG
'1$!PHWK\ODWLRQ!LQ#YLYRA!D%7KHSUHYLRXVO\GHVFULEHGGLUHFWLQWHUDFWLRQRI'107ZLWK8+5)DQG3&1$LVQRWVXI¿FLHQWIRU
PDLQWHQDQFH'1$PHWK\ODWLRQ%HVLGHVWKH8+5)GHSHQGHQW+.XELTXLWLQDWLRQUHFUXLWLQJ'107YLDLWV8,0IRUPDLQ@
WHQDQFH'1$PHWK\ODWLRQULJKWKDOIZHSURSRVHDQDOWHUQDWLYHSDWKZD\WKDWLQYROYHV+$.XELTXLWLQDWLRQE\5,1*$%
RI35&OHIWSDUW7KHLGHQWL¿FDWLRQRIWKH'1078,0QRZRSHQVWKHSRVVLELOLW\WKDWXELTXLWLQDWLRQRIKLVWRQHWDLOUHVLGXHV
E\XELTXLWLQ( OLJDVHVPLJKW FRQVWLWXWH DOWHUQDWLYH SDWKZD\V IRU'1$PHWK\ODWLRQE\'107&'EH\RQG FODVVLFPDLQWH@
QDQFH%OXHKH[DJRQVUHSUHVHQWDXELTXLWLQPRLHW\
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ZZZ<FHOO:UHVHDUFK<FRP(_(&HOO(5HVHDUFK
WKH*FHQWUDO*FRQVHUYHG*$*UHVLGXH*LV*QRW*SUHVHQW*LQ*'107,*
e6XSSOHPHQWDU\*LQIRUPDWLRQ-*)LJXUH*6G$f]*%DVHG*RQ*VHa
TXHQFH*DOLJQPHQWV*DQG*VWUXFWXUDO*LQIRUPDWLRQ-*8,0V*FDQ*
EH*VXEGLYLGHG*LQ*VLQJOHaVLGHG*VLQJOH*8,0V-*DV*LQ*67$0,-*
DQG* LQ* VLQJOHaVLGHG* WDQGHP*8,0V-* DV* LQ* WKH*SURWHDVRPH*
VXEXQLW*6AD*>AO@*e)LJXUH*A$f]*7KH*WDQGHP*8,0V*LQ*6AD*
SURYLGH* D*PRGHO* IRU* WKH* UHFRJQLWLRQ*RI* SRO\XELTXLWLQ*
FKDLQV* >Ad@]* ,Q* FRQWUDVW-* D* GRXEOHaVLGHG* VLQJOH*8,0* LQ*
WKH*KHSDWRF\WH* JURZWK* IDFWRUaUHJXODWHG* W\URVLQH*NLQDVH*
VXEVWUDWH +56DOORZV IRUHI¿FLHQWELQGLQJRIPXOWLSOH
PRQRXELTXLWLQDWHG*UHFHSWRUV*LQ*WKH*SURFHVV*RI*HQGRVRPDO*
SURWHLQ*VRUWLQJ*>AO@]*&RPSDULVRQ*ZLWK*WKHVH*NQRZQ*8,0V*
VXJJHVWV*WKDW*WKH*PRWLI*LQ*'107,*EHORQJV*WR*WKH*JURXS*
RI*VLQJOHaVLGHG*VLQJOH*8,0V-*ZKLFK*ZRXOG*EH*FRPSDWLEOH*
ZLWK*WKH*UHFRJQLWLRQ*RI*VLQJOH*XELTXLWLQDWHG*KLVWRQH*WDLOV]
,Q* VXPPDU\-* WKH* IXQFWLRQDO* DQDO\VLV* RI*8+5),*GRa
PDLQVDQG WKH LGHQWL¿FDWLRQRID8,0LQ'107FKDOa
OHQJH*WUDGLWLRQDO*YLHZV*RI*PDLQWHQDQFH*'1$*PHWK\ODWLRQ*
DV* D* VLPSOH* FRS\LQJ*PHFKDQLVP]* ,QVWHDG-*'1$*PHWK\Oa
DWLRQ*E\*'107,* UHTXLUHV* UHDGLQJ*RI*+.5D-*+..dPH.*
DQG*KHPLPHWK\ODWHG*'1$*E\*8+5),*DQG* VXEVHTXHQW*
XELTXLWLQDWLRQ*RI*+..,O*E\* LWV*5,1**GRPDLQ* WKHUHE\*
LQWHJUDWLQJ* VLJQDOV* IURP*GLIIHUHQW* HSLJHQHWLF* SDWKZD\V]*
7KHVH*PXOWLSOH* OD\HUV* FRQWUROOLQJ*'107,*DFWLYLW\*
VXJJHVW* WKDW* RYHUDOO*PHWK\ODWLRQ*GHQVLWLHV* LQ* FKURPDWLQ*
GRPDLQVDUHPDLQWDLQHGUDWKHUWKDQVSHFL¿FPHWK\ODWLRQ
SDWWHUQV*SUHFLVHO\* FRSLHG]*7KH* IXQFWLRQDO* FKDUDFWHUL]Da
WLRQ*RI* WKH*8,0* IXUWKHU* UDLVHV* WKH*SRVVLELOLW\* WKDW* RWKHU*
XELTXLWLQ*(.* OLJDVHV* OLNH*5,1*,$^,%*RI*35&,*PLJKW*
GLUHFW*'107,*DFWLYLW\*WR*UHSUHVVLYH*FKURPDWLQ*GRPDLQV*
EH\RQG*VLPSOH*PDLQWHQDQFH]
0DWHULDOV&DQG&0HWKRGV
([SUHVVLRQ*FRQVWUXFWV*DQG*DQWLERGLHV
)XVLRQ* FRQVWUXFWV*ZHUH*JHQHUDWHG*XVLQJ* HQKDQFHG**)3-*PRa
QRPHULF*5)3*RU*PRQRPHULF*&K]*7KH* H[SUHVVLRQ* FRQVWUXFWV* IRU*
*)35)3'107*)3'107ZW*)3'107¨
*)3a'107,*.[daGDO* e*)3a76f* DQG*8+5),a+LV* KDYH*EHHQ*
GHVFULEHGSUHYLRXVO\ >    @*)376¨
*)3'107¨DQG*)3'107SRLQWPXWDQW'$
(.OD$a6.dD$*DQG*'.O,$a(.OD$a0.OA$a6.dD$a'.dA$f* H[a
SUHVVLRQ* FRQVWUXFWV* DV*ZHOO* DV*8+5),a*)3*+./G**DQG*+M.[$*
ZHUH*GHULYHG* IURP* WKH* FRUUHVSRQGLQJ*ZW* FRQVWUXFWV* E\*RYHUODS*
H[WHQVLRQ*3&5* >GD@]*7KH**)3a8+5),* VLQJOHaGRPDLQ* FRQVWUXFW*
IRU* WKH*XELTXLWLQaOLNH*GRPDLQ* e8EOf*ZDV*JHQHUDWHG*E\*3&5*XVLQJ*
WKH*FRUUHVSRQGLQJ*ZW*IXOOaOHQJWK*FRQVWUXFW]*&Ka8+5),*DQG**)3a
8+5),*H[SUHVVLRQ*FRQVWUXFWV*KDYH*EHHQ*GHVFULEHG*SUHYLRXVO\*>DD-*
G.@]*([SUHVVLRQ*FRQVWUXFWV*IRU**)3a+.*5D$-*.,O$-*.D.$*DV*ZHOO*
DV*.,O$a.D.$*ZHUH*REWDLQHG*E\*RYHUODS* H[WHQVLRQ*3&5*RQ* WKH*
FRUUHVSRQGLQJ*ZW*FRQVWUXFW]*7KH*FRQVWUXFW*IRU*/DF,a*%3*KDV*EHHQ*
UHSRUWHGEHIRUH>@$OOFRQVWUXFWVZHUHYHUL¿HGE\'1$
VHTXHQFLQJ*e0:**%LRWHFKf]
)RULPPXQRÀXRUHVFHQFHVWDLQLQJRIKHWHURFKURPDWLQDPRXVH
DQWLa+..dPH.*DQG*DQ*DQWLa+/.D[PH.*DQWLERG\*ZHUH*XVHG*e$FWLYH*
0RWLIf]*(QGRJHQRXV*'107,*ZDV*VWDLQHG*ZLWK*WKH*UDW*PRQRFORQDO*
DQWLERG\*A$,[* >/@* DQG*3&1$*ZLWK* WKH* UDW*PRQRFORQDO* DQWLERG\*
,G',[* >GG@]*$V* VHFRQGDU\* DQWLERGLHV* DQ* DQWLaPRXVH*$OH[D*)OXRU*
Ad/* DQG* DQWLaUDW*$OH[D*)OXRU* G/M* DQWLERG\*ZHUH* DSSOLHG-* UHVSHFa
WLYHO\*e,QYLWURJHQf]*
)RU*GHWHFWLRQ*RI**)3*IXVLRQ*SURWHLQV*E\*ZHVWHUQ*EORW-*D*PRXVH*
DQWLa*)3* e5RFKHf* RU* D* UDW* DQWLa*)3* e&KURPRWHNf* DQWLERG\*ZDV*
XVHG]*5)3*RU*&K*IXVLRQ*SURWHLQV*ZHUH*GHWHFWHG*E\*WKH*UDW*DQWLaUHG*
DQWLERG\*A)O*>GM@]*8+5),*ZDV*YLVXDOL]HG*E\*D*UDEELW*DQWLa8+5),*
DQWLERG\*>D/@*DQG*+$aXELTXLWLQ*E\*WKH*PRXVH*PRQRFORQDO*DQWLa+$*
DQWLERG\*,D&$A]*(TXDO* ORDGLQJ*RI*FHOO* O\VDWHV*ZDV*DVVHVVHG*E\*D*
PRXVHDQWLȕ$FWLQDQWLERG\6LJPD$OGULFK7KHUDEELWDQWL+
DQWLERG\*ZDV*SXUFKDVHG* IURP*$EFDP*DQG* WKH* DQWLa+D$.,,dXE*
IURP*1HZ*(QJODQG*%LRODEV]*'HSHQGLQJ*RQ*WKH*H[SHFWHG*LQWHQVLW\*
RI*WKH*VLJQDOV-*VHFRQGDU\*DQWLERGLHV*HLWKHU*FRQMXJDWHG*WR*KRUVHUDGa
LVK*SHUR[LGDVH* eDQWLaUDEELW* e%LRUDGf-* DQWLaUDW* DQG* DQWLaPRXVH* e'La
DQRYDRUFRQMXJDWHGWRÀXRUHVFHQWG\HVDQWLPRXVHDQGDQWLUDW
$OH[D*)OXRU*G/M*DV*ZHOO*DV*DQWLaUDW*$OH[D*)OXRU*/OO*e,QYLWURJHQff*
ZHUH*DSSOLHG]*)RU*GHWHFWLRQ*RI*+53aFRQMXJDWHG*DQWLERGLHV-*DQ*(&/*
3OXVUHDJHQW*(+HDOWKFDUH7KHUPR6FLHQWL¿FZDVXVHG
&HOOFXOWXUHWUDQVIHFWLRQDQGLPPXQRÀXRUHVFHQFHVWDLQLQJ
+(.*Dd.7*DQG*%+.*FHOOV*ZHUH* FXOWXUHG* LQ*'0(0*VXSSOHa
PHQWHG*ZLWK*,[l* IHWDO* FDOI* VHUXP*DQG*A[*jJ^PO*JHQWDP\FLQH*
e3$$f]*0()*FHOOV*ZHUH* FXOWXUHG* LQ*'0(0*VXSSOHPHQWHG*ZLWK*
 IHWDO FDOI VHUXPP0ȕPHUFDSWRHWKDQRO ,QYLWURJHQ 
P0* OaJOXWDPLQH-* ,î*0(0*QRQaHVVHQWLDO* DPLQR* DFLGV-* ,[[*8^PO*
SHQLFLOOLQ* DQG*,[[*J^PO* VWUHSWRP\FLQ* e3$$f]*(6&V* LQFOXGLQJ* -,*
ZW-*'QPW!íí-*(,/*ZW* DQG*8KUI!íí*ZHUH* FXOWXUHG*ZLWKRXW* IHHGHU*
FHOOV LQJHODWLQL]HGÀDVNVDVGHVFULEHG>@&XOWXUHPHGLXPZDV
VXSSOHPHQWHG*ZLWK*,*[[[*8^PO* UHFRPELQDQW* OHXNHPLD* LQKLELWRU\*
IDFWRU* e0LOOLSRUHf]*7KH*'QPW!íí*(6&V*XVHG* LQ* WKLV*VWXG\*DUH*KRa
PR]\JRXV**IRU*WKH*F*DOOHOH*>GO@]*0RXVH*(,/*ZW*DQG*8KUI!íí*FHOOV*
KDYH*EHHQ*UHSRUWHG*EHIRUH*>G,@]*0RXVH*(6&V*DQG*0()*FHOOV*ZHUH*
WUDQVIHFWHG*ZLWK*)X*(1(*+'* e5RFKHf-*/LSRIHFWDPLQHp*D*[[[*
RU*.*[[[*UHDJHQW*e,QYLWURJHQf*DFFRUGLQJ*WR* WKH*PDQXIDFWXUHU¶V* LQa
VWUXFWLRQV]*+(.*Dd.7*FHOOV*DQG*%+.*FHOOV*ZHUH*WUDQVIHFWHG*XVLQJ*
SRO\HWK\OHQLPLQH*DV*WUDQVIHFWLRQ*UHDJHQW*e6LJPDf*DFFRUGLQJ*WR*WKH*
PDQXIDFWXUHU¶V* LQVWUXFWLRQV]*&HOO* IL[DWLRQ* DQG*PLFURVFRS\*ZHUH*
FDUULHG*RXW*DV*GHVFULEHG*>.A@]
*HQHUDWLRQ*RI*VWDEOH*(6&*OLQHV*DQG*'1$*PHWK\ODWLRQ*DQDOG
\VHV
)RUW\aHLJKW*KRXUV*DIWHU*H[SUHVVLRQ*RI**)3aWDJJHG*FRQVWUXFWV*LQ*
'QPW!íí*RU*8KUI!íí*(6&V-**)3aSRVLWLYH*PRXVH*(6&V*ZHUH*VHSDa
UDWHGXVLQJDÀXRUHVFHQFHDFWLYDWHGFHOOVRUWLQJ)$&6$ULD,,LQa
VWUXPHQW*e%HFWRQ*'LNLQVRQf]*6WDEO\*H[SUHVVLQJ*FHOOV*ZHUH*H[SDQGa
HG*LQ*VHOHFWLRQ*PHGLXP*FRQWDLQLQJ*,[*jJ^PO*EODVWLFLGLQ*e*)3a'1a
07ZW DQG*)3'107¨ RU QJPOSXURP\FLQ
e8+5),a*)3*ZW-*+./G**DQG*+M.[$f* DQG**)3aSRVLWLYH* FHOOV*
ZHUH*)$&6*VRUWHG*D* VHFRQG* WLPH]*)XUWKHUPRUH-* WKH*8+5),a*)3*
ZW-*+./G**DQG*+M.[$*FHOO* OLQHV*ZHUH* VLQJOHaFHOO* VRUWHG]*6LQJOH*
FORQHVRI*)3'107¨DQGFRUUHVSRQGLQJZW>@ZHUH
SLFNHG*PDQXDOO\]*)RU* DOO* FHOO* OLQHV-* FORQHV*ZLWK* ORZ*H[SUHVVLRQ*
OHYHOV*ZHUH*FKRVHQ*IRU*IXUWKHU*DQDO\VHV]*7KH*OHYHO*DQG*WKH*DFFXUDF\*
RI* WKH*H[SUHVVHG**)3*IXVLRQ*FRQVWUXFWV*ZHUH*FKHFNHG*E\*ZHVWHUQ*
EORW*DQDO\VHV*e)LJXUH*.$*DQG*6XSSOHPHQWDU\*LQIRUPDWLRQ-*)LJXUHV*
6,%*DQG*6.'f]*)RU* IXQFWLRQDO* DQDO\VHV* RI**)3a'107,*ZW* DQG*
*)3'1078,0PXWDQWV ¨'$($6$
DQG*'.O,$a(.OD$a0.OA$a6.dD$a'.dA$f* DV*ZHOO* DV*8+5),a
6Q
'1$(PHWK\ODWLRQ(UHTXLUHV('1076(XELTXLWLQ(LQWHUDFWLQJ(PRWLIQSJ
&HOO(5HVHDUFK(_(ZZZ<QDWXUH<FRPCFU
*)3*ZW*RU*8+5),a*)3*SRLQW*PXWDQWV* e+./G**DQG*+M.[$f*E\*
WUDQVLHQW* UHVFXH*DVVD\V-*/O*K*DIWHU*H[SUHVVLRQ*RI* WKHVH*SURWHLQV* LQ*
'QPW!íí*RU*8KUI!íí(6&V-* UHVSHFWLYHO\-**)3aSRVLWLYH* FHOOV*ZHUH*
FROOHFWHGZLWK)$&6*HQRPLF'1$ LVRODWLRQ ELVXO¿WH FRQYHUa
VLRQ*DQG*3&5*FRQGLWLRQV*ZHUH*GHVFULEHG*EHIRUH*>G-*G[-*Gd@]*3ULPHU*
VHWV* XVHG* IRU* DPSOLILFDWLRQ*RI*PLQRU* VDWHOOLWHV-*PDMRU* VDWHOOLWHV-*
VNHOHWDOĮDFWLQ*DQG*WKH*'QPW!R*SURPRWHU*DUH*OLVWHG*LQ*6XSSOHPHQa
WDU\* LQIRUPDWLRQ-*7DEOH*6,]*$OO*3&5*SURGXFWV*ZHUH* DQDO\]HG*E\*
S\URVHTXHQFLQJ*e9DULRQRVWLFf-*ZKLFK*UHVXOWV*LQ*D*TXDQWLWDWLYH*GDWD*
VHW*IRU*LQGLYLGXDO*&S**VLWHV*>M[@]
&RGLPPXQRSUHFLSLWDWLRQ*DQG*ZHVWHUQ*EORWWLQJ
)RU* FRaLPPXQRSUHFLSLWDWLRQ* DVVD\V-* WKH**)3*DQG*5)3-*&K*RU*
+LV* IXVLRQ* FRQVWUXFWV*ZHUH* FRaH[SUHVVHG* LQ*+(.*Dd.7*FHOOV* DQG*
SURWHLQ* H[WUDFWV*ZHUH*QRUPDOL]HG* WR* WKH* VDPH**)3*RU*5)3*FRQa
FHQWUDWLRQ*SULRU* WR*FRaLPPXQRSUHFLSLWDWLRQ*ZLWK* WKH**)3a7UDS*RU*
5)3a7UDS* e&KURPRWHNf]*%RXQG* IUDFWLRQV*ZHUH* ILUVW* GHWHFWHG*E\*
ÀXRUHVFHQFH LQWHQVLW\PHDVXUHPHQWV DQG VHFRQGE\ZHVWHUQEORW
DQDO\VHV]
$FLG*H[WUDFWLRQ*DQG*7&$*SUHFLSLWDWLRQ*RI*KLVWRQHV
+LVWRQHV*ZHUH*LVRODWHG*E\*DFLG*H[WUDFWLRQ*DV*UHSRUWHG*SUHYLRXVa
O\*>M,@]*,Q*EULHI-*,[M*PRXVH*(6&V*RU*+(.*Dd.7*FHOOV*ZHUH*WUHDWHG*
LQ*K\SRWRQLF*EXIIHU*e,[*P0*7ULVa+&O*S+*O-*,[*P0*.&O-*,]A*P0*
0J&OD-*,*P0*'77*DQG*,î*3URWHDVH* ,QKLELWRU-*D*P0*306)f* IRU*
.[*PLQ*DQG*FHQWULIXJHG*DW*,*[[[î*J*DW*/*s&*WR*JHW*WKH*LQWDFW*QXFOHL]*
$IWHU*ZDVKLQJ* VWHSV-* QXFOHL*ZHUH* UHVXVSHQGHG* LQ* []/*1*+D62/*
DQG*LQFXEDWHG*RQ*D*URWDWRU*DW*/*s&*RYHUQLJKW]*$IWHU*FHQWULIXJDWLRQ-*
KLVWRQHV* LQ* WKH* VXSHUQDWDQW*ZHUH* WUDQVIHUUHG* LQWR* D* IUHVK* UHDFWLRQ*
WXEH*DQG*SUHFLSLWDWHG*XVLQJ*..l*WULFKORURDFHWLF*DFLG*e7&$f]*$IWHU*
ZDVKLQJ*WZLFH*ZLWK*FROG*DFHWRQH-*KLVWRQHV*ZHUH*GLVVROYHG*LQ*+D2]*
+LVWRQH*FRQFHQWUDWLRQV*ZHUH*PHDVXUHG*XVLQJ*WKH*3LHUFH70*GG[*QP*
SURWHLQDVVD\NLW7KHUPR6FLHQWL¿F
8ELTXLWLQDWHG*KLVWRQH*ELQGLQJ*H[SHULPHQW
)RU*XELTXLWLQDWHG*KLVWRQH*ELQGLQJ* H[SHULPHQW-* DFLG* H[WUDFWHG*
KLVWRQHV* IURP*+(.*Dd.7*FHOOV*ZHUH*XVHG]**)3a'107,*DQG* LWV*
PXWDQWV*ZHUH*LPPRELOL]HG*RQ*WKH**)3a7UDS*e&KURPRWHNf*DQG*LQa
FXEDWHG*ZLWK*HTXDO*DPRXQWV*RI*DFLG*H[WUDFWHG*KLVWRQHV*IRU*.[*PLQ*
DW*/*s&]*$IWHU*ZDVKLQJ*VWHSV-*WKH*ERXQG*IUDFWLRQV*ZHUH*DQDO\]HG*E\*
ZHVWHUQ*EORW]
'XH WRXQVSHFL¿FELQGLQJRI KLVWRQHV WR WKH HSSHQGRUI WXEHV
ZH*XVHG* HSSHQGRUI* WXEHV*ZLWK* ORZ*ELQGLQJ* DIILQLW\* GXULQJ*PDVV*
VSHFWURPHWU\*VDPSOH*SUHSDUDWLRQ]
,PPXQRSUHFLSLWDWLRQ*RI*XELTXLWLQDWHG**)3G+L
*)3a+.*ZW* DQG*5D$*PXWDQW* FRQVWUXFWV*ZHUH* FRaH[SUHVVHG* LQ*
+(.*Dd.7*FHOOV*ZLWK*8+5),a+LV* DQG*KDUYHVWHG* DIWHU* WUHDWPHQW*
ZLWK*D*P0*1aHWK\OPDOHLPLGH*e1(0-*$SSOL&KHPf*IRU*A*PLQ]*/\a
VDWHVZHUHSUHSDUHGE\¿UVWO\LVRODWLQJQXFOHLLQK\SRWRQLFEXIIHU
e,[*P0*+(3(6*S+*M]d-*,[*P0*.&O-*[],*P0*0J&OD-*,[l*JO\Fa
HURO-*[],*P0*('7$-*[],*P0*'77-*,î*SURWHDVH* LQKLELWRU-*D*P0*
306)-*[],l*13a/[-*[]GDA*PJ^PO*1(0f*DQG*VHFRQGO\*E\*O\VLV*RI*
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,î*SURWHDVH*LQKLELWRU-*D*P0*306)-*,*PJ^PO*'QDVH,*e$SSOL&KHPf-*
[]GDA*PJ^PO*1(0f]*3ULRU* WR* LPPXQRSUHFLSLWDWLRQ-* WKH**)3*FRQa
FHQWUDWLRQ*ZDV* HTXDOL]HG*XVLQJ* O\VDWHV* IURP*8+5),a+LV* WUDQVa
IHFWHG*+(.*Dd.7*FHOOV*IRU*GLOXWLRQ]*$IWHU*LPPXQRSUHFLSLWDWLRQ*RI*
*)3a+.*ZLWK* WKH**)3a7UDS* e&KURPRWHNf* DQG*ZDVKLQJ* eD[*P0*
+(3(6*S+*M]d-*.[[*P0*.&O-*,[l*JO\FHURO-*[],l*7ULWRQ*;a,[[f-*
WKH*ERXQG*IUDFWLRQ*ZDV*DQDO\]HG*E\*ZHVWHUQ*EORW]
)RU* VHPLTXDQWLWDWLYH* DQDO\VLV* RI* WKH**)3a+.*ZW*RU*.,O$-*
.D.$-*.,O$a.D.$*DQG*5D$*XELTXLWLQDWLRQ-*WKH**)3*IXVLRQ*FRQa
VWUXFWV*ZHUH* FRaH[SUHVVHG*ZLWK*+$aXELTXLWLQ* LQ*+(.*Dd.7*FHOOV*
DQG*D*GD\V*DIWHU*WUDQVIHFWLRQ-*WKH*FHOOV*ZHUH*KDUYHVWHG*DV*GHVFULEHG*
DERYH*DQG*IXUWKHU*SURFHVVHG*DV*UHSRUWHG*SUHYLRXVO\*>Dd@]
)L+*DVVD\*DQG*WUDSSLQJ*DVVD\
7KH*).+*DVVD\*ZDV*SHUIRUPHG*DV*GHVFULEHG*SUHYLRXVO\*>GA@]*,Q*
WKH* WUDSSLQJ* DVVD\-*PRXVH*(6&V* VWDEO\* H[SUHVVLQJ**)3a'107,*
ZWRU¨ZHUH FXOWXUHG LQ ,ELGL FKDPEHUV DQG LQFXEDWHG
ZLWK0RIWKHF\WRVLQHDQDORJXHD]DƍGHR[\F\WLGLQH6LJa
PDf]*,PDJHV*ZHUH*DFTXLUHG*ZLWK*D*8OWUD9,(:*9R;*VSLQQLQJ*GLVF*
PLFURVFRSH*e3HUNLQ(OPHUf*DVVHPEOHG*WR*DQ*$[LR*2EVHUYHU*',*LQa
YHUWHG*VWDQG*e=HLVVf*DQG*XVLQJ*D*G.î^,]/*1$*3ODQa$SRFKURPDW*RLO*
LPPHUVLRQ*REMHFWLYH]
,Q*YLWUR*SHSWLGH*SXOOGGRZQ*DVVD\
7KH*SHSWLGH*SXOOaGRZQ*DVVD\*IURP*QXFOHDU*FHOO*H[WUDFWV*RI*+(.*
Dd.7*FHOOV* H[SUHVVLQJ*8+5),a*)3* IXVLRQ* FRQVWUXFWV*ZDV*SHUa
IRUPHGDVGHVFULEHG>@ZLWKWKHIROORZLQJPRGL¿FDWLRQV&WHUa
PLQDOO\*ELRWLQ\ODWHG*KLVWRQH*SHSWLGHV*ZHUH*SXUFKDVHG* IURP*36/*
DQG*DUH*OLVWHG*LQ*6XSSOHPHQWDU\*LQIRUPDWLRQ-*7DEOH*6D]*6WUHSWDFWLQ*
EHDGV*e,EDf*ZHUH*XVHG*IRU*WKH*LPPRELOL]DWLRQ*RI*ELRWLQ\ODWHG*SHSa
WLGHV*LQ*ELQGLQJ*EXIIHU*e,[*P0*7ULVa+&O-*S+*M]A-*.[[*P0*1D&O-*
[]A*P0*('7$-*,*P0*'77f]*$IWHU* WKH*ELQGLQJ* UHDFWLRQ-* EHDGV*
ZHUH*ZDVKHG*IRXU*WLPHV*ZLWK*ZDVK*EXIIHU*eD[*P0*+(3(6*S+*M]d-*
D[l*JO\FHURO-*[]D*P0*('7$-*.[[*P0*.&O-*[],l*7ULWRQ*;a,[[f]*
%RXQG* IUDFWLRQV*ZHUH* HOXWHG*E\*ERLOLQJ* LQ* Dî*/DHPPOL* VDPSOH*
EXIIHU*DQG*DQDO\]HG*E\*ZHVWHUQ*EORW]
0DVV*VSHFWURPHWU\
7KH*JHO*ZDV*VWDLQHG*ZLWK*&RRPDVVLH*DQG*+.*EDQGV*ZHUH*PDQXa
DOO\*H[FLVHG-*SURSLRQ\ODWHG*DQG*GLJHVWHG*ZLWK*WU\SVLQ*DV*GHVFULEHG*
EHIRUH >@ZLWKPLQRUPRGL¿FDWLRQV)RUSHSWLGHH[WUDFWLRQJHO
VOLFHV*ZHUH*LQFXEDWHG*WZLFH*ZLWK*A[*jO*RI*A[l*DFHWRQLWULOH*[]DAl*
7)$*DQG*WZLFH*PRUH*ZLWK*A[*jO*RI*DFHWRQLWULOH]*7KH*UHVXOWLQJ*OLTXLG*
FRQWDLQLQJ* WKH*GLJHVWHG*SHSWLGHV*ZDV* WRWDOO\* HYDSRUDWHG-* UHGLVa
VROYHGZLWKORIIRUPLFDFLGDQGVWRUHGDWí&XQWLO
IXUWKHU*SURFHVVLQJ]
7U\SWLF* SHSWLGHV*ZHUH* LQMHFWHG* eA*jOf* LQ* DQ*8OWLPDWH* .* [[[*
+3/&*V\VWHP*e/&*3DFNLQJV*'LRQH[f]*6DPSOHV*ZHUH*GHVDOWHG*RQa
OLQH*LQ*D*&,O*PLFURFROXPQ*e.[[*P*L]G]*î*A*PP-*SDFNHG*ZLWK*&,O*
3HS0DSt-*A*jP-*,[[*c*E\*/&*3DFNLQJVf-*DQG*SHSWLGHV*ZHUH*VHSa
DUDWHG*ZLWK*D*JUDGLHQW*IURP*Al*WR*G[l*DFHWRQLWULOH*LQ*[],l*IRUPLF*
DFLG*RYHU* /[*PLQ* DW* .[[*QO^PLQ*RQ* D*&,O* DQDO\WLFDO* FROXPQ* eMA*
jP*L]G]*î*,A*FP-*SDFNHG*ZLWK*&,O*3HS0DSt-*.*jP-*,[[*c*E\*/&*
3DFNLQJVf]
7KH HIÀXHQW IURP WKH+3/&ZDVGLUHFWO\ HOHFWURVSUD\HG LQWR
D*OLQHDU*WUDS*TXDGUXSROHa2UELWUDS*;/*PDVV*VSHFWURPHWHU*e7KHUPR*
)LVKHU*6FLHQWLILFf]*7KH*06* LQVWUXPHQW*ZDV*RSHUDWHG* LQ* GDWDaGHa
SHQGHQW*PRGH]*6XUYH\*IXOOaVFDQ*06*VSHFWUD*eIURP*P^]*.[[±D*[[[f*
ZHUH*DFTXLUHG*LQ*WKH*2UELWUDS*ZLWK*UHVROXWLRQ*5* *G[*[[[*DW*P^]*/[[*
eDIWHU*DFFXPXODWLRQ*WR*D*³WDUJHW*YDOXH´*RI*A[[*[[[*LQ*WKH*OLQHDU*LRQ*
WUDSf]*7KH*VL[*PRVW*LQWHQVH*SHSWLGH*LRQV*ZLWK*FKDUJH*VWDWHV*EHWZHHQ*
WZR*DQG*IRXU*ZHUH*VHTXHQWLDOO\*LVRODWHG*WR*D*WDUJHW*YDOXH*RI*,[*[[[*
DQG*IUDJPHQWHG*E\*FROOLVLRQaLQGXFHG*GLVVRFLDWLRQ*DQG*UHFRUGHG*LQ*
WKH*OLQHDU*LRQ*WUDS]*)RU*DOO*PHDVXUHPHQWV*ZLWK*WKH*2UELWUDS*GHWHFa
WRU-* WKUHH* ORFNaPDVV* LRQV*ZHUH*XVHG* IRU* LQWHUQDO* FDOLEUDWLRQ* >M/@]*
:HLKXD(4LQ(HW#DO<
6R
QSJ
ZZZ<FHOO:UHVHDUFK<FRP(_(&HOO(5HVHDUFK
7\SLFDO*06*FRQGLWLRQV*ZHUH*VSUD\*YROWDJH-*,]A*N9V*QR*VKHDWK*DQG*
DX[LOLDU\JDVÀRZKHDWHGFDSLOODU\WHPSHUDWXUH&QRUPDOa
L]HG*FROOLVLRQaLQGXFHG*GLVVRFLDWLRQ*HQHUJ\*.AlV*DFWLYDWLRQ*T* *[]DAV*
DQG*DFWLYDWLRQ*WLPH* *.[*PV]
0DVFRW ZDVXVHG IRU SURWHLQ LGHQWL¿FDWLRQZLWK WKH IROa
ORZLQJ* VHWWLQJV\*'DWDEDVH\*6ZLVVSURW* AM]MV*7D[RQRP\\*+RPR* VDG
SLHQV*eKXPDQfV*06*WROHUDQFH\*,[*SSPV*06^06*WROHUDQFH\*[]A*'DV*
SHSWLGH*)'5\*[],V*SURWHLQ*)'5\*[][,V*PLQLPXP*SHSWLGH*OHQJWK\*AV*
DQGYDULDEOHPRGL¿FDWLRQVSURSLRQ\O.1WHUP*O\*O\.
4XDQWL¿FDWLRQRIPRGL¿HG+SHSWLGHVZDVEDVHGRQWKH
LQWHQVLWLHV* RI* WKH*06,*SHDNV]*7KH* VSHFWUD* GHSLFWHG* LQ*)LJXUH*/$*
DQG*/%*ZHUH*XVHG*WR*GHWHUPLQH*WKH*H[DFW*PDVVHV*eP^]*z*,[*SSPf*
DQGXVHGDVDUHIHUHQFHIRUIXUWKHUTXDQWL¿FDWLRQ
4XDQWLWDWLYH*DQDO\VLV*RI*'107!*VXEQXFOHDU*ORFDOL]DWLRQ
'XULQJ*ODWH*6*SKDVH-*'107,*LV*HQULFKHG*LQ*UHSOLFDWLRQ*IRFL*DW*
FKURPRFHQWHUV]*,Q*RUGHU*WR*TXDQWLI\*WKH*VXEQXFOHDU*GLVWULEXWLRQ*RI*
*)3'107ZW DQGGH¿QHG8,0PXWDQWV WKH IROORZLQJSURFHa
GXUH*ZDV*XVHG\*FRQIRFDO*]aVWDFNV*e[]D,*jP*LQWHUYDOf*ZHUH*DFTXLUHG*
ZLWK* LGHQWLFDO* VFDQ* VHWWLQJV* LQ* WKUHH* FRORU* FKDQQHOV* WR* YLVXDOL]H*
UHSOLFDWLRQ*IRFL*eDQWLa3&1$*VWDLQLQJ-*Ad/*QP*H[FLWDWLRQf-*'107,*
ORFDOL]DWLRQ* e*)3a'107,* IXVLRQV* HQKDQFHG*ZLWK**)3aERRVWHU*
e&KURPRWHNf-*/OO*QP*H[FLWDWLRQf*DQG*'1$*FRXQWHUVWDLQLQJ*e'$3,-*
/[A*QP*H[FLWDWLRQf]*)RU* HDFK* FRORU* FKDQQHO-*PD[LPXP* LQWHQVLW\*
SURMHFWLRQV*ZHUH* FDOFXODWHG* DQG*RQO\**)3aH[SUHVVLQJ* FHOOV*ZHUH*
DQDO\]HG]*6HJPHQWDWLRQ*RI* UHSOLFDWLRQ* IRFL* RU*ZKROH*QXFOHL*ZDV*
SHUIRUPHG*ZLWK* WKH*:HND* VHJPHQWDWLRQ*SOXJLQ* >MA@* LQ*)LML* >MG@]*
7UDLQLQJRIWKHFODVVL¿HUZDV¿QDOL]HGXQWLOWKHUHVXOWPDWFKHGWKH
YLVXDO*LPSUHVVLRQ*e)LJXUH*M$f]*'XH*WR*YDULDWLRQV*LQ*(6&*VDPSOHV-*
UHSOLFDWLRQ IRFLZHUH VHJPHQWHGXVLQJGLIIHUHQW FODVVL¿HUV IRUZW
RU* WKH*GLIIHUHQW*8,0*PXWDQWV]* ,Q* FRQWUDVW-* IRU* DOO* VRPDWLF* FHOOV-*
RQH* FODVVLILHU*ZDV* VXIILFLHQW* WR* VHJPHQW* UHSOLFDWLRQ* IRFL]*:KROH*
QXFOHLZHUH VHJPHQWHGE\DFODVVL¿HUEDVHGRQ WKH'$3, VLJQDO
$IWHU:HNDVHJPHQWDWLRQWKHUHVXOWLQJELQDU\PDVNVZHUH¿OWHUHG
XVLQJWKHSDUWLFOHDQDO\]HURI)LMLZLWKDFLUFXODULW\YDOXH
7RVHOHFWIRUFHOOVLQODWH6SKDVHRQO\UHSOLFDWLRQIRFLSL[HO
ZKHUH*IXUWKHU*DQDO\]HG*LQ*WKH*(6&*VDPSOHV]*,Q*0()*FHOO*VDPSOHV-*
RQO\*ODWH*6*SKDVH*FHOOV*ZHUH*LPDJHG*DQG*DQDO\]HG*ZLWKRXW*DSSO\LQJ*
VL]H*H[FOXVLRQ*IRU*UHSOLFDWLRQ*IRFL]*1XFOHDU*PDVNV*VL]HSL[a
HOf*ZHUH*XVHG*WR*TXDQWLI\*WKH*WRWDO*DPRXQW*RI**)3*IXVLRQ*SURWHLQ*LQ*
D*VLQJOH*QXFOHXV]*1XFOHL*ZHUH*IXUWKHU*VXEVHJPHQWHG*E\*UHSOLFDWLRQ*
IRFL*PDVNV]*)RU* HDFK*QXFOHXV-* WKH* UDWLR* EHWZHHQ* WKH*PHDQ**)3*
VLJQDOV*LQ*UHSOLFDWLRQ*IRFL*UHODWLYH*WR*WKH*PHDQ**)3*VLJQDO*RXWVLGH*
WKH*IRFL*ZDV*FDOFXODWHG]*5DZ*GDWD*ZHUH*FRUUHFWHG*IRU*EDFNJURXQG*
VLJQDOV*E\*VXEWUDFWLQJ*WKH*PRGDO*JUH\*YDOXH]*5DWLRV*IURP*DOO*QXFOHL*
H[SUHVVLQJ**)3a'107,*ZW*RU*8,0*PXWDQWV*ZHUH*YLVXDOL]HG* DV*
ER[*SORWV]*1XPHULFDO*FDOFXODWLRQV*DQG*VWDWLVWLFDO*DQDO\VLV*ZHUH*SHUa
IRUPHG*ZLWK*5*>MM@]
6WDWLVWLFDO*DQDO\VLV
5HVXOWV*ZHUH*H[SUHVVHG*DV*PHDQ*YDOXHV*z*6'*RU*DV*PHDQ*YDOXHV*
z*6(0*IURP* WKH*QXPEHU*RI*ELRORJLFDO* UHSOLFDWHV* LQGLFDWHG* LQ* WKH*
FRUUHVSRQGLQJ¿JXUHOHJHQG
$FNQRZOHGJPHQWV
:H*WKDQN*6WHIDQ*-HQWVFK* e0D[*3ODQFN* ,QVWLWXWH*RI*%LRFKHPLVa
WU\-**HUPDQ\f*IRU*SURYLGLQJ*WKH*+$aXELTXLWLQ*FRQVWUXFW*DQG*3HWHU*
%HFNHU* e$GROI*%XWHQDQGW* ,QVWLWXWH-**HUPDQ\f* IRU* WKH*G[,*'1$*
FRQVWUXFW]*:H*DUH*JUDWHIXO*WR*WKH*IROORZLQJ*FROOHDJXHV*IRU*SURYLGa
LQJ*(6&V*DQG*VRPDWLF*FHOOV\*0DVDKLUR*0XWR*DQG*+DUXKLNR*.RVHa
NL* IRU*PRXVH*(,/*ZW* DQG*8KUI!íí*(6&VV*(Q*/L* DQG*7]*&KHQ* IRU*
PRXVH*-,*ZW*DQG*'QPW!ííV*7KRPDV*-HQXZHLQ*IRU*0()*FHOOVV*DQG*/]*
'DYLG*6SHFWRU*IRU*SURYLGLQJ*%+.*FHOOV*FRQWDLQLQJ*D* ODF*RSHUDWRU*
UHSHDW* DUUD\]*:H* WKDQN*(]0]*%DXU* e/XGZLJ*0D[LPLOLDQV*8QLYHUa
VLW\-**HUPDQ\f* IRU* WHFKQLFDO* KHOS*ZLWK* WKH**)3a76*8,0*SRLQW*
PXWDQW* SODVPLG* FRQVWUXFWV]*7KLV*ZRUN*ZDV* VXSSRUWHG*E\*JUDQWV*
IURP*WKH*'HXWVFKH*)RUVFKXQJVJHPHLQVFKDIW*e')*-*6)%,[G/*$,M*
WR*+/*DQG*=[.*WR*$,f-*WKH*1DQRV\VWHP*,QLWLDWLYH*0XQLFK*e1,0*WR*
+/f*DQG*WKH*(SLJHQRPLFV*)ODJVKLS*3URMHFW*e(3,*(1a&15*a,7*WR*
,0%f]*.)*DQG**3*ZHUH*VXSSRUWHG*E\*WKH*,QWHUQDWLRQDO*0D[*3ODQFN*
5HVHDUFK*6FKRRO* IRU*0ROHFXODU* DQG*&HOOXODU*/LIH*6FLHQFHV* e,0a
356a/6f]*3:-*1/*DQG*06*DUH*IHOORZV*RI*WKH**UDGXDWH*6FKRRO*/LIH*
6FLHQFH*0XQLFK*e/60f]*06*LV*D*IHOORZ*RI*WKH*,QWHJUDWHG*5HVHDUFK*
7UDLQLQJ**URXS* e,57*f*RI* WKH*6)%,[G/]*1/*DQG*:4*ZHUH* DOVR*
VXSSRUWHG*E\*WKH*&KLQD*6FKRODUVKLS*&RXQFLO*e&6&f]
5HIHUHQFHV
,** %LUG*$]*'1$*PHWK\ODWLRQ*SDWWHUQV* DQG* HSLJHQHWLF*PHPRU\]*
*HQHV*'HY*D[[DV*%O\GaD,]
D** /HRQKDUGW*+-*3DJH*$:-*:HLHU*+8-*%HVWRU*7+]*$* WDUJHWLQJ*
VHTXHQFH*GLUHFWV*'1$*PHWK\OWUDQVIHUDVH*WR*VLWHV*RI*'1$*UHSa
OLFDWLRQ*LQ*PDPPDOLDQ*QXFOHL]*&HOO*,ddDV*P%\OGAaOM.]
.** &KXDQJ*/6-* ,DQ*+,-*.RK*7:-*1J*++-*;X**-*/L*%)]*+XPDQ*
'1$aeF\WRVLQHaAf*PHWK\OWUDQVIHUDVHa3&1$*FRPSOH[*DV*D*WDUa
JHW*IRU*SD,:$),]*6FLHQFH*,ddMV*\,ddGaD[[[]
/** 6FKQHLGHU*.-*)XFKV*&-*'RED\*$-*HW* DOB*'LVVHFWLRQ*RI* FHOO*
F\FOHaGHSHQGHQW* G\QDPLFV*RI*'QPW,*E\*)5$3*DQG*GLIIXa
VLRQaFRXSOHG*PRGHOLQJ]*1XFOHLF*$FLGV*5HV* D[,.V*Q%\/OG[a
/OMG]
A** (DVZDUDQ*+3-*6FKHUPHOOHK*/-*/HRQKDUGW*+-*&DUGRVR*0&]*
5HSOLFDWLRQaLQGHSHQGHQW* FKURPDWLQ* ORDGLQJ*RI*'QPW,*GXULQJ*
*D*DQG*0*SKDVHV]*(0%2*5HS*D[[/V*R\,,O,a,,OG]
G** 6FKHUPHOOHK*/-*+DHPPHU*$-*6SDGD*)-*HW* DOB*'\QDPLFV*RI*
'QPW,*LQWHUDFWLRQ*ZLWK*WKH*UHSOLFDWLRQ*PDFKLQHU\*DQG*LWV*UROH*
LQ* SRVWUHSOLFDWLYH*PDLQWHQDQFH*RI*'1$*PHWK\ODWLRQ]*1XFOHLF*
$FLGV*5HV*D[[MV*FR\/.[,a/.,D]
M** 6SDGD*)-*+DHPPHU*$-*.XFK*'-*HW*DOB*'107,*EXW*QRW* LWV* LQa
WHUDFWLRQ*ZLWK*WKH*UHSOLFDWLRQ*PDFKLQHU\*LV*UHTXLUHG*IRU*PDLQa
WHQDQFH*RI*'1$*PHWK\ODWLRQ*LQ*KXPDQ*FHOOV]*-*&HOO*%LRO*D[[MV*
%PO\AGAaAM,]
O** 0DUJRW* -%-*$JXLUUHa$UWHWD*$0-*'L**LDFFR*%9-*HW* DOB* 6WUXFa
WXUH*DQG*IXQFWLRQ*RI* WKH*PRXVH*'1$*PHWK\OWUDQVIHUDVH*JHQH\*
'QPW,*VKRZV*D*WULSDUWLWH*VWUXFWXUH]*-*0RO*%LRO*D[[[V*\Dd.a
.[[]
d** )HOOLQJHU*.-*5RWKEDXHU*8-*)HOOH*0-*/DQJVW**-*/HRQKDUGW*+]*
'LPHUL]DWLRQ*RI*'1$*PHWK\OWUDQVIHUDVH*,* LV*PHGLDWHG*E\* LWV*
UHJXODWRU\*GRPDLQ]*-*&HOO*%LRFKHP*D[[dV*%SO\AD,aADO]
,[** 6\HGD*)-*)DJDQ*5/-*:HDQ*0-*HW*DOB*7KH*UHSOLFDWLRQ*IRFXV*WDUa
JHWLQJ*VHTXHQFH*e5)76f*GRPDLQ*LV*D*'1$aFRPSHWLWLYH*LQKLELa
WRU*RI*'QPW,]*-*%LRO*&KHP*D[,,V*\,A.//a,A.A,]
,,** 7DNHVKLWD*.-*6XHWDNH* ,-*<DPDVKLWD*(-*HW*DOB*6WUXFWXUDO* LQVLJKW*
LQWR*PDLQWHQDQFH*PHWK\ODWLRQ*E\*PRXVH*'1$*PHWK\OWUDQVIHUa
DVH*,*e'QPW,f]*3URF*1DWO*$FDG*6FL*86$*D[,,V*\d[AAad[Ad]
,D** $FKRXU*0-*-DFT*;-*5RQGH*3-*HW*DOB*7KH*LQWHUDFWLRQ*RI*WKH*65$*
GRPDLQ*RI* ,&%3d[*ZLWK* D* QRYHO* GRPDLQ*RI*'107,* LV* LQa
YROYHG*LQ*WKH*UHJXODWLRQ*RI*9(*)*JHQH*H[SUHVVLRQ]*2QFRJHQH*
6S
'1$(PHWK\ODWLRQ(UHTXLUHV('1076(XELTXLWLQ(LQWHUDFWLQJ(PRWLIQSJ
&HOO(5HVHDUFK(_(ZZZ<QDWXUH<FRPCFU
D[[OV*\D,OMaD,dM]
,.** )HOOH*0-*-RSSLHQ*6-*1HPHWK*$-*HW*DOB*7KH*863M^'QPW,*FRPa
SOH[* VWLPXODWHV* WKH*'1$*PHWK\ODWLRQ* DFWLYLW\* RI*'QPW,* DQG*
UHJXODWHV* WKH* VWDELOLW\* RI*8+5),]*1XFOHLF*$FLGV*5HV* D[,,V*
FH\O.AAaO.GA]
,/** %HUN\XUHN*$&-*6XHWDNH* ,-*$ULWD*.-*HW* DOB*7KH*'1$*0HWK\Oa
WUDQVIHUDVH*'QPW,*GLUHFWO\* LQWHUDFWV*ZLWK* WKH*6(7*DQG*5,1**
ILQJHU* DVVRFLDWHG* e65$f*GRPDLQ*RI* WKH*PXOWLIXQFWLRQDO* SURa
WHLQ*8KUI,* WR* IDFLOLWDWH* DFFHVVLRQ*RI* WKH* FDWDO\WLF* FHQWHU* WR*
KHPLaPHWK\ODWHG*'1$]*-*%LRO*&KHP*D[,.V*\.Mda.OG]
,A** =KDQJ* --**DR*4-*/L*3-*HW* DOB* 6* SKDVHaGHSHQGHQW* LQWHUDFWLRQ*
ZLWK*'107,*GLFWDWHV* WKH* UROH*RI*8+5),*EXW*QRW*8+5)D* LQ*
'1$*PHWK\ODWLRQ*PDLQWHQDQFH]*&HOO*5HV*D[,,V*\,MD.a,M.d]
,G** %RVWLFN*0-*.LP*-.-*(VWHYH*32-*&ODUN*$-*3UDGKDQ*6-*-DFREVHQ*
6(]*8+5),*SOD\V*D* UROH* LQ*PDLQWDLQLQJ*'1$*PHWK\ODWLRQ* LQ*
PDPPDOLDQ*FHOOV]*6FLHQFH*D[[MV*F%P\,MG[a,MG/]
,M** 6KDULI*--*0XWR*0-*7DNHED\DVKL*6-*HW*DOB*7KH*65$*SURWHLQ*1SdA*
PHGLDWHV*HSLJHQHWLF*LQKHULWDQFH*E\*UHFUXLWLQJ*'QPW,*WR*PHWKa
\ODWHG*'1$]*1DWXUH*D[[MV*QRS\d[Oad,D]
,O** /L*(-*%HVWRU*7+-* -DHQLVFK*5]*7DUJHWHG*PXWDWLRQ*RI* WKH*'1$*
PHWK\OWUDQVIHUDVH*JHQH* UHVXOWV* LQ* HPEU\RQLF* OHWKDOLW\]*&HOO*
,ddDV*OH\d,AadDG]
,d** $ULWD*.-*$UL\RVKL*0-*7RFKLR*+-*1DNDPXUD*<-*6KLUDNDZD*0]*
5HFRJQLWLRQ*RI* KHPLaPHWK\ODWHG*'1$*E\* WKH*65$*SURWHLQ*
8+5)E\DEDVHÀLSSLQJPHFKDQLVP1DWXUH*D[[OV*QRR\O,Oa
OD,]
D[** $YYDNXPRY**9-*:DONHU*-5-*;XH*6-*HW*DOB*6WUXFWXUDO*EDVLV*IRU*
UHFRJQLWLRQ*RI*KHPLaPHWK\ODWHG*'1$*E\* WKH*65$*GRPDLQ*RI*
KXPDQ*8+5),]*1DWXUH*D[[OV*QRR\ODDaODA]
D,** 4LDQ*&-*/L*6-*-DNRQFLF*--*=HQJ*/-*:DOVK*0--*=KRX*00]*6WUXFa
WXUH* DQG*KHPLPHWK\ODWHG*&S**ELQGLQJ*RI* WKH*65$*GRPDLQ*
IURP*KXPDQ*8+5),]*-*%LRO*&KHP*D[[OV*\.//d[a.//d/]
DD** 5RWWDFK*$-*)UDXHU*&-*3LFKOHU**-*%RQDSDFH* ,0-*6SDGD*)-*
/HRQKDUGW*+]*7KH*PXOWLaGRPDLQ*SURWHLQ*1SdA*FRQQHFWV*'1$*
PHWK\ODWLRQDQGKLVWRQHPRGL¿FDWLRQ1XFOHLF*$FLGV*5HV*D[,[V*
\,MdGa,O[/]
D.** &KHQJ* --*<DQJ*<-*)DQJ* --*HW* DOB* 6WUXFWXUDO* LQVLJKW* LQWR* FRa
RUGLQDWHG* UHFRJQLWLRQ*RI* WULPHWK\ODWHG*KLVWRQH*+.* O\VLQH*d*
e+..dPH.f*E\* WKH*SODQW* KRPHRGRPDLQ* e3+'f* DQG* WDQGHP*
WXGRU* GRPDLQ* e77'f*RI*8+5),* eXELTXLWLQaOLNH-* FRQWDLQLQJ*
3+'DQG5,1*¿QJHUGRPDLQVSURWHLQ-*%LRO*&KHP*D[,.V*
\,.Dda,..d]
D/** &LWWHULR*(-*3DSDLW*5-*1LFDVVLR*)-*HW*DOB*1SdA*LV*D*KLVWRQHaELQGa
LQJ*SURWHLQ* HQGRZHG*ZLWK*XELTXLWLQ* OLJDVH* DFWLYLW\]*0RO*&HOO*
%LRO*D[[/V*\DADGaDA.A]
DA** .DUDJLDQQL*3-*$PD]LW*/-*4LQ* --*:RQJ* -]* ,&%3d[-* D* QRYHO*
PHWK\O*.d*+.*ELQGLQJ*SURWHLQ* OLQNLQJ*SURWHLQ*XELTXLWLQDWLRQ*
ZLWK*KHWHURFKURPDWLQ*IRUPDWLRQ]*0RO*&HOO*%LRO*D[[OV*\M[Aa
M,M]
DG** ;LH*6-*-DNRQFLF*--*4LDQ*&]*8+5),*GRXEOH* WXGRU*GRPDLQ*DQG*
WKHDGMDFHQW3+'¿QJHUDFWWRJHWKHUWRUHFRJQL]H.PHFRQa
WDLQLQJ*KLVWRQH*+.*WDLO]*-*0RO*%LRO*D[,DV*Q%R\.,Oa.DO]
DM** 3DSDLW*5-*3LVWRUH*&-**UD]LQL*8-*HW* DOB*7KH*3+'*GRPDLQ*RI*
1SdA* eP8+5),f* LV* LQYROYHG* LQ* ODUJHaVFDOH* UHRUJDQL]DWLRQ*
RI* SHULFHQWURPHULF* KHWHURFKURPDWLQ]*0RO*%LRO*&HOO* D[[OV*
%H\.AA/a.AG.]
DO** -HQNLQV*<-*0DUNRYWVRY*9-*/DQJ*:-*HW* DOB*&ULWLFDO* UROH* RI* WKH*
XELTXLWLQ* OLJDVH* DFWLYLW\* RI*8+5),-* D* QXFOHDU*5,1** ILQJHU*
SURWHLQ-* LQ* WXPRU* FHOO* JURZWK]*0RO*%LRO*&HOO* D[[AV*%O\AGD,a
AGDd]
Dd** 4LQ*:-*/HRQKDUGW*+-*6SDGD*)]*8VSM*DQG*8KUI,*FRQWURO*XELTa
XLWLQDWLRQ*DQG*VWDELOLW\*RI*WKH*PDLQWHQDQFH*'1$*PHWK\OWUDQVa
IHUDVH*'QPW,]*-*&HOO*%LRFKHP*D[,,V*\/.da///]
.[** 'X*=-*6RQJ*--*:DQJ*<-*HW*DOB*'107,*VWDELOLW\*LV*UHJXODWHG*E\*
SURWHLQV* FRRUGLQDWLQJ*GHXELTXLWLQDWLRQ* DQG* DFHW\ODWLRQaGULYHQ*
XELTXLWLQDWLRQ]*6FL*6LJQDO*D[,[V*F\UDO[]
.,** 0XGEKDU\*5-*+RVKLGD*<-*&KHUQ\DYVND\D*<-*HW* DOB*8+5),*
RYHUH[SUHVVLRQ*GULYHV*'1$*K\SRPHWK\ODWLRQ*DQG*KHSDWRFHOOXa
ODU*FDUFLQRPD]*&DQFHU*&HOO*D[,/V*\,dGaD[d]
.D** 1LVKL\DPD*$-*<DPDJXFKL*/-*6KDULI* --*HW*DOB*8KUI,aGHSHQGHQW*
+..D.*XELTXLW\ODWLRQ*FRXSOHV*PDLQWHQDQFH*'1$*PHWK\ODWLRQ*
DQG*UHSOLFDWLRQ]*1DWXUH*D[,.V*\D/daDA.]
..** 6FKHUPHOOHK*/-*6SDGD*)-*(DVZDUDQ*+3-*HW* DOB*7UDSSHG* LQ* DFa
WLRQ\*GLUHFW*YLVXDOL]DWLRQ*RI*'1$*PHWK\OWUDQVIHUDVH*DFWLYLW\*LQ*
OLYLQJ*FHOOV]*1DW*0HWKRGV*D[[AV*\MA,aMAG]
./** /LX*;-**DR*4-*/L*3-*HW*DOB*8+5),* WDUJHWV*'107,*IRU*'1$*
PHWK\ODWLRQ* WKURXJK* FRRSHUDWLYH*ELQGLQJ*RI* KHPLaPHWK\ODWHG*
'1$*DQG*PHWK\ODWHG*+..d]*1DW*&RPPXQ*D[,.V*Q\,AG.]
.A** /'DPEDFKHU*6-*'HQJ*:-*+DKQ*0-*HW* DOB*&(13a&* IDFLOLWDWHV*
WKH*UHFUXLWPHQW*RI*0,O%3,*WR*FHQWURPHULF*FKURPDWLQ]*1XFOHXV*
D[,DV*F\,[,a,,[]
.G** =ROJKDGU*.-*0RUWXVHZLF]*2-*5RWKEDXHU*8-*HW*DOB$ÀXRUHVFHQW
WZRaK\EULG* DVVD\* IRU* GLUHFW* YLVXDOL]DWLRQ*RI* SURWHLQ* LQWHUDFa
WLRQV*LQ*OLYLQJ*FHOOV]*0RO*&HOO*3URWHRPLFV*D[[OV*P\DDMdaDDOM]
.M** +X*/-*/L*=-*:DQJ*3-*/LQ*<-*;X*<]*&U\VWDO* VWUXFWXUH* RI*3+'*
GRPDLQRI8+5)DQGLQVLJKWVLQWRUHFRJQLWLRQRIXQPRGL¿HG
KLVWRQH*+.*DUJLQLQH*UHVLGXH*D]*&HOO*5HV*D[,,V*\,.M/a,.MO]
.O** 5DMDNXPDUD*(-*:DQJ*=-*0D*+-*HW*DOB3+'¿QJHUUHFRJQLWLRQ
RIXQPRGL¿HGKLVWRQH+5OLQNV8+5)WRUHJXODWLRQRIHXa
FKURPDWLF*JHQH*H[SUHVVLRQ]*0RO*&HOO*D[,,V*QF\DMAaDO/]
.d** :DQJ*&-*6KHQ*--*<DQJ*=*HW*DOB6WUXFWXUDOEDVLVIRUVLWHVSHFL¿F
UHDGLQJRIXQPRGL¿HG5RIKLVWRQH+WDLOE\8+5)3+'
¿QJHU&HOO*5HV*D[,,V*\,.Mda,.OD]
/[** )UDXHU*&-*/HRQKDUGW*+]*$*YHUVDWLOH*QRQaUDGLRDFWLYH*DVVD\* IRU*
'1$*PHWK\OWUDQVIHUDVH* DFWLYLW\* DQG*'1$*ELQGLQJ]*1XFOHLF*
$FLGV*5HV*D[[dV*FP\HDD]
/,** %HVWRU*7+-* ,QJUDP*90]*7ZR*'1$*PHWK\OWUDQVIHUDVHV* IURP*
PXULQH* HU\WKUROHXNHPLD* FHOOV\* SXULILFDWLRQ-* VHTXHQFH* VSHFLa
¿FLW\DQGPRGHRILQWHUDFWLRQZLWK'1$3URF*1DWO*$FDG*6FL*
86$*,dO.V*\AAAdaAAG.]
/D** <RGHU* -$-*6RPDQ*16-*9HUGLQH**/-*%HVWRU*7+]*'1$* eF\WRa
VLQHaAfaPHWK\OWUDQVIHUDVHV*LQ*PRXVH*FHOOV*DQG*WLVVXHV]*6WXGLHV*
ZLWK* D*PHFKDQLVPaEDVHG*SUREH]*-*0RO*%LRO* ,ddMV*\.OAa
.dA]
 -HOWVFK$2QWKHHQ]\PDWLFSURSHUWLHVRI'QPWVSHFL¿FLW\
SURFHVVLYLW\-*PHFKDQLVP*RI*OLQHDU*GLIIXVLRQ*DQG*DOORVWHULF*UHJa
XODWLRQ*RI*WKH*HQ]\PH]*(SLJHQHWLFV*D[[GV*%\G.aGG]
//** %DVKWU\NRY*3-* -DQNHYLFLXV**-* -XUNRZVND*5=-*5DJR]LQ*6-*
-HOWVFK*$]*7KH*8+5),*SURWHLQ*VWLPXODWHV*WKH*DFWLYLW\*DQG*VSHFa
L¿FLW\RIWKHPDLQWHQDQFH'1$PHWK\OWUDQVIHUDVH'107E\
DQ*DOORVWHULF*PHFKDQLVP]*-*%LRO*&KHP*D[,/V*\/,[Ga/,,A]
/A** 5RWKEDUW*6%-*'LFNVRQ*%0-*2QJ*06-*HW*DOB*0XOWLYDOHQW*KLVWRQH*
HQJDJHPHQW* E\* WKH* OLQNHG* WDQGHP*7XGRU* DQG*3+'*GRPDLQV*
RI*8+5),* LV* UHTXLUHG* IRU* WKH*HSLJHQHWLF* LQKHULWDQFH*RI*'1$*
PHWK\ODWLRQ]**HQHV*'HY*D[,.V*\,DOOa,DdO]
/G** 5RWKEDUW*6%-*.UDMHZVNL*.-*1DG\*1-*HW* DOB*$VVRFLDWLRQ*RI*
8+5),*ZLWK*PHWK\ODWHG*+..d*GLUHFWV* WKH*PDLQWHQDQFH*RI*
'1$*PHWK\ODWLRQ]*1DW*6WUXFW*0RO*%LRO*D[,DV*%H\,,AAa,,G[]
/M** 6RQJ*--*5HFKNREOLW*2-*%HVWRU*7+-*3DWHO*'-]*6WUXFWXUH*RI*'1a
07,a'1$*FRPSOH[*UHYHDOV*D*UROH*IRU*DXWRLQKLELWLRQ*LQ*PDLQa
:HLKXD(4LQ(HW#DO<
6;
QSJ
ZZZ<FHOO:UHVHDUFK<FRP(_(&HOO(5HVHDUFK
WHQDQFH*'1$*PHWK\ODWLRQ]*6FLHQFH*D[,,V*FF%\,[.Ga,[/[]
/O** .DOE*5-*/DWZLHO*6-*%D\PD]*+,-*HW*DOB*+LVWRQH*+D$*PRQRXELTa
XLWLQDWLRQ*SURPRWHV* KLVWRQH*+.*PHWK\ODWLRQ* LQ*3RO\FRPE* UHa
SUHVVLRQ]*1DW*6WUXFW*0RO*%LRO*D[,/V*\AGdaAM,]
/d** /HHE*0-*:XW]*$]*5,1*,%*LV*FUXFLDO*IRU*WKH*UHJXODWLRQ*RI*GHa
YHORSPHQWDO*FRQWURO*JHQHV*DQG*35&,*SURWHLQV*EXW*QRW*;*LQDFa
WLYDWLRQ*LQ*HPEU\RQLF*FHOOV]*-*&HOO*%LRO*D[[MV*\D,daDDd]
A[** %ODFNOHGJH*13-*)DUFDV*$0-*.RQGR*7-*HW* DOB*9DULDQW*35&,*
FRPSOH[aGHSHQGHQW*+D$*XELTXLW\ODWLRQ*GULYHV*35&D* UHFUXLWa
PHQW*DQG*SRO\FRPE*GRPDLQ*IRUPDWLRQ]*&HOO*D[,/V*%RP\,//Aa
,/Ad]
A,** 9LUH*(-*%UHQQHU*&-*'HSOXV*5-*HW*DOB*7KH*3RO\FRPE*JURXS*SURa
WHLQ*(=+D*GLUHFWO\* FRQWUROV*'1$*PHWK\ODWLRQ]*1DWXUH* D[[GV*
QFH\OM,aOM/]
AD** &RRSHU*6-*'LHQVWELHU*0-*+DVVDQ*5-*HW*DOB*7DUJHWLQJ*SRO\FRPE*
WR*SHULFHQWULF*KHWHURFKURPDWLQ*LQ*HPEU\RQLF*VWHP*FHOOV*UHYHDOV*
D* UROH* IRU*+D$.,,dX,* LQ*35&D* UHFUXLWPHQW]*&HOO* UHSRUWV*
D[,/V*P\,/AGa,/M[]
A.** .XUGLVWDQL*6.-*7DYD]RLH*6-**UXQVWHLQ*0]*0DSSLQJ*JOREDO*
KLVWRQH* DFHW\ODWLRQ*SDWWHUQV* WR* JHQH* H[SUHVVLRQ]*&HOO* D[[/V*
%%P\MD,aM..]
A/** 7VDL*::-*:DQJ*=-*<LX*77-*HW*DOB*75,0D/*OLQNV*D*QRQaFDQRQa
LFDO*KLVWRQH*VLJQDWXUH*WR*EUHDVW*FDQFHU]*1DWXUH*D[,[V*\dDMa
d.D]
AA** :DQJ*=-*=DQJ*&-*5RVHQIHOG*-$-*HW*DOB*&RPELQDWRULDO*SDWWHUQV*
RI*KLVWRQH*DFHW\ODWLRQV*DQG*PHWK\ODWLRQV*LQ*WKH*KXPDQ*JHQRPH]*
1DW**HQHW*D[[OV*QS\OdMad[.]
AG** 5DLERUJ*&-*6WHQPDUN*+]*7KH*(6&57*PDFKLQHU\*LQ*HQGRVRPDO*
VRUWLQJ*RI* XELTXLW\ODWHG*PHPEUDQH*SURWHLQV]*1DWXUH* D[[dV*
\//Aa/AD]
AM** /LP*--*6RQ*:6-*3DUN*-.-*.LP*((-*/HH*%--*$KQ*+&]*6ROXWLRQ*
VWUXFWXUH*RI*8,0*DQG*LQWHUDFWLRQ*RI*WDQGHP*XELTXLWLQ*ELQGLQJ*
GRPDLQV* LQ*67$0,*ZLWK*XELTXLWLQ]*%LRFKHP*%LRSK\V*5HV*
&RPPXQ*D[,,V*QSR\D/a.[]
AO** +LUDQR*6-*.DZDVDNL*0-*8UD*+-*HW*DOB*'RXEOHaVLGHG*XELTXLWLQ*
ELQGLQJ*RI*+UVa8,0*LQ*HQGRVRPDO*SURWHLQ*VRUWLQJ]*1DW*6WUXFW*
0RO*%LRO*D[[GV*%F\DMDaDMM]
Ad** :DQJ*4-*<RXQJ*3-*:DOWHUV*.-]*6WUXFWXUH* RI*6AD*ERXQG* WR*
PRQRXELTXLWLQ*SURYLGHV*D*PRGHO*IRU*SRO\XELTXLWLQ*UHFRJQLWLRQ]*
-*0RO*%LRO*D[[AV*\MDMaM.d]
G[** )UDXHU*&-*5RWWDFK*$-*0HLOLQJHU*'-*HW* DOB*'LIIHUHQW* ELQGLQJ*
SURSHUWLHV* DQG* IXQFWLRQ*RI*&;;&*]LQF* ILQJHU* GRPDLQV* LQ*
'QPW,*DQG*7HW,]*3/R6*2QH*D[,,V*O\H,GGDM]
G,** 0HLOLQJHU*'-*)HOOLQJHU*.-*%XOWPDQQ*6-*HW* DOB*1SdA* LQWHUDFWV*
ZLWK*GH*QRYR*'1$*PHWK\OWUDQVIHUDVHV-*'QPW.D*DQG*'QPW.E-*
DQG*PHGLDWHV*HSLJHQHWLF*VLOHQFLQJ*RI*WKH*YLUDO*&09*SURPRWHU*
LQ*HPEU\RQLF*VWHP*FHOOV]*(0%2*5HS*D[[dV*%S\,DAda,DG/]
GD** +R*61-*+XQW*+'-*+RUWRQ*50-*3XOOHQ*-.-*3HDVH*/5]*6LWHaGLa
UHFWHG*PXWDJHQHVLV*E\*RYHUODS*H[WHQVLRQ*XVLQJ*WKH*SRO\PHUDVH*
FKDLQ*UHDFWLRQ]**HQH*,dOdV*PP\A,aAd]
G.** 3LFKOHU**-*:ROI*3-*6FKPLGW*&6-*HW*DOB*&RRSHUDWLYH*'1$*DQG*
KLVWRQH*ELQGLQJ*E\*8KUID* OLQNV* WKH* WZR*PDMRU* UHSUHVVLYH*HSLa
JHQHWLF*SDWKZD\V]*-*&HOO*%LRFKHP*D[,,V*\DAOAaDAd.]
G/** 5RWKEDXHU*8-*=ROJKDGU*.-*7LOOLE*6-*HW*DOB*7DUJHWLQJ*DQG*WUDFLQJ*
DQWLJHQV LQ OLYHFHOOVZLWKÀXRUHVFHQWQDQRERGLHV1DW*0HWKG
RGV*D[[GV*F\OOMaOOd]
GA** +HUFH*+'-*'HQJ*:-*+HOPD* --*/HRQKDUGW*+-*&DUGRVR*0&]*
9LVXDOL]DWLRQ*DQG*WDUJHWHG*GLVUXSWLRQ*RI*SURWHLQ*LQWHUDFWLRQV*LQ*
OLYLQJ*FHOOV]*1DW*&RPPXQ*D[,.V*Q\DGG[]
GG** 5RWWDFK*$-*.UHPPHU*(-*1RZDN*'-*HW*DOB**HQHUDWLRQ*DQG*FKDUa
DFWHUL]DWLRQRIDUDWPRQRFORQDODQWLERG\VSHFL¿FIRU3&1$
+\EULGRPD*O/DUFKPWP*D[[OV*\d,adO]
GM** 5RWWDFK*$-*.UHPPHU*(-*1RZDN*'-*/HRQKDUGW*+-*&DUGRVR*0&]*
*HQHUDWLRQ*DQG*FKDUDFWHUL]DWLRQ*RI*D*UDW*PRQRFORQDO*DQWLERG\*
VSHFLILF* IRU*PXOWLSOH* UHG* IOXRUHVFHQW* SURWHLQV]*+\EULGRPD*
O/DUFKPWP*D[[OV*\..Ma./.]
GO** /HL*+-*2K*63-*2NDQR*0-*HW*DOB*'H*QRYR*'1$*F\WRVLQH*PHWK\Oa
WUDQVIHUDVH*DFWLYLWLHV*LQ*PRXVH*HPEU\RQLF*VWHP*FHOOV]*'HYHORSG
PHQW*,ddGV*\.,dAa.D[A]
Gd** 7XFNHU*./-*%HDUG*&-*'DXVPDQQ*--*HW*DOB**HUPaOLQH*SDVVDJH*LV*
UHTXLUHG*IRU*HVWDEOLVKPHQW*RI*PHWK\ODWLRQ*DQG*H[SUHVVLRQ*SDWa
WHUQV*RI* LPSULQWHG*EXW*QRW*RI*QRQLPSULQWHG*JHQHV]**HQHV*'HY*
,ddGV*%S\,[[Oa,[D[]
M[** 7RVW*--**XW*,*]*'1$*PHWK\ODWLRQ*DQDO\VLV*E\*S\URVHTXHQFLQJ]*
1DW*3URWRF*D[[MV*\DDGAaDDMA]
M,** 6KHFKWHU*'-*'RUPDQQ*+/-*$OOLV*&'-*+DNH*6%]*([WUDFWLRQ-*
SXUL¿FDWLRQDQGDQDO\VLVRIKLVWRQHV1DW*3URWRF*D[[MV*\,//Aa
,/AM]
MD** :\VRFND* -]* ,GHQWLI\LQJ*QRYHO* SURWHLQV* UHFRJQL]LQJ*KLVWRQH*
PRGL¿FDWLRQVXVLQJSHSWLGHSXOOGRZQDVVD\0HWKRGV* D[[GV*
QS\..da./.]
 9LOODU*DUHD$,VUDHO/,PKRI$$QDO\VLVRIKLVWRQHPRGL¿a
FDWLRQV*E\*PDVV*VSHFWURPHWU\]*&XUU*3URWRF*3URWHLQ*6FL*D[[OV*
&KDSWHU*,/\8QLW*,/],[]
M/** 2OVHQ* -9-*GH**RGR\*/0-*/L**-*HW*DOB*3DUWV*SHU*PLOOLRQ*PDVV*
DFFXUDF\*RQ*DQ*2UELWUDS*PDVV*VSHFWURPHWHU*YLD*ORFN*PDVV*LQa
MHFWLRQ*LQWR*D*&aWUDS]*0RO*&HOO*3URWHRPLFV*D[[AV*Q\D[,[aD[D,]
MA** 0DUN*+DOO*()-**HRIIUH\*+ROPHV-*%HUQKDUG*3IDKULQJHU-*3HWHU*
5HXWHPDQQ-*,DQ*+]*:LWWHQ]*7KH*:(.$*GDWD*PLQLQJ*VRIWZDUH\*
DQ*XSGDWH]*$&0*6,*.''*([SORUDWLRQV*1HZVOHWWHU* D[[dV*
%%\,[a,O]
MG** 6FKLQGHOLQ*--*$UJDQGDa&DUUHUDV*,-*)ULVH*(-*HW*DOB*)LML\*DQ*RSHQa
VRXUFH*SODWIRUP* IRU* ELRORJLFDOaLPDJH* DQDO\VLV]*1DW*0HWKRGV*
D[,DV*H\GMGaGOD]
MM** 5*&RUH*7HDP*eD[,/f]*5\*D*ODQJXDJH*DQG*HQYLURQPHQW*IRU*VWDa
WLVWLFDO* FRPSXWLQJ]*5*)RXQGDWLRQ* IRU*6WDWLVWLFDO*&RPSXWLQJ-*
9LHQQD-*$XVWULD]*85/*KWWS\^^ZZZ]5aSURMHFW]RUJ^]
MO** 5REHUW*;-**RXHW*3]*'HFLSKHULQJ*NH\*IHDWXUHV*LQ*SURWHLQ*VWUXFa
WXUHV*ZLWK*WKH*QHZ*(1'VFULSW*VHUYHU]*1XFOHLF*$FLGV*5HV*D[,/V*
\:.D[a:.D/]
e6XSSOHPHQWDU\&LQIRUPDWLRQ*LV*OLQNHG*WR*WKH*RQOLQH*YHUVLRQ*RI
WKH*SDSHU*RQ*WKH*&HOO*5HVHDUFK*ZHEVLWH]f
7KLVZRUNLVOLFHQVHGXQGHUWKH&UHDWLYH&RPPRQV
$WWULEXWLRQ1RQ&RPPHUFLDO1R'HULYDWLYH:RUNV
8QSRUWHG/LFHQVH7R YLHZD FRS\RI WKLV OLFHQVH
YLVLWKWWSFUHDWLYHFRPPRQVRUJOLFHQVHVE\QFQG
!
6XSSOHPHQWDU\LQIRUPDWLRQ'DWD6
0DWHULDOVDQGPHWKRGV
$QWLERGLHV
)RUGHWHFWLRQRI*)3'107E\ZHVWHUQEORWDPRXVHDQWL'107DQWLERG\S$7+>@ZDVXVHG
(TXDOORDGLQJZDVFRQILUPHGE\LPPXQREORWWLQJZLWKDVSHFLILFDQWL/DPLQ%$EFDPRUDQWLȕ$FWLQ6LJPD
DQWLERG\7KHUDEELWDQWL+$DQWLERG\ZDVSXUFKDVHGIURP0LOOLSRUH
,Q+YLWUR+'1$+PHWK\ODWLRQ+DVVD\
)RUDQDO\VHVRILQ+YLWUR'1$PHWK\ODWLRQDFWLYLW\*)3'107ZDVSXULILHGE\LPPXQRSUHFLSLWDWLRQIURP
+(.7H[WUDFWV7KHFRQFHQWUDWLRQRI*)3'107LQWKHERXQGIUDFWLRQVZDVPHDVXUHGE\IOXRUHVFHQWUHDG
RXW,QRUGHUWRJHWHQRXJKXQPRGLILHG'1$WHPSODWHVWKH'1$VHTXHQFHVZHUHDPSOLILHGZLWKWKHSULPHUV
7*&$7*7$77*$$&$*IRUZDUGDQG7*&$&$**$7*7$7$7$7&UHYHUVHȝJRI*)3'107ZHUH
LQFXEDWHGZLWKQJRI'1$WHPSODWH LQPHWK\ODWLRQEXIIHUFRQWDLQLQJȝ06$0DQGQJȝO%6$DW
&IRUKRXUV$IWHULQDFWLYDWLRQRIWKHUHDFWLRQDW&IRUPLQWKH'1$ZDVLVRODWHGZLWKD1XFOHRVSLQ
3&5FOHDQLQJNLW0DFKHUH\1DJHODQGELVXOILWHWUHDWHGZLWK(='1$0HWK\ODWLRQ*ROG.LW=\PRUHVHDUFK
3ULPHU VHTXHQFHV IRU WKH  '1$ ZHUH 7*7$7*7$77*$$7$* IRUZDUG SULPHU DQG
7$&$&$$$$7$7$7$7$7&UHYHUVHSULPHU)RUDPSOLILFDWLRQZHXVHG4LDJHQ+RW6WDUW3RO\PHUDVHLQ[
4LDJHQ+RW6WDUW3RO\PHUDVHEXIIHUVXSSOHPHQWHGZLWKP0G173V0IRUZDUGSULPHU0UHYHUVH
SULPHUP0%HWDLQH6LJPDDQGP07HWUDPHWK\ODPPRQLXPFKORULGH70$&6LJPD3\URVHTXHQFLQJ
UHDFWLRQVZHUHFDUULHGRXWE\9DULRQRVWLF*PE+8OP
3UHSDUDWLRQ+RI+KHPLPHWK\ODWHG+'1$+VXEVWUDWHV
7RSUHSDUHWKHKHPLPHWK\ODWHG'1$DQHIILFLHQWPHWKRGIRUORQJKHWHURGXSOH['1$ZDVXVHGDVGHVFULEHG
>@ 2QH SDLU RI PRGLILHG 3&5 SULPHUV ZHUH V\QWKHVL]HG ZKLFK DUH ODEHOHG ZLWK SKRVSKDWH DW ¶HQG ¶
SKRVSKRU\ODWHG7*&$7*7$77*$$&$*¶DQG¶SKRVSKRU\ODWHG7*&$&$**$7*7$7$7$7&¶7RJHW
VLQJOHDQGXSSHUVWUDQG'1$WKH'1$ZDVDPSOLILHGZLWKWKHUHYHUVHSULPHUODEHOHGZLWKSKRVSKDWHDWWKH¶
HQG IROORZLQJ D ODPEGDQXFOHDVH GLJHVWLRQ 1(% 7KH VDPH SURFHGXUH LV UHTXLUHG IRUPDNLQJ ORZHU VWUDQG
'1$ 7R SUHSDUH WKH PHWK\ODWHG ORZHU VWUDQG '1$ RQH PRUH VWHS LQ+ YLWUR PHWK\ODWLRQ E\ EDFWHULDO
PHWK\OWUDQVIHUDVH 06VV, 1(% LV UHTXLUHG EHIRUH WUHDWPHQW ZLWK WKH ODPEGDQXFOHDVH ,Q WKH HQG HTXDO
DPRXQWVRIXSSHUDQGORZHUVWUDQG'1$ZHUHPL[HGDQGLQFXEDWHGDW&IRUPLQIROORZHGE\DQQHDOLQJ
7R JHW ULG RI FRQWDPLQDWLRQ IURP GRXEOH VWUDQG '1$ DIWHU ODPEGDQXFOHDVH WUHDWPHQW WKH K\GUR[\DSDWLWH
FKURPDWRJUDSK\ZDVFDUULHGRXW+\GUR[\DSDWLWHFROXPQ6LJPDZDVSDFNHGDFFRUGLQJ WR WKHPDQXIDFWXUHU¶V
LQVWUXFWLRQVDQGWKHVLQJOHVWUDQGHG'1$ZDVHOXWHGE\HOXWLRQEXIIHUFRQWDLQLQJP0VRGLXPSKRVSKDWH
,Q+YLWUR+'1$+ELQGLQJ+DVVD\V
,Q+YLWUR'1$ELQGLQJDVVD\VZHUHSHUIRUPHGDVGHVFULEHGSUHYLRXVO\>@%ULHIO\WZRGRXEOHVWUDQGHG'1$
ROLJRQXFOHRWLGHVODEHOHGZLWKGLIIHUHQW$772IOXRURSKRUHVZHUHXVHGDVVXEVWUDWHVLQGLUHFWFRPSHWLWLRQ'1$
ROLJRQXFOHRWLGH VXEVWUDWHV ZLWK LGHQWLFDO VHTXHQFH FRQWDLQHG DQ XQPRGLILHG RU KHPLPHWK\ODWHG F\WRVLQH DW D
VLQJOH FHQWUDO &S* VLWH 80% XQPHWK\ODWHG ELQGLQJ VXEVWUDWH $772 +0% KHPLPHWK\ODWHG ELQGLQJ
VXEVWUDWHV$77216XSSOHPHQWDU\7DEOH6*)3IXVLRQSURWHLQVZHUHH[SUHVVHGLQ+(.7FHOOVDQG
LPPXQRSUHFLSLWDWHGXVLQJWKH*)37UDS&KURPRWHN,PPRELOL]HG8+5)*)3ZWDQGPXWDQWVZHUHZDVKHG
WKUHH WLPHVEHIRUH LQFXEDWLRQZLWK'1$VXEVWUDWHVDW D ILQDOFRQFHQWUDWLRQRIQ0HDFK$IWHU UHPRYDORI
XQERXQG VXEVWUDWHV SURWHLQ DPRXQWV *)3 IOXRUHVFHQFH DQG ERXQG '1$ ZHUH PHDVXUHG ZLWK DQ ,QILQLWH
0SODWHUHDGHU7HFDQ
,Q+YLYR+DXWRXELTXLWLQDWLRQ+DVVD\
7KH LQ+YLYRDXWRXELTXLWLQDWLRQDVVD\RI8+5)*)3ZDVSHUIRUPHGDVGHVFULEHGEHIRUH >@7KHUHVXOWLQJ
XELTXLWLQDWLRQOHYHOVZHUHGHWHFWHGZLWKDVSHFLILFPRXVHPRQRFORQDODQWL+$DQWLERG\&$DQGTXDQWLILHG
XVLQJ,PDJH-DQGDVWDWLVWLFDO6WXGHQW¶VWWHVWDQDO\VLV(TXDODPRXQWVRI8+5)*)3LQWKHERXQGIUDFWLRQ
ZHUHYHULILHGE\LPPXQREORWWLQJZLWKDVSHFLILFDQWL*)3DQWLERG\&KURPRWHN
6ORW+EORW+DQDO\VLV
7R TXDQWLI\ JOREDO '1$ PHWK\ODWLRQ OHYHOV WKH %LR5DG VORW EORW V\VWHP ZDV XVHG DFFRUGLQJ WR WKH
PDQXIDFWXUHU¶V LQVWUXFWLRQ 3ULRU WR ORDGLQJ RQ D 1LWURFHOOXORVH PHPEUDQH $PHUVKDP JHQRPLF '1$ ZDV
GHQDWXUHGLQ[66&EXIIHUIRUPLQDW&DQGLQFXEDWHGIRUPLQRQLFH7KHPHPEUDQHZDVFURVVOLQNHG
EORFNHGZLWKPLONDQG LPPXQRVWDLQHGZLWK VSHFLILF UDEELW DQWLVV'1$(XURJHQWHFDQGPRXVHDQWLP&
,%/DQWLERGLHV4XDQWLILFDWLRQZDVSHUIRUPHGXVLQJWKH,PDJH-JHODQDO\VLVWRRO
,Q+YLWUR+KLVWRQH+WDLO+SHSWLGH+ELQGLQJ+DVVD\
7KH LQ+ YLWUR KLVWRQH WDLO SHSWLGH ELQGLQJ DVVD\ZDV SHUIRUPHG DV GHVFULEHG EHIRUH >@ZLWK WKH IROORZLQJ
PRGLILFDWLRQ *)3 IXVLRQ SURWHLQV ZHUH HTXDOL]HG WR D *)3 FRQFHQWUDWLRQ RI  Q0 SULRU WR
LPPXQRSUHFLSLWDWLRQ ZLWK WKH *)37UDS 7KH 7$05$ODEHOHG + SHSWLGHV XVHG LQ WKLV DVVD\ DUH OLVWHG LQ
6XSSOHPHQWDU\7DEOH6
8ELTXLWLQDWHG+KLVWRQH++>+ELQGLQJ+H[SHULPHQW
)RU XELTXLWLQDWHG+ ELQGLQJ H[SHULPHQW+(.7 FHOOVZHUH LQFXEDWHGZLWK P01(WK\OPDOHLPLGH
1(0$SSOL&KHPIRUPLQEHIRUHKDUYHVWLQJDQGZHUHWUHDWHGLQK\SRWRQLFEXIIHUP07ULV+&OS+
P0.&OP00J&OP0'77DQG[3URWHDVH,QKLELWRUP0306)IRUPLQRQLFHWRLVRODWH
WKHLQWDFWQXFOHL1XFOHLUHVXVSHQGHGLQ01DVHGLJHVWLRQEXIIHUP07ULV+&OS+P01D&OP0
&D&O13[3URWHDVH,QKLELWRU6HUYDP0306)ZHUHGLJHVWHGZLWK8PO01DVHDW&IRU
PLQWRJHWPRQRQXFOHRVRPHV
*)3'107 DQG LWV PXWDQWV ZHUH LPPRELOL]HG RQ WKH *)37UDS DQG LQFXEDWHG ZLWK HTXDO DPRXQW RI
PRQRQXFOHRVRPHVIRUKRXUV$IWHUZDVKLQJVWHSVWKHERXQGIUDFWLRQVZHUHDQDO\]HGE\ZHVWHUQEORW
6XSSOHPHQWDU\UHIHUHQFHV
 %HVWRU7+$FWLYDWLRQRIPDPPDOLDQ'1$PHWK\OWUDQVIHUDVHE\FOHDYDJHRID=QELQGLQJUHJXODWRU\
GRPDLQ(0%2+-+
 /L ( %HVWRU 7+ -DHQLVFK 5 7DUJHWHG PXWDWLRQ RI WKH '1$ PHWK\OWUDQVIHUDVH JHQH UHVXOWV LQ
HPEU\RQLFOHWKDOLW\&HOO
 7KRPDV(3LQJRXG$)ULHGKRII3$QHIILFLHQWPHWKRGIRUWKHSUHSDUDWLRQRIORQJKHWHURGXSOH['1$
DVVXEVWUDWHIRUPLVPDWFKUHSDLUE\WKH(VFKHULFKLDFROL0XW+/6V\VWHP%LRO+&KHP

 )UDXHU&/HRQKDUGW+$YHUVDWLOHQRQUDGLRDFWLYHDVVD\IRU'1$PHWK\OWUDQVIHUDVHDFWLYLW\DQG'1$
ELQGLQJ1XFOHLF+$FLGV+5HVH
 4LQ:/HRQKDUGW+6SDGD)8VSDQG8KUIFRQWUROXELTXLWLQDWLRQDQGVWDELOLW\RIWKHPDLQWHQDQFH
'1$PHWK\OWUDQVIHUDVH'QPW-+&HOO+%LRFKHP
 3LFKOHU*:ROI36FKPLGW&6HW DO&RRSHUDWLYH'1$DQGKLVWRQHELQGLQJE\8KUI OLQNV WKH WZR
PDMRUUHSUHVVLYHHSLJHQHWLFSDWKZD\V-+&HOO+%LRFKHP
 5REHUW ; *RXHW 3 'HFLSKHULQJ NH\ IHDWXUHV LQ SURWHLQ VWUXFWXUHV ZLWK WKH QHZ (1'VFULSW VHUYHU
1XFOHLF+$FLGV+5HV:
 +LUDQR6.DZDVDNL08UD+HWDO'RXEOHVLGHGXELTXLWLQELQGLQJRI+UV8,0LQHQGRVRPDOSURWHLQ
VRUWLQJ1DW+6WUXFW+0RO+%LRO
!
!
6XSSOHPHQWDU\, LQIRUPDWLRQ0, )LJXUH,63 *)3'107FDUU\LQJDGHOHWLRQRIDPLQRDFLGVLQ WKH76GRPDLQ LVVWLOO
DFWLYHLQ+YLWUREXWLQDFWLYHLQ+YLYR!$#6FKHPDWLFRXWOLQHRI'107GRPDLQVDQGWKH76GRPDLQGHOHWLRQ¨7KHGHOHWHG
UHJLRQFRPSULVHVDFRQVHUYHGFRUHRIWKH76GRPDLQVKRZLQJKLJKVHTXHQFHVLPLODULWLHVDPRQJKLJKHUHXNDU\RWHV7KHDOLJQPHQW
ZDVJHQHUDWHGXVLQJ(63ULSW>@!%#([SUHVVLRQOHYHOVRI*)3'107ZWFORQHVDQGDQGWKH76GRPDLQGHOHWLRQPXWDQW
¨FORQHVDQGLQVWDEOH(6&OLQHVZHUHFRPSDUHGWRWKHHQGRJHQRXV'107OHYHOLQ-ZWFHOOV/DPLQ%LVVKRZQ
DVORDGLQJFRQWURO'107ZDVGHWHFWHGZLWKDVSHFLILFDQWL'107DQWLERG\!&#,Q+YLWURPHWK\ODWLRQDVVD\RI*)3'107ZW
DQG ¨PXWDQW XVLQJ XQPRGLILHG RU KHPLPHWK\ODWHG'1$ DV D VXEVWUDWH !'# /RFDO '1$PHWK\ODWLRQ DQDO\VHV DWPLQRU
VDWHOOLWHUHSHDWVDQGWKH'QPWHRSURPRWHU&S*PHWK\ODWLRQOHYHOVRIPRXVH-'QPWHIJI (6&VVWDEO\H[SUHVVLQJ*)3'107ZWRU
¨PXWDQWFRQVWUXFWVZHUHDQDO\]HGE\ELVXOILWHWUHDWPHQWRIJHQRPLF'1$3&5DPSOLILFDWLRQDQGGLUHFWS\URVHTXHQFLQJ
7KHPHWK\ODWLRQ OHYHORI WKH-ZWFHOO OLQH HQGRJHQRXV'107DQGXQWUDQVIHFWHG-'QPWHIJIFHOOVDUHVKRZQIRUFRPSDULVRQ
'LVSOD\HGDUHPHDQYDOXHV6'IURPWZRGLIIHUHQWFORQHV 
!
!
6XSSOHPHQWDU\, LQIRUPDWLRQ0, )LJXUH, 64 7KH 8+5)*)3 3+' DQG 5,1* GRPDLQ PXWDQWV SUHVHUYH WKHLU SUHIHUHQFH IRU
KHPLPHWK\ODWHG '1$ DQG WKHLU KHWHURFKURPDWLQ DVVRFLDWLRQ EXW FDQQRW UHFUXLW HQGRJHQRXV '107 WR KHWHURFKURPDWLQ !$#
3ULPDU\VHTXHQFHDOLJQPHQWRIPRXVHDQGKXPDQ8+5)DQG8+5)DWUHJLRQVRIWKH3+'DQG5,1*GRPDLQUHVSHFWLYHO\1RWH
WKDWWKHPXWDWLRQVDIIHFWFRQVHUYHGDPLQRDFLGVFRQWULEXWLQJWRWKHFRRUGLQDWLRQRI]LQF=QLRQV!%#,Q+YLWUR'1$ELQGLQJDVVD\
7KHELQGLQJRILPPXQRSUHFLSLWDWHG8+5)*)3ZWRU3+'+*DQG5,1*GRPDLQ+$PXWDQWVWRHLWKHUXQ80%RU
KHPLPHWK\ODWHG+0%IOXRUHVFHQWO\ ODEHOHGGRXEOHVWUDQGHGROLJRQXFOHRWLGHSUREHVZDV WHVWHG LQGLUHFWFRPSHWLWLRQ6KRZQDUH
PHDQIOXRUHVFHQFHLQWHQVLW\UDWLRVRIERXQGSUREHRYHUERXQG*)3IXVLRQRIWKUHHLQGHSHQGHQWH[SHULPHQWV6'*)3ZDVXVHGDV
QHJDWLYH FRQWURO !&# ,Q+ YLYR DXWRXELTXLWLQDWLRQ DVVD\ RI 8+5)*)3:W RU 3+' DQG 5,1* GRPDLQ PXWDQW FRQVWUXFWV ZHUH
WUDQVLHQWO\ FRH[SUHVVHG ZLWK +$XELTXLWLQ LQ +(. 7 FHOOV DQG 8+5)*)3 ZDV LPPXQRSUHFLSLWDWHG XVLQJ WKH *)37UDS
8ELTXLWLQDWLRQOHYHOVZHUHGHWHFWHGE\LPPXQREORWWLQJZLWKDQDQWL+$DQWLERG\DQGERXQGIUDFWLRQVZHUHYHULILHGZLWKDVSHFLILF
DQWL*)3DQWLERG\*)3ZDVXVHGDVQHJDWLYHFRQWURO,LQSXW%ERXQG2QHUHSUHVHQWDWLYHEORWRIWKUHHLQGHSHQGHQWUHSOLFDWHVLV
GHSLFWHG !'# 4XDQWLILFDWLRQ RI WKH LQ+ YLYR DXWRXELTXLWLQDWLRQ DFWLYLW\ RI 8+5)*)3 ZW RU 3+' DQG 5,1* GRPDLQ PXWDQW
!
FRQVWUXFWV GHSLFWHG LQ & 6KRZQ DUHPHDQ YDOXHV  6' RI WKUHH LQGHSHQGHQW ELRORJLFDO UHSOLFDWHV DQDO\]HG XVLQJ ,PDJH- DQG
QRUPDOL]HG WR WKHXELTXLWLQDWLRQ OHYHORI WKH8+5)*)3ZWFRQVWUXFW'LIIHUHQFHVEHWZHHQ WKH8+5)*)3ZWRU3+'PXWDQW
DQGWKH5,1*GRPDLQPXWDQWZHUHDQDO\]HGXVLQJD6WXGHQW¶VWWHVWDQGFRQVLGHUHGVWDWLVWLFDOO\VLJQLILFDQWIRU3DQG
KLJKO\VLJQLILFDQWIRU3!(#DQG!)#&RQIRFDOPLGVHFWLRQVRIIL[HG(8KUIHIJI(6&VVWDEO\H[SUHVVLQJ8+5)*)3
ZW RU 3+' +* DQG 5,1* GRPDLQ +$ PXWDQW FRQVWUXFWV !(# +.PH DQG +.PH ZHUH VWDLQHG ZLWK VSHFLILF
DQWLERGLHVDVPDUNHUVIRUKHWHURFKURPDWLQDQG'1$ZDVFRXQWHUVWDLQHGZLWK'$3,6FDOHEDUP!)#(QGRJHQRXV'107LQ
(6&VVWDEO\H[SUHVVLQJ8+5)*)3ZWRULWV3+'DQG5,1*GRPDLQPXWDQWVZDVVWDLQHGE\DVSHFLILFDQWLERG\DQG'1$ZDV
FRXQWHUVWDLQHGZLWK'$3,6FDOHEDUP






!!
6XSSOHPHQWDU\, LQIRUPDWLRQ0,)LJXUH,65 7KH%8+5)*+*)3%3+'%DQG%5,1* GRPDLQ%PXWDQWV%FDQQRW%PHGLDWH '1$ UHPHWK\ODWLRQ%LQ%
PRXVH%(*!%8KUIHIJI (6&VB% !$# /RFDO%'1$ PHWK\ODWLRQ%DQDO\VHV% DW%PLQRU% VDWHOOLWH% UHSHDWV% DQG% WKH%'QPWHR SURPRWHUB%&S*%PHWK\ODWLRQ%
OHYHOV%RI%PRXVH%(*!%8KUIHIJI (6&V%VWDEO\%H[SUHVVLQJ%8+5)*+*)3%ZW%RU%3+'%K+L!M*N%DQG%5,1* GRPDLQ%K+OLP$N%PXWDQW%FRQVWUXFWV%
ZHUH%DQDO\]HG%E\%ELVXOILWH% WUHDWPHQW%RI%JHQRPLF%'1$R%3&5%DPSOLILFDWLRQ%DQG%GLUHFW%S\URVHTXHQFLQJB%7KH%PHWK\ODWLRQ% OHYHO%RI%(*!%ZW%
(6&V%KHQGRJHQRXV%8+5)*N%DQG%XQWUDQVIHFWHG%(*!%8KUIHIJI FHOOV%DUH%VKRZQ%IRU%FRPSDULVRQB%0HDQ%YDOXHV%U%6'%IURP%WZR%GLIIHUHQW%FORQHV%
ZHUH%FDOFXODWHGB%!%# DQG% !&# *OREDO%'1$%PHWK\ODWLRQ%DQDO\VLV%RI%VWDEOH%8+5)*+*)3%ZW%RU%3+'%DQG%5,1* GRPDLQ%PXWDQW%FHOO% OLQHV%
FRPSDUHG%WR%(*!%ZW%(6&V%H[SUHVVLQJ%HQGRJHQRXV%8+5)*%DQG%(*!%8KUIHIJI (6&VB%!%# 6ORW%EORW%DQDO\VLV%XVLQJ%D%GLOXWLRQ%VHULHV%RI%JHQRPLF%
'1$%DQG%LPPXQRGHWHFWLRQ%ZLWK%VSHFLILF%DQWL+VLQJOH%VWUDQGHG%KVVN%'1$%DQG%DQWL+V+PHWK\OF\WRVLQH%KVP&N DQWLERGLHVB%$%UHSUHVHQWDWLYH%VORW%
EORW%RI%WHFKQLFDO%GXSOLFDWHV%LV%VKRZQB%!&# 7KH%VP&%VLJQDOV%UHODWLYH%WR%WKH%VLJQDOV%RI%VV'1$%ZHUH%TXDQWLILHG%XVLQJ%WKH%,PDJH- JHO%DQDO\VLV%
WRROB% 5HODWLYH% JOREDO% '1$%PHWK\ODWLRQ% OHYHOV% DUH% LQGLFDWHG% DV% PHDQ% YDOXHV U% 6'% RI% WHFKQLFDO% GXSOLFDWHVB% !'# ([SUHVVLRQ DQDO\VLV RI%
8+5)*+*)3%ZW RU 3+'%DQG%5,1* GRPDLQ%PXWDQWV DIWHU%WUDQVLHQW%WUDQVIHFWLRQ LQ%(*!%8KUIHIJI (6&V%DQG%)$&6%VRUWLQJB%)XVLRQ%SURWHLQV%
ZHUH%GHWHFWHG%ZLWK%D%VSHFLILF DQWL+*)3DQWLERG\DQGȕ+$FWLQ%VHUYHV%DV% D% ORDGLQJ%FRQWUROB% !(# /RFDO%'1$%PHWK\ODWLRQ%DQDO\VHV%RI%(*!%
8KUIHIJI (6&V%WUDQVLHQWO\%H[SUHVVLQJ%*)3+8+5)*%ZW%RU%3+'%K+L!M*N%DQG%5,1* GRPDLQ%K+OLP$N%PXWDQW%FRQVWUXFWVB%&S*%PHWK\ODWLRQ%
OHYHOV%DW%WKH%PDMRU VDWHOOLWH%UHSHDWV%ZHUH%DQDO\]HG%E\%ELVXOILWH%WUHDWPHQW%RI%JHQRPLF%'1$R%3&5%DPSOLILFDWLRQ%DQG%GLUHFW%S\URVHTXHQFLQJB
6KRZQ%DUH%PHDQ%YDOXHV%U%6'%IURP%WKUHH%LQGHSHQGHQW%H[SHULPHQWV%QRUPDOL]HG%WR%WKH%YDOXH%RI%8+5)*+*)3%ZW%DW%WKH%ILUVW%&S*%VLWHB

!
6XSSOHPHQWDU\, LQIRUPDWLRQ0, )LJXUH,66 +LVWRQH+ELQGLQJE\8+5)*)3LVVHQVLWLYH WR5PHWK\ODWLRQ)OXRUHVFHQW LQ+
YLWUR KLVWRQH WDLO SHSWLGH ELQGLQJ DVVD\ RI 8+5)*)3 XVLQJ 7$05$ ODEHOHG + WDLOV FDUU\LQJ QR PRGLILFDWLRQ + DQ
DV\PPHWULFDOO\GLPHWK\ODWHGDUJLQLQH+5PHRUDWULPHWK\ODWHGO\VLQH+.PH6KRZQDUHPHDQYDOXHVRIWKHUHODWLYH
ELQGLQJUDWLRRIKLVWRQHWDLOSHSWLGHVRYHU*)3IXVLRQSURWHLQVIURPILYHLQGHSHQGHQWH[SHULPHQWV6(0*)3ZDVXVHGDVQHJDWLYH
FRQWURO
! !
!
!
6XSSOHPHQWDU\,LQIRUPDWLRQ0,)LJXUH,67 +KLVWRQHWDLOXELTXLWLQDWLRQDQGGHSHQGHQFHRQ5!$#$IWHUH[SUHVVLRQRI8+5)
*)3DQG+$8ELTXLWLQLQ+(.7FHOOVDFLGH[WUDFWHGXELTXLWLQDWHGKLVWRQHVZHUHLPPXQRSUHFLSLWDWHGZLWKDQDQWL+$DQWLERG\
DQGDQDO\]HGE\PDVVVSHFWURPHWU\7KH&ROOLVLRQLQGXFHGGLVVRFLDWLRQ &,'0606VSHFWUXPRI WKHKLVWRQH+SHSWLGH
VKRZVXELTXLWLQDWLRQ**DWWKH.UHVLGXHDQGQRPRGLILFDWLRQ3UDWWKH.UHVLGXH'HWDLOHGLQIRUPDWLRQLVSURYLGHGLQWKH
PHWKRGVHFWLRQ!%#0DSSLQJDQGTXDQWLILFDWLRQRI8+5)XELTXLWLQDWLRQWDUJHWVLWHVLQ+1WHUPLQDOWDLOVDQGGHSHQGHQFHRIWKH
XELTXLWLQDWLRQRQ5*)3+FRQVWUXFWVFDUU\LQJ5$.$.$RU.$.$PXWDWLRQVZHUH WUDQVLHQWO\FRH[SUHVVHGLQ
+(. 7 FHOOV ZLWK +$XELTXLWLQ DQG DIWHU LPPXQRSUHFLSLWDWLRQ ZLWK WKH *)37UDS XELTXLWLQDWHG *)3+ ZDV GHWHFWHG E\
ZHVWHUQ EORW ZLWK DQ DQWL+$ DQWLERG\ (TXDO ORDGLQJ RI *)3+ LV VKRZQ E\ WKH DQWL*)3 EORW EHORZ , LQSXW % ERXQG
4XDQWLILFDWLRQVZHUHSHUIRUPHGZLWK,PDJH-6KRZQDUHPHDQYDOXHV6(0RIIRXUWRILYHLQGHSHQGHQWH[SHULPHQWV! 
!
!
6XSSOHPHQWDU\,LQIRUPDWLRQ0,)LJXUH,68 '1078,0GHOHWLRQDQGSRLQWPXWDQWVDUHGHIHFWLYHLQXELTXLWLQDWHG+ELQGLQJ!$#
3ULPDU\ VHTXHQFH DOLJQPHQW RI WKH XELTXLWLQ LQWHUDFWLQJPRWLI 8,0 LQ WKH 76 GRPDLQ RI '107 IURP GLIIHUHQW VSHFLHV 7KH
FRQVHQVXVVHTXHQFHIRUVLQJOHVLGHG8,0V>@DQGWKH8,0PXWDWLRQVXVHGLQWKLVVWXG\'$($6$'$($
0$6$'$DUHLQGLFDWHG!%#8ELTXLWLQDWHGKLVWRQH+ELQGLQJDVVD\$IWHUH[WUDFWLRQRIPRQRQXFOHRVRPHVIURP+(.
7FHOOV WKHH[WUDFWVZHUH LQFXEDWHGZLWK*)3'107ZWRUPXWDQWV LPPRELOL]HGRQ WKH*)37UDSDQG WKHERXQG IUDFWLRQV
ZHUHDQDO\]HGZLWKVSHFLILFDQWL+DQWLXELTXLWLQDQGDQWL*)3DQWLERGLHV!&#&KDUDFWHUL]DWLRQRIWKHDQWL+$.XEDQWLERG\
1HZ(QJODQG%LRODEVLQFRPSDULVRQWRWKHDQWLERG\DJDLQVWQRQXELTXLWLQDWHG+$0LOOLSRUHE\LPPXQREORWWLQJRUJRI
DFLG H[WUDFWHG KLVWRQHV ZHUH ORDGHG WR DQDO\]H WKH VSHFLILFLW\ RI WKH DQWLERGLHV +$XE PRQRXELTXLWLQDWHG +$ +$XE
GLXELTXLWLQDWHG+$ !'# ,GHQWLILFDWLRQ RI WKH+$ SHSWLGH FDUU\LQJ XELTXLWLQDWLRQ ** RQ.E\/&0606 7KH
VDPSOHZDVSUHSDUHGE\H[FLVLRQRIDEDQGIURPDFLGH[WUDFWHGKLVWRQHVFRUUHVSRQGLQJWR+$XELQWKHLPPXQREORWIURP&06
IUDJPHQWDWLRQVSHFWUXPRIWKHSUHFXUVRULRQLVVKRZQLQWKHLQVHW7KHGLVSOD\HGEDQG\LRQVHULHVJHQHUDWHGE\&,'IUDJPHQWDWLRQ
RIWKH+$SHSWLGHPRGLILHGZLWK**RQ.SURYLGHGKLJKO\FRQILGHQWLGHQWLILFDWLRQDQGSRVWWUDQVODWLRQDOPRGLILFDWLRQ
ORFDOL]DWLRQ ,QVHWPDVV FKDUJH DQG PHDVXUHPHQW HUURU GHWHUPLQDWLRQ RI WKH+$ SHSWLGH RI LQWHUHVW 'LVSOD\HG LV WKH LVRWRSLF
GLVWULEXWLRQ RI WKH +$ SHSWLGH IURP ZKLFK WKH PDVVWRFKDUJH UDWLR PJ] DQG WKH FKDUJH  ZHUH REWDLQHG ¨P GLIIHUHQFH
EHWZHHQWKHH[SHFWHGDQGWKHPHDVXUHGPDVVHV5UHVROXWLRQRIWKH06PHDVXUHPHQW
!
!
6XSSOHPHQWDU\, LQIRUPDWLRQ0, )LJXUH, 69 '107 8,0 GHOHWLRQ DQG SRLQW PXWDQWV VWLOO LQWHUDFWLQJ ZLWK 8+5) DIIHFW
PDLQWHQDQFH'1$PHWK\ODWLRQ!$#/RFDO'1$PHWK\ODWLRQDQDO\VHVRI'QPWHIJI(6&VWUDQVLHQWO\H[SUHVVLQJ*)3'107ZWRU
¨DQG8,0SRLQWPXWDQWV'$($6$'$($0$6$'$&S*PHWK\ODWLRQOHYHOVDWWKH
PLQRU VDWHOOLWH UHSHDWV DQG WKH'QPWHR SURPRWHUZHUH DQDO\]HG E\ ELVXOILWH WUHDWPHQW RI JHQRPLF'1$ 3&5 DPSOLILFDWLRQ DQG
GLUHFWS\URVHTXHQFLQJ0HWK\ODWLRQOHYHOVRIXQWUDQVIHFWHG-'QPWHIJIFHOOVDUHVKRZQIRUFRPSDULVRQ0HDQYDOXHV6'RIWZRWR
IRXU LQGHSHQGHQW H[SHULPHQWV ZHUH FDOFXODWHG !%# &RLPPXQRSUHFLSLWDWLRQ DVVD\ RI *)376 DQG &K8+5) LQ+ YLWUR *)3
'10776GRPDLQZWRU8,0PXWDQWVZHUHFRH[SUHVVHGZLWK&K8+5)DQGDIWHUFRLPPXQRSUHFLSLWDWLRQXVLQJWKH*)37UDS
WKHERXQGIUDFWLRQVZHUHGHWHFWHGE\ZHVWHUQEORWZLWKVSHFLILFDQWLERGLHVDJDLQVW*)3DQG&K*)3ZDVXVHGDVQHJDWLYHFRQWURO,
LQSXW%ERXQG
!
6XSSOHPHQWDU\, LQIRUPDWLRQ0, )LJXUH, 6: '1078,0PXWDQWV VKRZRQO\ZHDNDVVRFLDWLRQZLWK3&1$VWDLQHG UHSOLFDWLRQ
VLWHVHVSHFLDOO\ LQ ODWH6SKDVH&RQIRFDOPLGVHFWLRQVRI*)3'107ZWRU¨DQG8,0SRLQWPXWDQWV '$($
6$'$($0$6$'$WUDQVLHQWO\H[SUHVVHGLQ-'QPWHIJI(6&VZLWKUHVSHFWWRUHSOLFDWLQJ'1$VWDLQHG
ZLWKDVSHFLILFDQWL3&1$DQWLERG\&KURPDWLQZDVFRXQWHUVWDLQHGZLWK'$3,6FDOHEDUP
6XSSOHPHQWDU\,LQIRUPDWLRQ0,7DEOH,63 3&5SULPHUVIRUELVXOILWH3&5DQGS\URVHTXHQFLQJ
1DPH 6HTXHQFH
)PDMRUVDWHOOLWHV ¶$$$$7*$*$$$7$777$777*¶
5PDMRUVDWHOOLWHVELRWLQ\ODWHG ¶*$*$$$7$7$7$&777$**$¶
)RXWHUVNHOHWDOĮIDFWLQ ¶$*77****$7$777777$7$¶
5RXWHUVNHOHWDOĮIDFWLQ ¶7***$$***7$*7$$7$777¶
)LQQHUVNHOHWDOĮIDFWLQ ¶7777**77$*7*7$**$*$7¶
5LQQHUVNHOHWDOĮIDFWLQELRWLQ\ODWHG ¶7***$$***7$*7$$7$777¶
)'QPWHR ¶*77*777777**77777*7***7$7¶
5RXWHU'QPWHR ¶&$$&&77$$&$$&$&$$&7$$$$7$¶
5LQQHU'QPWHRELRWLQ\ODWHG ¶&$$&7$7$&$&7$7&$$$7$$&&7$¶
)PLQRUVDWHOOLWHV ¶7$$7*$*77$7$$7*$*$$$¶
5PLQRUVDWHOOLWHVELRWLQ\ODWHG ¶$7$7$&$&7$77&7$&$$$7¶
6XSSOHPHQWDU\, LQIRUPDWLRQ0, 7DEOH, 64 6HTXHQFH RI KLVWRQH+  SHSWLGHV XVHG IRU WKH KLVWRQH SHSWLGH SXOOGRZQ DQG
KLVWRQHSHSWLGHELQGLQJDVVD\V;WULPHWK\ODWHGO\VLQH=DFHW\ODWHGO\VLQH;DDV\PPHWULFDOO\GLPHWK\ODWHGDUJLQLQH
1DPH 6HTXHQFH /DEHO
+ $57.47$5.67**.$35.4/.
%LRWLQDW&WHUPLQXV+.PH $57.47$5;67**.$35.4/.
+.DF $57.47$5=67**.$35.4/.
+ $57.47$5.67**.$35.4/.
7$05$DW&WHUPLQXV+.PH $57.47$5;67**.$35.4/.
+5PH $;D7.47$5.67**.$35.4/.
6XSSOHPHQWDU\, LQIRUPDWLRQ0,7DEOH,65 '1$ROLJRQXFOHRWLGHVXVHGIRUWKHSUHSDUDWLRQRIGRXEOHVWUDQGHGSUREHVIRULQ+YLWUR
'1$ELQGLQJDVVD\VZLWKWKHSULPHUH[WHQVLRQUHDFWLRQ0PHWK\OF\WRVLQH
2OLJRQDPH '1$VHTXHQFH
&*XS ¶&7&$$&$$&7$$&7$&&$7&&**$&&$*$$*$*7&$7&$7**¶
0*XS ¶&7&$$&$$&7$$&7$&&$7&0**$&&$*$$*$*7&$7&$7**¶
)LOO,Q ¶$772&&$7*$7*$&7&77&7**7&¶
)LOO,Q1 ¶$7721&&$7*$7*$&7&77&7**7&¶
6XEVWUDWH &RPELQDWLRQRIROLJRVLQWKHSULPHUH[WHQVLRQUHDFWLRQ
80% &*XS)LOO,Q
+0%1 0*XS)LOO,Q1
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ABSTRACT
Any profound comprehension of gene function re-
quires detailed information about the subcellu-
lar localization, molecular interactions and spatio-
temporal dynamics of gene products. We developed
a multifunctional integrase (MIN) tag for rapid and
versatile genome engineering that serves not only
as a genetic entry site for the Bxb1 integrase but
also as a novel epitope tag for standardized detection
and precipitation. For the systematic study of epi-
genetic factors, including Dnmt1, Dnmt3a, Dnmt3b,
Tet1, Tet2, Tet3 and Uhrf1, we generated MIN-tagged
embryonic stem cell lines and created a toolbox of
prefabricated modules that can be integrated via
Bxb1-mediated recombination. We used these func-
tional modules to study protein interactions and their
spatio-temporal dynamics as well as gene expres-
sion and specific mutations during cellular differenti-
ation and in response to external stimuli. Our genome
engineering strategy provides a versatile open plat-
form for efficient generation of multiple isogenic cell
lines to study gene function under physiological con-
ditions.
INTRODUCTION
In the last decades targeted gene disruption has been a
widely used approach to gain first insights into gene func-
tion. However, gene disruption studies are often hampered
by high functional redundancy in mammalian systems and
yield little information about the subcellular localization,
interactions and spatio-temporal dynamics of gene prod-
ucts. In order to gain comprehensive understanding of
gene function these studies need to be complemented by
more complex genetic manipulations such as fluorophore
knockin, specific domain deletions or introduction of point
mutations. Additionally, a systematic analysis of gene func-
tion requires application of biochemical as well as imag-
ing techniques, which usually rely on the generation of
gene specific antibodies, a technically demanding and time-
consuming process.
Recently, RNA guided endonucleases (RGENs) derived
from the prokaryotic Type II CRISPR/Cas (clustered
regularly interspaced short palindromic repeats/CRISPR-
associated) system have emerged as promising tools for the
manipulation and modification of genetic sequences (1–4).
The specificity of RGENs is mediated by small guide
RNAs (gRNAs) that bind to 20 bp within the target se-
quence and recruit the Cas9 nuclease to introduce a dou-
ble strand break. Although this two-component system
has greatly facilitated the generation of gene disruptions in
bacteria, plants and mammals, concerns have been raised
about considerable off-target effects (5–7). Furthermore,
the low frequency of homologous recombination in mam-
mals makes insertion of exogenous components such as flu-
orophore tags difficult and time-consuming.
In addition to RGENs, phage-derived serine integrases
have received considerable attention as novel tools for
genome engineering. Recently, Bxb1 was shown to have the
highest accuracy and efficiency in a screen of fifteen candi-
date serine integrases tested in mammalian cells (8). Serine
integrases are unidirectional, site-specific recombinases that
promote the conservative recombination between phage at-
tachment sites (attP) and bacterial attachment sites (attB)
*To whom correspondence should be addressed. Tel: +49 89 2180 74233; Fax: +49 89 2180 74236; Email: bultmann@bio.lmu.de
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(9) with much higher recombination efficiencies (up to 80%)
than the commonly used bidirectional tyrosine integrases,
Cre or Flp (9–12).
In this study, we aim to combine the advantages of both
RGENS and unidirectional integrases into one fast, widely
applicable and flexible method. We developed a novel strat-
egy for genome engineering based on a CRISPR/Cas as-
sisted in-frame insertion of an attP site, which we refer to
as the multifunctional integrase (MIN) tag. At the genetic
level, the MIN-tag serves as an attachment site for the serine
integrase Bxb1 that can be used to introduce a broad range
of prefabricated functional cassettes into the genomic locus
with high specificity and efficiency. At the protein level, the
MIN-tag functions as a novel epitope tag that can be de-
tected with a highly specific monoclonal antibody and used
for immunoprecipitation as well as immunofluorescence ex-
periments. To demonstrate the versatility of the strategy, we
generated MIN-tagged murine embryonic stem cell (mESC)
lines for a variety of major epigenetic factors, including
Dnmt1, Dnmt3a, Dnmt3b, Tet1, Tet2, Tet3 and Uhrf1. We
created a toolbox of vectors for Bxb1-mediated recombina-
tion to generate isogenic cell lines harboring knockout cas-
settes, fluorescent protein fusions, enzymatic tags and spe-
cific mutations; all derived from a single entry cell line en-
suring maximal biological comparability. We demonstrate
the power of this strategy using proximity-dependent pro-
tein labeling to identify novel interactors of TET1 in mESCs
as well as to systematically study the subcellular localiza-
tion, binding kinetics and protein expression dynamics of
the de novo methyltransferase DNMT3B during epiblast
differentiation.
MATERIALS AND METHODS
Western blotting and immunoprecipitation
Western blot analysis was performed using the follow-
ing primary antibodies: anti-DNMT1, anti-DNMT3a (Im-
genex, 64B1446); anti-DNMT3b (Abcam, 52A1018); anti-
UHRF1 (13); anti-TET1, anti-TET2 and anti-TET3 (14);
anti-GFP antibody (Roche, 11814460001); anti-!-Actin
(Sigma, A5441); anti-SNF2H (Abcam, ab22012). Blots
were probed with anti-rat (Jackson ImmunoResearch,
112-035-068), anti-mouse (Sigma, A9044) and anti-rabbit
(Biorad, 170–6515) secondary antibodies conjugated to
horseradish peroxidase (HRP) and visualized using an ECL
detection kit (Pierce). An anti-mouse antibody conjugated
to Alexa 488 (Life Technologies, A21202) was used for fluo-
rescence detection of western blots using the Typhoon 9400
(GE Healthcare) imaging system.
For immunoprecipitation, ∼1 × 106 Dnmt1attP/attP,
Dnmt3battP/attP or wt cells were harvested in ice cold phos-
phate buffered saline (PBS), washed twice and subsequently
homogenized in 200 "l lysis buffer (20 mM Tris/HCl pH
7.5, 150 mM NaCl, 0.5 mM EDTA, 1 mM PMSF, 0.5%
NP40). After centrifugation (10 min, 14 000 g, 4◦C) the
supernatant was adjusted with dilution buffer (20 mM
Tris/HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 1 mM
PMSF) to a final volume of 300 "l. A total of 50 "l were
mixed with sodium dodecyl sulphate (SDS)-containing
sample buffer (referred to as input (I)). For pull-downs,
100 "l (4 "g) of either 5A10 DNMT1 antibody (15) or
the newly generated MIN-tag antibody 1E1 was added to
the cell lysates and incubated 2 h at 4◦C. For pull-down
of immunocomplexes, 40 "l of protein G agarose beads
(GE Healthcare, Freiburg, Germany) equilibrated in dilu-
tion buffer were added and incubation continued for 2 h.
After centrifugation (2 min, 5000 × g, 4◦C) 50 "l of the su-
pernatant was collected (referred to as flow-through (FT))
while the remaining supernatant was removed. The beads
were washed twice with 1 ml dilution buffer containing 300
mM NaCl. After the last washing step, the beads were re-
suspended in 50 "l Laemmli buffer and boiled for 10 min
at 95◦C. For immunoblot analysis, 3% of the input and
the flow-through as well as 30% of the bound (B) frac-
tion were separated on a 10% sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) and sub-
jected to western blot analysis.
Immunofluorescence staining and microscopy
Immunostaining was performed as described previously
(16). Briefly, cells cultured on coverslips were fixed with
4% paraformaldehyde for 10 min, washed with PBST (PBS,
0.02% Tween20) and permeabilized with PBS supplemented
with 0.5% Triton X-100. Both primary and secondary an-
tibody were diluted in blocking solution (PBST, 2% BSA,
0.5% fish skin gelatin). Coverslips with cells were incubated
with primary and secondary antibody solutions in dark hu-
mid chambers for 1 h at RT; washings after primary and
secondary antibodies were done with PBST. Following sec-
ondary antibody incubations, cells were post-fixed with 4%
paraformaldehyde for 10 min. For DNA counterstaining,
coverslips were incubated in a solution of DAPI (2 "g/ml)
in PBS. Coverslips were mounted in antifade medium (Vec-
tashield, Vector Laboratories) and sealed with colorless nail
polish.
For immunolabeling, the following primary anti-
bodies were used: anti-DNMT1 (15); anti-DNMT3A
(Imgenex, 64B1446); anti-DNMT3B (Abcam, 52A1018);
anti-UHRF1 (13); anti-TET1, anti-TET2 (14); GFP-
Booster ATTO488 (Chromotek). The secondary antibod-
ies were anti-rabbit conjugated to DyLight fluorophore 594
(Jackson ImmunoResearch, 711-505-152), anti-mouse con-
jugated to Alexa 488 (Life Technologies, A21202), anti-rat
conjugated to Alexa 488 (Life Technologies, A21208) or
Alexa 594 (Life Technologies, A21209).
Single optical sections or stacks of optical sections were
collected using a Leica TCS SP5 confocal microscope
equipped with Plan Apo 63×/1.4 NA oil immersion objec-
tive and lasers with excitation lines 405, 488, 561 and 633
nm.
Live cell imaging experiments were performed on an
UltraVIEW VoX spinning disc microscope assembled to
an Axio Observer D1 inverted stand (Zeiss) and using a
63×/1.4 NA Plan-Apochromat oil immersion objective.
The microscope was equipped with a heated environmen-
tal chamber set to 37◦C and 5% CO2. Fluorophores were
excited with 488 nm or 561 nm solid-state diode laser lines.
Confocal image series were typically recorded with 14-bit
image depth, a frame size of 1024 × 1024 pixels and a pixel
size of 110 nm. z-stacks of 12 "m with a step size of 1 "m
were recorded every 30 min for about 24 h or for the live
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cell series of Dnmt3battP/attP every hour for 60 h. To avoid
photodamage of the cells, the AOTF of the laser was set to
low transmission values of 6–10%. Binning was set to 2×.
Super-resolution microscopy
Super-resolution images were obtained with a DeltaVision
OMX V3 3D-SIM microscope (Applied Precision Imaging,
GE Healthcare), equipped with a 60×/1.42 NA PlanApo
oil objective and sCMOS cameras (Olympus). A z-step
size of 125 nm was used during acquisition. SI raw data
were reconstructed and deconvolved with the SoftWorX 4.0
software package (Applied Precision). FIJI and Photoshop
CS5.1 (Adobe) were used for image processing and assem-
bly.
Antigen preparation, immunization, generation of hybrido-
mas and ELISA screening
For the translated attP peptide, the MIN antigen (attP
peptide) was designed with the following sequence
SGQPPRSQWCTVQT-Cys. Peptides were synthesized,
HPLC purified and coupled to OVA (Peps4LifeSciences-
Anette Jacob; Heidelberg). Lou/c rats were immunized
subcutaneously and intraperitoneally with a mixture of
50 "g peptide-OVA, 5 nmol CPG oligonucleotide (Tib
Molbiol, Berlin), 500 "l PBS and 500 "l incomplete
Freund’s adjuvant. A boost without adjuvant was given
6 weeks after primary injection. Fusion of the myeloma
cell line P3 × 63-Ag8.653 with the rat immune spleen
cells was performed using polyethylene glycol 1500 (PEG
1500, Roche, Mannheim, Germany). After fusion, the
cells were plated in 96 well plates using RPMI1640 with
20% fetal calf serum, penicillin/streptomycin, pyruvate,
non-essential amino acids (Gibco) supplemented by
hypoxanthine-aminopterin-thymidine, (HAT) (Sigma, St
Louis, MO, USA). Hybridoma supernatants were tested
in a solid-phase immunoassay. Microliter plates were
coated with avidin (3 "g/ml, Sigma) over night. After
blocking with 2% FCS in PBS, plates were incubated with
biotinylated MIN peptide at a concentration of 0.2 "g/ml
in blocking buffer. After washing the plates, the hybridoma
supernatants were added. Bound rat mAbs were detected
with a cocktail of HRP-labeled mouse mAbs against the
rat IgG heavy chains, thus avoiding IgM mAbs (#-IgG1,
#-IgG2a, #-IgG2b (ATCC, Manassas, VA, USA), #-IgG2c
(Ascenion, Munich, Germany). HRP substrate conversion
was visualized with ready to use TMB (1-StepTM Ultra
TMB-ELISA, Thermo). MIN-tag clone 1E1 (rat IgG1)
was stably subcloned and further characterized.
A set of 25 rat derived hybridoma supernatants were
tested for specificity against an integrated attP peptide in
the Dnmt1 locus using both western blot analysis and high
content microscopy. Western blots were prepared as men-
tioned previously. Each supernatant was used in a 1:10 dilu-
tion. Blots were probed with an anti-rat secondary antibody
conjugated to HRP.
Cells were prepared for immunofluorescence as described
above, with the exception that cells were fixed on a 96-well
Cell Carrier R⃝ plate (Greiner). Cells in individual wells were
incubated with the various hybridoma supernatants (1:100)
for 1 h. As a secondary antibody, anti-rat conjugated to
Alexa 488 (Life Technologies, A21208) was used. Nuclei
were counterstained using DAPI. Images of stained cells
were acquired automatically with an Operetta high-content
imaging system using a 40× air objective (PerkinElmer).
DAPI and ATTO488 coupled antibodies were excited and
their emissions recorded using standard filter sets. Exposure
times were 10 and 400 ms for DAPI and ATTO488, respec-
tively. All monoclonal antibodies described in this study are
available upon request.
The MIN antibody are available via http://human.bio.
lmu.de/ webtools/MINtool/AB info.html.
DNA methylation analysis
For the analysis of DNA methylation levels, genomic DNA
was isolated using the QIAamp DNA Mini Kit (QIAGEN).
Bisulfite treatment was performed using the EZ DNA
Methylation-GoldTM Kit (Zymo Research Corporation)
according to the manufacturer’s protocol. Subsequently,
the major satellite repeats sequence was amplified using
the primers described in (17). The biotinylated polymerase
chain reaction (PCR) products of the second PCR were an-
alyzed by pyrosequencing (Varionostic GmbH, Ulm, Ger-
many).
Targeting donor and plasmid construction
Plasmid sequences can be found in Supplementary Table
S6. Targeting donor constructs were either synthesized as
ssDNA oligonucleotides (Integrated DNA Technologies)
or produced by amplifying 300 to 200 bp long homology
arms with the respective external and internal primer sets
(Supplementary Table S2). These PCR products of the
5′ and 3′ homology arms were pooled and an overlap
extension PCR with the external primers was performed
to yield the final targeting fragments. The gRNA vector
was synthesized at Eurofins MWG Operon based on
the sequences described (3). The subcloning of targeting
sequences was performed by circular amplification. The
surrogate reporter (pSR) was generated by inserting in vitro
annealed DNA oligos via AsiSI and NruI into pCAG-mCh
(18). eGFP was amplified using the primers eGFP-F and
eGFP-R and sequentially cloned into pCAG-mCh-NruI
linker to generate the pSR construct. Reporters were
generated by subcloning in vitro annealed DNA oligos
containing CRISPR target sites into KpnI and NheI
digested pSR. The attB-GFP-knockin construct was
generated from R6K-NFLAP (19) by ligation free cloning
(20) rearranging the backbone sequences into the artificial
intron and introducing the attB site 5′ of the GFP open
reading frame (ORF), removing its start codon. The
attB-GFP-Poly(A) and attB-mCh-Poly(A) constructs were
created by amplifying the GFP ORF including the stop
codon and SV40 Poly(A) signal from pCAG-eGFP-IB and
inserted into the attB-LAP-tag backbone by ligation free
cloning. The attB-mCh-Poly(A)-mPGK-PuroR construct
was generated by subcloning the mPGK-PuroR sequence
from pPthc-Oct3/4 (21) and ligating it into the EcoRV
site of the attB-mCh-Poly(A) construct. The attB-GFP-
Poly(A)-mPGK-NeoR was produced by first exchanging
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the PuroR in pPthc-Oct3/4 with NeoR from pEGFP-C1
(22) using HindIII. The combined mPGK-NeoR was
then subcloned into the attB-GFP-Poly(A) vector via the
same EcoRV site mentioned previously. The attB-GFP-
Dnmt1cDNA-Poly(A), attB-GFP-Tet1cDNA-Poly(A)
and attB-GFP-Dnmt3b1cDNA-Poly(A) constructs were
generated by inserting the appropriate cDNAs from
constructs reported previously (17,23–24) via AsiSI/NotI
sites into the attB-GFP-Poly(A) and attB-mCh-Poly(A)
vectors respectively. The attB-GFP-Dnmt3b6-Poly(A),
attB-GFP-Tet1-d1–1363-Poly(A), attB-GFP-Tet1-d833–
1053-Poly(A), attB-GFP-Tet1-d833–1363-Poly(A) vectors
were produced via circular amplification with overlap
extension primers using the above mentioned attB-GFP-
Dnmt1/Dnmt3b1/Tet1cDNA-Poly(A) constructs as
templates.
The attB-GFP-Dnmt3b6-Poly(A)-mPGK-NeoR and
attB-mCh-Dnmt3b1-Poly(A)-mPGK-PuroR integration
constructs were created by inserting the Dnmt3b6 and
Dnmt3b1 sequences (from attB-GFP-Dnmt3b6-Poly(A)
and attB-GFP-Dnmt3b1-Poly(A)) using AsiSI/NotI sites
into attB-GFP-Poly(A)-mPGK-NeoR and attB-mCh-
Poly(A)-mPGK-PuroR vectors, respectively.
All constructs described in this study are available via Ad-
dgene or via http://human.bio.lmu.de/ webtools/MINtool/.
Cell culture
J1 ESCs were maintained on gelatin-coated dishes in
Dulbecco’s modified Eagle’s medium supplemented with
16% fetal bovine serum (FBS, Biochrom), 0.1 mM ß-
mercaptoethanol (Invitrogen), 2 mM L-glutamine, 1×
MEM Non-essential amino acids, 100 U/ml penicillin,
100 "g/ml streptomycin (PAA Laboratories GmbH), 1000
U/ml recombinant mouse LIF (Millipore) and 2i (1
"M PD032591 and 3 "M CHIR99021 (Axon Medchem,
Netherlands), referred to as ESC medium. Differentiation
of naive pluripotent stem cells to epiblast-like cells was
performed according to the protocol of (25). Briefly, J1
ESCs were maintained in the ground state in Geltrex (Life
Technologies) coated flasks and cultured in N2B27 (50%
neurobasal medium (Life Technologies), 50% DMEM/F12
(Life Technologies), 2 mM L-glutamine (Life Technolo-
gies), 0.1 mM !-mercaptoethanol, N2 supplement (Life
Technologies), B27 serum-free supplement (Life Technolo-
gies) containing 2i and 1000 U/ml LIF 100 U/ml Penicillin-
streptomycin) for at least three passages before differentia-
tion. To differentiate naive ESCs into epiblast-like cells, cells
were replated in N2B27 differentiation medium containing
10 ng/ml Fgf2 (R&D), 20 ng/ml Activin A (R6D) and 0.1×
Knockout Serum Replacement (KSR)(Life Technologies).
Time point 0 h in differentiation time-course experiments
corresponds to the time N2B27 differentiation medium was
added to cells.
Generation of MIN-tagged and Bxb1-mediated knockin cell
lines
To produce MIN-tagged cell lines, 5 × 105 cells were disso-
ciated and seeded in 0.2% gelatin (Sigma-Aldrich) coated
p35 plates. After 3 h, cells were transfected with 2 "g of
the MIN-tag donor/homology ssDNA oligo or PCR prod-
uct, 0.5 "g gRNA construct, 0.5 "g surrogate reporter
construct and 1 "g Cas9 using Lipofectamine 3000 (In-
vitrogen) according to the manufacturer’s instructions. For
Bxb1-mediated recombination of attB constructs, 5 × 105
cells were transfected with 1 "g pCAG-NLS-HA-Bxb1 ex-
pression plasmid ((26) addgene 51271), 1 "g of the respec-
tive attB construct and 0.5 "g Bxb1 surrogate reporter.
For both MIN-Tagging and Bxb1-mediated recombina-
tion, cells were dissociated, resuspended in ESC medium
48 h post transfection and then analyzed and sorted with
a FACS Aria II (Becton Dickinson). For MIN-tagging, en-
richment of cells with RGEN activity was accomplished
by single-cell sorting GFP and mCherry positive cells into
96-well plates (Falcon) containing 150 "l of ESC medium.
For Bxb1-mediated recombination, cells with Bxb1 activity
were enriched for by single-cell sorting GFP positive cells
into 96-well plates. Alternatively for Bxb1-mediated inte-
gration using antibiotic selection, cells were replated into
p150 plates with ESC medium containing G418 (0.5 mg/ml,
AppliChem) and puromycin (1 "g/ml, AppliChem) 48 h
post transfection.
Identification of MIN-tagged and Bxb1-mediated knockin
cell lines with restriction fragment analysis and PCR screen-
ing
After ∼7 days (until colonies were readily visible), plates
from single-cell sortings were screened for colony growth.
Surviving colonies were dissociated and individually re-
plated onto two 96-well plates. Genomic DNA was isolated
from one plate after 2–3 days, while the second plate re-
mained in culture. To identify MIN-tagged clones, the re-
gion surrounding the ATG (or stop codon in the case of
C-terminal tagging) was PCR amplified using the appro-
priate external and screening primers (Supplementary Ta-
ble S2). For restriction fragment analysis, 10 "l of these
PCR products were digested with either HincII or SacII
and then analyzed on 1.5% agarose gels. PCRs of positive
clones were confirmed by Sanger sequencing. To screen for
Bxb1-mediated recombiation, we employed a three-primer
PCR strategy using the respective external primers flank-
ing the MIN-tagged locus and an attL-specific primer (Sup-
plementary Figure S3A, Table S2). For Bxb1-mediated in-
tegrations using antibiotic selection, mESC colonies were
picked, dissociated using trypsin and plated into individual
wells on 96-well plates ∼7 days after starting antibiotic se-
lection. Genomic DNA isolation and screening PCRs were
performed as described above. Clones harboring the desired
MIN-tag insertion or Bxb1-mediated integration were ex-
panded, frozen and stored in liquid nitrogen.
All cell lines are available at http://human.bio.lmu.de/
webtools/MINtool/cell lines.html.
Genomic DNA isolation for PCR
Cells were lysed in multi-well plates by the addition of 50 "l
lysis buffer (10mM Tris/HCl pH 7.4, 10mM EDTA, 10mM
NaCl, 50"g/ml Proteinase K, 1.7 "M SDS) per well. The
Plates were subsequently incubated at −80◦C for 15 min,
followed by 3 h at 56◦C. Heat inactivation of Proteinase K
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was performed by incubation at 85◦C for 20 min. The re-
sulting crude DNA lysates were directly subjected to PCR.
BioID
BioID experiments were performed after (27) using ex-
tracted crude nuclei (adapted from (28)) as input material.
In brief, cells were cultured for 48 h with or without ad-
dition of 50 "M biotin. Cell pellets (∼4 ×107 cells) were
washed once in buffer A (10 mM HEPES/KOH pH 7.9, 10
mM KCl, 1.5 mM MgCl2) and resuspended in buffer A con-
taining 0.15% NP-40 and 1× protease inhibitor (SERVA).
Samples were homogenized using a pellet pestle. After cen-
trifugation, crude nuclei pellets were washed once with PBS.
Crude nuclei were resuspended in BioID-lysis buffer (0.2%
SDS, 50 mM Tris/HCl pH 7.4, 500 mM NaCl, 1 mM
DTT, 1× protease inhibitor), supplemented with 2% Triton
X-100 and subjected to sonication twice using a Branson
Sonifier 450 (15% amplitude, 0.3 s pulse, 0.6 s pause, total
time 30 s). Samples were diluted 1:1 with 50 mM Tris/HCl
pH 7.4 after the first sonication step. Pulldown of biotiny-
lated proteins was performed overnight at 4◦C with rotation
using M-280 Streptavidin Dynabeads (Life Technologies)
for subsequent mass spectrometry or Streptactin-Superflow
agarose beads (IBA) for SDS-PAGE analysis, respectively.
Beads were washed with wash buffer 1 (2% SDS), wash
buffer 2 (0.1% desoxycholic acid, 1% Triton X-100, 1 mM
EDTA, 500 mM NaCl, 50 mM HEPES/KOH pH 7.5) and
wash buffer 3 (0.5% desoxycholic acid, 0.5% NP-40, 1 mM
EDTA, 500 mM NaCl, 10 mM Tris/HCl pH 7.4) followed
by two washing steps with 50 mM Tris/HCl pH 7.4. For
SDS-PAGE analysis, proteins were silverstained after (29).
Digest of proteins and sample preparation for LC-MS/MS
On-beads digest of proteins was performed as described in
(28). All steps were carried out at room temperature. Beads
were resuspended in 2 M Urea in Tris/HCl pH 7.5, reduced
with 10 mM DTT for 20 min and subsequently alkylated
with 50 mM chloroacetamide for 20 min. A total of 0.25 "g
Pierce Trypsin Protease (Thermo Scientific) was added for 2
h. Beads were collected by centrifugation and the resulting
peptide supernatant was further incubated overnight with
addition of 0.1 "g trypsin. Peptides were desalted using
StageTips (30).
LC-MS/MS and data analysis
Peptides were reconstituted in 20 "l mobile phase A (2% v/v
acetonitrile, 0.1% v/v formic acid) and analyzed by tandem
mass spectrometry using a EASY-nLC 1000 nano-HPLC
system connected to a LTQ Orbitrap Elite mass spectrom-
eter (Thermo Fisher Scientific). About 2–4 "l of the pep-
tide mixture were separated onto a PepMap RSLC column
(75 "m ID, 150 mm length, C18 stationary phase with 2
"m particle size and 100 Å pore size, Thermo Fisher Sci-
entific) and introduced into the mass spectrometer at a flow
rate of 300 nl/min running a gradient from 5 to 35% mo-
bile phase B (98% v/v acetonitrile, 0.1% v/v formic acid).
Ion source and transmission parameters of the mass spec-
trometer were set to spray voltage = 2 kV, capillary tem-
perature = 275◦C. The mass spectrometer was operated in
data-dependent mode, selecting up to 10 precursors from a
MS1 scan (resolution = 60 000) in the range of m/z 250–
1800 for collision-induced dissociation (CID). Singly (+1)
charged precursor ions and precursors of unknown charge
states were rejected. CID was performed for 10 ms using
35% normalized collision energy and the activation q of
0.25. Dynamic exclusion was activated with a repeat count
of one, exclusion duration of 30 s, list size of 500 and the
mass window of ±10 ppm. Ion target values were 1 000 000
(or maximum 10 ms fill time) for full scans and 10 000 (or
maximum 100 ms fill time) for MS/MS scans, respectively.
Raw data were analyzed using MaxQuant Version 1.5.2.8
(31) using the MaxLFQ label free quantification algorithm
(32) and the match-between-runs functionality. UniprotKB
MOUSE.fasta was used as a reference database (33). A
maximum of two missed cleavages and a false discovery rate
of 1% were set as parameters. Oxidation of methionine and
biotinylation were searched as variable modifications and
carbamidomethylation of cysteine residues as fixed modifi-
cation. For statistical analysis, the Perseus software version
1.5.1.6 was used (31). Significance was tested using a two
sided Student’s t-test and a permutation based FDR cal-
culation. GO enrichment analysis was performed with the
Gene Ontology enRIchment anaLysis and visuaLizAtion tool
(GOrilla, (34)). A P-value < 0.01 was considered signifi-
cant.
FRAP
Live cell imaging and FRAP experiments were typically
performed on an UltraVIEW VoX spinning disc mi-
croscope with integrated FRAP PhotoKinesis accessory
(PerkinElmer) assembled to an Axio Observer D1 inverted
stand (Zeiss) and using a 63×/1.4 NA Plan-Apochromat oil
immersion objective. The microscope was equipped with a
heated environmental chamber set to 37◦C. Fluorophores
were excited with 488 nm (exposure time: 400 ms, laser
power: 15%) or 561 nm (exposure time: 450 ms, laser power:
30%) solid-state diode laser lines. Confocal image series
were typically recorded with 14-bit image depth, a frame
size of 256 × 256 pixels and a pixel size of 110 nm. For pho-
tobleaching experiments, the bleach regions, typically with
a diameter of 2 "m, were manually chosen to cover the chro-
mocenters. Photobleaching was performed using one itera-
tion with the acousto-optical tunable filter (AOTF) of the
488 nm laser line set to 100% transmission. Typically, 10
pre-bleach images were acquired at a rate of 1 s per time-
point and 60 post-bleach frames were recorded at a rate
of 10 s per timepoint. Data correction, normalization and
quantitative evaluations were performed by automated pro-
cessing with ImageJ (http://rsb.info.nih.gov/ij/) using a set
of newly developed macros followed by calculations in Ex-
cel.
RESULTS
A fast and efficient strategy to generate MIN-tagged genomic
loci
Our novel genome engineering strategy relies on the
CRISPR/Cas-assisted insertion of the MIN-tag sequence
into the open reading frame of a target gene either directly
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downstream of the start codon or upstream of the stop
codon (Figure 1A and Supplementary Figure S2H). Nei-
ther regulatory regions nor gene structure are altered, lead-
ing to preservation of the endogenous expression pattern
and post-transcriptional processing of the gene of interest.
Since epigenetic processes undergo dramatic changes
during early embryonic development and are tightly regu-
lated, we tested the efficacy and versatility of our method
by targeting the DNA modifying enzymes Dnmt1, Dnmt3a,
Dnmt3b, Tet1, Tet2 and Tet3 as well as the chromatin bind-
ing protein Uhrf1 in mESCs (Figure 1D). We generated
targeting donors containing the 48 bp MIN-tag sequence
flanked by short homology arms (200–300 bp for PCR-
based donors or 76 bp for single stranded DNA oligos).
We next designed specific gRNAs to target sequences lo-
cated either in close proximity to or overlapping the start
or stop codon of the respective genes. As scarless inte-
gration of the MIN-tag requires a resistance free selec-
tion strategy we used a surrogate reporter assay to enrich
for cells that express an active Cas9:gRNA complex by
fluorescence-activated cell sorting (FACS) (Figure 1B and
C). In this reporter assay, the target sequence is inserted be-
tween the ORF of mCherry (mCh) and GFP thereby dis-
rupting the reading frame of the fusion. GFP is expressed
only when the target sequence is cleaved by a specific and ac-
tive Cas9:gRNA complex, which causes small, frameshift-
ing insertions or deletions by non-homologous end joining
(NHEJ) restoring the reading frame of the fluorescent pro-
tein (35). For each targeting, we co-transfected mESCs with
a mixture of surrogate reporter construct, gRNA vector,
Cas9 expression plasmid and the specific targeting MIN-
tag donor fragment. After single cell sorting of GFP posi-
tive cells and expansion of the resulting colonies, we isolated
genomic DNA by a fast and simplified in-well lysis proto-
col to screen for positive clones by PCR and analytical re-
striction digest. This allows the identification of hetero- and
homozygous insertions already at this stage (Supplemen-
tary Figure S1D). Combined, all targeting yielded positive
clones with an average efficiency of 3% for homozygous and
1% for heterozygous insertions (Supplementary Table S1).
All targeted genes were expressed normally and subcellular
localization as well as enzymatic activity was not disrupted
in comparison to wild-type (wt) cells (Supplementary Fig-
ures S1 and S2). In addition, the possibility of C-terminal
tagging (see Uhrf1 (C); Figure 1D and Supplementary Fig-
ure S2H) allows the MIN-tag to be used in cases where N-
terminal targeting disturbs protein function.
Taken together, these results demonstrate that the MIN-
tag can efficiently be integrated at precise genomic locations
using a CRISPR/Cas assisted, fluorescence based selection
strategy.
Generation of a highly specific monoclonal antibody recog-
nizing the MIN epitope
Insertion of the MIN-tag into the ORF of target genes
leads to expression of a small peptide that does not occur
in the mammalian proteome (Figure 2A). This unique fea-
ture allowed us to generate a highly specific monoclonal an-
tibody against MIN-tagged proteins. Immunofluorescence
(IF) stainings of a mixed Dnmt1attP/attP and wt culture dis-
tinguished single MIN-tagged cells and colonies from wt
cells, demonstrating the high specificity of the anti-MIN an-
tibody (Figure 2B). Pull-down experiments in Dnmt1attP/attP
cell extracts showed a quantitative enrichment of DNMT1
in the bound fraction (Figure 2C). Furthermore, pull-down
of DNMT3B using the anti-MIN antibody efficiently co-
precipitated SNF2H, a known interactor of DNMT3B, in
protein extracts of Dnmt3battP/attP cells, but not in wt con-
trol extracts (Figure 2D) (36).
Collectively, these data show that the MIN-tag can be uti-
lized as a universal epitope tag for IF and immunoprecip-
itation (IP), thus allowing the investigation of localization
and molecular interactions of MIN-tagged proteins.
Functionalization of MIN-tagged genes by Bxb1-mediated
recombination
To demonstrate the versatility of the MIN-tag as a Bxb1
integration site, we constructed a toolbox of functional
cassettes, which we recombined into the MIN-tagged lo-
cus of the maintenance DNA methyltransferase Dnmt1
(Dnmt1attP/attP). First, we generated a knockout vector car-
rying the attB site directly in front of the ORF of GFP
followed by a stop codon and a polyadenylation signal
(attB-GFP-Poly(A), Figure 3A) that we transfected to-
gether with a codon-optimized Bxb1 expression construct
in the Dnmt1attP/attP cell line. Successful recombination
events were identified by GFP expression and single cells
sorted by FACS (Figure 3B). We designed a multiplex PCR
strategy that takes advantage of the unique attL site gener-
ated by successful recombination to facilitate identification
of positive clones and their zygosity (Figure 3D and Supple-
mentary Figure S3A). PCR screening of sorted clones re-
vealed that the attB-GFP-Poly(A) construct had been suc-
cessfully integrated into both alleles in 13 (56.5%) clones
(Supplementary Table S3). Of those, we examined three
clonal cell lines all of which exhibited no residual expres-
sion of DNMT1 by western blot analysis and IF (Figure
3F; Supplementary Figure S3B and C). For functional char-
acterization, we analyzed DNA methylation levels at major
satellite repeats, one of the main substrates for DNA methy-
lation activity of DNMT1 during replication (37,38). Due
to the loss of the maintenance DNA methyltransferase in
the Dnmt1KO/KO clones, a severe hypomethylation was ob-
served at this sequence (Figure 3E). Taken together, our
attB-GFP-Poly(A) vector proved to be a valuable tool to
generate genetically-defined gene knockouts in MIN-tagged
cell lines.
Second, we designed a GFP knockin construct that can
be used to generate in-frame GFP fusions of MIN-tagged
genes. To avoid disruption of the gene locus and preserve the
endogenous splicing sites, we placed the bacterial backbone
sequences into an artificial intron splitting the GFP ORF
into two exons (19) (Figure 3A). After recombination and
FACS sorting for GFP expressing cells, the GFP knockin
construct integrated in both alleles of the Dnmt1 locus in 13
clones (41.9%), without altering physiological DNMT1 ex-
pression levels (Figure 3G, Supplementary Figure S3D and
Table S3). Live cell imaging of Dnmt1GFP/GFP cells revealed
a normal localization of GFP-DNMT1 throughout the cell
cycle (15,24)(Supplementary Figure S3E), demonstrating
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Figure 1. Generation of MIN-tagged cell lines. (A) Schematic overview of MIN-tag insertion into the Dnmt1 locus via CRISPR/Cas assisted gene editing.
The MIN-tag donor harbors the attP site and homology to the genomic sequence 5′ and 3′ of the start codon. Integration is facilitated by double strand
breaks created by Cas9 directed to the target sequence by a specific gRNA. Restriction enzyme recognition sites used for screening in this study are indicated
above the attP sequence. (B) Schematic overview of the surrogate reporter used to enrich for cells expressing a functional Cas9 complex. The respective Cas9
target sequence (tSeq) is placed downstream of mRFP followed by a stop codon and an out-of-frame GFP ORF. This surrogate reporter is transfected
into the cells together with a vector expressing Cas9 and a U6 driven gRNA expression cassette. (C) Cells that express a functional Cas9 complex can
then be identified by expression of GFP and enriched via FACS. (D) Screening PCRs followed by restriction digest with HincII or SacII of all generated
MIN-tagged cell lines. (N) and (C) refer to N- and C-terminal tagging, respectively.
that DNMT1 regulation was not impaired. Albeit only at
low frequencies, Bxb1 has been shown to damage recom-
bination sites (8). Therefore, we sought to confirm that the
Bxb1-mediated recombination of the GFP cassette at the
MIN-tagged locus occurred without error via site-specific
recombination. We sequenced the region flanking the attL
site in the Dnmt1GFP/GFP cell line (Supplementary Figure
S4) and determined that the GFP cassette was accurately
integrated in a scarless fashion. In summary, this attB-GFP
vector is suited to express GFP fusion proteins from the en-
dogenous promoter preserving physiological regulation and
splicing of the target gene.
Finally, we investigated whether the MIN-tag can be used
to generate cell lines expressing mutants of the target gene
for functional screenings or disease modeling. We cloned
the cDNA of Dnmt1 into the attB-GFP-Poly(A) construct
in-frame with GFP and performed recombination as de-
scribed above. We identified 10 (66.6%) clones in which in-
tegration had occurred, of which 9 (60%) were homozygous
for the Dnmt1 cDNA knockin (Supplementary Table S3).
Expression analysis by western blot and live cell imaging
revealed that the endogenous DNMT1 protein was com-
pletely replaced by the Dnmt1 mini gene product and exhib-
ited normal localization (Figure 3H, Supplementary Figure
S3F).
All in all, we show that MIN-tagged entry cell lines can
be efficiently functionalized with a flexible toolbox of attB-
vectors to generate gene knockouts, N-terminal fusion con-
structs such as GFP and cDNA knockins. In total, we
generated 15 derivatives of our MIN-tagged cell lines so
far. The efficiency of Bxb1-mediated recombination ranged
from 33 to 67%, with an average of 50% (Supplementary
Table S3, Figure S5). This demonstrates the efficacy of our
system as well as the simplicity with which MIN-tagged cell
lines can be modified and functionalized by prefabricated
cassettes. The error-prone step of CRISPR/Cas-mediated
insertion of the MIN-tag is necessary only once to generate
an entry cell line, which can then be specifically manipulated
with a variety of recombination vectors, allowing maximum
biological comparability.
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Figure 2. Application of the anti-MIN monoclonal antibody. (A) DNA sequence of the attP site and corresponding translated MIN peptide sequence
(orange). (B) Fluorescence micrographs of wt mESCs, Dnmt1attp/attp cells and of a mixed culture (1:10) of wt and Dnmt1attP/attP cells stained with
the anti-MIN antibody. DAPI is used as DNA counterstain. Scale bars represent 5 "m. (C) IP experiments performed with anti-MIN and anti-DNMT1
antibody in Dnmt1attP/attP cell extracts (input (I), flow through (FT), bound (B)). (D) Co-IP of DNMT3B in wt and Dnmt3battP/attP cells using the
anti-MIN antibody. DNMT3B co-precipitated SNF2H in Dnmt3battP/attP cells as determined by western blot.
Using the MIN-tag strategy to study endogenous protein reg-
ulation
As elucidating the function of uncharacterized protein do-
mains requires systematic analysis, we generated a series
of deletion constructs covering the N-terminus of TET1,
which we aimed to recombine into our Tet1attP/attP cell line
(Figure 4A). However, we were unable to identify positive
recombination events by FACS due to low expression of
this target gene. To circumvent this problem, we developed
a surrogate reporter system for Bxb1 mediated recombina-
tion that can be used to enrich for positive recombination
events (Figure 3C). The Bxb1 surrogate reporter construct
consists of a constitutive promoter followed by an attP site
and a Poly(A) sequence. Upon transfection, Bxb1 mediates
the recombination of a fluorophore (e.g. GFP) containing
attB plasmid with the Bxb1 surrogate reporter, which re-
sults in the expression of GFP. This allows enrichment of
positive recombination events, even when the MIN-tagged
gene is not expressed or only at low levels.
Using the Bxb1 surrogate reporter for enrichment and the
above described PCR strategy for screening, we were able to
generate four Tet1 knockin cell lines expressing N-terminal
deletion constructs from the endogenous promoter. West-
ern blot analysis revealed complete replacement of wt TET1
expression by the knockin constructs (Figure 4B). These cell
lines can be used for future systematic studies of the regu-
latory function of the TET1 N-terminus that is largely un-
known so far.
Taking advantage of the MIN-tag strategy to express fu-
sion constructs at endogenous levels, we expanded our tool-
box to include a BirA* cassette which we knocked into the
Tet1 locus (Supplementary Figure S5G). In contrast to clas-
sical IP approaches, proximity-dependent protein labeling
by the promiscuous biotin ligase, BirA* (BioID) (27), al-
lows the characterization of the full microenvironment of a
protein of interest independent of physical protein–protein
interactions. This technique enabled us to pull down pro-
teins within close proximity (∼10 nm radius, (39)) of TET1
that were subsequently identified by LC-MS/MS (Figure
4C). We found nine proteins to be significantly enriched (40)
upon addition of exogenous biotin to the culture medium of
our Tet1BirA*/BirA* mESC line, including SIN3A, a known
interactor of TET1 (41) (Figure 4D and E). Interestingly,
these proteins are associated with chromatin modification
and organization (Figure 4F). This marks the first time that
the BioID method has been used in mESCs and in a non-
overexpression context with the BirA* ligase fused to the
endogenous protein.
Using the MIN-tag strategy to study dynamic cellular pro-
cesses
During early embryonic development, the epigenome un-
dergoes massive rearrangements that are precisely regu-
lated. Knockout of the major epigenetic factors is often
embryonic lethal (38,42) and over-expression studies fre-
quently fail to reflect the tight regulation of these proteins.
Therefore, more flexible and delicate genetic manipulations
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Figure 3. Bxb1-mediated insertion of functional cassettes into the Dnmt1 locus. (A) Schematic outline of the strategy and vectors used to create knockout,
GFP knockin and cDNA knockin functionalizations of the Dnmt1attP/attP cell line. cDNAs can be cloned into the attB-GFP-Stop-Poly(A) vector using the
8-cutters AsiSI and NotI. (B) FACS plot depicting the gating and sorting of mESCs to enrich for cells positive for integration of the knockout cassette (2.05%
of parent population) based on GFP expression. (C) The Bxb1 surrogate reporter consists of a constitutive CMV promoter followed by an attP site. If Bxb1
and attB donor plasmid containing GFP is present in the cell, recombination of the donor into the reporter leads to expression of GFP. The Bxb1 surrogate
reporter can be used to enrich for successful recombination events by FACS. (D) Gel electrophoresis of the multiplex PCR for wt, Dnmt1attP/attP (attP/attP),
Dnmt1KO/KO (KO/KO), Dnmt1cDNA/cDNA (cDNA/cDNA) and Dnmt1GFP/GFP (GFP/GFP) as well as 1:1 mixtures with Dnmt1attP/attP genomic DNA, to
control for amplification biases. Blue arrows indicate expected sizes of the non-recombined (attP) and recombined allele (attL). (E) DNA methylation
levels at the major satellite repeats of Dnmt1KO/KO cells compared to wt and Dnmt1attP/attP cells. (F) Western blot analysis of DNMT1 expression levels
in wt, Dnmt1attP/attP and Dnmt1KO/KO cells generated by Bxb1-mediated insertion of a knockout cassette. (G) Western blot analysis of DNMT1 and GFP
expression in Dnmt1attP/attP and homozygous GFP-knockin cells (Dnmt1GFP/GFP) generated by Bxb1-mediated insertion. (H) Western blot analysis of
DNMT1 and GFP expression in Dnmt1attP/attP and Dnmt1cDNA/cDNA cells expressing a GFP-Dnmt1 minigene from the endogenous promoter.
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Figure 4. Study of TET1 regulation. (A) Schematic representation of the Tet1 cDNA constructs used for Bxb1-mediated recombination into Tet1attP/attP
cells. (B) Western blot analysis of TET1 expression in Tet1attP/attP cell line and its derivatives expressing GFP-TET1!1–1363 (!1–1363), GFP-TET1!833–1053
(1!833–1053) and GFP-TET1!833–1363 (!833–1363). Note that fusion to GFP increases the MW of TET1 constructs by 29 kDa. (C) Schematic represen-
tation of the BioID approach as described by Roux etal. (27). (D) SDS-PAGE analysis of a BioID pulldown experiment using the Tet1BirA*/BirA* cell line.
Cells were cultured either without (control) or with 50 "M biotin (+biotin). C: Cytoplasm, I: Crude nuclei input, FT: Flowthrough, B: Bound, W1-W3:
Wash. (E) Volcano plot of proteins identified in the streptavidin pulldown of the TET1-BioID experiment, quantified with the MaxQuant Label-Free-
Quantification algorithm (32). The x-axis reflects the difference in protein abundance in the BioID pull-down compared to the negative control while the
y-axis shows the logarithmized P-value of a student’s t-test. Significantly enriched proteins are highlighted in pink (FDR = 0.01, S0 = 3, indicated by black
line (40)). Experiments were performed in duplicates. (F) GO term enrichment of proteins identified as significant in BioID.
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are needed to study the function of epigenetic factors in vivo.
Here, we focus on the de novo DNA methyltransferase 3B
(DNMT3B), one of the key factors during epiblast differen-
tiation. While it has been shown that DNMT3B, in concert
with DNMT3A and DNMT3L, is responsible for the global
wave of de novo DNA methylation occurring during epiblast
differentiation (42–44), little is known about its localization
and protein kinetics during this developmental time period.
To address this question in a systematic fashion,
we generated a homozygous GFP knockin cell line
(Dnmt3bGFP/GFP) from the Dnmt3battP/attP cell line by Bxb1-
mediated recombination (Figure 5A and 6A). This allowed
us to follow expression of DNMT3B under native regu-
latory conditions and to monitor its localization during
the two-day transition from naive pluripotent ESCs to
Epiblast-like cells (EpiLCs, (25)) using live cell imaging with
high temporal resolution (1 image per hour).
At the naive pluripotent state, we observed very low ex-
pression levels of DNMT3B. Upon addition of differen-
tiation medium, protein expression was strongly and uni-
formly upregulated reaching its maximum at 48–52 h (Fig-
ure 5B, Supplementary video 1). Overall, these findings
were consistent with Dnmt3b mRNA levels in wt and
Dnmt3battP/attP cells (Figure 5C). Interestingly, we observed
a highly dynamic subnuclear distribution of DNMT3B dur-
ing differentiation that can be classified into three patterns
(Figure 5B). (i) In the first 14 h of differentiation, DNMT3B
is expressed at low levels and no clear enrichment is visi-
ble. (ii) Between 14–40 h after initiation of differentiation,
DNMT3B expression is upregulated and accumulates at
constitutive heterochromatin of chromocenters (CCs). (iii)
After 40 h of differentiation, DNMT3B is highly expressed
and localization to CCs is diminished. The above-described
patterns were not related to specific cell cycle stages, in-
dicating a differentiation stage dependent localization of
DNMT3B (Supplementary Figure S6A).
To investigate the specific chromatin distribution of
DNMT3B during differentiation in more detail, we per-
formed super-resolution 3D structured illumination mi-
croscopy (3D-SIM) with the anti-MIN antibody for protein
visualization. DAPI and trimethylated lysine 4 of histone 3
(H3K4me3) were used as markers of heterochromatin and
euchromatin (45), respectively. In agreement with the live
cell imaging experiments, DNMT3B localizes at CCs, clus-
ters of subcentromeric regions, at the 30 h time point and
shows a broader distribution at 60 h after differentiation
(Figure 5D). Interestingly, the higher resolution of 3D-SIM
revealed an accumulation of the signal in facultative hete-
rochromatin at perinuclear and perinucleolar regions at the
60 h time point (Figure 5D; right panel).
DNMT3B has been shown to be responsible for the
methylation of major satellite DNA, a main constituent
of CCs (42,46–47). As DNMT3B is enriched at CCs be-
tween 14–40 h of differentiation, we investigated whether
DNMT3B is actively methylating these sequences during
this period. Therefore, we performed fluorescence recov-
ery after photobleaching (FRAP) of GFP-DNMT3B lo-
calized at CCs. Using our Dnmt3bGFP/GFP cell line, we per-
formed FRAP experiments at 35 h of differentiation. Using
circular regions of interest (ROIs) that encompassed indi-
vidual CCs, we monitored signal recovery for 10 min after
bleaching. We found that the signal exhibited a slow recov-
ery rate (t1/2 = 42 s) and did not recover completely. As
DNA methylation has been shown to have a slow turnover
rate (48,49), this suggested the immobile fraction (∼20%) of
DNMT3B could be catalytically active at CCs (Figure 6B
and D, Supplementary Table S4). To test this hypothesis,
we performed FRAP experiments on cells treated with the
DNA methyltransferase inhibitor 5-aza-2’-deoxycytidine
(5-azadC), which irreversibly traps DNMTs at their site of
action (50). We found that 5-azadC treated CCs exhibited a
large immobile fraction (∼80%) suggesting that DNMT3B
is actively methylating CCs at this time point. However,
we were surprised to find that ∼20% of DNMT3B enzyme
still remained mobile (Figure 6C). Considering the long 5-
azadC treatment time of 12 h this suggested that a fraction
of the enzyme never engaged in catalytic reactions. As our
GFP cassette preserves endogenous splicing patterns, the
GFP-DNMT3B fusions used in this study represent a mix-
ture of different protein isoforms. This prompted us to in-
vestigate the contribution of Dnmt3b splicing isoforms to
the observed FRAP kinetics.
For Dnmt3b, nine splicing isoforms, all originating from
the same translational start site, have been described
(51). Besides the catalytically active isoform DNMT3B1,
DNMT3B6 has been shown to be highly expressed in ESCs.
This isoform is produced by alternative splicing, skipping
exons 23 and 24, resulting in a protein that lacks several
highly conserved motifs within the catalytic domain and has
therefore been suggested to be inactive (52).
To dissect the contributions of DNMT3B1 and
DNMT3B6 to the observed FRAP kinetics of
Dnmt3bGFP/GFP cells, we generated a cell line express-
ing fluorescent fusions of each isoform. For this, we
produced cDNA knockin constructs in which DNMT3B1
was fused to a red fluorescent protein mCherry (mCh) and
DNMT3B6 was fused to GFP. To facilitate the generation
of knockin cell lines expressing each isoform from one allele
we equipped the Dnmt3b1 and Dnmt3b6 constructs with a
Neomycin and Puromycin resistance cassette, respectively.
We successfully established a cell line that simultaneously
expressed mCh-DNMT3B1 and GFP-DNMT3B6, both
under the control of the endogenous Dnmt3b promoter
(Figure 6A, Supplementary Figure S6B), allowing us to
directly compare the FRAP kinetics of DNMT3B1 and
DNMT3B6 within the same cell. In the absence of 5-azadC,
GFP-DNMT3B6 exhibited a fast (t1/2 = 5 s) and complete
recovery while mCh-DNMT3B1 recovered slower (t1/2 =
95 s) (Figure 6B, Supplementary Table S4).
Intriguingly, FRAP kinetics of DNMT3B6 were not in-
fluenced by the presence of 5-azadC, supporting that it
is catalytically inactive. In contrast, DNMT3B1 was com-
pletely immobilized by addition of 5-azadC exhibiting vir-
tually no recovery after photobleaching (Figure 6C and E).
Taken together, our MIN-tag strategy enabled us to show
that DNMT3B exhibits a dynamic localization to distinct
chromatin regions during epiblast differentiation. Super-
resolution micrographs of cells stained with anti-MIN an-
tibodies at different time points of epiblast differentiation
hint towards progression of de novo DNA methylation in
a hierarchical fashion starting at constitutive (CCs) and
progressing towards facultative (perinuclear/perinucleolar)
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Figure 5. Spatio-temporal dynamics of DNMT3B during epiblast differentiation. (A) Gel electrophoresis of the multiplex screening PCR for wt,
Dnmt3battP/attP and Dnmt3bGFP/GFP. Blue arrows indicate expected sizes of the non-recombined (attP) and recombined allele (attL). (B) Evaluation of
GFP signals during live cell imaging of Dnmt3bGFP/GFP cells. The graph depicts mean gray values of nuclear GFP signals. Error bars represent standard
deviations (n > 81). Lower panels show Z-projections of Dnmt3bGFP/GFP cells representative of the indicated time frame. Scale bar represents 10 "m. (C)
Quantitative real-time PCR of Dnmt3b mRNA levels in wt and Dnmt3battP/attP cells during epiblast differentiation. (D) 3D-SIM nuclear mid-sections
of anti-MIN (green) and anti-H3K4me3 (red) antibody distributions 30 and 60 h after induction of EpiLC differentiation combined with DAPI coun-
terstaining (gray) in Dnmt3battP/attP cells. Lower panels represent 7× magnifications of selected boxed regions. Scale bars represent 3 "m and 500 nm in
insets.
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Figure 6. Protein dynamics of DNMT3B and its isoforms during epiblast differentiation. (A) Schematic representation of the Dnmt3b genomic loci in
the Dnmt3bGFP/GFP and the Dnmt3bmCh-3b1/GFP-3b6 cell lines. (B) Quantitative evaluation of FRAP experiments (average of 11–14 cells) comparing GFP-
DNMT3B with GFP-DNMT3B6 and mCh-DNMT3B1 in Dnmt3bGFP/GFP and the Dnmt3bmCh-3b1/GFP-3b6 cell lines differentiated for 35 h. Error bars
represent standard error of the mean. (C) Quantitative evaluation of FRAP experiments (average of 10–12 cells) as in (B) with cells treated with 5-azadC
12 h before imaging. (D and E) Representative images of FRAP experiments performed in (B) and (C), respectively. White circles indicate the bleach ROI
with a diameter of 2 "m.
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heterochromatin. Finally, FRAP experiments revealed that
the two isoforms DNMT3B1 and DNMT3B6 exhibit dra-
matically different DNA binding kinetics.
DISCUSSION
Recent advances in genome engineering technology, based
on TALEN and CRISPR/Cas systems, have greatly facili-
tated the process of manipulating genetic information. Plat-
forms have been established that allow genome-wide gene
disruption screenings for factors involved in any biologi-
cal process (20,53–54). While these methods provide valu-
able information about the genes and pathways involved,
in-depth analysis of target genes is needed to understand
their function. This, in turn, requires the implementation of
various genetic, cell biological and biochemical techniques.
To gain meaningful insights into gene function, these tech-
niques have to be applied under physiological conditions
requiring extensive and complex genetic manipulations. Al-
though modern genome engineering tools have made such
manipulations possible, a more efficient and universal ap-
proach would be highly desirable to implement the above-
mentioned techniques in a systematic manner.
The MIN-tag strategy offers a new means of rapid, ef-
ficient, yet flexible genetic manipulation of target loci. We
show that CRISPR/Cas assisted insertion of the MIN-tag
can be performed efficiently with short homology donors.
Several studies have shown that CRISPR/Cas mediated
gene targeting is associated with a significant risk of off-
target cleavage, which can result in indel (insertions or
deletions) formation due to NHEJ (5–7,55–56). The MIN-
tag strategy requires a single nuclease assisted gene edit-
ing event, thereby keeping the likelihood of off-target ef-
fects at a minimum. Further modifications are then per-
formed using Bxb1-mediated recombination. In contrast to
the phiC31 integrase, Bxb1 has been shown to be highly
specific with virtually no unwanted genomic insertions at
pseudo attP sites (8–9,57–58). Once a MIN-tagged cell line
is established, in-frame fusion of the MIN-tag to the target
gene also results in the expression of a novel epitope tag.
We show that this epitope tag can be detected by a highly
specific antibody, which can be used to screen for posi-
tive clones, perform co-immunoprecipitation (co-IP) exper-
iments, as well as conventional and super resolution mi-
croscopy.
Using Bxb1 and the MIN-tag toolbox, a MIN-tagged en-
try cell line can be used to generate multiple isogenic deriva-
tives within 2–3 weeks (Figure 7), without the risk of in-
troducing off-target effects. Our collection of vectors for
Bxb1 mediated recombination currently contains over 80
different plasmids (Supplementary Table S5). These prefab-
ricated functional cassettes constitute an expandable tool-
box for the simple and flexible genetic alteration of any
tagged loci, without the need of locus-specific homology.
Using our stop cassette, we show that the MIN-tag strat-
egy can be used to reliably achieve genetically defined gene
disruption of MIN-tagged genes. Harboring a Poly(A) sig-
nal, insertion of this cassette efficiently eliminates target
gene expression with the added advantage of precluding un-
wanted downstream initiation. As fluorescent protein re-
porters are commonly used to study spatio-temporal dy-
namics and protein kinetics in living cells, we generated a
GFP knockin construct (attB-GFP) for Bxb1-mediated in-
tegration. GFP knockin cell lines made with this construct
retain not only their endogenous expression levels but also
their endogenous splicing pattern. Similarly, a BirA* cas-
sette can be introduced at any MIN-tagged locus to allow
for proximity-dependent labeling of the microenvironment
of a given protein.
Understanding protein function often necessitates the
systematic alteration of individual domains through muta-
tions as well as deletions. Equipped with a fluorescent pro-
tein and strategic cloning sites, our cDNA knockin cassette
is especially tailored for simple and expedient insertion of
user-defined cDNAs. PCR-based approaches can be used
to easily alter the coding sequence and quickly produce a
library of gene specific cDNA mutants. These can then be
inserted into target loci by Bxb1-mediated recombination,
completely replacing expression of the wt gene while retain-
ing endogenous control. While this strategy does not di-
rectly introduce the mutations into the gene locus, it offers a
means of inserting and testing multiple mutant constructs in
a short time frame without the need to design and perform
additional nuclease-assisted targetings. This feature can be
used to gain insights into the functional implications of the
rapidly growing number of mutations found in cancer and
disease. Likewise, the generation of large deletion mutants is
easily accomplished facilitating the investigation of protein
domain function and interaction mapping. This eliminates
the need for excising large genomic regions or cloning long
site-specific homology donors.
Obviously, the above mentioned plasmids by no means
represent the extent of all possible functional cassettes. For
example, MIN-tag toolbox modules allowing inducible pro-
tein stabilization or localization (59,60) as well as enzymatic
labeling of DNA binding sites (DamID (61)) would greatly
assist the elucidation of protein function and protein-
chromatin interactions, respectively.
Employing our strategy in mESCs, we inserted the MIN-
tag into the genes coding for all mammalian DNA mod-
ifying enzymes and a cofactor (Dnmt1, Dnmt3a, Dnmt3b,
Tet1, Tet2, Tet3 and Uhrf1). These MIN-tagged cell lines
as well as their functional derivatives (Supplementary Ta-
ble S3) constitute a valuable resource to investigate the
role of these proteins during fundamental processes such as
pluripotency, cellular reprogramming, embryonic develop-
ment and disease.
One gold standard method to study protein–protein in-
teractions is co-IP. However, chromatin- or membrane-
bound proteins are often barely soluble and consequently
difficult to investigate by this approach. Making use of our
BirA* cassette, we investigated factors in the microenviron-
ment of TET1, a dioxygenase that oxidizes DNA at methy-
lated cytosines (62). Besides the known interactor SIN3A,
we identify eight other proteins in proximity to TET1 that
are involved in chromatin modification and organization,
including the closely related TET2. This is in accordance
with the findings by Costa et al. (63) that TET1 and TET2
have partially overlapping target sites. In conclusion, inte-
gration of the BirA* cassette into the endogenous locus is
a perfectly suited method to study dynamic protein–protein
interactions.
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Figure 7. The MIN-tag strategy. (A) Schematic outline of the genome engineering strategy. Small homology donors are used to insert serine integrase
(attP) sites in-frame after the ATG codon of target genes via CRISPR/Cas assisted HR. The attP site is translated as a novel epitope tag suitable for IF
and IP with the specific monoclonal antibody. The attP site is also recognized by the serine integrase Bxb1 and used for specific and directional integration
of attB-carrying functional cassettes into the tagged gene locus. All derivatives are subjected to their endogenous gene regulation ensuring that subsequent
studies are performed at physiological expression levels. (B) Timeline for generation of MIN-tagged genes and subsequent modification by Bxb1-mediated
recombination. MIN-tagged cell lines can be generated within 2–3 weeks. These cell lines can then be modified within another 2–3 weeks to generate
multiple isogenic cell lines with different functional modifications.
We also applied the MIN-tag strategy to study the de
novo DNA methyltransferase DNMT3B during the transi-
tion from naive pluripotent ESCs to primed EpiLCs, a pe-
riod of dramatic epigenetic change. While distinct patterns
have been described for ESCs and somatic cells (46,64), the
subnuclear distribution of DNMT3B during differentiation
remains largely unknown. We discovered that DNMT3B
exhibits a highly dynamic subnuclear distribution during
epiblast differentiation. Our observations suggest that the
global wave of de novo DNA methylation during epiblast
differentiation follows a distinct spatio-temporal order, ini-
tiating at constitutive pericentromeric heterochromatin fol-
lowed by transition to facultative heterochromatin.
Exploiting the unique possibilities of our MIN-tag
strategy, we furthermore generated a cell line simultane-
ously expressing differentially tagged splicing isoforms of
DNMT3B from different alleles. This approach revealed
that the major catalytically active isoform DNMT3B1 was
completely immobilized at chromocenters after 5-azadC
treatment, while the FRAP kinetics of DNMT3B6 were not
affected. This, to our knowledge, is the first time that FRAP
has been performed on different isoforms of a protein at en-
dogenous expression levels in the same cell.
While this study was performed using mouse ESCs, our
strategy can be applied to any cell type as long as no Bxb1
attP site is present in the respective genomes. The human
genome is free of this entry site and introduction of the
MIN-tag into cell lines such as human induced pluripo-
tent stem cells should greatly facilitate the generation of
clinically relevant disease models. Moreover, MIN-tagged
mESCs could be used in blastocyst injections to gener-
ate MIN-tagged mice. Different tissues and cells could not
only be used for Bxb1-mediated genetic manipulation in
vitro, free of the limitation posed by inefficient endogenous
homologous recombination, but also to study tissue spe-
cific protein regulation with the MIN-tag antibody. Fur-
thermore, widely used cell biological model systems such as
HeLa and U2OS cells as well as model organisms such as
Caenorhabditis elegans or Drosophila could benefit from the
versatility and efficiency of our approach.
In summary, with our combined genome engineering ap-
proach, a plethora of functional derivatives can be gener-
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ated from one entry line with high efficiency. To simplify
the distribution of MIN-tagged cell lines and the MIN-tag
toolbox as well as to assist with the design of targeting
strategies, we have developed a web-tool that is accessible
at http://human.bio.lmu.de/ webtools/MINtool/. As entry
lines can be shared and the genetic toolbox easily expanded
with new functional modules, the MIN-tag strategy repre-
sents a dynamic flexible open platform and facilitates sys-
tematic functional studies with direct biological compara-
bility.
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Supplemental Figure and Video Legends  
 
Supplemental Figure S1. Characterization of MIN-tagged DNA methyltransferase 
cell lines.  
(A) Western blot analysis of DNMT1 expression levels in the homozygous Dnmt1attP/attP 
and wild type J1 cells. Beta-actin is used as a loading control. (B) Immunofluorescence 
stainings of Dnmt1 in wt and Dnmt1attP/attP cells. Scale bar represent 5 µm. (C) DNA 
methylation analysis of the major satellite repeats in Dnmt1attP/attP and wild type cells. 
(D) Example of the screening PCRs, with and without HincII treatment, of clones found 
to be heterozygous and homozygous for the MIN-tag at the Dnmt1 locus. Monoallelic 
and  biallelic insertions of the MIN-tag can be distinguished by complete and incomplete 
digests, respectively. (E) Western blot analysis of DNMT3A expression levels in a 
heterozygous (#2) and homozygous (#1, #3-4) Dnmt3aattP/attP cell lines compared to wild 
type cells. Beta-actin is used as a loading control. (F) DNA methylation analysis of major 
satellite repeats in Dnmt3aattP/attP compared to wt cells. (G) Immunofluorescence 
stainings of DNMT3A together with the replication marker EdU in wt cells and the the 
homozygous Dnmt3aattP/attP clone #1. Scale bar represents 10 µm. (H) 
Immunofluorescence stainings of DNMT3B in Dnmt3battP/attp and wt cells after 35 hours 
of EpiLC differentiation. Scale bar represents 5 µm. Error bar represent standard 
deviation (n=2). 
 
Supplemental Figure S2. Characterization of MIN-tagged Tet1, Tet2 and Uhrf1 cell 
lines and C-terminal MIN-tag integration.  
(A-C) Western blot analysis of TET1, TET2, and UHRF1 expression levels in the 
homozygous Tet1attP/attP, Tet2attP/attP, and N-terminal Uhrf1attP/attP cell lines, respectively, 
compared to the wt J1 control. β-Actin (ACTB) was used as loading control. (D) 
Immunofluorescence stainings of TET1 in wt and Tet1attP/attP cells. (E) 
Immunofluorescence stainings of 5-hydroxymethylcytosine (5-hmC) in wt and Tet1attP/attP 
cells. (F) Immunofluorescence stainings of TET2 in wt  and Tet2attP/attP cells. (G) 
Immunofluorescence stainings of UHRF1 in wt and Uhrf1attP/attP cells. DAPI is used for 
DNA counterstaining; scale bars represent 15 µm. (H) Schematic overview of 
CRISPR/Cas-assisted C-terminal integration of the MIN-tag. MIN-tag donors contain the 
attP site (depicted in orange) flanked by sequences (200-300 for PCR fragments or 76 for 
ssDNA oligos) homologous to 5’ and 3’ of the target gene stop codon (depicted in red). 
Restriction enzyme sites available for restriction fragment analysis based screening are 
shown above the attP sequence. 
 
Supplemental Figure S3. Evaluating functionality of Bxb1 mediated 
recombination in Dnmt1attP/attP cells.  
(A) Schematic outline of the multiplex PCR strategy to identify positive recombination 
events and their zygosity. (B) Immunofluorescence stainings of DNMT1 and GFP in wt 
cells and three Dnmt1KO/KO clones. Diffuse GFP indicates a successful integration of the 
KO cassette into the locus. (C) Western blot analysis of DNMT1 expression levels in 
three Dnmt1KO/KO clonal cell lines generated by Bxb1-mediated insertion of a knock-out 
cassette, compared to wt and Dnmt1attP/attP cells. (D) Western blot analysis of DNMT1 
and GFP expression in Dnmt1attP/attP cells  and two homozygous GFP-knock in cell lines 
(Dnmt1GFP/GFP #1-2) generated by Bxb1 mediated insertion. (E-F) Live cell imaging of  
Dnmt1GFP/GFP  and Dnmt1cDNA/cDNA cells transiently expressing RFP-labeled PCNA, a 
DNA replication marker, during cell-cycle progression. Scale bars represent 5 μm 
 
Supplemental Figure S4. Alignments of the expected sequence flanking the attL 
site after recombination 
Alignments of the expected sequence flanking the attL site after recombination of the 
attB-GFP KI at the Dnmt1, Dnmt3b, Tet1, and Tet2 locus (A-D) with the sequencing 
results from the Dnmt1GFP/GFP, Dnmt3bGFP/GFP, Tet1GFP/GFP, and Tet2GFP/GFP cell lines. 
 
Supplemental Figure S5. Demonstration of Bxb1 mediated recombination in 
multiple MIN-tagged genes.  
(A-D) Gel electrophoresis of the multiplex PCR (using the attL primer and locus specific 
external primers, see also Table S1) performed on cell lines generated by Bxb1-
mediated integration of various MIN-tag toolbox components (Table S5) into the loci of: 
(A) Tet1, (B) Tet2, (C) Dnmt3b, and (D) Uhrf1. Equal mixtures of genomic DNA from 
non-recombined cell lines and recombined cell lines are used to control for  possible 
amplification biases arising from the use of different locus specific external primers. (E) 
PCR to confirm insertion of the BirA* cassette into the Tet1 genomic locus. I: multiplex 
PCR, II: wt specific PCR, III: attL (recombination) specific PCR 
 
Supplemental Figure S6. Cell cycle analysis of DNMT3b localization during 
differentiation.  
(A) Immunofluorescence stainings of MIN-tagged DNMT3B and Histone 3 Serine 10 
phosphorylation (H3S10P), a marker of G2/M phase (Ref Hendzel:1997wo) during 
differentiation of naive pluripotent Dnmt3battP/attP stem cells into epiblast-like cells. Cells 
were fixed directly after (0 h)35 h, or 60 hafter induction of differentiation. The H3S10P 
mark was used to determine if cells were in G2 or G1 phase in order to assess whether 
changes in DNMT3B localization during differentiation are cell-cycle dependent. Scale 
bar represents 5 µm. (B) Fluorescence microscopy images of Dnmt3bmCh-3b1/GFP-3b6 cells 
fixed after 35 h of differentiation. Both DNMT3B isoforms (GFP-DNMT3B1in green and 
mCh-DNMT3B6 in red) localize at chromocenters (visible as bright DAPI spots). Scale 
bar represents 5 µm 
 
Supplemental Video 1. Live cell imaging of Dnmt3bGFP/GFP cells during 
differentiation.  
Long-term (60 h), live cell imaging tracking the transition of Dnmt3bGFP/GFP cells from the 
naive pluripotency ground state into the primed, epiblast-like state. Images were 
acquired once per hour and entailing at least 10 µm z-stacks. The left panel depicts the 
projection of GFP signal, while the right panel shows that projection superimposed onto 
the acquired brightfield images. 
 
Supplemental Tables (S1-S5) 
Table S1: CRISPR/Cas9-mediated MIN-tag insertion efficiencies  
Gene$ Position$ MIN-tag$Donor$ Heterozygotes$ Homozygotes$ TOTAL$$
Dnmt1& N"terminal+ PCR+Product+ 1/67+(1.5%)+ 1/67+(1.5%)+
2/67+
(2.9%)+
Dnmt3a& N"terminal+ PCR+Product+ 0/86+(0%)+ 3/86+(3.5%)+
3/86+
(3.5%)+
Dnmt3b& N"terminal+ ssDNA+oligo+ 0/65(0%)+ 1/65(1.5%)+
1/65+
(1.5%)+
Uhrf1& N"terminal+ PCR+Product+ 0/6+(0%)+ 1/6(16.7%)+
1/6+
(16.7%)+
Uhrf1& C"terminal+ ssDNA+oligo+ 2/36+(5.5%)+ 2/36+(5.6+%)+
4/36+
(11.1%)+
Tet1& N"terminal+ PCR+Product+ 0/70(0%)+ 1/70+(1.4%)+
1/70+
(1.4%)+
Tet2& N"terminal+ PCR+Product+ 1/24+(4.2%)+ 2/24+(8.3%)+
3/24+
(12.5%)+
Tet3& N"terminal+ PCR+Product+ 0/38+(0%)+ 2/38+(5.3%)+
2/38+
(5.3%)+
  
Table S2: Oligonucleotide sequences used for CRISPR/Cas assisted targeting 
and screening  
$ Name$ Sequence$
Dnmt1&  
gRNA_F& TGTTCGCGCTGGCATCTTGCGTTTTAGAGCTAGAAATAGCAAG 
gRNA_R& GCAAGATGCCAGCGCGAACACGGTGTTTCGTCCTTTCCAC 
surrogate_F& CTAGCTGTTCGCGCTGGCATCTTGCAGGGGATTCC 
surrogate_R& CCGGAGGAATCCCCTGCAAGATGCCAGCGCGAACAG 
internal_R& CACTATAGCCAGGAGGTGTGGG 
internal_F& TGTACCGTACACCACTGAGACCGCGGTGGTTGACCAGACAAACCCATCTTGCAGGTTGCA
GACGACAG 
external_R& GTCTGGTCAACCACCGCGGTCTCAGTGGTGTACGGTACAAACCCCAGCGCGAACAGCTCC
AGC 
external_F& GCGCGACAGGAAGCACAGCC 
screening_F& GTCGCAGCACGGACGAG 
Uhrf1&(N)&  
gRNA_F& CATCGGCATCATGTGGATCCGTTTTAGAGCTAGAAATAGCAAG 
gRNA_R& GGATCCACATGATGCCGATGCGGTGTTTCGTCCTTTCCAC 
surrogate_F& CTAGCCATCGGCATCATGTGGATCCAGGGGATTCCT 
surrogate_R& GGCCAGGAATCCCCTGGATCCACATGATGCCGATGG 
internal_R& CATCGGCATCATGTGGATCCGTTTTAGAGCTAGAAATAGCAAG 
internal_F& GGATCCACATGATGCCGATGCGGTGTTTCGTCCTTTCCAC 
external_R& ACCACCGCGGTCTCAGTGGTGTACGGTACAAACCTGGATCCAGGTTCGAACTATG 
external_F& CTATTGCTTGGTGGCTTTGAG 
screening_F& GGCAATTCACATTCAAGTGTCCC 
Uhrf1&(C)&  
gRNA_F& TGCCTGGGTCTCAGCATCACGTTTTAGAGCTAGAAATAGCAAG 
gRNA_R& GTGATGCTGAGACCCAGGCACGGTGTTTCGTCCTTTCCAC 
surrogate_F& CTAGCTGCCTGGGTCTCAGCATCACCGGGGATTCCT 
surrogate_R& CCGGAGGAATCCCCGGTGATGCTGAGACCCAGGCAG 
ssDNA&oligo&
CAGCTCCCCAACCCGGGTGAACCAGCCCTTGCAGACCATTCTCAACCAGCTCTTCCCTGG
CTATGGCAGCGGCCGGGGTTTGTCTGGTCAACCACCGCGGTCTCAGTGGTGTACGGTACA
AACCTGATGCTGAGACCCAGGCAGAGGGCTCATGGTTCCAACTTCATAGTGTGTTTAGCT
TGAAGGTGTTGTCCTTCACG 
external_R& TTTCTAGGCAGCTGGTGTGG 
external_F& TGTACGTGAGAGGACGGAGT 
screening_F& TGTTGCCAGGAGCTACCAAG 
Dnmt3a&  
gRNA_F& GGGCCGCTGGAGGGCATTGCGTTTTAGAGCTAGAAATAGCAAG 
gRNA_R& GCAATGCCCTCCAGCGGCCCCGGTGTTTCGTCCTTTCCAC 
surrogate_F& CTAGCGGGCCGCTGGAGGGCATTGCTGGGGATTCCT 
surrogate_R& CCGGAGGAATCCCCAGCAATGCCCTCCAGCGGCCCG 
internal_R& CTTCTCTTCCCCACAGGCAG 
internal_F& ACCACTGAGACCGCGGTGGTTGACCAGACAAACCCATTGCTGGGCAGTAGGCG 
external_R& ACCACCGCGGTCTCAGTGGTGTACGGTACAAACCCCCTCCAGCGGCCCCG 
external_F& GTTCCCAGCCAAGCACCTAT 
screening_F& ATGGTCCTGCAACCAGAGTG 
Dnmt3b&  
gRNA_F& TTCCCCACAGGAAACAATGAGTTTTAGAGCTAGAAATAGCAAG 
gRNA_R& TCATTGTTTCCTGTGGGGAACGGTGTTTCGTCCTTTCCAC 
surrogate_F& CTAGCTTCCCCACAGGAAACAATGAAGGGGATTCCT 
surrogate_R& CCGGAGGAATCCCCTTCATTGTTTCCTGTGGGGAAG 
ssDNA&oligo&
GAACTGGTGGTGTAAACCTTGCAGTGTGCCCTGTCTGCCTCTTACATATCCTGATCTTTC
CCCACAGGAAACAATGGGTTTGTCTGGTCAACCACCGCGGTCTCAGTGGTGTACGGTACA
AACCAAGGGAGACAGCAGACATCTGAATGAAGAAGAGGGTGCCAGCGGGTATGAGGAGTG
CATTATCGTTAATGGGAACT 
external_R& ACCACCGCGGTCTCAGTGGTGTACGGTACAAACCGGAGACAGCAGACATCTGAATG 
external_F& ATCTGTCATGGAACCTGCCG 
screening_F& GAGCTGGCCAATTGCAGAAC 
Tet1&  
gRNA_F& AGACATGGCTGCAGAGTAAGCGGTGTTTCGTCCTTTCCAC 
gRNA_R& CTTACTCTGCAGCCATGTCTAGCTTTCTTGTACAAAGTTGGCAT 
surrogate_F& CTAGCCTTACTCTGCAGCCATGTCTCGGGGATCCCT 
surrogate_R& CCGGAGGGATCCCCGAGACATGGCTGCAGAGTAAGG 
internal_R& ACTCAGTCTCCCAAATGCTGG 
internal_F& ACCACTGAGACCGCGGTGGTTGACCAGACAAACCAGACATGGCTGCAGAGTAAGTAAAG 
external_R& ACCACCGCGGTCTCAGTGGTGTACGGTACAAACCCGGTCCCGCCCCGCAAAG 
external_F& TCGGGGTTTTGTCTTCCGTT 
screening_F& GGGCAATGTTGTGACTCATGC 
Tet2&  
gRNA_F& CGAAGCAAGCCTGATGGAACGTTTTAGAGCTAGAAATAGCAAG 
gRNA_R& GTTCCATCAGGCTTGCTTCGCGGTGTTTCGTCCTTTCCAC 
surrogate_F& CTAGCCGAAGCAAGCCTGATGGAACAGGGGATTCCT 
surrogate_R& CCGGAGGAATCCCCTGTTCCATCAGGCTTGCTTCGG 
internal_R& ACCACTGAGACCGCGGTGGTTGACCAGACAAACCCATCAGGCTTGCTTCGGGG 
internal_F& ACCACCGCGGTCTCAGTGGTGTACGGTACAAACCGAACAGGACAGAACCACCCAT 
external_R& TGGTTCACTGACTGTGCGTT 
external_F& CCAGGATCACACAGGAAGCA 
screening_F& GGATGGAGCCCAGAGAGAGA 
Tet3&  
gRNA_F& GTTCCAGGTCAGATGGACTCGTTTTAGAGCTAGAAATAGCAAG 
gRNA_R& GAGTCCATCTGACCTGGAACCGGTGTTTCGTCCTTTCCAC 
surrogate_F& CTAGCGTTCCAGGTCAGATGGACTCAGGGGATTCCT 
surrogate_R& CCGGAGGAATCCCCTGAGTCCATCTGACCTGGAACG 
internal_R& ACCACTGAGACCGCGGTGGTTGACCAGACAAACCCATCTGACCTGGAACAGGTC 
internal_F& ACCACCGCGGTCTCAGTGGTGTACGGTACAAACCGACTCAGGGCCAGTGTACC 
external_R& CAGTCGGGCTTCTGGTCTAC 
external_F& GATCTGAGCTCTCACAGGGC 
screening_F& AGTAGACAGGGCCTTGGGAT  
attL_F+ CCGGCTTGTCGACGACG 
  
Table S3: Bxb1-mediated recombination efficiencies  
Gene$ Integration$Construct$ Heterozygotes$ Homozygotes$ TOTAL$$
Dnmt1& attB"GFP+ N/A+ 13/31+(41.9%)+
13/31+
(41.9%)+
Dnmt3b& attB"GFP+ 0/3+(0%)+ 1/3+(33.3%)+ 1/3+(33.3%)+
Tet1& attB"GFP+ 14/45+(31.1%)+ 13/45+(28.9%)+ 27/45+(60%)+
Tet2& attB"GFP+ 28/81+(34.6%)+ 15/81(18.5%)+ 43/81+(53%)+
Dnmt1& attB"GFP"STOP"Poly(A)+ 2/23+(8.7%)+ 13/23+(56.5%)+
15/23+
(65.2%)+
Uhrf1& attB"GFP"STOP"Poly(A)+ 5/32+(15.6%)+ 14/32+(43.8%)+
19/32+
(59.4%)+
Dnmt1& attB"GFP"cDNA"STOP"Poly(A)+ 1/15+(6.6%)+ 9/15+(60%)+
10/15+
(66.6%)+
Dnmt3b& attB"GFP"cDNA"STOP"Poly(A)+ 28/84+(33.3%)+ 26/84+(31%)+
54/84+
(64.3%)+
Tet1& attB"GFP"cDNA"STOP"Poly(A)+ 12/58+(20.7%)+ 7/58+(12.1%)+
19/58+
(32.8%)+
Dnmt3b&
attB"GFP/mCh"cDNA"STOP"Poly(A)+
PuroR/neoR+
29/102+
(28.4%)+
64/102+
(62.7%)+
93/102+
(91.2%)+
 
 
Table S4: Evaluation of FRAP protein kinetics  
$ GFP-DNMT3B$ mCh-DNMT3B1$ GFP-DNMT3B6$
Mobile&fraction&[A]& 87+ 81+ 100+
Diffusion&coef.&[µm2/s]& 4.2E"03+ 1.2E"03+ 4.1E"02+
Half?time&recovery&[s]& 42.2+ 94.8+ 5.1+
  
Table S5: The MIN-tag toolbox  
Name$ Fluorescent$protein$ Application$
Universal$constructs$
attBBGFP& GFP& GFP&KI&
attBBmCh& mCherry& mCherry&KI&
attBBGFPBT2ABBirA*& GFP& Protein&interaction&
attBBGFPBPoly(A)& GFP& KO&
attBBmChBPoly(A)& mCherry& KO&
attBBGFPBPoly(A)BNeoR& GFP& KO&/w&selection&
attBBGFPBPoly(A)BPuroR& GFP& KO&/w&selection&
attBBmChBPoly(A)BNeoR& mCherry& KO&/w&selection&
attBBmChBPoly(A)BPuroR& mCherry& KO&/w&selection&
Gene$specific$cDNA$KI$constructs$
attBBGFPBDnmt1BPoly(A)& GFP& cDNA&KI&
attBBGFPBDnmt3b1BPoly(A)& GFP& cDNA&KI&
attBBGFPBDnmt3b6BPoly(A)& GFP& cDNA&KI&
attB_eGFP_Dnmt3b_C656A_Poly(A)& GFP& cDNA&KI&
attB_eGFP_Dnmt3b_D809G_Poly(A)& GFP& cDNA&KI&
attB_eGFP_Dnmt3b_dX_Poly(A)& GFP& cDNA&KI&
attB_eGFP_Dnmt3b_G655S_Poly(A)& GFP& cDNA&KI&
attB_eGFP_Dnmt3b_L656T_Poly(A)& GFP& cDNA&KI&
attB_eGFP_Dnmt3b_V718G_Poly(A)& GFP& cDNA&KI&
attB_eGFP_Dnmt3b_V810M_Poly(A)& GFP& cDNA&KI&
attB_eGFP_Dnmt3b6_Poly(A)& GFP& cDNA&KI&
attB_eGFP_Dnmt3b1_dPWWP_Poly(A)& GFP& cDNA&KI&
attB_eGFP_Dnmt3b1_dPHD_Poly(A)& GFP& cDNA&KI&
attB_mCh_Dnmt3b_C656A_Poly(A)& mCherry& cDNA&KI&
attB_&mCh&_Dnmt3b_D809G_Poly(A)& mCherry& cDNA&KI&
attB_&mCh&_Dnmt3b_dX_Poly(A)& mCherry& cDNA&KI&
attB_&mCh&_Dnmt3b_G655S_Poly(A)& mCherry& cDNA&KI&
attB_&mCh&_Dnmt3b_L656T_Poly(A)& mCherry& cDNA&KI&
attB_&mCh&_Dnmt3b_V718G_Poly(A)& mCherry& cDNA&KI&
attB_&mCh&_Dnmt3b_V810M_Poly(A)& mCherry& cDNA&KI&
attB_&mCh&_Dnmt3b6_Poly(A)& mCherry& cDNA&KI&
attBBGFPBDnmt3b1BPoly(A)&BNeoR& GFP& cDNA&KI&/w&selection&
attBBGFPBDnmt3b6BPoly(A)&BNeoR& GFP& cDNA&KI&/w&selection&
attB_eGFP_Dnmt3b_C656A_Poly(A)BNeoR& GFP& cDNA&KI&/w&selection&
attB_eGFP_Dnmt3b_D809G_Poly(A)BNeoR& GFP& cDNA&KI&/w&selection&
attB_eGFP_Dnmt3b_dX_Poly(A)BNeoR& GFP& cDNA&KI&/w&selection&
attB_eGFP_Dnmt3b_G655S_Poly(A)BNeoR& GFP& cDNA&KI&/w&selection&
attB_eGFP_Dnmt3b_L656T_Poly(A)BNeoR& GFP& cDNA&KI&/w&selection&
attB_eGFP_Dnmt3b_V718G_Poly(A)BNeoR& GFP& cDNA&KI&/w&selection&
attB_eGFP_Dnmt3b_V810M_Poly(A)BNeoR& GFP& cDNA&KI&/w&selection&
attB_eGFP_Dnmt3b6_Poly(A)BNeoR& GFP& cDNA&KI&/w&selection&
attBB&mCh&BDnmt3b1BPoly(A)&BNeoR& mCherry& cDNA&KI&/w&selection&
attBB&mCh&BDnmt3b6BPoly(A)&BNeoR& mCherry& cDNA&KI&/w&selection&
attB_&mCh&_Dnmt3b_C656A_Poly(A)BNeoR& mCherry& cDNA&KI&/w&selection&
attB_&mCh&_Dnmt3b_D809G_Poly(A)BNeoR& mCherry& cDNA&KI&/w&selection&
attB_&mCh&_Dnmt3b_dX_Poly(A)BNeoR& mCherry& cDNA&KI&/w&selection&
attB_&mCh&_Dnmt3b_G655S_Poly(A)BNeoR& mCherry& cDNA&KI&/w&selection&
attB_&mCh&_Dnmt3b_L656T_Poly(A)BNeoR& mCherry& cDNA&KI&/w&selection&
attB_&mCh&_Dnmt3b_V718G_Poly(A)BNeoR& mCherry& cDNA&KI&/w&selection&
attB_&mCh&_Dnmt3b_V810M_Poly(A)BNeoR& mCherry& cDNA&KI&/w&selection&
attB_&mCh&_Dnmt3b6_Poly(A)BPuroR& mCherry& cDNA&KI&/w&selection&
attBB&mCh&BDnmt3b1BPoly(A)BPuroR& mCherry& cDNA&KI&/w&selection&
attBB&mCh&BDnmt3b6BPoly(A)BPuroR& mCherry& cDNA&KI&/w&selection&
attB_&mCh&_Dnmt3b_C656A_Poly(A)BPuroR& mCherry& cDNA&KI&/w&selection&
attB_&mCh&_Dnmt3b_D809G_Poly(A)BPuroR& mCherry& cDNA&KI&/w&selection&
attB_&mCh&_Dnmt3b_dX_Poly(A)B&PuroR& mCherry& cDNA&KI&/w&selection&
attB_&mCh&_Dnmt3b_G655S_Poly(A)BPuroR& mCherry& cDNA&KI&/w&selection&
attB_&mCh&_Dnmt3b_L656T_Poly(A)BPuroR& mCherry& cDNA&KI&/w&selection&
attB_&mCh&_Dnmt3b_V718G_Poly(A)BPuroR& mCherry& cDNA&KI&/w&selection&
attB_&mCh&_Dnmt3b_V810M_Poly(A)BPuroR& mCherry& cDNA&KI&/w&selection&
attB_&mCh&_Dnmt3b6_Poly(A)BPuroR& mCherry& cDNA&KI&/w&selection&
attBBGFPBTet1BPoly(A)& GFP& cDNA&KI&
attBBGFPBTet1d1B389BPoly(A)& GFP& cDNA&KI&
attBBGFPBTet1d390B565BPoly(A)& GFP& cDNA&KI&
attBBGFPBTet1d566B833BPoly(A)& GFP& cDNA&KI&
attBBGFPBTet1d834B1053BPoly(A)& GFP& cDNA&KI&
attBBGFPBTet1d1054B1363BPoly(A)& GFP& cDNA&KI&
attBBGFPBTet1d1B833BPoly(A)& GFP& cDNA&KI&
attBBGFPBTet1d834B1363BPoly(A)& GFP& cDNA&KI&
attBBGFPBTet2BPoly(A)& GFP& cDNA&KI&
attBBGFPBTet2d1B225BPoly(A)& GFP& cDNA&KI&
attBBGFPBTet2d226B398BPoly(A)& GFP& cDNA&KI&
attBBGFPBTet2d399B650BPoly(A)& GFP& cDNA&KI&
attBBGFPBTet2d651B848BPoly(A)& GFP& cDNA&KI&
attBBGFPBTet2d849B1038BPoly(A)& GFP& cDNA&KI&
attBBGFPBTet2d1B650BPoly(A)& GFP& cDNA&KI&
attBBGFPBTet2d651B1038BPoly(A)& GFP& cDNA&KI&
attBBGFPBUhrf1BPoly(A)& GFP& cDNA&KI&
attBBGFPBUhrf1dSRABPoly(A)& GFP& cDNA&KI&
 
Supplemental Table Legends 
Table S1: CRISPR/Cas9-mediated MIN-tag insertion efficiencies  
For MIN-tag Insertion, J1 mESCs transfected with the appropriate MIN-tag donor 
oligonucleotides or PCR products along with the Cas9, gRNA, and CRISPR surrogate 
reporter vector were single cell sorted after enriching for cells with CRISPR/Cas activity. 
The number of clones with either a monoallelic or biallelic insertion of the MIN-Tag is 
shown in relation to the number of clones screened. 
 
Table S2: Oligonucleotide sequences used for CRISPR/Cas assisted targeting 
and screening  
DNA oligonucleotides used for the generation of target specific gRNA expression 
vectors, surrogate reporters, and homology donors for MIN-tag integration. 
 
Table S3: Bxb1-mediated recombination efficiencies  
For Bxb1-mediated recombination, J1 mESCs transfected with NLS-Bxb1, the Bxb1 
surrogate reporter, and the respective attB-site containing integration construct were 
single-cell sorted after enrichment for cells with Bxb1 activity. The number of clones with 
either a monoallelic or biallelic integration of the listed construct is shown in relation to 
the total number of clones screened. 
 
Table S4: Evaluation of FRAP protein kinetics  
Evaluation of FRAP kinetics (w/o 5-azadC treatment) performed in Dnmt3bGFP/GFP 
and Dnmt3bmCh-3b1/GFP-3b6 cells 
 
Table S5: The MIN-tag toolbox  
Vectors generated for Bxb1 mediated recombination into MIN-tagged cell lines. KO: 
knockout, KI: knockin 
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SUMMARY
Single-cell RNA sequencing (scRNA-seq) offers new
possibilities to address biological and medical ques-
tions. However, systematic comparisons of the per-
formance of diverse scRNA-seq protocols are lack-
ing. We generated data from 583 mouse embryonic
stem cells to evaluate six prominent scRNA-seq
methods: CEL-seq2, Drop-seq, MARS-seq, SCRB-
seq, Smart-seq, and Smart-seq2. While Smart-seq2
detected the most genes per cell and across cells,
CEL-seq2, Drop-seq, MARS-seq, and SCRB-seq
quantified mRNA levels with less amplification noise
due to the use of unique molecular identifiers (UMIs).
Power simulations at different sequencing depths
showed that Drop-seq is more cost-efficient for tran-
scriptome quantification of large numbers of cells,
while MARS-seq, SCRB-seq, and Smart-seq2 are
more efficient when analyzing fewer cells. Our quan-
titative comparison offers the basis for an informed
choice among six prominent scRNA-seq methods,
and it provides a framework for benchmarking
further improvements of scRNA-seq protocols.
INTRODUCTION
Genome-wide quantification of mRNA transcripts is highly infor-
mative for characterizing cellular states and molecular circuitries
(ENCODE Project Consortium, 2012). Ideally, such data are
collected with high spatial resolution, and single-cell RNA
sequencing (scRNA-seq) now allows for transcriptome-wide an-
alyses of individual cells, revealing exciting biological and med-
ical insights (Kolodziejczyk et al., 2015a; Wagner et al., 2016).
scRNA-seq requires the isolation and lysis of single cells, the
conversion of their RNA into cDNA, and the amplification of
cDNA to generate high-throughput sequencing libraries. As the
amount of starting material is so small, this process results in
substantial technical variation (Kolodziejczyk et al., 2015a; Wag-
ner et al., 2016).
One type of technical variable is the sensitivity of a scRNA-
seq method (i.e., the probability to capture and convert a
particular mRNA transcript present in a single cell into a
cDNA molecule present in the library). Another variable of in-
terest is the accuracy (i.e., how well the read quantification
corresponds to the actual concentration of mRNAs), and a
third type is the precision with which this amplification occurs
(i.e., the technical variation of the quantification). The combi-
nation of sensitivity, precision, and number of cells analyzed
determines the power to detect relative differences in expres-
sion levels. Finally, the monetary cost to reach a desired level
of power is of high practical relevance. To make a well-
informed choice among available scRNA-seq methods, it is
important to quantify these parameters comparably. Some
strengths and weaknesses of different methods are already
known. For example, it has previously been shown that
scRNA-seq conducted in the small volumes available in the
automated microfluidic platform from Fluidigm (C1 platform)
outperforms CEL-seq2, Smart-seq, or other commercially
available kits in microliter volumes (Hashimshony et al.,
2016; Wu et al., 2014). Furthermore, the Smart-seq protocol
has been optimized for sensitivity, more even full-length
coverage, accuracy, and cost (Picelli et al., 2013), and this
improved Smart-seq2 protocol (Picelli et al., 2014b) has also
become widely used (Gokce et al., 2016; Reinius et al.,
2016; Tirosh et al., 2016).
Other protocols have sacrificed full-length coverage in order
to sequence part of the primer used for cDNA generation. This
enables early barcoding of libraries (i.e., the incorporation of
cell-specific barcodes), allowing for multiplexing the cDNA
amplification and thereby increasing the throughput of scRNA-
seq library generation by one to three orders of magnitude
(Hashimshony et al., 2012; Jaitin et al., 2014; Klein et al., 2015;
Macosko et al., 2015; Soumillon et al., 2014). Additionally, this
approach allows the incorporation of unique molecular identi-
fiers (UMIs), random nucleotide sequences that tag individual
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mRNA molecules and, hence, allow for the distinction between
original molecules and amplification duplicates that derive from
the cDNA or library amplification (Kivioja et al., 2011). Utilization
of UMI information improves quantification of mRNA molecules
(Gr€un et al., 2014; Islam et al., 2014), and it has been imple-
mented in several scRNA-seq protocols, such as STRT (Islam
et al., 2014), CEL-seq (Gr€un et al., 2014; Hashimshony et al.,
2016), CEL-seq2 (Hashimshony et al., 2016), Drop-seq (Ma-
cosko et al., 2015), inDrop (Klein et al., 2015), MARS-seq (Jaitin
et al., 2014), and SCRB-seq (Soumillon et al., 2014).
However, a thorough and systematic comparison of relevant
parameters across scRNA-seq methods is still lacking. To
address this issue, we generated 583 scRNA-seq libraries from
mouse embryonic stem cells (mESCs), using six different
methods in two replicates, and we compared their sensitivity,
accuracy, precision, power, and efficiency (Figure 1).
RESULTS
Generation of scRNA-Seq Libraries
Variation in gene expression as observed among single cells is
caused by biological and technical variation (Kolodziejczyk
et al., 2015a; Wagner et al., 2016). We used mESCs cultured
under two inhibitor/leukemia inhibitory factor (2i/LIF) condi-
tions to obtain a relatively homogeneous cell population
(Gr€un et al., 2014; Kolodziejczyk et al., 2015b), so that biolog-
ical variation was similar among experiments and, hence, we
mainly compared technical variation. In addition, we spiked
in 92 poly-adenylated synthetic RNA transcripts of known con-
centration designed by the External RNA Control Consortium
(ERCCs) (Jiang et al., 2011). For all six tested scRNA-seq
methods (Figure 2), we generated libraries in two independent
replicates.
Figure 1. Schematic Overview of the Experimental and Computational Workflow
Mouse embryonic stem cells (mESCs) cultured in 2i/LIF and ERCC spike-in RNAs were used to generate single-cell RNA-seq data with six different library
preparation methods (CEL-seq2/C1, Drop-seq, MARS-seq, SCRB-seq, Smart-seq/C1, and Smart-seq2). The methods differ in the usage of unique molecular
identifier (UMI) sequences, which allow the discrimination between reads derived from original mRNA molecules and duplicates generated during cDNA
amplification. Data processing was identical across methods, and the given cell numbers per method and replicate were used to compare sensitivity, accuracy,
precision, power, and cost efficiency. The six scRNA-seq methods are denoted by color throughout the figures of this study as follows: purple, CEL-seq2/C1;
orange, Drop-seq; brown, MARS-seq; green, SCRB-seq; blue, Smart-seq; and yellow, Smart-seq2. See also Figures S1 and S2.
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For each replicate of the Smart-seq protocol, we performed
one run on the C1 platform from Fluidigm (Smart-seq/C1) using
microfluidic chips that automatically capture up to 96 cells (Wu
et al., 2014). We imaged captured cells, added lysis buffer
together with the ERCCs, and we used the commercially avail-
able Smart-seq kit (Clontech) to generate full-length double-
stranded cDNA that we converted into 96 sequencing libraries
by tagmentation (Nextera, Illumina).
For each replicate of the Smart-seq2 protocol, we sorted
mESCs by fluorescence activated cell sorting (FACS) into
96-well PCR plates containing lysis buffer and the ERCCs. We
generated cDNA as described (Picelli et al., 2013, 2014b), and
we used an in-house-produced Tn5 transposase (Picelli et al.,
2014a) to generate 96 libraries by tagmentation. While Smart-
Seq/C1 and Smart-seq2 are very similar protocols that generate
full-length libraries, they differ in how cells are isolated, their re-
action volume, and in that the Smart-seq2 chemistry has been
systematically optimized (Picelli et al., 2013, 2014b). The main
disadvantage of both Smart-seq protocols is that the generation
of full-length cDNA libraries precludes an early barcoding step
and the incorporation of UMIs.
For each replicate of the SCRB-seq protocol (Soumillon et al.,
2014), we also sorted mESCs by FACS into 96-well PCR plates
containing lysis buffer and the ERCCs. Similar to the Smart-
seq protocols, cDNA was generated by oligo-dT priming,
template switching, and PCR amplification of full-length cDNA.
However, the oligo-dT primers contained well-specific (i.e.,
cell-specific) barcodes and UMIs. Hence, cDNA from one plate
could be pooled and then converted into sequencing libraries,
using a modified tagmentation approach that enriches for the
30 ends. SCRB-seq is optimized for small volumes and few
handling steps.
The fourth method evaluated was Drop-seq, a recently devel-
opedmicrodroplet-based approach (Macosko et al., 2015). Here
a flow of beads suspended in lysis buffer and a flow of a single-
cell suspension were brought together in a microfluidic chip that
generated nanoliter-sized emulsion droplets. On each bead,
oligo-dT primers carrying a UMI and a unique, bead-specific bar-
code were covalently bound. Cells were lysed within these drop-
lets, their mRNAbound to the oligo-dT-carrying beads, and, after
breaking the droplets, cDNA and library generation was per-
formed for all cells in parallel in one single tube. The ratio of
beads to cells (20:1) ensured that the vast majority of beads
had either no cell or one cell in its droplet. Hence, similar to
SCRB-seq, each cDNA molecule was labeled with a bead-spe-
cific (i.e., cell-specific) barcode and a UMI. We confirmed that
Figure 2. Schematic Overview of Library Preparation Steps
For details, see the text. See also Table S1.
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the Drop-seq protocol worked well in our setup bymixing mouse
and human T cells, as recommended by Macosko et al. (2015)
(Figure S1A). The main advantage of the protocol is that a high
number of scRNA-seq libraries can be generated at low cost.
One disadvantage of Drop-seq is that the simultaneous inclusion
of ERCC spike-ins is quite expensive, as their addition would
generate cDNA from ERCCs also in beads that have zero cells
and thus would double the sequencing costs. As a proxy for
the missing ERCC data, we used a published dataset (Macosko
et al., 2015), where ERCC spike-ins were sequenced using the
Drop-seq method without single-cell transcriptomes.
As a fifth method we chose CEL-seq2 (Hashimshony et al.,
2016), an improved version of the original CEL-seq (Hashimsh-
ony et al., 2012) protocol, as implemented for microfluidic chips
on Fluidigm’s C1 (Hashimshony et al., 2016). As for Smart-seq/
C1, this allowed us to capture 96 cells in two independent repli-
cates and to include ERCCs in the cell lysis step. Similar to Drop-
seq and SCRB-seq, cDNA was tagged with barcodes and UMIs;
but, in contrast to the four PCR-based methods described
above, CEL-seq2 relies on linear amplification by in vitro tran-
scription after the initial reverse transcription. The amplified, bar-
coded RNAs were harvested from the chip, pooled, fragmented,
and reverse transcribed to obtain sequencing libraries.
MARS-seq, the sixth method evaluated, is a high-throughput
implementation of the original CEL-seq method (Jaitin et al.,
2014). In this protocol, cells were sorted by FACS in 384-well
plates containing lysis buffer and the ERCCs. As in CEL-seq
and CEL-seq2, amplified RNA with barcodes and UMIs were
generated by in vitro transcription, but libraries were prepared
on a liquid-handling platform. An overview of the methods and
their workflows is provided in Figure 2 and in Table S1.
Processing of scRNA-Seq Data
For each method, we generated at least 48 libraries per replicate
and sequenced between 241 and 866million reads (Figure 1; Fig-
ure S1B). All data were processed identically, with cDNA reads
clipped to 45bpandmappedusingSpliced TranscriptsAlignment
to a Reference (STAR) (Dobin et al., 2013) and UMIs quantified
using the Drop-seq pipeline (Macosko et al., 2015). To adjust for
differences in sequencing depths, we selected all libraries with
at least one million reads, and we downsampled them to one
million reads each. This resulted in 96, 79, 73, 93, 162, and 187 li-
braries for CEL-seq2/C1, Drop-seq, MARS-seq, SCRB-seq,
Smart-seq/C1, and Smart-seq2, respectively.
To exclude doublets (libraries generated from two or more
cells) in the Smart-seq/C1 data, we analyzed microscope im-
ages and identified 16 reaction chambers with multiple cells.
For the four UMI methods, we calculated the number of UMIs
per library, and we found that libraries that have more than twice
themean total UMI count can be readily identified (Figure S1C). It
is unclear whether these libraries were generated from two sepa-
rate cells (doublets) or, for example, from one large cell before
mitosis. However, for the purpose of this method comparison,
we removed these three to nine libraries. To filter out low-quality
libraries, we used a method that exploits the fact that transcript
detection and abundance in low-quality libraries correlate poorly
with high-quality libraries as well as with other low-quality li-
braries (Petropoulos et al., 2016). Therefore, we determined
the maximum Spearman correlation coefficient for each cell
in all-to-all comparisons that allowed us to identify low-quality
libraries as outliers of the distributions of correlation coefficients
by visual inspection (Figure S1D). This filtering led to the
removal of 21, 0, 4, 0, 16, and 30 cells for CEL-seq2/C1, Drop-
seq, MARS-seq, SCRB-seq, Smart-seq/C1, and Smart-seq2,
respectively.
In summary, we processed and filtered our data so that we
ended up with a total of 583 high-quality scRNA-seq libraries
that could be used for a fair comparison of the sensitivity, accu-
racy, precision, power, and efficiency of the methods.
Single-Cell Libraries Are Sequenced to a Reasonable
Level of Saturation at One Million Reads
For all six methods, >50% of the reads could be unambiguously
mapped to the mouse genome (Figure 3A), which is comparable
to previous results (Jaitin et al., 2014; Wu et al., 2014). Overall,
between 48% (Smart-seq2) and 30% (Smart-seq/C1) of all reads
were exonic and, thus, were used to quantify gene expression
levels. However, the UMI data showed that only 14%, 5%,
7%, and 15% of the exonic reads were derived from indepen-
dent mRNA molecules for CEL-seq2/C1, Drop-seq, MARS-
seq, and SCRB-seq, respectively (Figure 3A). To quantify the
relationship between the number of detected genes or mRNA
molecules and the number of reads in more detail, we down-
sampled reads to varying depths, and we estimated to what
extent libraries were sequenced to saturation (Figure S2). The
number of unique mRNA molecules plateaued at 56,760 UMIs
per library for CEL-seq2/C1 and 26,210 UMIs per library for
MARS-seq, was still marginally increasing at 17,210 UMIs per li-
brary for Drop-seq, and was considerably increasing at
49,980 UMIs per library for SCRB-seq (Figure S2C). Notably,
CEL-seq2/C1 and MARS-seq showed a steeper slope at low
sequencing depths than both Drop-seq and SCRB-seq, poten-
tially due to a less biased amplification by in vitro transcription.
Hence, among the UMI methods, CEL-seq2/C1 and SCRB-seq
libraries had the highest complexity of mRNA molecules, and
this complexity was sequenced to a reasonable level of satura-
tion with one million reads.
To investigate saturation also for non-UMI-based methods,
we applied a similar approach at the gene level by counting
the number of genes detected by at least one read. By fitting
an asymptote to the downsampled data, we estimated that
!90% (Drop-seq and SCRB-seq) to 100% (CEL-seq2/C1,
MARS-seq, Smart-Seq/C1, and Smart-seq2) of all genes pre-
sent in a library were detected at one million reads (Figure 3B;
Figure S2A). In particular, the deep sequencing of Smart-seq2 li-
braries showed clearly that the number of detected genes did not
change when increasing the sequencing depth from one million
to five million reads per cell (Figure S2B).
All in all, these analyses show that scRNA-seq libraries were
sequenced to a reasonable level of saturation at one million
reads, a cutoff that also has been suggested previously for
scRNA-seq datasets (Wu et al., 2014). While it can be more
efficient to invest in more cells at lower coverage (see our power
analyses below), one million reads per cell is a reasonable
sequencing depth for our purpose of comparing scRNA-seq
methods.
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Smart-Seq2 Has the Highest Sensitivity
Taking the number of detected genes per cell as a measure of
sensitivity, we found that Drop-seq andMARS-seqhad the lowest
sensitivity, with a median of 4,811 and 4,763 genes detected per
cell, respectively, while CEL-seq2/C1, SCRB-seq, and Smart-
seq/C1 detected a median of 7,536, 7,906, and 7,572 genes per
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Figure 3. Sensitivity of scRNA-Seq Methods
(A) Percentage of reads (downsampled to one million per cell) that cannot be mapped to the mouse genome (gray) are mapped to regions outside exons (orange)
or inside exons (blue). For UMI methods, dark blue denotes the exonic reads with unique UMIs.
(B) Median number of genes detected per cell (countsR1) when downsampling total read counts to the indicated depths. Dashed lines above one million reads
represent extrapolated asymptotic fits.
(C) Number of genes detected (countsR1) per cell. Each dot represents a cell and each box represents the median and first and third quartiles per replicate and
method.
(D) Cumulative number of genes detected as more cells are added. The order of cells considered was drawn randomly 100 times to display mean ± SD (shaded
area). See also Figures S3 and S4.
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cell (Figure3C).Smart-seq2detected thehighestnumberofgenes
per cell with a median of 9,138. To compare the total number of
genes detected across many cells, we pooled the sequence
data of 65 cells per method, and we detected !19,000 genes for
CEL-Seq2/C1, !17,000 for MARS-seq, !18,000 for Drop-seq
and SCRB-Seq, !20,000 for Smart-seq/C1, and !21,000 for
Smart-seq2 (Figure 3D). While the majority of genes (!13,000)
were detected by all methods, !400 genes were specific to
each of the 30 countingmethods, and!1,000 geneswere specific
to each of the two full-length methods (Figure S3A). This higher
sensitivity of both full-length methods also was apparent when
plotting the genes detected in all available cells, as the 30 counting
methods leveled off below 20,000 genes while the two full-length
methods leveledoff above20,000genes (Figure3D). Suchadiffer-
ence could be caused by genes that have 30 ends that are difficult
tomap.However,we found that genes specific toSmart-seq2and
Smart-seq/C1map as well to 30 ends as genes with similar length
distribution that are not specifically detected by full-length
methods (Figure S3B). Hence, it seems that full-length methods
turn a slightly higher fraction of transcripts into sequenceablemol-
ecules than 30 counting methods and are more sensitive in this
respect. Importantly, method-specific genes are detected in
very few cells (87% of genes occur in one or two cells) with very
low counts (mean counts < 0.2, Figure S3C). This suggests that
they are unlikely to remain method specific at higher expression
levels and that their impact on conclusions drawn from scRNA-
seq data is rather limited (Lun et al., 2016).
Next, we investigated how reads are distributed along the
mRNA transcripts for all genes. As expected, the 30 counting
methods showed a strong bias of reads mapped to the 30 end
(Figure S3D). However, it is worthmentioning that a considerable
fraction of reads also covered other segments of the transcripts,
probably due to internal oligo-dT priming (Nam et al., 2002).
Smart-seq2 showed a more even coverage than Smart-seq,
confirming previous findings (Picelli et al., 2013). A general differ-
ence in expression values between 30 counting and full-length
methods also was reflected in their strong separation by the first
principal component, explaining 37% of the total variance, and
when taking into account that one needs to normalize for gene
length for the full-length methods (Figure S4E).
As an absolute measure of sensitivity, we compared the prob-
ability of detecting the 92 spiked-in ERCCs, for which the num-
ber of molecules available for library construction is known (Fig-
ures S4A and S4B). We determined the detection probability of
each ERCC RNA as the proportion of cells with at least one
read or UMI count for the particular ERCC molecule (Marinov
et al., 2014). For Drop-seq, we used the previously published
ERCC-only dataset (Macosko et al., 2015), and for the other
five methods, 2%–5% of the one million reads per cell mapped
to ERCCs that were sequenced to complete saturation at that
level (Figure S5B). A 50% detection probability was reached at
!7, 11, 14, 16, 17, and 28 ERCC molecules for Smart-seq2,
Smart-seq/C1, CEL-seq2/C1, SCRB-seq, Drop-seq, and
MARS-seq, respectively (Figure S4C). Notably, the sensitivity
estimated from the number of detected genes does not fully
agree with the comparison based on ERCCs. While Smart-
seq2 was the most sensitive method in both cases, Drop-seq
performed better and SCRB-seq and MARS-seq performed
worse when using ERCCs. The separate generation and
sequencing of the Drop-seq ERCC libraries could be a possible
explanation for their higher sensitivity. However, it remains un-
clear why SCRB-seq and MARS-seq had a substantially lower
sensitivity when using ERCCs. It has been noted before that
ERCCs can be problematic for modeling endogenous mRNAs
(Risso et al., 2014), potentially due to their shorter length, shorter
poly-A tail, and their missing 50 cap (Gr€un and van Oudenaarden,
2015; Stegle et al., 2015). While ERCCs are still useful to gauge
the absolute range of sensitivities, the thousands of endogenous
mRNAs are likely to be a more reliable estimate for comparing
sensitivities as we used the same cell type for all methods.
In summary, we find that Smart-seq2 is the most sensitive
method, as it detects the highest number of genes per cell and
the most genes in total across cells and has the most even
coverage across transcripts. Smart-seq/C1 is slightly less sensi-
tive per cell and detects almost the same number of genes
across cells with slightly less even coverage. Among the 30
counting methods, CEL-seq2/C1 and SCRB-seq detect about
as many genes per cell as Smart-seq/C1, whereas Drop-seq
and MARS-seq detect considerably fewer genes.
Accuracy of scRNA-Seq Methods
To measure the accuracy of transcript level quantifications, we
compared the observed expression values (counts per million
or UMIs per million) with the known concentrations of the 92
ERCC transcripts (Figure S5A). For each cell, we calculated the
coefficient of determination (R2) for a linear model fit (Figure 4).
Methods differed significantly in their accuracy (Kruskal-Wallis
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Figure 4. Accuracy of scRNA-Seq Methods
ERCC expression values (counts per million reads for Smart-seq/C1 and
Smart-seq2 and UMIs per million reads for all others) were correlated to their
annotated molarity. Shown are the distributions of correlation coefficients
(adjusted R2 of linear regression model) across methods. Each dot represents
a cell/bead and each box represents the median and first and third quartiles.
See also Figure S5.
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test, p < 2.2e"16), but all methods had a fairly high R2 ranging
between 0.83 (MARS-seq) and 0.91 (Smart-seq2). This suggests
that, for all methods, transcript concentrations across this broad
range can be predicted fairly well from expression values. As ex-
pected, accuracy was worse for narrower and especially for
lower concentration ranges (Figure S5C). It is worth emphasizing
that the accuracy assessed here refers to absolute expression
levels across genes within cells. This accuracy can be important,
for example, to identify marker genes with a high absolute mRNA
expression level. However, the small differences in accuracy
seen here will rarely be a decisive factor when choosing among
the six protocols.
Precision of Amplified Genes Is Strongly Increased
by UMIs
While a high accuracy is necessary to compare absolute expres-
sion levels, one of the most common experimental aims is to
compare relative expression levels to identify differentially ex-
pressed genes or different cell types. Hence, the precision (i.e.,
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Figure 5. Precision of scRNA-Seq Methods
We compared precision among methods using
the 13,361 genes detected in at least 25% of all
cells by any method in a subsample of 65 cells per
method.
(A) Distributions of dropout rates across the
13,361 genes are shown as violin plots, and me-
dians are shown as bars and numbers.
(B) Extra Poisson variability across the 13,361
genes was calculated by subtracting the ex-
pected amount of variation due to Poisson sam-
pling (square root of mean divided by mean)
from the CV (SD divided by mean). Distributions
are shown as violin plots and medians are
shown as bars and numbers. For 349, 336, 474,
165, 201, and 146 genes for CEL-seq2/C1, Drop-
seq, MARS-seq, SCRB-seq, Smart-seq/C1, and
Smart-seq2, respectively, no extra Poisson vari-
ability could be calculated. See also Figures S6
and S7.
the reproducibility of the expression-level
estimate) is amajor factor when choosing
a method. As we used the same cell type
under the same culture conditions for all
methods, the amount of biological varia-
tion should be the same in the cells
analyzed by each of the six methods.
Hence, we can assume that differences
in the total variation among methods
are due to differences in their technical
variation. Technical variation is substan-
tial in scRNA-seq data primarily because
a substantial fraction of mRNAs is lost
during cDNA generation and small
amounts of cDNA get amplified. There-
fore, both the dropout probability and
the amplification noise need to be
considered when quantifying variation.
Indeed, a mixture model including a dropout probability and a
negative binomial distribution, modeling the overdispersion in
the count data, have been shown to represent scRNA-seq
data better than the negative binomial alone (Finak et al., 2015;
Kharchenko et al., 2014).
To compare precision without penalizing more sensitive
methods, we selected a common set of 13,361 genes that
were detected in 25% of the cells by at least one method (Fig-
ure S6A). We then analyzed these genes in a subsample of 65
cells per method to avoid a bias due to unequal numbers of cells.
We estimated the dropout probability as the fraction of cells with
zero counts (Figure 5A; Figure S6B). As expected from the num-
ber of detected genes per cell (Figure 3C), MARS-seq had the
highest median dropout probability (74%) and Smart-seq2 had
the lowest (26%) (Figure 5A). To estimate the amplification noise
of detected genes, we calculated the coefficient of variation (CV,
SD divided by the mean, including zeros), and we subtracted the
expected amount of variation due to Poisson sampling (i.e., the
square root of the mean divided by the mean). This was possible
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for 96.5% (MARS-seq) to 98.9% (Smart-seq2) of all the 13,361
genes. This extra Poisson variability includes biological variation
(assumed to be the same across methods in our data) and tech-
nical variation, and the latter includes noise introduced by ampli-
fication (Brennecke et al., 2013; Gr€un et al., 2014; Stegle et al.,
2015). That amplification noise can be a major factor is seen
by the strong increase of extra Poisson variability when ignoring
UMIs and considering read counts only (Figure 5B, left; Fig-
ure S7A). This is expected, as UMIs should remove amplification
noise, which has been described previously for CEL-seq (Gr€un
et al., 2014). For SCRB-seq and Drop-seq, which are PCR-
based methods, UMIs removed even more extra Poisson vari-
ability than for CEL-seq2/C1 and MARS-seq (Figure 5B), which
is in line with the notion that amplification by PCR is more noisy
than amplification by in vitro transcription. Of note, Smart-seq2
had the lowest amplification noise when just considering reads
(Figure 5B, left), potentially because its higher sensitivity requires
less amplification and, hence, leads to less noise.
In summary, Smart-seq2 detects the common set of 13,361
genes in more cells than the UMI methods, but it has, as ex-
pected, more amplification noise than the UMI-based methods.
How the different combinations of dropout rate and amplification
noise affect the power of themethods is not evident, neither from
this analysis nor from the total coefficient of variation that ignores
the strong mean variance and mean dropout dependencies of
scRNA-seq data (Figure S7B).
Power Is Determined by aCombination of Dropout Rates
and Amplification Noise and Is Highest for SCRB-Seq
To estimate the combined impact of sensitivity and precision on
the power to detect differential gene expression, we simulated
scRNA-seq data given the observed dropout rates and variance
for the 13,361 genes. As these depend strongly on the expres-
sion level of a gene, it is important to retain the mean variance
and mean dropout relationships. To this end, we estimated the
mean, the variance (i.e., the dispersion parameter of the negative
binomial distribution), and the dropout rate for each gene and
method. We then fitted a cubic smoothing spline to the resulting
pairs of mean and dispersion estimates to predict the dispersion
of a gene given its mean (Figure S8A). Furthermore, we applied a
local polynomial regression model to account for the dropout
probability given a gene’s mean expression (Figure S8B).
When simulating data according to these fits, we recovered dis-
tributions of dropout rates and variance closely matching the
observed data (Figures S8C and S8D). To compare the power
for differential gene expression among the methods, we simu-
lated read counts for two groups of n cells and added log-fold
changes to 5%of the 13,361 genes in one group. Tomimic a bio-
logically realistic scenario, these log-fold changes were drawn
from observed differences between microglial subpopulations
from a previously published dataset (Zeisel et al., 2015). Simu-
lated datasets were tested for differential expression using
limma (Ritchie et al., 2015), and the true positive rate (TPR) and
the false discovery rate (FDR) were calculated. Of note, this
does include undetected genes, i.e., the 2.5% (SCRB-seq) to
6.8% (MARS-seq) of the 13,361 genes that had fewer than two
measurements in a particular method (Figure S6B) and for which
we could not estimate the variance. In our simulations, these
genes could be drawn as differentially expressed, and in our
TPR they were then counted as false negatives for the particular
method. Hence, our power simulation framework considers the
full range of dropout rates and is not biased against more sensi-
tive methods.
First, we analyzed how the number of cells affects TPR and
FDR by running 100 simulations each for a range of 16 to 512
cells per group (Figure 6A). FDRs were similar in all methods
ranging from 3.9% to 8.7% (Figure S9A). TPRs differed consid-
erably amongmethods and SCRB-seq performed best, reaching
a median TPR of 80% with 64 cells. CEL-seq2/C1, Drop-seq,
MARS-seq, and Smart-seq2 performed slightly worse, reaching
80% power with 86, 99, 110, and 95 cells per group, respec-
tively, while Smart-seq/C1 needed 150 cells to reach 80%power
(Figure 6A). When disregarding UMIs, Smart-seq2 performed
best (Figure 6B), as expected from its low dropout rate and its
low amplification noise when considering reads only (Figure 5B).
Furthermore, power dropped especially for Drop-seq and
SCRB-seq (Figure 6B), as expected from the strong increase in
amplification noise of these two methods when considering
reads only (Figure 5B). When we stratified our analysis (consid-
ering UMIs) across five bins of expression levels, the ranking of
methods was recapitulated and showed that the lowest expres-
sion bin strongly limited the TPR in all methods (Figure S9B). This
ranking also was recapitulated when we analyzed a set of 19
genes previously reported to contain cell-cycle variation in the
2i/LIF culture condition (Kolodziejczyk et al., 2015b). The vari-
ance of these cell-cycle genes was clearly higher than the vari-
ance of 19 pluripotency and housekeeping (ribosomal) genes
in all methods. The p value of that difference was lowest for
SCRB-seq, the most powerful method, and highest for Smart-
seq/C1, the least powerful method (Figure S10D).
Notably, this power analysis, as well as the sensitivity, accu-
racy, and precision parameters analyzed above, includes the
variation that is generated in the two technical replicates
(batches) per method that we performed (Figure 1). These esti-
mates were very similar among our technical replicates, and,
hence, ourmethod comparison is valid with respect to batch var-
iations (Figures S10B–S10D). In addition, as batch effects are
known to be highly relevant for interpreting scRNA-seq data
(Hicks et al., 2015), we gauged the magnitude of batch effects
with respect to identifying differentially expressed genes. To
this end, we used limma to identify differentially expressed genes
between batches (FDR < 1%), using 25 randomly selected cells
per batch andmethod. All methods had significantly more genes
differentially expressed between batches than expected from
permutations (zero to four genes), with a median of 119 (Drop-
seq) to !1,135 (CEL-seq2/C1) differentially expressed genes
(Figure S10A). Notably, genes were affected at random across
methods, as there was no significant overlap among them
(extended hypergeometric test [Kalinka, 2013], p > 0.84). Hence,
this analysis once more emphasizes that batches are important
to consider in the design of scRNA-seq experiments (Hicks et al.,
2015). While a quantitative comparison of the magnitude of
batch effects among methods would require substantially more
technical replicates per method, the methods differ in their flex-
ibility to incorporate batch effect into the experimental design,
which is an important aspect to consider as discussed below.
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As a next step, we analyzed how the performance of the six
methods depends on sequencing depth. To this end, we per-
formed power simulations as above, but we estimated the
mean dispersion and mean dropout relationships from data
downsampled to 500,000 or 250,000 reads per cell. Overall,
the decrease in power was moderate (Figure 6C; Table 1) and
followed the drop in sensitivity at different sequencing depths
(Figure 3B). While Smart-seq2 and CEL-seq2/C1 needed just
1.3-fold more cells at 0.25 million reads than at one million reads
to reach 80% power, SCRB-seq and Drop-seq required 2.6-fold
more cells (Table 1). In summary, SCRB-seq is themost powerful
method at one million reads and half a million reads, but CEL-
seq2/C1 is the most powerful method at a sequencing depth
of 250,000 reads. The optimal balance between the number of
cells and their sequencing depth depends on many factors,
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Figure 6. Power of scRNA-Seq Methods
Using the empirical mean/dispersion and mean/
dropout relationships (Figures S8A and S8B), we
simulated data for two groups of n cells each for
which 5% of the 13,361 genes were differentially
expressed, with log-fold changes drawn from
observed differences between microglial sub-
populations from a previously published dataset
(Zeisel et al., 2015). The simulated data were then
tested for differential expression using limma
(Ritchie et al., 2015), from which the average true
positive rate (TPR) and the average false discov-
ery rate (FDR) were calculated (Figure S9A).
(A) TPR for one million reads per cell for sample
sizes n = 16, n = 32, n = 64, n = 128, n = 256, and
n = 512 per group. Boxplots represent the median
and first and third quartiles of 100 simulations.
(B) TPR for one million reads per cell for n = 64 per
group with and without using UMI information.
Boxplots represent the median and first and third
quartiles of 100 simulations.
(C) TPRs as in (A) using mean/dispersion
and mean/dropout estimates from one million
(as in A), 0.5 million, and 0.25 million reads. Line
areas indicate the median power with SE from
100 simulations. See also Figures S8–S10 and
Table 1.
including the scientific questions ad-
dressed, the experimental design, or the
sample availability. However, the mone-
tary cost is certainly an important one,
and we used the results of our simula-
tions to compare the costs among the
methods for a given level of power.
Cost Efficiency Is Similarly High for
Drop-Seq, MARS-Seq, SCRB-Seq,
and Smart-Seq2
Given the number of cells needed to
reach 80% power as simulated above
for three sequencing depths (Figure 6C),
we calculated the minimal costs to
generate and sequence these libraries.
For example, at a sequencing depth of one million reads,
SCRB-seq requires 64 cells per group to reach 80% power.
Generating 128 SCRB-seq libraries costs!260$ and generating
128 million reads costs !640$. Note that the necessary paired-
end reads for CEL-seq2/C1, SCRB-seq, MARS-seq, and Drop-
seq can be generated using a 50-cycle sequencing kit, and,
hence, we assume that sequencing costs are the same for all
methods.
Calculating minimal costs this way, Drop-seq (690$) is the
most cost-effective method when sequencing 254 cells at a
depth of 250,000 reads, and SCRB-seq (810$), MARS-seq
(820$), and Smart-seq2 (1,090$) are slightly more expensive at
the same performance (Table 1). For Smart-seq2 it should be
stressed that the use of in-house-produced Tn5 transposase
(Picelli et al., 2014a) is required to keep the cost at this level, as
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was done in our experiments. When instead using the Tn5 trans-
posase of the commercial Nextera kit as described (Picelli et al.,
2014b), the costs for Smart-seq2 are 10-fold higher. Even if one
reduces the amount of Nextera transposase to a quarter, as done
in the Smart-seq/C1 protocol, the Smart-seq2 protocol is still
four times more expensive than the early barcoding methods.
CEL-seq2/C1 is fairly expensive due to the microfluidic chips
that make up 69% of the library costs, and Smart-seq/C1 is
almost 13-fold less efficient than Drop-seq due to its high library
costs that arise from the microfluidic chips, the commercial
Smart-seq kit, and the costs for commercial Nextera XT kits.
Of note, these calculations are the minimal costs of the exper-
iment and several factors are not considered, such as labor
costs, costs to set up the methods, costs to isolate cells of inter-
est, or costs due to practical constraints in generating a fixed
number of scRNA-seq libraries with a fixed number of reads. In
many experimental settings, independent biological and/or tech-
nical replicates are needed when investigating particular factors,
such as genotypes or developmental time points, and Smart-
seq/C1, CEL-seq2/C1, and Drop-seq are less flexible in distrib-
uting scRNA-seq libraries across replicates than the other three
methods that use PCR plates. Furthermore, the costs are
increased by unequal sampling from the included cells as well
as from sequencing reads from cells that are excluded. In our
case, between 6% (SCRB-seq) and 32% (Drop-seq) of the reads
came from cell barcodes that were not included. While it is diffi-
cult to exactly calculate and compare these costs among
methods, it is clear that they will increase the costs for Drop-
seq relatively more than for the other methods. In summary,
we find that Drop-seq, SCRB-seq, and MARS-seq are the
most cost-effective methods, closely followed by Smart-seq2,
if using an in-house-produced transposase.
DISCUSSION
Here we have provided an in-depth comparison of six prominent
scRNA-seq protocols. To this end, we generated data for all six
compared methods from the same cells, cultured under the
same condition in the same laboratory. While there would be
manymore datasets andmethods for a comparison of the sensi-
tivity and accuracy of the ERCCs (Svensson et al., 2016), our
approach provides a more controlled and comprehensive com-
parison across thousands of endogenous genes. This is impor-
tant, as can be seen by the different sensitivity estimates that
we obtained for Drop-seq, MARS-seq, and SCRB-seq using
the ERCCs. In our comparison, we clearly find that Smart-seq2
is the most sensitive method, closely followed by SCRB-seq,
Smart-seq/C1, and CEL-seq2/C1, while Drop-seq and MARS-
seq detect nearly 50% fewer genes per cell (Figures 3B and
3C). In addition, Smart-seq2 shows themost even read coverage
across transcripts (Figure S3D), making it the most appropriate
method for the detection of alternative splice forms and for ana-
lyses of allele-specific expression using SNPs (Deng et al., 2014;
Reinius et al., 2016). Hence, Smart-seq2 is certainly the most
suitable method when an annotation of single-cell transcrip-
tomes is the focus. Furthermore, we find that Smart-seq2 is
also themost accurate method (i.e., it has the highest correlation
of known ERCC spike-in concentrations and read counts per
million), which is probably related to its higher sensitivity. Hence,
differences in expression values across transcripts within the
same cell predict differences in the actual concentrations of
these transcripts well. All methods do this rather well, at least
for higher expression levels, and we think that the small differ-
ences among methods will rarely be a decisive factor. Impor-
tantly, the accuracy of estimating transcript concentrations
across cells (relevant, e.g., for comparing the total RNA content
of cells) depends on different factors and cannot be compared
well among the tested methods as it would require known con-
centration differences of transcripts across cells. However, it is
likely that methods that can use UMIs and ERCCs (CEL-seq2/
C1, MARS-seq, and SCRB-seq) would have a strong advantage
in this respect.
How well relative expression levels of the same genes can be
compared across cells depends on two factors. First, how often
(i.e., in how many cells and from how many molecules) it is
measured. Second, with how much technical variation (i.e.,
with how much noise, e.g., from amplification) it is measured.
For the first factor (dropout probability), we find Smart-seq2 to
be the best method (Figure 5A), as expected from its high gene
detection sensitivity. For the second factor (extra Poisson vari-
ability), we find the four UMI methods to perform better (Fig-
ure 5B), as expected from their ability to eliminate variation intro-
duced by amplification. To assess the combined effect of these
two factors, we performed simulations for differential gene
Table 1. Cost Efficiency Extrapolation for Single-Cell RNA-Seq Experiments
Method TPRa FDRa (%) Cell per Groupb Library Cost ($) Minimal Costc ($)
CEL-seq2/C1 0.8 !6.1 86/100/110 !9 !2,420/2,310/2,250
Drop-seq 0.8 !8.4 99/135/254 !0.1 !1,010/700/690
MARS-seq 0.8 !7.3 110/135/160 !1.3 !1,380/1,030/820
SCRB-seq 0.8 !6.1 64/90/166 !2 !900/810/1,080
Smart-seq/C1 0.8 !4.9 150/172/215 !25 !9,010/9,440/11,290
Smart-seq2 (commercial) 0.8 !5.2 95/105/128 !30 !10,470/11,040/13,160
Smart-seq2 (in-house Tn5) 0.8 !5.2 95/105/128 !3 !1,520/1,160/1,090
See also Figure 6.
aTrue positive rate and false discovery rate are based on simulations (Figure 6; Figure S9).
bSequencing depth of one, 0.5, and 0.25 million reads.
cAssuming $5 per one million reads.
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expression scenarios (Figure 6). This allowed us to translate the
sensitivity and precision parameters into the practically relevant
power to detect differentially expressed genes. Of note, our po-
wer estimates include the variation that is caused by the two
different replicates per method that constitutes an important
part of the variation. Our simulations show that, at a sequencing
depth of one million reads, SCRB-seq has the highest power,
probably due to a good balance of high sensitivity and low ampli-
fication noise. Furthermore, amplification noise and power
strongly depend on the use of UMIs, especially for the PCR-
based methods (Figures 5B and 6B; Figure S7). Notably, this is
due to the large amount of amplification needed for scRNA-
seq libraries, as the effect of UMIs on power for bulk RNA-seq
libraries is negligible (Parekh et al., 2016).
Perhaps practically most important, our power simulations
also allow us to compare the efficiency of the methods by calcu-
lating the costs to generate the data for a given level of power.
Using minimal cost calculations, we find that Drop-seq is the
most cost-effective method, closely followed by SCRB-seq,
MARS-seq, and Smart-seq2. However, Drop-seq costs are likely
to be more underestimated, due to lower flexibility in generating
a specified number of libraries and the higher fraction of reads
that come from bad cells. Hence, all four UMI methods are in
practice probably similarly cost-effective. In contrast, for
Smart-seq2 to be similarly cost-effective it is absolutely neces-
sary to use in-house-produced transposase or to drastically
reduce volumes of commercial transposase kits (Lamble et al.,
2013; Mora-Castilla et al., 2016).
Given comparable efficiencies of Drop-seq, MARS-seq,
SCRB-seq, and Smart-seq2, additional factors will play a
role when choosing a suitable method for a particular ques-
tion. Due to its low library costs, Drop-seq is probably prefer-
able when analyzing large numbers of cells at low coverage
(e.g., to find rare cell types). On the other hand, Drop-seq in
its current setup requires a relatively large amount of cells
(>6,500 for 1 min of flow). Hence, if few and/or unstable cells
are isolated by FACS, the SCRB-seq, MARS-seq, or Smart-
seq2 protocols are probably preferable. Additional advantages
of these methods over Drop-seq include that technical varia-
tion can be estimated from ERCCs for each cell, which can
be helpful to estimate biological variation (Kim et al., 2015;
Vallejos et al., 2016), and that the exact same setup can be
used to generate bulk RNA-seq libraries. While SCRB-seq is
slightly more cost-effective than MARS-seq and has the
advantage that one does not need to produce the transposase
in-house, Smart-seq2 is preferable when transcriptome anno-
tation, identification of sequence variants, or the quantification
of different splice forms is of interest. Furthermore, the pres-
ence of batch effects shows that experiments need to be
designed in a way that does not confound batches with bio-
logical factors (Hicks et al., 2015). Practically, plate-based
methods might currently accommodate complex experimental
designs with various biological factors more easily than micro-
fluidic chips.
We find that Drop-seq, MARS-seq, SCRB-seq, and Smart-
seq2 (using in-house transposase) are 2- to 13-fold more cost
efficient than CEL-seq2/C1, Smart-seq/C1, and Smart-seq2
(using commercial transposase). Hence, the latter methods
would need to increase in their power and/or decrease in their
costs to be competitive. The efficiency of the Fluidigm C1 plat-
form can be further increased bymicrofluidic chips with a higher
throughput, as available in the high-throughput (HT) mRNA-seq
integrated fluidic circuit (IFC) chip. While CEL-seq2/C1 has
been found to more sensitive than the plate-based version of
CEL-seq2 (Hashimshony et al., 2016), the latter might be
more efficient when considering its lower costs. Our finding
that Smart-seq2 is themost sensitive protocol also hints toward
further possible improvements of SCRB-seq and Drop-seq. As
these methods also rely on template switching and PCR ampli-
fication, the improvements found in the systematic optimization
of Smart-seq2 (Picelli et al., 2013) also could improve the sensi-
tivity of SCRB-seq and Drop-seq. Furthermore, the costs of
SCRB-seq libraries per cell can be halved when switching to
a 384-well format (Soumillon et al., 2014). Similarly, improve-
ments made for CEL-seq2 (Hashimshony et al., 2016) could
be incorporated into the MARS-seq protocol. Hence, it is clear
that scRNA-seq protocols will become even more efficient in
the future. The results of our comparative analyses of six
currently prominent scRNA-seq methods may facilitate such
developments, and they provide a framework for method eval-
uation in the future.
In summary, we systematically compared six prominent
scRNA-seq methods and found that Drop-seq is preferable
when quantifying transcriptomes of large numbers of cells
with low sequencing depth, SCRB-seq and MARS-seq is pref-
erable when quantifying transcriptomes of fewer cells, and
Smart-seq2 is preferable when annotating and/or quantifying
transcriptomes of fewer cells as long one can use in-house-
produced transposase. Our analysis allows an informed
choice among the tested methods, and it provides a frame-
work for benchmarking future improvements in scRNA-seq
methodologies.
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Deng, Q., Ramsköld, D., Reinius, B., and Sandberg, R. (2014). Single-cell RNA-
seq reveals dynamic, random monoallelic gene expression in mammalian
cells. Science 343, 193–196.
Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut,
P., Chaisson,M., andGingeras, T.R. (2013). STAR: ultrafast universal RNA-seq
aligner. Bioinformatics 29, 15–21.
ENCODE Project Consortium (2012). An integrated encyclopedia of DNA ele-
ments in the human genome. Nature 489, 57–74.
Finak, G., McDavid, A., Yajima, M., Deng, J., Gersuk, V., Shalek, A.K., Slichter,
C.K., Miller, H.W., McElrath, M.J., Prlic, M., et al. (2015). MAST: a flexible sta-
tistical framework for assessing transcriptional changes and characterizing
heterogeneity in single-cell RNA sequencing data. Genome Biol. 16, 278.
Frazee, A.C., Jaffe, A.E., Langmead, B., and Leek, J.T. (2015). Polyester: simu-
lating RNA-seq datasets with differential transcript expression. Bioinformatics
31, 2778–2784.
Gokce, O., Stanley, G.M., Treutlein, B., Neff, N.F., Camp, J.G., Malenka, R.C.,
Rothwell, P.E., Fuccillo, M.V., S€udhof, T.C., and Quake, S.R. (2016). Cellular
taxonomy of the mouse striatum as revealed by single-cell RNA-seq. Cell
Rep. 16, 1126–1137.
Gr€un, D., and van Oudenaarden, A. (2015). Design and analysis of single-cell
sequencing experiments. Cell 163, 799–810.
Gr€un, D., Kester, L., and van Oudenaarden, A. (2014). Validation of noise
models for single-cell transcriptomics. Nat. Methods 11, 637–640.
Hashimshony, T., Wagner, F., Sher, N., and Yanai, I. (2012). CEL-seq: single-
cell RNA-seq by multiplexed linear amplification. Cell Rep. 2, 666–673.
Hashimshony, T., Senderovich, N., Avital, G., Klochendler, A., de Leeuw, Y.,
Anavy, L., Gennert, D., Li, S., Livak, K.J., Rozenblatt-Rosen, O., et al. (2016).
CEL-seq2: sensitive highly-multiplexed single-cell RNA-Seq. Genome Biol.
17, 77.
Hicks, S.C., Teng, M., and Irizarry, R.A. (2015). On the widespread and critical
impact of systematic bias and batch effects in single-cell RNA-Seq data.
bioRxiv. http://dx.doi.org/10.1101/025528.
Islam, S., Zeisel, A., Joost, S., La Manno, G., Zajac, P., Kasper, M.,
Lönnerberg, P., and Linnarsson, S. (2014). Quantitative single-cell RNA-seq
with unique molecular identifiers. Nat. Methods 11, 163–166.
Jaitin, D.A., Kenigsberg, E., Keren-Shaul, H., Elefant, N., Paul, F., Zaretsky, I.,
Mildner, A., Cohen, N., Jung, S., Tanay, A., and Amit, I. (2014). Massively par-
allel single-cell RNA-seq for marker-free decomposition of tissues into cell
types. Science 343, 776–779.
Jiang, L., Schlesinger, F., Davis, C.A., Zhang, Y., Li, R., Salit, M., Gingeras,
T.R., and Oliver, B. (2011). Synthetic spike-in standards for RNA-seq experi-
ments. Genome Res. 21, 1543–1551.
Kalinka, A.T. (2013). The probability of drawing intersections: extending the hy-
pergeometric distribution. arXiv, arXiv:1305.0717. https://arxiv.org/abs/
1305.0717.
Kharchenko, P.V., Silberstein, L., and Scadden, D.T. (2014). Bayesian
approach to single-cell differential expression analysis. Nat. Methods 11,
740–742.
Kim, J.K., Kolodziejczyk, A.A., Ilicic, T., Teichmann, S.A., and Marioni, J.C.
(2015). Characterizing noise structure in single-cell RNA-seq distinguishes
genuine from technical stochastic allelic expression. Nat. Commun. 6, 8687.
Kivioja, T., V€ah€arautio, A., Karlsson, K., Bonke, M., Enge, M., Linnarsson, S.,
and Taipale, J. (2011). Counting absolute numbers of molecules using unique
molecular identifiers. Nat. Methods 9, 72–74.
Klein, A.M., Mazutis, L., Akartuna, I., Tallapragada, N., Veres, A., Li, V.,
Peshkin, L., Weitz, D.A., and Kirschner, M.W. (2015). Droplet barcoding for sin-
gle-cell transcriptomics applied to embryonic stem cells. Cell 161, 1187–1201.
Kolodziejczyk, A.A., Kim, J.K., Svensson, V., Marioni, J.C., and Teichmann,
S.A. (2015a). The technology and biology of single-cell RNA sequencing.
Mol. Cell 58, 610–620.
Kolodziejczyk, A.A., Kim, J.K., Tsang, J.C.H., Ilicic, T., Henriksson, J.,
Natarajan, K.N., Tuck, A.C., Gao, X., B€uhler, M., Liu, P., et al. (2015b). Single
cell RNA-sequencing of pluripotent states unlocks modular transcriptional
variation. Cell Stem Cell 17, 471–485.
Lamble, S., Batty, E., Attar, M., Buck, D., Bowden, R., Lunter, G., Crook, D., El-
Fahmawi, B., and Piazza, P. (2013). Improved workflows for high throughput
library preparation using the transposome-based Nextera system. BMC
Biotechnol. 13, 104.
Law, C.W., Chen, Y., Shi, W., and Smyth, G.K. (2014). voom: Precision weights
unlock linear model analysis tools for RNA-seq read counts. Genome Biol.
15, R29.
Li, E., Bestor, T.H., and Jaenisch, R. (1992). Targeted mutation of the DNA
methyltransferase gene results in embryonic lethality. Cell 69, 915–926.
Liao, Y., Smyth, G.K., and Shi, W. (2013). The Subread aligner: fast, accurate
and scalable read mapping by seed-and-vote. Nucleic Acids Res. 41, e108.
Lun, A.T.L., Bach, K., and Marioni, J.C. (2016). Pooling across cells to
normalize single-cell RNA sequencing data with many zero counts. Genome
Biol. 17, 75.
Macosko, E.Z., Basu, A., Satija, R., Nemesh, J., Shekhar, K., Goldman, M.,
Tirosh, I., Bialas, A.R., Kamitaki, N., Martersteck, E.M., et al. (2015). Highly par-
allel genome-wide expression profiling of individual cells using nanoliter drop-
lets. Cell 161, 1202–1214.
Marinov, G.K., Williams, B.A., McCue, K., Schroth, G.P., Gertz, J., Myers,
R.M., and Wold, B.J. (2014). From single-cell to cell-pool transcriptomes: sto-
chasticity in gene expression and RNA splicing. Genome Res. 24, 496–510.
Martin, M. (2011). Cutadapt removes adapter sequences from high-
throughput sequencing reads. EMBnet.journal 17, 10–12.
Mora-Castilla, S., To, C., Vaezeslami, S., Morey, R., Srinivasan, S., Dumdie,
J.N., Cook-Andersen, H., Jenkins, J., and Laurent, L.C. (2016).
Miniaturization technologies for efficient single-cell library preparation for
next-generation sequencing. J. Lab. Autom. 21, 557–567.
642 Molecular Cell 65, 631–643, February 16, 2017
Nam, D.K., Lee, S., Zhou, G., Cao, X., Wang, C., Clark, T., Chen, J., Rowley,
J.D., and Wang, S.M. (2002). Oligo(dT) primer generates a high frequency of
truncated cDNAs through internal poly(A) priming during reverse transcription.
Proc. Natl. Acad. Sci. USA 99, 6152–6156.
Parekh, S., Ziegenhain, C., Vieth, B., Enard, W., and Hellmann, I. (2016). The
impact of amplification on differential expression analyses by RNA-seq. Sci.
Rep. 6, 25533.
Petropoulos, S., Edsg€ard, D., Reinius, B., Deng, Q., Panula, S.P., Codeluppi,
S., Plaza Reyes, A., Linnarsson, S., Sandberg, R., and Lanner, F. (2016).
Single-cell RNA-seq reveals lineage and X chromosome dynamics in human
preimplantation embryos. Cell 165, 1012–1026.
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REAGENT or RESOURCE SOURCE IDENTIFIER
Chemicals, Peptides, and Recombinant Proteins
Esgro recombinant mouse LIF Millipore ESG1107
CHIR99021 Axon Med Chem 1386
PD0325901 Axon Med Chem 1408
2-Mercaptoethanol Sigma-Aldrich M3148
FBS Sigma-Aldrich F7524
Penicillin/Streptomycin Sigma-Aldrich P4333
MEM non-essential amino acids Sigma-Aldrich M7145
L-glutamine Sigma-Aldrich G7513
Dulbecco’s modified Eagle’s medium Sigma-Aldrich D6429
Perfluoroctanol Sigma-Aldrich 370533
Maxima H- Reverse Transcriptase Thermo Fisher Scientific EP0753
SuperScript II Life Technologies 18064071
Exonuclease I New England Biolabs M0293L
RNAprotect Cell Reagent QIAGEN 76526
RNase inhibitor Promega N2515
RNase inhibitor Lucigen 30281-2-LU
Phusion HF buffer New England Biolabs B0518S
Proteinase K Ambion AM2546
KAPA HiFi HotStart polymerase KAPA Biosystems KAPBKK2602
Phusion HF PCR Master Mix Thermo Fisher Scientific F531L
dNTPs New England Biolabs N0447L
Triton X-100 Sigma-Aldrich T8787
SDS Sigma-Aldrich L3771
Tn5 transposase Picelli et al., 2014a N/A
Critical Commercial Assays
C1 Single-Cell System Fluidigm N/A
C1 IFC for Open App (10-17 mm) Fluidigm 100-8134
C1 IFC for mRNA-seq (10-17 mm) Fluidigm 100-6041
Nextera XT DNA Sample Preparation Kit Illumina FC-131-1096
SMARTer Ultra Low RNA Kit for Fluidigm C1 Clontech 634833
MinElute Gel Extraction Kit QIAGEN 28606
Deposited Data
single-cell RNA-seq data This paper GEO: GSE75790
Drop-seq ERCC data Macosko et al., 2015 GEO: GSE66694
Experimental Models: Cell Lines
J1 mouse embryonic stem cells Li et al., 1992 N/A
Sequence-Based Reagents
Nextera XT Index Kit Illumina FC-121-1012
SCRB-seq P5 primer, AATGATACGGCGACCACCG
AGATCTACACTCTTTCCCTACACGACGCTCTTC
CG*A*T*C*T, * PTO bond
IDT N/A
SCRB-seq oligo-dT primer, Biotin-ACACTCTTTCCCT
ACACGACGCTCTTCCGATCT[BC6][N10][T30]VN
IDT ‘‘TruGrade Ultramer’’
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the corresponding author
Wolfgang Enard (enard@biologie.uni-muenchen.de).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
J1 mouse embryonic stem cells (Li et al., 1992) were maintained on gelatin-coated dishes in Dulbecco’s modified Eagle’s medium
supplemented with 16% fetal bovine serum (FBS, Sigma-Aldrich), 0.1mM b-mercaptoethanol (Sigma-Aldrich), 2mML-glutamine, 1x
MEM non-essential amino acids, 100 U/ml penicillin, 100 mg/ml streptomycin (Sigma-Aldrich), 1000 U/ml recombinant mouse LIF
(Millipore) and 2i (1 mM PD032591 and 3 mM CHIR99021 (Axon Medchem, Netherlands). J1 embryonic stem cells were obtained
from E. Li and T. Chen and mycoplasma free determined by a PCR-based test. Cell line authentication was not recently performed.
METHOD DETAILS
Published data
Drop-seq ERCC (Macosko et al., 2015) data were obtained under accession GEO: GSE66694. Raw fastq files were extracted using
the SRA toolkit (2.3.5). We trimmed cDNA reads to the same length and processed raw reads in the same way as data sequenced for
this study.
Single cell RNA-seq library preparations
CEL-seq2/C1
CEL-seq2/C1 libraries were generated as previously described (Hashimshony et al., 2016). Briefly, cells (200,000/ml), ERCC spike-
ins, reagents and barcoded oligo-dT primers (Sigma-Aldrich) were loaded on a 10-17 mm C1 Open-App microfluidic IFC (Fluidigm).
Cell lysis, reverse transcription, second strand synthesis and in-vitro transcription were performed on-chip. Subsequently, harvested
aRNA was pooled from 48 capture sites. After fragmentation and clean-up, 5 ml of aRNA was used to construct final libraries by
reverse transcription (SuperScript II, Thermo Fisher) and library PCR (Phusion HF, Thermo Fisher).
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
SCRB-seq template-switch oligo, iCiGiCACACTCTTTCC
CTACACGACGCrGrGrG
Eurogentech N/A
Drop-seq P5 primer, AATGATACGGCGACCACCGAGA
TCTACACGCCT GTCCGCGGAAGCAGTGGTATCAACG
CAGAGT*A*C, * PTO bond
IDT N/A
Drop-seq oligo-dT primer beads, Bead–Linker-
TTTTTTTAAGCAGTGGTATCAAC
GCAGAGTAC[BC12][N8][T30]
Chemgenes MACOSKO-2011-10
Drop-seq template-switch oligo, AAGCAGTGGTATCA
ACGCAGAGTGAATrGrGrG
IDT N/A
CEL-seq2 oligo-dT primer, GCCGGTAATACGACTCACTATA
GGGAGTTCTACAGTCCGACGATC[N6][BC6][T25]
Sigma-Aldrich N/A
ERCC RNA Spike-In Mix Ambion 4456740
Software and Algorithms
STAR Dobin et al., 2013 https://github.com/alexdobin/STAR
Drop-seq tools Macosko et al.,
2015
http://mccarrolllab.com/dropseq/
featureCounts Liao et al., 2013 https://bioconductor.org/packages/release/
bioc/html/Rsubread.html
R N/A www.r-project.org
Other
Drop-seq PDMS device Nanoshift Drop-seq
2% E-Gel Agarose EX Gels Life Technologies G402002
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Drop-seq
Drop-seq experiments were performed as published (Macosko et al., 2015) and successful establishment of the method in our lab
was confirmed by a species-mixing experiment (Figure S1A). For this work, J1 mES cells (100/ml) and barcode-beads (120/ml, Chem-
genes) were co-flown in Drop-seq PDMS devices (Nanoshift) at rates of 4000 ml/hr. Collected emulsions were broken by addition of
perfluorooctanol (Sigma-Aldrich) and mRNA on beads was reverse transcribed (Maxima RT, Thermo Fisher). Unused primers were
degraded by addition of Exonuclease I (New England Biolabs). Washed beads were counted and aliquoted for pre-amplification
(2000 beads / reaction). Nextera XT libraries were constructed from 1 ng of pre-amplified cDNA with a custom P5 primer (IDT).
MARS-seq
To construct single cell libraries from polyA-tailed RNA, we appliedmassively parallel single-cell RNA sequencing (MARS-Seq) (Jaitin
et al., 2014). Briefly, single cells were FACS-sorted into 384-well plates, containing lysis buffer and reverse-transcription (RT) primers.
The RT primers contained the single cell barcodes and unique molecular identifiers (UMIs) for subsequent de-multiplexing and
correction for amplification biases, respectively. Spike-in transcripts (ERCC, Ambion) were added, polyA-containing RNA was con-
verted into cDNA as previously described and then pooled using an automated pipeline (liquid handling robotics). Subsequently,
samples were linearly amplified by in vitro transcription, fragmented, and 30 ends were converted into sequencing libraries. The li-
braries consisted of 48 single cell pools.
SCRB-seq
RNA was stabilized by resuspending cells in RNAprotect Cell Reagent (QIAGEN) and RNase inhibitors (Promega). Prior to FACS
sorting, cells were diluted in PBS (Invitrogen). Single cells were sorted into 5 ml lysis buffer consisting of a 1/500 dilution of Phusion
HF buffer (New England Biolabs) and ERCC spike-ins (Ambion), spun down and frozen at "80#C. Plates were thawed and libraries
prepared as described previously (Soumillon et al., 2014). Briefly, RNA was desiccated after protein digestion by Proteinase K (Am-
bion). RNA was reverse transcribed using barcoded oligo-dT primers (IDT) and products pooled and concentrated. Unincorporated
barcode primers were digested using Exonuclease I (New England Biolabs). Pre-amplification of cDNA pools were done with the
KAPA HiFi HotStart polymerase (KAPA Biosystems). Nextera XT libraries were constructed from 1 ng of pre-amplified cDNA with
a custom P5 primer (IDT).
Smart-seq/C1
Smart-seq/C1 libraries were prepared on the Fluidigm C1 system using the SMARTer Ultra Low RNA Kit (Clontech) according to the
manufacturer’s protocol. Cells were loaded on a 10-17 mm RNA-seq microfluidic IFC at a concentration of 200,000/ml. Capture site
occupancy was surveyed using the Operetta (Perkin Elmer) automated imaging platform.
Smart-seq2
mESCswere sorted into 96-well PCR plates containing 2 ml lysis buffer (1.9 ml 0.2%Triton X-100; 0.1 ml RNase inhibitor (Lucigen)) and
spike-in RNAs (Ambion), spun down and frozen at"80#C. To generate Smart-seq2 libraries, priming buffermix containing dNTPs and
oligo-dT primers was added to the cell lysate and denatured at 72#C. cDNA synthesis and pre-amplification of cDNA was performed
as described previously (Picelli et al., 2014b, 2013). Sequencing libraries were constructed from 2.5 ng of pre-amplified cDNA using
an in-house generated Tn5 transposase (Picelli et al., 2014a). Briefly, 5 ml cDNA was incubated with 15 ml tagmentation mix (1 ml of
Tn5; 2 ml 10x TAPS MgCl2 Tagmentation buffer; 5 ml 40% PEG8000; 7 ml water) for 8 min at 55#C. Tn5 was inactivated and released
from the DNA by the addition of 5 ml 0.2% SDS and 5 min incubation at room temperature. Sequencing library amplification was per-
formed using 5 ml Nextera XT Index primers (Illumina) that had been first diluted 1:5 in water and 15 ml PCR mix (1 ml KAPA HiFi DNA
polymerase (KAPA Biosystems); 10ml 5x KAPA HiFi buffer; 1.5 ml 10mM dNTPs; 2.5ml water) in 10 PCR cycles. Barcoded libraries
were purified and pooled at equimolar ratios.
DNA sequencing
For SCRB-seq and Drop-seq, final library pools were size-selected on 2% E-Gel Agarose EX Gels (Invitrogen) by excising a range of
300-800 bp and extracting DNA using the MinElute Kit (QIAGEN) according to the manufacturer’s protocol.
Smart-seq/C1, CEL-seq2/C1, Drop-seq and SCRB-seq library pools were sequenced on an Illumina HiSeq1500. Smart-seq2
pools were sequenced on Illumina HiSeq2500 (Replicate A) and HiSeq2000 (Replicate B) platforms. MARS-seq library pools were
sequenced on an Illumina HiSeq2500 using the Rapid mode. Smart-seq/C1 and Smart-seq2 libraries were sequenced 45 cycles sin-
gle-end, whereas CEL-seq2/C1, Drop-seq and SCRB-seq libraries were sequenced paired-end with 15-20 cycles to decode cell
barcodes andUMI from read 1 and 45 cycles into the cDNA fragment. MARS-seq libraries were paired-end sequencedwith 52 cycles
on read 1 into the cDNA and 15 bases for read 2 to obtain cell barcodes and UMIs. Similar sequencing qualities were confirmed by
FastQC v0.10.1 (Figure S1B).
QUANTIFICATION AND STATISTICAL ANALYSIS
Basic data processing and sequence alignment
Smart-seq/C1/Smart-seq2 libraries (i5 and i7) and CELseq2/C1/Drop-seq/SCRB-seq pools (i7) were demultiplexed from the Illumina
barcode reads using deML (Renaud et al., 2015). MARS-seq library pools were demultiplexed with the standard Illumina pipeline. All
reads were trimmed to the same length of 45 bp by cutadapt (Martin, 2011) (v1.8.3) and mapped to the mouse genome (mm10)
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including mitochondrial genome sequences and unassigned scaffolds concatenated with the ERCC spike-in reference. Alignments
were calculated using STAR 2.4.0 (Dobin et al., 2013) using all default parameters.
For libraries containing UMIs, cell- and gene-wise count/UMI tables were generated using the published Drop-seq pipeline (v1.0)
(Macosko et al., 2015). We discarded the last 2 bases of the Drop-seq cell and molecular barcodes to account for bead synthesis
errors. For Smart-seq/C1 and Smart-seq2, features were assigned and counted using the Rsubread package (v1.20.2) (Liao
et al., 2013).
Power Simulations
We developed a framework in R for statistical power evaluation of differential gene expression in single cells. For each method, we
estimated the mean expression, dispersion and dropout probability per gene from the same number of cells per method. In the read
count simulations, we followed the framework proposed in Polyester (Frazee et al., 2015), i.e., we retained the observed mean-vari-
ance dependency by applying a cubic smoothing spline fit to capture the heteroscedasticity observed. Furthermore, we included a
local polynomial regression fit for the mean-dropout relationship. In each iteration, we simulated count measurements for the 13,361
genes for sample sizes of 24, 25, 26, 27, 28 and 29 cells per group. The read count for a gene i in a cell j is modeled as a product of a
binomial and negative binomial distribution:
Xij ! Bðp= 1" p0Þ & NBðm; qÞ:
Themean expressionmagnitude mwas randomly drawn from the empirical distribution. 5 percent of the genes were defined as differ-
entially expressed with an effect size drawn from the observed fold changes betweenmicroglial subpopulations in Zeisel et al. (Zeisel
et al., 2015). The dispersion q and dropout probability p0 were predicted by above mentioned fits.
For each method and sample size, 100 RNA-seq experiments were simulated and tested for differential expression using limma
(Ritchie et al., 2015) in combination with voom (Law et al., 2014) (v3.26.7). The power simulation framework was implemented in
R (v3.3.0).
ERCC capture efficiency
To estimate the singlemolecule capture efficiency, we assume that the success or failure of detecting an ERCC is a binomial process,
as described before (Marinov et al., 2014). Detections are independent from each other and are thus regarded as independent Ber-
noulli trials. We recorded the number of cells with nonzero and zero read or UMI counts for each ERCC per method and applied a
maximum likelihood estimation to fit the probability of successful detection. The fit line was shaded with the 95%Wilson score con-
fidence interval.
Cost efficiency calculation
We based our cost efficiency extrapolation on the power simulations starting from empirical data at different sequencing depths
(250,000 reads, 500,000 reads, 1,000,000 reads; Figure 6C). We determined the number of cells required per method and depth
for adequate power (80%) by an asymptotic fit to the median powers. For the calculation of sequencing cost, we assumed 5V
per million raw reads, independent of method. Although UMI-based methods need paired-end sequencing, we assumed a 50 cycle
sequencing kit is sufficient for all methods. We used prices in Euro as a basis and consider an exchange course of 1:1 for the given
prices in USD.
DATA AND SOFTWARE AVAILABILITY
The accession number for the raw and analyzed scRNA-seq data reported in this paper is GEO: GSE75790.
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Supplementary Figure Legends
Figure S1 (related to Figure 1) | Quality control and filtering. A Drop-seq species mixing 
experiment using human and murine T-cells. For each cell-barcode human- and mouse read 
numbers are plotted. B Per-base quality scores were summarized using FastQC. Lines 
indicate median Phred quality score with upper and lower quartile shaded. C Total UMI 
content per cell, with the filter cutoff (two times mean) shown as black lines. Violin plots 
indicate the density of the UMI content distribution per replicate. D Nearest-neighbor filtering 
based on the maximum pairwise Spearman’s rho for each cell. Violin plots indicate the 
density of rho distribution per replicate. Black lines indicate the employed cutoffs.
Figure S2 (related to Figure 1) | Downsampling of scRNA-seq libraries. A Detected genes 
(>= 1 count) in relation to indicated sequencing depths. The ranges of the boxes indicate the 
upper and lower quartiles of cells and horizontal bars indicate the medians. B Boxplots of 
the number of detected genes in high-depth sequencing of Smart-seq2 libraries, showing a 
plateau above 1 million reads. C Boxplots of the number of detected UMIs per cell in relation 
to indicated sequencing depths.
Figure S3 (related to Figure 3) | Sensitivity A The overlap of detected genes (>= 1 count) 
between methods for 65 random cells is displayed as a barplot. Colors indicate the level of 
overlap: Green (detected in all methods), dark blue (detected in five methods) ,yellow 
(detected in four methods), orange (detected in three methods), light blue (detected in two 
methods), grey (method-specific detection). B Gene body coverage (left to right equalling 5’ 
to 3’) of ~3000 genes detected by Smart-seq/C1 and/or Smart-seq2 (right panel) versus a 
random control set of 3000 genes detected by all methods. C Method-specific detected 
genes are shown as scatter plots with their rate of detection and mean counts over all cells. 
D For genes and their transcript variants of at least 2 kb length, we calculated the fraction of 
reads mapping to positions relative to the 3’ end. For each method, we show mapping 
positions and a fit line per replicate. The dashed line indicates theoretical even distribution of 
reads across the 2.5 kb window. (E) Gene expression values were normalized as transcripts 
per million TPM or UMIs per million UPM. Principal component analysis was performed on 
the 1000 most variable genes to display the major variance between single cells. The 200 
genes with the highest loading for PC1 were analysed and neither showed significant 
enrichment in GO categories (GOrilla) nor in technical properties such as gene length or GC 
content.
Figure S4 (related to Figure 3) | Detection probabilities were estimated from ERCC 
dropouts, where the RNA molecule number is known. A Thick lines indicate the maximum-
likelihood estimate of the detection probability with the thin lines showing the 
95% confidence interval of the fit. B Shown are per-method maximum-likelihood estimates of 
mRNA detection probabilities. C Sensitivity per method estimated as the 50% probability to 
detect a transcript. The 95% confidence interval of estimate is displayed as error bars.
Figure S5 (related to Figure 4) | A Exemplary correlations of ERCC expression values 
(transcripts per million TPM or UMIs per million UPM) with annotated concentrations. For 
each method, we chose a representative cell/bead with a linear model correlation coefficient 
close to the median of all cells. B Detection of ERCC genes (>= 1 count) in relation to 
sampling depth. Each boxplot represents the median, upper and lower quartile of all cells 
within each method. C Accuracy of scRNA-seq methods. ERCC expression values were 
correlated to their annotated molarity. Shown are the distributions of correlation coefficients 
(adjusted R2 of linear regression model) across methods for for bins of ERCC molarity. Each 
boxplot represents the median, first and third quartile for the R2 in the indicated bin.
Figure S6 (related to Figure 5) | Gene detection sparsity. A For all detected genes (>= 1 
CPM) per method, we calculated the rate of detection. Histograms show this measure for 
detection sparsity. Filled bars represent the genes detected in at least 25% of cells of each 
method along with the number of these reproducibly detected genes. B For genes detected 
in at least 25% of cells of any method, we calculate the rate of detection in 65 random cells.
Figure S7 (related to Figure 5) | Variation in scRNA-seq data. A Gene-wise mean and 
coefficient of variation from all cells are shown as scatterplots for all methods. The black line 
indicates variance according to the poisson distribution. The two populations of genes seen 
for read-count data are unamplified genes (close to Poisson, one or very few reads per UMI) 
and amplified genes (higher CV for a given mean, several reads per UMI). B Gene-wise 
coefficient of variation (CV) of scRNA-seq data were calculated for all cells including 
detection dropouts. Violin plots are shown for UMI and read-count based quantification 
indicating the density of the distribution.
Figure S8 (related to Figure 6) | A-B Power simulation parameters estimated from 1 million 
reads per cell. A Mean expression and size parameters were estimated for each method 
and their functional relation was approximated by a smooth spline fit. B The dropout 
probability p0 was calculated per gene and shown in relation to mean expression levels. We 
fitted this relationship using a local polynomial regression. C-D Validation of power 
simulation framework. C Gene-wise Extra-Poisson Variability was calculated from empirical 
data and simulated data without addition of differentially expressed genes. Shown are the 
distributions with the black line indicating the median. D Gene-wise dropout rate distributions 
are shown from empirical data and simulated data. The black line indicates the median 
dropout rate.
Figure S9 (related to Figure 6 and Table 1) | A FDR. Simulations were performed using 
empirical mean, dispersion and dropout relationships (see Figure S8). For variable sample 
sizes of n=16, n=32, n=64, n=128, n=256 and n=512, we show points representing the mean 
FDR of 100 simulations with standard error. B | Stratified analysis of power. Shown are TPR 
for 1 million reads per cell for sample sizes n=16, n=32, n=64, n=128, n=256 and n=512 per 
group. Genes are grouped in five percentiles of mean expression with lines representing the 
median TPR of 100 simulations.
Figure S10 (related to Figure 6) | A-D Batch effects A For each method, we test for 
differential expression between random subsets of 25 cells per group (left box) and subsets 
of 25 cells of each batch (right box) in 20 permutations using limma. Shown are the number 
of significantly differentially expressed genes (FDR <0.01) as boxplots. B Sensitivity is 
shown as the number of detected genes (>= 1 count) per batch. C Accuracy is shown per 
batch as the correlation coefficient of observed expression (TPM/UPM) to annotated ERCC 
molecule numbers. D Precision is shown per batch as the Extra-Poisson Variability for the 
common 13,361 genes. For 3’ counting methods, UMI quantification is shown. The 
distribution was only shown between values of 0 and 3 to make differences more visible. D 
Cell cycle analysis. For each method, we show the coefficient of variation (CV) for a set of 
19 cell cycle genes previously found to be variable in 2i/LIF cultured mESCs (Kolodziejczyk, 
2015) (left violin) compared to 19 ribosomal and pluripotency genes. Numbers above the 
violins indicate p-values of a t-test between the two groups.  
Supplementary Tables
Table S1 (related to Figure 2): Overview of single-cell RNA-seq methods. 
* in-house produced Tn5 / commercial Tn5 
Method CEL-seq2/C1 Drop-seq MARS-seq SCRB-seq Smart-seq/C1 Smart-seq2
Single-cell 
isolation
automated in 
the C1 
system
droplets FACS FACS automated in 
the C1 
system
FACS
ERCC  
spike-ins
yes no yes yes yes yes
UMI 6 bp 8 bp 8 bp 10 bp no no
Full-length 
coverage
no no no no yes yes
1st strand 
synthesis
oligo-dT oligo-dT oligo-dT oligo-dT oligo-dT oligo-dT
2nd strand 
synthesis
RNAseH / 
DNA Pol
template 
switching
RNAseH / 
DNA Pol
template 
switching
template 
switching
template 
switching
Amplification IVT PCR IVT PCR PCR PCR
Imaging of 
cells possible
yes no no no yes no
Protocol 
usable for 
bulk
yes no yes yes yes yes
Sequencing paired-end paired-
end
paired-end paired-end single-end single-end
Library  
cost /cell
~9.5€ ~0.1€ ~1.3€ ~2€ ~25€ ~3/30*
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Abstract  
Ubiquitination is a pivotal posttranslational modification of proteins associated with distinct 
physiological effects such as functional modulation, subcellular localization and targeted degradation. 
The E3 ligase UHRF1 is an essential epigenetic cofactor for DNMT1 dependent maintenance DNA 
methylation, which provides a binding platform for DNMT1 by both cooperative binding of histones 
and hemi-methylated DNA as well as by ubiquitinating histone H3. However, the catalytic role of 
UHRF1 in non-epigenetic pathways has been discovered only recently. Here, we conduct a 
comprehensive screen in mouse embryonic stem cells to identify novel ubiquitination targets of 
UHRF1 and its paralogue UHRF2, which are highly similar in both sequence and structure. We find 
differentially ubiquitinated peptides involved in a variety of biological processes such as transcriptional 
regulation and DNA damage response. Most importantly, we discover PCNA associated factor PAF15 
(mouse: Pclaf, Ns5atp9, human: KIAA0101, OEATC-1) as a specific ubiquitination target of UHRF1. 
Although the function of PAF15 ubiquitination in translesion DNA synthesis (TLS) is well 
characterized, the respective E3 ligase remained unknown until now. We show that UHRF1 
ubiquitinates PAF15 at Lys 15 and Lys 24 and further promotes its binding to PCNA during late S-
phase. In summary, we uncover novel UHRF1-dependent ubiquitination targets thereby shedding light 
on its functional relevance beyond epigenetic regulation. 
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Introduction 
Posttranslational modifications such as ubiquitination greatly affect protein function in a variety of 
cellular processes. The reversible conjugation of ubiquitin molecules to a target protein has distinct 
physiological effects such as destabilization of target proteins, altered protein trafficking and functional 
modulation (Hicke and Dunn 2003; Pickart 2004; Sun and Chen 2004; Pickart and Fushman 2004). 
Ubiquitination of lysine residues is mediated in a E1–E2–E3 tri-enzyme cascade, where ubiquitin 
transfer from a E2∼Ub intermediate to a lysine on a substrate is mediated by E3 ligase enzymes. E3 
ligase activity is often endowed in a  Really Interesting New Gene (RING) domain (Brown et al. 2015), 
which is present in Ubiquitin-like PHD and RING finger domain-containing protein 1 (UHRF1) and its 
paralogue UHRF2. UHRF1 (also known as NP95 or ICBP90) is not only a well-characterized factor in 
DNA methylation maintenance, rendering it essential for early embryonic development, but also for 
cell cycle regulation and genome stability (Muto 2002; Jenkins et al. 2005).  
First, UHRF1 targets maintenance DNA methyltransferase 1 (DNMT1) to newly synthesized 
DNA in heterochromatin after replication (Bostick et al. 2007; Sharif et al. 2007; Achour et al. 2008), 
by cooperative binding of repressive H3K9me3 marks and hemimethylated DNA (Liu et al. 2013) and 
by ubiquitination of H3 tails on K18 (K23 in Xenopus), which is specifically recognized (and bound) by 
the ubiquitin interacting motif (UIM) in the TS domain of DNMT1 (Nishiyama et al. 2013; Qin et al. 
2015). 
Second, UHRF1 plays a role in cell cycle progression as shown by its co-localization with proliferating 
cell nuclear antigen (PCNA) during S phase (Uemura et al. 2000) and the increased sensitivity of 
UHRF1-deficient embryonic stem cells (ESCs) towards treatment with the replication-inhibiting 
reagent hydroxyurea (Muto 2002).  
Finally, UHRF1 has a critical role in maintenance of genome stability (Muto 2002; Luo et al. 2013) by 
recognizing and binding DNA interstrand crosslinks (ICLs) and thereby inducing repair pathways such 
as the Fanconi anemia pathway (Liang et al. 2015; Tian et al. 2015). Further, UHRF1 is important for 
the repair of DNA double strand breaks in a cell cycle dependent manner (Zhang et al. 2016). 
Although numerous reported functions of UHRF1 involve ubiquitination activity of target proteins, such 
as DNMT1 (Qin, Leonhardt, and Spada 2011a; Du et al. 2010) and histone H3 (Nishiyama et al. 2013; 
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Qin et al. 2015; Citterio et al. 2004), no comprehensive screen of ubiquitination targets of UHRF1 was 
published so far. 
Here, we screen for specific ubiquitination targets of UHRF1 by comparing the ubiquitome of wildtype 
(wt), UHRF1- and UHRF2-deficient mouse ESCs. With an antibody-dependent enrichment of ubiquitin 
remnant motif-containing peptides followed by isobaric-labeling based quantitative mass 
spectrometry, we find both known and novel E3 ligase substrates of UHRF1 involved in a variety of 
biological processes such as RNA processing, DNA methylation and DNA damage repair. Our results 
uncover that PCNA-interacting factor (PAF15) 15 (Yu et al. 2001) is a ubiquitination target of UHRF1 
but not UHRF2. Ubiquitination of PAF15 is well characterized to be important in replication block 
bypass by regulating the recruitment of translesion DNA synthesis (TLS) polymerases (Povlsen et al. 
2012) but the respective E3-ligase was not identified until now. We demonstrate that UHRF1-
dependent ubiquitination promotes binding of PAF15 to PCNA, thereby unraveling a novel function of 
UHRF1 in regulating DNA damage response. 
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Results 
Ubiquitome of mouse embryonic stem cells deficient for UHRF1  
To identify specific ubiquitination targets of UHRF1 in ESCs, we compared the ubiquitome of UHRF1- 
and UHRF2-deficient cells relative to wt. Enrichment of formally ubiquitinated tryptic peptides was 
performed with a specific K-gly-gly antibody, which recognizes a remnant gly-gly motif on the formerly 
ubiquitinated lysine residue (Xu, Paige, and Jaffrey 2010). For relative peptide quantification in mass 
spectrometry, enriched peptide fractions were labeled with isobaric tandem mass tag (TMT) reagents 
and pooled for subsequent LC-MS/MS analysis (Figure 1A). In total, we quantified 1248 K-gly-gly 
containing peptides across two measurements (_A, _B, Supplementary Table S1). 53 peptides show 
high abundance differences with an intensity change of 3 (log2 = 1.58) or higher in at least two 
replicates (Figure 1B). We detect both enriched and de-enriched ubiquitinated peptides in UHRF1-
depleted cells compared to wt. The abundance of K-gly-gly peptides is not necessarily reflected by 
altered protein expression (Figure 1C), thus the observed differences are due to posttranslational 
effects. 
PAF15 as a ubiquitination target of UHRF1  
For statistical analysis of UHRF1 ubiquitination targets, we compared peptides quantified across all 
measured samples and found differentially ubiquitinated peptides in both Uhrf1-/- and Uhrf2-/- cells 
(Supplementary Table S2). Peptides with significant ubiquitination changes can be assigned to GO 
terms such as transcriptional regulation, cell cycle regulation and DNA damage response (Figure 2A 
and 2B), indicating that the UHRF family is involved in the regulation of a variety of different proteins. 
We found 94 differentially regulated peptides in Uhrf1-/- cells of which 62,8% is not found to be 
differentially ubiquitinated in the Uhrf2-/- (Supplementary Figure S1). Notably, in Uhrf1-/- cells the 
highest loss of ubiquitination was observed for lysine 15 and 24 of PAF15 (Figure 3A), whereas the 
ubiquitination state of PAF15 in Uhrf2-/- cells remained unchanged (Figure 2C, D), indicating that 
PAF15 is a ubiquitination target of UHRF1.  
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The RING domain of UHRF1 ubiquitinates PAF15 on Lys 15 and Lys 24  
We confirmed UHRF1 as the E3-ligase of PAF15 by analysis of a Uhrf1-/- ESC line with a different 
genetic background (E14). Due to its low protein abundance, we performed immunoprecipitation 
experiments to enrich PAF15. In wt ESCs, PAF15 is mono- and mainly di-ubiquitinated, whereas in 
Uhrf1-/- cells PAF15 is unmodified. Ubiquitination of PAF15 is reestablished upon 
expression/reintroduction of wt UHRF1-GFP but not UHRF1-GFP H730A, a mutation with reduced E3 
ligase activity (Qin et al. 2015)  (Figure 3B). Thus, UHRF1 does not recruit the E3 ligase but rather 
directly modifies PAF15 with/by/dependent on its RING domain. 
 
Endogenous PAF15 localization throughout S-phase  
PAF15 was originally found to be associated with PCNA in a yeast-two-hybrid screen (Yu et al. 2001), 
while UHRF1 is mainly associated with replicating heterochromatin (Uemura et al. 2000; Papait et al. 
2007). As the interaction with PCNA is essential for PAF15 ubiquitination (Povlsen et al. 2012), we 
investigated the spatial distribution of UHRF1 and PAF15 at sites of replication. With super-resolution 
microscopy, we showed that PAF15 and PCNA co-localize predominantly in late S-phase in C2C12 
myoblasts (median correlation coefficient = 0,55; Figure 4A, 4C). Likewise, PAF15 and UHRF1 also 
display the closest proximity in late S-phase (median correlation coefficient = 0,35; Fig. 4B, D, 
Supplementary Material, SFig. 2). Taken together, UHRF1 co-localizes with PAF15 at sites of PCNA 
foci in late S-phase, where heterochromatic regions are replicated and thereby could ubiquitinate 
PAF15 in a cell cycle dependent manner. 
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PAF15-PCNA interaction is promoted by UHRF1 dependent ubiquitination  
To investigate the role of UHRF1 for PAF15 localization, we performed immunofluorescence stainings 
and found PAF15 co-localizing with PCNA in wt and UHRF2 depleted ESCs, whereas in Uhrf1-/- 
ESCs, PAF15 displays a diffuse pattern in late S-phase (Fig. 5A). Furthermore, the subcellular 
localization of PAF15 in Uhrf1-/- is restored by expressing UHRF1-GFP wt (Fig. 5B).  
To test if PAF15 binding to PCNA is promoted by mono-ubiquitination on positions Lys 15 and Lys 24, 
we performed a rescue experiment in PAF15-/- ESCs with GFP-PAF15 wt and double-mutant GFP-
PAF15 K15R.K24R (dm). Interestingly, GFP-PAF15 wt co-localizes with PCNA, whereas GFP-PAF15 
dm is diffusely distributed in the nucleus and only to a little extent associated with PCNA in late S-
phase (Supplementary Fig. S3A). Consistent results were obtained in a fluorescence-three-hybrid 
(F3H) assay (Herce et al. 2013), where RFP-PCNA is recruited to GFP-PAF15 wt, but not to GFP-
PAF15 dm (Supplementary Fig. S3B) confirming that the ubiquitination mark promotes PAF15-PCNA 
interaction. 
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Discussion  
E3 ligase proteins mediate the final step of ubiquitin attachment to a target protein, thereby influencing 
protein degradation, cell cycle progression, DNA repair and transcription (Hicke and Dunn 2003; 
Pickart 2004; Sun and Chen 2004; Pickart and Fushman 2004).  
In this study, we investigated specific ubiquitination targets of E3 ligase UHRF1 in mouse embryonic 
stem cells. We used a proteomics approach to perform an unbiased, proteome-wide and site-specific 
analysis of ubiquitination changes (Udeshi et al. 2013). Since the paralogue UHRF2 is highly similar 
to UHRF1 in both sequence and structure, we compared the ubiquitome of Uhrf1 and Uhrf2 knock-out 
cells to exclude redundancy.  
We find numerous differentially ubiquitinated proteins that encompass biological processes such as 
transcriptional regulation, RNA binding, DNA damage response and cell cycle regulation. We find 
ubiquitination targets of/for both UHRF1 and UHRF2 such as HSP90, DNMT3b (Ding et al. 2016; 
Meilinger et al. 2009; Quenneville et al. 2011) as well as UHRF1 specific targets such as UHRF1 
itself, Trim28 and H3K18 (Qin et al. 2015; Quenneville et al. 2011; Citterio et al. 2004). (Further, we 
find differentially ubiquitinated histones: H3, H2B, H2A, not different: H1, which is consistent with 
studies of UHRF1 in vitro and in vivo ubiquitination (Harrison et al. 2016).)  
Most importantly, we find PAF15 as a protein undergoing highest loss of ubiquitination upon UHRF1 
depletion. Mono-ubiquitination of PAF15 at Lys 15 and 24 has been associated with TLS inhibition by 
masking TLS polymerase binding sites on PCNA during undisturbed S-phase (Povlsen et al. 2012). 
Stalled replication caused by DNA lesions leads to PAF15 ubiquitin chain elongation and subsequent 
degradation, which is the basis for TLS polymerase recruitment to PCNA (Povlsen et al. 2012).   
However, the E3 ligase responsible for PAF15 mono-ubiquitination remained unknown until now (Xie, 
Yao, and Dong 2014). Here, we show that the RING domain of UHRF1 ubiquitinates PAF15 at Lys 15 
and 24 and influences its association with PCNA throughout S-phase.  
The PIP domain dependent PCNA interaction of PAF15 is necessary for its ubiquitination (Povlsen et 
al. 2012) and our high resolution microscopy analyses revealed PAF15 co-localization with PCNA and 
UHRF1 exclusively during late S-phase. Thus, we suggest that the ubiquitination takes place in a cell 
cycle dependent manner. 
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Furthermore, both UHRF1 depletion and mutation of the lysine residues result in loss of PAF15 
association with PCNA, which hints towards a role for PAF15 ubiquitination in stabilizing the PAF15-
PCNA complex during replication. We speculate that the ubiquitination mark could potentially be 
recognized by adjacent protein domains such as the ubiquitin interacting motif (UIM) of DNMT1 (Qin 
et al. 2015). 
In summary, this study provides a novel aspect of UHRF1 in regulating replication block bypass by 
ubiquitinating PAF15, thereby uncovering an additional mode-of-action of UHRF1 in replication-
dependent DNA damage response. 
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Experimental Procedures 
Cell culture and transfection  
Mouse J1 and E14 ESCs were cultured without feeder cells in gelatinized flasks as described before 
(Meilinger et al. 2009). Culture medium was either supplemented with 1000 U/ml recombinant 
leukemia inhibitory factor LIF (Millipore) or additionally with 1 µM MEK inhibitor PD0325901, 3 µM 
GSK-3 inhibitor CHIR99021 (2i, Axon Medchem) to keep ESCs in unprimed state. E14 ESCs and E14 
Uhrf1 knockout cells stably rescued with either UHRF1-GFP (wt) or RING domain point mutant 
UHRF1-GFP H730A were described previously (Qin et al. 2015). 
Somatic cell lines used in this study were BHK cells containing multiple lac operator repeats 
(Tsukamoto et al. 2000) and C2C12 mouse myoblast cells (Yaffe and Saxel 1977). All cell lines were 
grown in a humidified atmosphere at 37°C and 5% CO2, in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 1 µM gentamycin and 10% (BHK) or 20% (C2C12) fetal calf serum. All 
cell lines were tested for mycoplasma on a regular basis. 
ESCs were transfected with Lipofectamine® 3000 reagent (Thermo Fisher Scientific) according to the 
manufacturer’s instructions. BHK cells were transfected using polyethylenimine (Sigma) according to 
the manufacturer’s instructions.  
 
Generation of Uhrf1-/-, Uhrf2-/- and PAF15-/- ESC lines 
To generate PAF15, Uhrf1 and Uhrf2 knock-out ESC lines (J1), we used the MIN tag strategy 
(Mulholland et al. 2015). In brief, we used a genome engineering strategy based on a CRISPR/Cas 
assisted in-frame insertion of an attP site, which we refer to as the multifunctional integrase (MIN) tag. 
At the genetic level, the MIN-tag serves as an attachment site for the serine integrase Bxb1 that can 
be used to recombine a knockout cassette into the genomic locus.  
 
Mammalian expression constructs 
Fusion constructs were generated using enhanced green fluorescent protein (GFP) or monomeric red 
monomeric cherry (Ch). The PAF15 wt sequence was amplified from E14 cDNA. GFP-PAF15 
K15R.K24R double mutant (dm) expression construct was derived from the corresponding wt 
constructs by overlap extension PCR (Ho et al. 1989). Other constructs used in this study were 
UHRF1-GFP (Qin, Leonhardt, and Spada 2011b), RFP-PCNA (Easwaran et al. 2004) and pGBP-LacI 
(Herce et al. 2013). 
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Protein extraction and sample preparation for mass spectrometry 
J1 wt, Uhrf1-/- and Uhrf2-/- mouse embryonic stem cells were cultured under serum/LIF conditions. For 
whole cell proteome analysis, 106 cells were harvested in biological quadruplicates and further 
processed using the iST Sample Preparation Kit (PreOmics).  
 
Enrichment of K-gly-gly peptides 
Proteins were extracted from 2 × 107 cells per sample and digested to peptides resulting in a K-gly-gly 
motif at former sites of ubiquitination, which was then used for antibody dependent enrichment as 
described in (Udeshi et al. 2013). In brief, cell were lysed in urea lysis buffer (8 M urea, 50 mM Tris-
HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 1 × Protease inhibitor, 50 µM PR-619, 1 mM 
chloroacetamide, 1 mM PMSF) and protein concentration was determined using a 660 nm Protein 
Assay (Pierce™). Proteins were reduced using 5 mM DTT, alkylated with 10 mM chloroacetamide 
and digested overnight using Lys-C (Wako Chemicals, 1:250 enzyme/protein ratio) and Trypsin 
(TPCK-treated, Worthington Biochem, 1:50 enzyme/protein ratio). Peptides were desalted using 200 
mg tC18 Sep Pak Cartridges (Waters) and eluates were dried completely by vacuum centrifugation. 
For enrichment of K-gly-gly peptides, peptides were reconstituted in IAP buffer (50 mM MOPS pH 7.2, 
10 mM sodium phosphate, 50 mM NaCl) and incubated for 1 h at 4°C with 120 µg α-K-gly-gly 
antibody (Cell Signaling Technology) crosslinked to protein G sepharose beads (Roche) with dimethyl 
pimelimidate dihydrochloride (DMP, Sigma). Beads were washed twice with IAP buffer and twice with 
phosphate buffered saline (Sigma) and peptides were eluted in 0.15% trifluoroacetic acid (TFA). 
Enriched peptide fractions were labeled using isobaric Tandem Mass Tag™ (TMTsixplex™, Thermo 
Fisher Scientific) reagents according to the manufacturer’s instructions and pooled into one sample. 
Subsequently, the sample complexity was reduced by high pH reversed-phase chromatography (High 
pH Reversed-Phase Peptide Fractionation Kit, Pierce™). Peptides were separated to five fractions 
based on their hydrophobicity with buffers containing 17.5%, 20%, 22.5%, 25% or 30% acetonitrile in 
0.1% triethylamine, respectively. 
  
Liquid Chromatography Coupled to Tandem Mass Spectrometry 
For mass spectrometry analysis, desalted peptide fractions were injected in an Ultimate 3000 
RSLCnano system (Thermo) and separated in a 15-cm analytical column (75 µm ID packed in-house 
with ReproSil-Pur C18-AQ 2.4 µm from Dr. Maisch) with a 60 min gradient from 5 to 40% acetonitrile 
in 0.1% formic acid. The effluent from the HPLC was directly electrosprayed into a Qexactive HF 
(Thermo) operated in data dependent mode to automatically switch between full scan MS and MS/MS 
acquisition. Survey full scan MS spectra (from m/z 350–1400) were acquired with resolution 
R=120,000 at m/z 400 (AGC target of 3 × 106). The 10 most intense peptide ions with charge states 
between 3 and 6 were sequentially isolated (window 0.7 m/z) to a target value of 1 × 105, with 
resolution R=30,000, fragmented at 32% normalized collision energy and fixed first mass 100 m/z. 
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Typical mass spectrometric conditions were: spray voltage, 1.5 kV; no sheath and auxiliary gas flow; 
heated capillary temperature, 250°C; ion selection threshold, 33.000 counts.  
 
Computational data analysis 
Raw data analysis was performed using the MaxQuant software suite version 1.5.2.8 (Cox and Mann 
2008). Peptide sequences were searched against the UniprotKB mouse proteome database 
(Swissprot) (UniProt Consortium 2015). Trypsin/P and Lys-C derived peptides with a maximum of 
three missed cleavages and a protein false discovery rate of 1% were set as analysis parameters. 
Carbamidomethylation of cysteine residues was considered a fixed modification, while oxidation of 
methionine, protein N-terminal acetylation and Gly-Gly modification of lysines were defined as 
variable modifications. For whole cell extract analysis, peptide/protein intensities were quantified 
based on MS1 intensities with the MaxLFQ algorithm (Cox et al. 2014). Reporter ions derived from the 
fragmented tandem mass tag were quantified on MS2 level with a minimum precursor intensity 
fraction of 75% and a reporter mass tolerance of 0.01 Da. Lot-specific reporter ion isotopic 
distributions of the TMT label reagents were used as isotopic correction factor. 
Quantified K-gly-gly peptides were further evaluated using R (R Core Team 2016) and Perseus 
version 1.5.4.1 or 1.5.5.1 (Tyanova et al. 2016). The dataset was filtered for common contaminants 
classified by the MaxQuant algorithm and only proteins quantified across both biological replicates 
were subjected to statistical analysis. Differentially ubiquitinated peptides were identified using the 
Limma software package (Ritchie et al. 2015; Smyth 2004) after variance stabilization normalization 
(vsn) of peptides intensities (Huber et al. 2002).  
 
Co-immunoprecipitation and Western Blot 
For Western Blot analysis, 107 ESCs cultured in serum/LIF conditions were lysed in standard lysis 
buffer (20 mM Tris pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 2 mM MgCl2, 0.5% NP40, 2 mM PMSF) 
supplemented with 1x Protease inhibitor, 1 U/µl benzonase, 50 µM PR-619 and 2.5 mM NEM. PAF15 
was enriched from whole cell lysate using an anti-PAF15 antibody (Santa Cruz, sc-390515). Enriched 
proteins were separated on a SDS-PAGE (15% PAA) and transferred to a PVDF membrane 
(Millipore). PAF15 was detected using anti-PAF15 (1:500), a horseradish peroxidase conjugated anti-
mouse secondary antibody (Dianova, 1:5,000) and Pierce ECL substrate (Fisher Scientific). 
 
Immunofluorescence staining and confocal microscopy      
Immunostaining was performed as described previously (Solovei, Irina, and Marion 2010). Cells 
cultured on coverslips were fixed with 4% paraformaldehyde for 10 min, washed with PBS-T (PBS, 
0.02% Tween20) and permeabilized with 100% methanol. Both primary and secondary antibodies 
were diluted in blocking solution (PBS-T, 2% BSA). Coverslips with cells were incubated with primary 
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and secondary antibody solutions in dark humid chambers for 1 h at RT; washing steps after primary 
and secondary antibodies were done with PBS-T. For DNA counterstaining, coverslips were 
incubated in a solution of DAPI (1 µg/ml) in PBS. Coverslips were mounted in antifade medium 
(Vectashield, Vector Laboratories) and sealed with nail polish. For immunolabeling, the following 
primary antibodies were used: anti-PCNA (Rottach et al. 2008), anti-PAF15 (Santa Cruz, sc-390515) 
and anti-UHRF1 (Citterio et al. 2004). Secondary antibodies were anti-mouse conjugated to 
fluorophore 594 (Invitrogen), anti-rat conjugated to Alexa647 (Invitrogen). Single optical sections were 
collected using a Leica TCS SP5 confocal microscope equipped with Plan Apo 63×/1.4 NA oil 
immersion objective and lasers with excitation lines 405, 488, 561 and 633 nm. 
               
Super-resolution microscopy      
Cells were initially found and staged in S-phase based on their distribution of PCNA signal on a 
DeltaVision Elite system, equipped a 62x/1.42 PlanApo objective an interline CCD camera. To 
perform super-resolution structured illumination microscopy, stage coordinates of selected cells were 
then transferred to a DeltaVision OMX V3 3D-SIM system (Applied Precision Imaging, GE 
Healthcare), equipped with a 100x/1.40 NA PlanApo oil objective, three Cascade II EMCCD cameras 
(Photometrics), and 405-, 488-, and 594-nm laser lines. Structured Illumination (SI) images stacks 
consisting of 15 images per plane (five phases, at three different angles) were acquired with a z-step 
size of 125 nm. SI raw data were reconstructed and deconvolved with the SoftWorX 4.0 software 
package (Applied Precision). Registration of the three different channels was performed with the 
Multiview Reconstruction plugin in Fiji, using images of the nuclear pore complex stained with CF405-, 
Alexa488-, and Alexa594-conjugated secondary antibodies. Registered images were manually 
cropped to include one cell per image, background subtracted, scaled to 8-bit based on minimum and 
maximum pixel intensities, and colocalization analysis was performed in Fiji using the Coloc2 plugin 
on 5 central slices of the image stacks, taking the Pearson’s Correlation coefficient without threshold 
as a readout of colocalization. 
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Figures and Figure legends 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1. Ubiquitome characterization of mouse embryonic stem cells (ESCs) deficient for UHRF1 
and UHRF2. (A) Experimental workflow. Uhrf1-/-, Uhrf2-/- and wt mouse ESCs were digested to 
peptides and ubiquitin remnant motif (K-gly-gly) -containing peptides were enriched using an antibody. 
Peptides were labelled using TMT sixplex reagents, pooled for fractionation and subsequent mass 
spectrometry analysis. (B) Heatmap of differentially ubiquitinated K-gly-gly peptides (Gene name _ 
amino acid position of ubiquitination) identified in wt, Uhrf1-/- and Uhrf2-/- ESCs. Only peptides with at 
least a three-fold intensity change (log2 > 1.58) in at least two replicates are shown (53 peptides out of 
total 1248). Experiments were carried out in biological (r1, r2) and technical duplicates (_A, _B). (C) 
Total protein abundance (log2 LFQ intensity fold change) of the respective peptides in Uhrf1-/- (U1) 
and Uhrf2-/- (U2) relative to wt cells. 
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FIGURE 2. UHRF1 and UHRF2 dependent changes in the ubiquitome of ESC. (A) Protein 
associations of differentially ubiquitinated peptides (Limma adjusted p-value < 0.05) in Uhrf1-/- cells 
and (B) Uhrf2-/- cells. Proteins networks were derived from the String database. Only protein 
associations with an interaction score of 0.7 or higher are shown. (C) Volcano Plot of ubiquitinated 
PAF15 peptides (red) in Uhrf1-/- cells and (D) Uhrf2-/- cells (blue = Limma adjusted p-value < 0.05).  
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FIGURE 3. PAF15 ubiquitination by UHRF1. (A) Schematic outline of the PAF15 protein. (B) Co-
immunoprecipitation and Western Blot analysis of endogenous PAF15 from wt (E14), Uhrf1-/- and 
Uhrf1-/- ESC expressing wt UHRF1-GFP (U1WT) and RING domain mutant (H730A) construct (U1RING). 
Antibody conjugated beads were used as negative control. I = Input, B = Bound. Asterisks indicate 
unmodified PAF15 while circles and triangles indicate mono- and di-ubiquitinated PAF15, 
respectively. 
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FIGURE 4. PAF15 localization with PCNA and UHRF1 throughout cell cycle. (A+B) 3D-SIM nuclear 
mid-sections of anti-PAF15 (red) antibody distributions with (A) anti-PCNA (green) and (B) anti-
UHRF1 (green) with DAPI counterstaining (gray) in C2C12 cells. Scale bar = 5 µm and 2 × 
magnifications of selected boxed regions. Scale bars = 2,5 µm. (C) Pearson correlation coefficient of 
PAF15 and PCNA (C) and PAF15 and UHRF1 (D) in non S-phase, early/mid and late S-phase C2C12 
cells depicted as scatter plots with median and 95% confidence interval. 
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Figure 5. PAF15 localization in dependence of UHRF1. (A) Confocal mid sections of wt, Uhrf1-/- and 
Uhrf2-/- ESC were stained with antibodies anti-PAF15 (green) and PCNA (magenta). DNA was 
counterstained with DAPI. (B) Confocal mid sections of Uhrf1-/- ESCs expressing UHRF1-GFP. ESCs 
were stained with antibodies anti-PAF15 (green) and PCNA (magenta). DNA was counterstained with 
DAPI. Scale bars = 5 µm. Line intensity profiles of PAF15 and PCNA are shown next to the image. 
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Table S1 (corresponding to Figure 1) 
Quantified K-gly-gly peptides in wildtype (wt), Uhrf1-/- (U1) and Uhrf2-/- (U2) embryonic stem 
cells.  
 
Table S2 (corresponding to Figure 2) 
Limma analysis results of differentially regulated K-gly-gly peptides in Uhrf1-/- and Uhrf2-/- 
embryonic stem cells. 
 
Figure S1 
 
 
Supplementary Figure S1: Venn diagram of significantly regulated K-gly-gly peptides (gene 
name_position of ubiquitination) in Uhrf1-/- and Uhrf2-/- cells (Limma adj. p-value < 0.05).  
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Supplementary Figure S2: PAF co-
localization with PCNA and UHRF1 is 
cell cycle dependent. (A) 3D-SIM 
nuclear mid-sections of anti-PCNA 
(green) and anti-PAF (red) antibody 
distributions with DAPI counterstaining 
(gray) in C2C12 cells in different stages of 
S-phase. (B) 3D-SIM nuclear mid-
sections of anti-UHRF1  
(blue) and anti-PAF (red) antibody 
distributions with DAPI counterstaining 
(gray) in C2C12 cells. Scale bar = 5 µm 
and 2 × magnifications of selected boxed 
regions. Scale bar = 2,5 µm  
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Supplementary Figure S3: Di-ubiquitinated PAF is recruited to PCNA. (A) Paf KO mESCs 
rescued with transiently transfected with GFP-PAF wild type (wt, upper panel) or GFP-PAF 
K15R/K24R mutant (dm, lower panel). Line intensity profiles of PAF and PCNA are shown next to the 
image. (B) Analysis of ubiquitination-mediated recruitment of PAF to PCNA in a cell-based F3H 
assay. F3H assay of mCherry-PCNA (red) with GFP-PAF wildtype and double mutant GFP-PAF 
K15R/K24R (green). Line intensity profiles of the GFP-PAF constructs and mCherry-PCNA are shown 
next to the images.  Scale bar = 5 µm. 
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3 Discussion 
3.1 DNMT1 mutations found in HSAN1E patients affect interaction with 
UHRF1 and neuronal differentiation 
    
DNA methylation has been regarded a stable epigenetic mark set by the de novo 
DNA methyltransferases DNMT3A and DNMT3B during development and 
maintained by DNMT1 after DNA replication (Bird 2002; Goll and Bestor 2005; X. 
Cheng and Blumenthal 2008; Law and Jacobsen 2010; Smith and Meissner 2013). 
However, this view of DNMT1 as a simple copy machine, cannot explain why 
DNMT1 is expressed and required in postmitotic cells like neurons (Goto et al. 
1994; Inano et al. 2000). Despite or because of the central and ubiquitous role in 
DNA methylation, only very few human diseases were linked to DNMT1 mutations. 
To date, 14 different DNMT1 point mutations and one deletion mutation have been 
identified, which are associated with two neurodegenerative diseases, HSAN1E and 
ADCA-DN (4.3 Supplementary Material, Supplementary Table) (Klein et al. 2011; 
Rotthier et al. 2012; Winkelmann et al. 2012). Strikingly, all point and deletion 
mutations are located within the TS domain in the NTD of DNMT1 (Figure 10), which 
is crucially involved in the functional regulation of DNMT1 activity (Leonhardt et al. 
1992). HSAN1E associated mutations cluster in the central part, while ADCA-DN 
associated mutations are located in the C-terminal part of the TS domain. However, 
the underlying molecular mechanism of DNMT1 dysfunction remains under 
investigation. 
Figure 10. The TS domain of DNMT1. 
Outline of the TS domain of DNMT1 and the 
enzymatically relevant regions within the TS 
domain as determined by functional 
complementation assays (Smets et al. 
2017). HSAN1E (red) and ADCA-DN (blue) 
associated point mutations (Klein et al. 
2011; Rotthier et al. 2012; Winkelmann et al. 
2012) are indicated by arrows and the 
deletion by Δ. 
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To investigate how a single exchange in the amino acid sequence outside the 
catalytic domain of DNMT1 may lead to global hypomethylation and 
neurodegenerative diseases, we transferred two mutations (P496Y and Y500C) to 
an ESC differentiation system and assayed for cellular defects. As UHRF1 is an 
essential cofactor of DNMT1 and the TS domain in DNMT1 has been described to 
mediate the interaction with UHRF1 (Achour et al. 2008; Felle et al. 2011), we first 
investigated whether the HSAN1E mutations affect this protein-protein interaction. 
Our co-immunoprecipitation experiments and deletion analyses are consistent with 
previous yeast-two hybrid screens (Achour et al. 2008) showing an interaction of the 
TS domain with the SRA domain of UHRF1. In absence of hemimethylated DNA, the 
TS domain binds the catalytic center in the CTD of DNMT1 and inhibits de novo 
methylation. This autoinhibitory mechanism is resolved when the TS domain 
interacts with the SRA domain of UHRF1 resulting in allosteric activation of DNMT1 
(Bashtrykov, Jankevicius, et al. 2014; Berkyurek et al. 2014). Consequently, the 
release of the TS domain from the catalytic center of DNMT1 accompanied by a 
conformational change is a prerequisite for enzyme activation (Takeshita et al. 
2011). Interestingly, HSAN1E mutations are located within the part of the TS domain 
that interacts with UHRF1 and weaken the protein-protein interaction. 
We could further demonstrate that mutated DNMT1 failed to maintain DNA 
methylation in ESCs and showed weaker association with heterochromatin in late S 
phase, which is consistent with the previous observation that UHRF1 is required for 
recruitment of DNMT1 (Bostick et al. 2007). The weakened interaction of DNMT1 
with UHRF1 could explain the reduced activity of mutated DNMT1 pull-downs in 
vitro (Klein et al. 2011) and fits well with our observation that DNMT1 harboring 
HSAN1E mutations is impaired in catalytic complex formation as measured with our 
trapping assay in living cells (Schermelleh et al. 2005).  
In addition to defects in enzyme activation and targeting, we show that 
HSAN1E mutations render DNMT1 unstable in late S and G2 phase due to 
proteasomal degradation. This might be a result of failed heterochromatin binding, 
which is in line with previous studies (Klein et al. 2011). Chromatin unbound 
DNMT3A and DNMT3B showed a similar protein destabilization (Jeong et al. 2009; 
Sharma et al. 2011). In addition to UHRF1 binding, DNMT1 activity is influenced by 
further protein interactions and multiple posttranslational modifications, which likely 
contribute to proper regulation of maintenance DNA methylation (Qin, Leonhardt, 
and Pichler 2011).  
Several of these interactions may not be absolutely required but may 
enhance efficiency and thereby contribute to fine tuning of DNMT1 activity as we 
found for the interaction with PCNA, which two-fold enhances DNMT1 efficiency in 
living cells (Schermelleh et al. 2007; Spada et al. 2007). While it is unclear which of 
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these interactions are impaired by the HSAN1E mutations in different cell types, we 
could clearly show that ESCs carrying these mutations are impaired in neuronal 
differentiation, which is accompanied by an increased apoptosis rate. 
Interestingly, although HSAN1E mutations in the TS domain are present in all 
patient cells, they mostly affect the neuronal lineage and induce both central and 
peripheral neurodegeneration. Although it is not clear yet how dynamic DNA 
methylation changes could be in postmitotic neurons, the turnover of DNA 
methylation was proposed as one possible modulator of neuronal plasticity in 
response to external or internal stimuli (Fan et al. 2001; Borrelli et al. 2008; Yu, 
Baek, and Kaang 2011).  
This fits well with the observation that neuronal tissues are characterized by high 
5hmC levels and strong expression of TET genes (Tahiliani et al. 2009; Globisch et 
al. 2010; Szwagierczak et al. 2010; Ito et al. 2011). Therefore, DNA modifications 
might be more dynamic in postmitotic neurons than previously thought so that even 
subtle changes in protein-protein interactions and enzymatic activity might 
unbalance the equilibrium of DNA modifications. However, it remains unclear why in 
particular neuronal tissues are affected by these DNMT1 mutations in HSAN1E 
patients. 
HSAN1E patients are characterized by heterozygous mutations (Klein et al. 2011). 
However, Sun and colleagues only detected subtle changes in DNA methylation in 
HSAN1E patients with whole-genome bisulfite sequencing (Z. Sun et al. 2014). Our 
experimental setup is based on a stable complementation experiment in a DNMT1-/- 
background, which is suited to amplify the mutant phenotype for biochemical 
studies. To gain insight into the biological pathways underlying the late-onset 
degeneration of neuronal tissues and for physiological relevance, future studies 
might benefit from mouse models that can help to understand the molecular 
dysfunction. Moreover, a promising research model for functional assays to further 
understand HSAN1E related mechanisms under physiological conditions might be 
the use of human induced pluripotent stem cells (iPSCs) derived from patients (G. 
Lee et al. 2009; Jung et al. 2012).  
In summary, we show that HSAN1E mutations affect the direct DNMT1 
interaction with the essential maintenance DNA methylation cofactor UHRF1, cause 
cell cycle dependent degradation of DNMT1 and impair neuronal differentiation. 
These data add to our understanding of the role and regulation of DNMT1 during 
differentiation and help to understand DNMT1 dysfunction and hypomethylation in 
the pathogenesis of this neurodegenerative disease. 
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3.2 DNA methylation requires a DNMT1 ubiquitin interacting motif (UIM) 
and histone ubiquitination  
 
The maintenance DNA methyltransferase DNMT1 specifically recognizes 
hemimethylated DNA substrates. However, the preference of DNMT1 for 
hemimethylated DNA measured in vitro (Bestor and Ingram 1983; Yoder et al. 1997; 
Jeltsch 2006; Frauer and Leonhardt 2009) is not sufficient to explain efficient 
maintenance of DNA methylation patterns over many cell division cycles in vivo. As 
already discussed in 3.1, the cofactor UHRF1 is essential for DNA methylation as 
UHRF1 recruits and allosterically activates DNMT1 (Sharif et al. 2007; Bostick et al. 
2007; Bashtrykov, Jankevicius, et al. 2014; Berkyurek et al. 2014). For this process, 
heterochromatin binding of UHRF1 is mediated by the TTD, PHD and SRA domain 
and defects in any of these domains lead to lower DNA methylation levels (Jeltsch 
2006; Rothbart et al. 2012, 2013). Accordingly, it was suggested that UHRF1 reads 
and binds hemimethylated DNA and repressive histone marks and then by binding 
DNMT1 recruits it for maintenance DNA methylation. Interestingly, the RING domain 
of UHRF1 was shown to ubiquitinate histones but the function of his catalytic activity 
was unknown (Citterio et al. 2004).  
In this study, I participated in investigating the distinct roles of different UHRF1 
domains and their function in mediating DNA methylation. We found that the RING 
domain is important for DNA methylation by DNMT1, although it is not required for 
UHRF1 chromatin binding or interaction with DNMT1. However, UHRF1 with 
decreased ubiquitin E3 ligase activity failed to recruit DNMT1 to chromatin 
suggesting that DNMT1 recruitment to replication forks is influenced by the 
ubiquitination activity of the RING domain. 
Recently, it was shown that ubiquitination of H3K23 in Xenopus egg extracts 
by UHRF1 provides a binding site for DNMT1 on chromatin. This mark recruits 
DNMT1 and further enables maintenance DNA methylation throughout replication 
(Nishiyama et al. 2013). Nishiyama et al. showed that a 100 bp TS domain deletion 
mutant does not bind ubiquitinated histone H3 in vitro, in contrast to the wt TS 
domain (Nishiyama et al. 2013). To understand how the TS domain may contribute 
to H3 ubiquitination binding, we screened for potential binding motifs within DNMT1 
using bioinformatic analyses and found a ubiquitin interacting motif (UIM) in the N-
terminal part of the TS domain of DNMT1. 
Further, we identified H3K18 as the ubiquitination substrate of UHRF1 in mammalian 
cells using proteomic analysis and could show that the UIM mediates the 
recognition of ubiquitinated H3 in vitro. The binding of ubiquitinated H3K18 
(H3K18ub) is essential for DNMT1 subnuclear distribution and maintenance DNA 
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methylation. Moreover, we confirmed that hemimethylated DNA is bound by the 
SRA domain (Bostick et al. 2007; Sharif et al. 2007) and could show that UHRF1 
PHD binding to H3R2 is a prerequisite for H3 ubiquitination. Taken together, we 
propose that concomitant binding of the TTD, the PHD and the SRA domain to 
H3K9me3, H3R2 and hemimethylated DNA, respectively, is required for H3K18 
ubiquitination and further DNA methylation.  
Recently, DNMT1 was identified as a specific binder of H2Aub nucleosomes in 
mammalian cells (Kalb et al. 2014). Consistently, we found that DNMT1 binds 
ubiquitinated H2AK119 (H2AK119ub) via its UIM. H2A ubiquitination is set by the 
dimer RING1A and RING1B as part of PRC1 and was shown to be important in 
regulating gene expression (Leeb and Wutz 2007). Similar to UHRF1-dependent H3 
ubiquitination, H2AK119ub might play a role in DNA methylation. We propose that 
UIM-mediated binding of DNMT1 to H2AK119ub might direct DNMT1 to un- or 
hemimethylated sites dependent on PRC1 ubiquitination activity. 
In absence of its enzymatic substrate and UHRF1, DNMT1 activity is 
conformationally inhibited via an intramolecular interaction between its TS domain 
and the catalytic domain (see 1.3.1) (Syeda et al. 2011; Takeshita et al. 2011). 
Based on our observations, we speculate that the UIM may also play a role in the 
activation of the enzyme. In such a scenario, the interaction between UIM with 
ubiquitinated histone tails outcompetes the autoinhibitory TS/CD interaction and 
induces a conformational change, allosterically activating the enzyme  
 Ubiquitination can be reversed by USPs. As the UHRF1-DNMT1 complex 
interacts with USP7, which was shown to deubiquitinate and thereby stabilize 
DNMT1 (Du et al. 2010; Qin, Leonhardt, and Spada 2011), USP7 might regulate 
histone H3 ubiquitination and thereby DNMT1 targeting. Interestingly, among other 
core histone lysine residues, H3K18 was found to be acetylated (Kurdistani, 
Tavazoie, and Grunstein 2004; Tsai et al. 2010), giving rise to an alternative 
pathway to regulate H3K18ub abundance and thereby DNMT1 chromatin 
association. Acetylated H3K18 is enriched at TSSs of active and poised genes 
(Zhibin Wang et al. 2008) and might prevent the binding and silencing by DNMT1. 
In consequence, proteins that might be involved in the transcriptional activation and 
repression via the regulation of H3K18ac abundance are of major interest. 
Promising candidates might be the sirtuin (SIRT) family members as they were 
shown to deacetylate histones as well as non-histone proteins (Chalkiadaki and 
Guarente 2015). SIRTs are conserved enzymes that catalyze NAD+-dependent 
deacetylation reactions with a broad range of substrates such as tumor suppressor 
p53, forkhead transcription factors, nuclear receptor co-activator PGC-1a, histone 
acetyltransferase p300, and NFkB (Mantel and Broxmeyer 2008). In mammals, 
there are seven homologue SIRTs: SIRT1, SIRT2, SIRT6 and SIRT7 localize in the 
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nucleus, while SIRT3, SIRT4 and SIRT5 are found in the mitochondria. SIRTs have 
been shown to bind to bivalent genomic regions, to affect DNA methylation by 
modulating DNMT1 as well as to modify the histone acetylation status of the 
DNMT3L promoter (Kuzmichev et al. 2005; Peng et al. 2011; Heo et al. 2017). These 
results suggest promising candidate proteins to investigate histone deacetylation 
and subsequent DNA methylation dynamics (Figure 11).  
Finally, H3K18 has also been found to be methylated (Zee et al. 2010) by yet 
unknown HMTs suggesting another possible regulatory pathway that might 
influence DNMT1 recruitment or repulsion. 
 
Figure 11. Overview of dynamic H3 tai l  
modif ications with known and postulated 
protein interactions involved in the 
regulation of DNA modif ications. 
Recognition of H3K18ub via the UIM of DNMT1 is 
essential for DNA methylation. Therefore, the (de-) 
ubiquitination of H3K18 and competing PTMs like 
acetylation and methylation are candidates for 
indirect regulation of DNA methylation.  
 
 
 
In summary, we showed that DNA methylation by DNMT1 requires recognizing of 
H3R2-K9me3 histone tails and hemimethylated DNA by UHRF1, which then 
ubiquitinates H3K18 with its RING domain and thereby constitutes a binding site for 
the UIM of DNMT1. Dynamic histone modifications likely control DNMT1 chromatin 
binding and thereby direct methylation activity. As ubiquitination of H3K18 is 
required for DNA methylation, it is now of interest how this ubiquitination mark is 
removed and how competing PTMs of H3K18 like (de)acetylation and 
(de)methylation regulate the availability of H3K18 for ubiquitination with subsequent 
DNA methylation.  
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3.3 A modular open platform for systematic functional studies under 
physiological conditions  
 
CRISPR/Cas has revolutionized the genome engineering field and provides an easy 
and fast method for the site-directed manipulation of genes and genomes in cells 
and organisms. While genome-wide gene disruption screenings are informative 
about genes and pathways involved (Shalem et al. 2014; T. Wang et al. 2014), 
further investigation and functional characterization of target genes is essential to 
understand their function. It is important that biochemical, genetic and cell 
biological studies are applied under physiological conditions that require complex 
and time-consuming genetic manipulations.  
CRISPR/Cas mediated DSBs can either lead to indel (insertions or deletions) 
formation due to error-prone NHEJ or to HDR. Together with short homology donors, 
HDR allows targeted sequence insertion into the genome (Capecchi 2005). 
However, a significant risk of off-target cleavage mediated by CRISPR/Cas can also 
lead to NHEJ and thereby result in indel formation (Kuscu et al. 2014; X. Wu et al. 
2014). Due to this off-target activity, CRISPR/Cas in a classical sense can lead to 
unwanted gene disruption and might confound the use in research and therapeutic 
applications. In this project, I participated in establishing a more efficient approach 
(multifunctional integrase (MIN)-tag strategy) (Figure 12) that offers rapid, precise 
and efficient genetic manipulation of target genes.  
 
 
 
      
Figure 12. Schematic outl ine of the MIN 
tag strategy. A serine integrase site (attP) is 
inserted in-frame after the start codon mediated 
by CRISPR/Cas assisted HR resulting in a novel 
epitope tag that can be used for downstream 
experiments in vitro. The attP site can then be 
used to integrate functional cassettes on the 
genetic level. Modified from (Mulholland et al. 
2015). 
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The MIN tag strategy reduces the risk of off-target effects as it only requires a single 
CRISPR/Cas mediated cleavage event to insert a donor sequence (MIN tag) that 
carries a recognition site (attP) for BXB1, a highly specific integrase (Keravala et al. 
2006; Russell et al. 2006; Brown et al. 2011; Z. Xu et al. 2013). The genomic 
sequence of the MIN tag enables BXB1-mediated recombination of any 
prefabricated functional cassettes that are then expressed under the respective, 
endogenous promoter (Figure 12). 
Fusing the MIN tag in frame with the desired target gene results in the expression of 
a novel epitope tag that is absent in the mammalian proteome. Therefore, with a α 
MIN antibody, the MIN tag can be used for co-immunoprecipitation experiments, as 
well as microscopy. 
So far, we characterized a GFP knockin construct, a BirA* cassette and a knockout 
cassette. The GFP knockin construct is useful to study spatio-temporal dynamics 
and kinetics of proteins in living cells. The BirA* cassette enables proximity-
dependent labeling of the microenvironment (10 nm) of a given protein. This is 
mediated by the promiscuous biotin ligase activity of BirA* (Roux et al. 2012; D. I. 
Kim et al. 2014). The knockout cassette is used to induce a genetically defined 
gene disruption of any MIN tagged genes. 
The above mentioned functional cassettes are by no means all possible functional 
modules. Inducible protein destruction/stabilization, expression or subcellular 
localization as well as enzymatic labeling of DNA binding sites by employing the 
Escherichia coli DNA adenine methyltransferase (DamID) would greatly advance 
the knowledge of protein function and protein-chromatin binding (van Steensel, 
Delrow, and Henikoff 2001; Banaszynski et al. 2006; Kennedy et al. 2010). 
To validate the MIN tag strategy and its functional applications, we focused on a 
number of epigenetic factors that are well characterized and known in our 
laboratory and ESCs as a cellular model system. The MIN tag was successfully 
inserted in seven different genes: DNMT1, DNMT3A, DNMT3B, TET1, TET2, TET3 
and UHRF1. 
First, we tested the applicability of the BirA* cassette, investigated the 
microenvironment of TET1 and could identify besides SIN3A other chromatin 
associated proteins including the closely related TET2. Costa et al. already could 
show that TET1 and TET2 have partially overlapping target sites (Costa et al. 2013), 
which is in accordance with our proteomics data. In conclusion, we could validate 
that the integration of the BirA* cassette into the locus of a gene of interest is a well-
suited approach to investigate transient protein–protein interactions.    
Second, we used the GFP knockin cassette to study subnuclear distribution of 
DNMT3B during differentiation. Early embryonic development is an interesting 
model to study a period of dramatic epigenetic change (see 1.3.2) that can be 
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recapitulated by differentiating naive ESCs to primed epiblast-like cells (EpiLCs) in 
vitro (Hayashi and Saitou 2013). The de novo DNA methyltransferase DNMT3B is 
important during the transition, which is accompanied by increased genome-wide 
methylation levels (Bachman 2001; T. Chen, Tsujimoto, and Li 2004; H. J. Lee, 
Hore, and Reik 2014), however the subnuclear distribution of DNMT3B during this 
dynamic process remains largely unknown. We could show that the global wave of 
de novo DNA methylation during epiblast differentiation follows a distinct spatio-
temporal order, initiating at constitutive pericentromeric heterochromatin followed 
by facultative heterochromatin. 
Exploiting the possibilities of the MIN tag strategy, we generated a cell line 
simultaneously expressing differentially tagged splicing isoforms of DNMT3B from 
different alleles. Interestingly, splicing isoforms of DNMT3B from different alleles 
behave differently. After 5-aza-dC treatment of ESCs, the major catalytically active 
isoform DNMT3B1 was immobilized at heterochromatic sites, while the DNMT3B6 
fraction was not immobilized. This irreversible catalytic complex formation assay 
shows that only DNMT3B1 is catalytically active in this differentiation period. 
The previously used integration cassettes were flanked by bacterial sequences 
derived from the original cloning constructs. It is known that foreign sequences 
such as bacterial sequences that are integrated into mammalian genomes become 
epigenetically silenced (Z. Y. Chen et al. 2004). To circumvent a potential silencing 
event occurring on recombined functional cassettes, a possibility could be to 
introduce solely eukaryotic expression cassettes that lack a bacterial backbone. A 
molecular approach could be the use of DNA molecules called minicircles (MCs) 
that solely contain a eukaryotic expression cassette as well as an integrase 
attachment site and lack a bacterial origin of replication as well as antibiotic 
resistance genes (Darquet et al. 1997, 1999). 
Taken together, combination of the two genome engineering approaches, 
CRISPR/Cas assisted genomic sequence alterations and BXB1 mediated 
recombinations of functional cassettes, enables the generation of multiple cell lines 
with different functional derivatives from a single entry cell line. This approach can 
facilitate an easy and fast investigation of functional implications of mutations found 
in cancer and other human diseases.  
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3.4 Comparative Analysis of Single-Cell RNA Sequencing Methods  
Over the last years, advancements in whole-transcriptome analyses have been 
achieved to investigate systemic biological questions. Most RNAseq analyses are 
performed on tissue samples or cell populations, in which biological differences 
between cells can be masked by averaging or mistaken for technical noise 
(Macaulay and Voet 2014). Single-cell approaches revolutionized the 
methodological approach to understand genomic, epigenomic and transcriptomic 
diversity that occurs during embryonic and even cancer development. Recent 
studies investigate cell-to-cell variability with scRNA-seq and thereby open up new 
possibilities to address highly complex biological questions, such as the 
development of heterogenous cell states within a tumor that is one of the major 
obstacles for cancer treatment (Ebinger et al. 2016; H. Li et al. 2017). To date, 
different high-throughput methods for scRNA-seq have been introduced that vary in 
coverage, sensitivity and accuracy. 
In this study, I participated in comparing six prominent scRNA-seq protocols 
(Drop-seq, MARS-seq, SCRB-seq, Smart-seq2, Smart-seq/C1 and CEL-seq2/C1) 
with regard to the respective strengths and weaknesses in answering specific 
biological questions. The corresponding scRNA-seq libraries were generated in the 
same laboratory from wt mESCs, cultured under the same condition, which 
facilitates a comprehensive comparison across thousands of endogenous genes. 
To measure the sensitivity of each method, 96 different exogenous, poly(A)-tail 
positive, synthetic RNA transcripts were spiked-in with a known concentration 
developed by the External RNA Control Consortium (ERCC) (Jiang et al. 2011). The 
ERCC RNA standards undergo the steps of library preparation and thereby can be 
compared to the endogenous sample. 
By comparing the different sensitivity estimates of the six methods, Drop-seq 
and MARS-seq were found to be the least sensitive, while Smart-seq2 is the most 
sensitive method, followed by SCRB-seq, Smart-seq/C1 and CEL-seq2/C1. For the 
detection of splicing events and different splicing forms an even read coverage 
across transcripts is necessary (Marinov et al. 2014). If an alternative splicing 
analysis is the focus, Smart-seq2 is the method of choice. Probably related to its 
higher sensitivity, it is also the most accurate method as the correlation of the ERCC 
spike-ins was the highest. 
If the focus of the analysis lies on comparing the total RNA content of cells, known 
concentration differences of transcripts across cells would be required. In this 
regard, CEL-seq2/C1, MARS-seq, and SCRB-seq would have a strong advantage 
as UMIs and ERCCs can be used and compared. 
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To compare relative expression across cells of any gene of interest, technical 
variation and the dropout probability are important factors to consider. Smart-seq2 
performs best concerning dropout probability as it has a high sensitivity to detect 
even low expressed genes, while in UMI based methods perform better concerning 
technical variation as read duplicates that originate from PCR amplification can be 
excluded from down-stream analysis. 
To assess the power to detect differentially expressed genes (Vieth et al. 2017), we 
combined the effects of dropout probability with technical variance and performed 
simulations for differential gene expression scenarios. In this analysis, SCRB-seq 
has a high sensitivity and a low amplification noise and also the highest power in 
scRNA-seq data at sequencing depth of one million reads, while in bulk RNA-seq 
libraries the effect of UMIs on power is minor (Parekh et al. 2016).  
Besides the level of statistical power, also the expenses to generate the respective 
libraries and the sequencing costs per one million reads can be a decisive factor. 
Drop-seq is the most cost-effective method, but also generates a higher subset of 
reads that come from unfit cells and only has a low flexibility concerning the number 
of prepared libraries. SCRB-seq, MARS-seq, and Smart-seq2 follow Drop-seq 
concerning costs and are similarly cost-effective. Smart-seq/C1 and Smart-seq2 are 
the most expensive approaches. But using an in-house-purified Tn5 can drastically 
decrease the costs (Mora-Castilla et al. 2016). 
In summary, the choice of the suitable method depends on the 
biological/experimental question. Drop-seq is the approach of choice when a rare 
cell type in a large cell pool is under investigation and the coverage is not essential 
for the downstream analysis. SCRB-seq and MARS-seq are preferable when 
quantifying transcriptomes of fewer cells, and Smart-seq2 is preferable when 
transcriptome annotation, identification of sequence variants, or the quantification of 
alternative splicing events are of interest, preferentially using the in-house-produced 
Tn5. ScRNA-seq protocols can still be improved by combining their strengths to 
become even more efficient. The results of our comparative analyses of six currently 
prominent scRNA-seq methods may facilitate such developments, and allow an 
informed choice among the tested methods.  
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3.5 Ubiquitome analysis reveals PAF as a specific ubiquitination target 
of UHRF1 in embryonic stem cells 
E3 ligases mediate the final step of ubiquitin attachment to a target protein, thereby 
influencing protein localization, cell cycle progression, DNA repair and transcription 
(Hicke and Dunn 2003; Pickart 2004; L. Sun and Chen 2004; Pickart and Fushman 
2004). The specific activity of most E3 ligases is mediated by a RING domain, 
which binds to an E2∼ubiquitin thioester and initiates the transfer of the ubiquitin 
entity. E3 ligases harboring a RING domain are specified by more than 600 human 
genes, while protein kinases are encoded by 518 genes. Accordingly, RING E3 
ligases have been linked to the control of many cellular processes and to multiple 
human diseases (Deshaies and Joazeiro 2009). Despite their critical importance, 
our knowledge of the physiological partners and biological functions for most RING 
E3 ligases remains limited. 
Recently, we were able to show that binding of DNMT1 to ubiquitinated 
H3K18, which is set by the RING domain of UHRF1, is essential for DNA methylation 
(see 3.2). Prompted by our ubiquitination data (see 2.2), we set out to systematically 
screen also for non-histone targets of UHRF1 and its paralogue UHRF2, which has 
the same conserved motifs and overall structure as UHRF1.  
In this study, we investigated specific ubiquitination targets of E3 ligases 
UHRF1 and UHRF2 in mouse ESCs by comparing isogenic UHRF1 and UHRF2 
single KO ESC lines (see in 3.3) to exclude redundant ubiquitination targets. We 
used a published proteomics approach (Udeshi et al. 2013) to perform an 
unbiased, proteome-wide and site-specific analysis of ubiquitination levels. We 
enriched ubiquitin remnant motif-containing peptides (K-gly-gly) using an α-K-gly-
gly antibody. This proteomics approach is a powerful method for unbiased 
quantification of former ubiquitinated peptides. However, this approach also has 
some limitations. It can only identify the sites of ubiquitination, but provides no 
information about the type of ubiquitin linkage. After trypsin digestion, the K-gly-gly 
motif can result from ubiquitin- but also NEDD8- or ISG15-modified proteins. 
However, K-gly-gly-containing peptides for the most part originate from 
ubiquitinated proteins in cultured cells (W. Kim et al. 2011). Despite the above 
mentioned limitations, this approach can provide information about sites of 
ubiquitination and further help to generate hypotheses, which can be then tested 
using biochemical and cell biological assays. 
With this approach, we were able to identify several differentially 
ubiquitinated proteins that encompass biological processes such as transcriptional 
regulation, RNA binding, DNA damage response and cell cycle regulation. We find 
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ubiquitination targets for both UHRF1 and UHRF2 such as HSP90, DNMT3B as well 
as UHRF1 specific targets such as UHRF1 itself, Trim28 and H3K18 (Citterio et al. 
2004; Meilinger et al. 2009; Quenneville et al. 2011; Qin et al. 2015; Ding et al. 
2016). Further, consistent with studies of UHRF1 activity in vitro and in vivo, we find 
differentially ubiquitinated histones: H3, H2A, H2B (Citterio et al. 2004; Harrison et 
al. 2016).  
 
 
 
 
 
 
 
 
 
 
Figure 13. Overview of dif ferential ly ubiquit inated peptides. Venn diagram showing 
differentially ubiquitinated K-gly-gly peptides (gene name_position of ubiquitination) in UHRF1 and 
UHRF2 single knockout cells (Limma adj. p-value < 0.05). Modified from (Smets et al., 2017, 
manuscript in preparation). 
 
 
Among the differentially ubiquitinated peptides, we focused on PCNA-associated 
factor (PAF) 15, the protein undergoing the highest loss of ubiquitination upon 
UHRF1 depletion. Mono-ubiquitination of PAF15 at Lys 15 and 24 is necessary for 
its interaction with PCNA and was described to be associated with translesion 
synthesis (TLS) inhibition during undisturbed S phase (Figure 14). Stalled replication 
caused by DNA damage sites leads to ubiquitin chain elongation on PAF15 by an 
unknown E3 ligase and subsequent degradation, which then allows for TLS 
polymerase recruitment to PCNA (Povlsen et al. 2012).   
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Figure 14. Model of the role of PAF15 in TLS. During undisturbed DNA replication, PCNA-
bound PAF15 is ubiquitinated on Lys 15 and 24 by UHRF1. When PCNA encounters a site of DNA 
damage, ubiquitinated PAF15 is displaced from PCNA, which facilitates the interaction between TLS 
polymerases with mono-ubiquitinated PCNA (K164) at the stalled fork allowing lesion bypass. After 
the damage bypass, the reassociation of PAF15 with PCNA may help to promote reinitiation of 
normal replication. UHRF1 might also be responsible for ubiquitination of PAF15 after DNA damage 
bypass. Modified from (Povlsen et al. 2012; De Biasio et al. 2015). 
 
However, the E3 ligase responsible for PAF15 double mono-ubiquitination remained 
unknown (Xie, Yao, and Dong 2014). Here, we show that the RING domain of 
UHRF1 ubiquitinates PAF15 at Lys 15 and 24 and influences its association with 
PCNA throughout S phase. As the interaction of PAF with PCNA is necessary for the 
ubiquitination step (Povlsen et al. 2012) and our high resolution microscopy 
analyses revealed co-localization with PCNA and UHRF1 exclusively during late S 
phase, we suggest that the ubiquitination takes place in a cell cycle dependent 
manner. Furthermore, both UHRF1 depletion and mutation of the lysine residues 
result in loss of PAF15 association with PCNA, which hints towards a role for PAF15 
ubiquitination in stabilizing the PAF15-PCNA complex during replication. We 
speculate that the ubiquitination mark could potentially be recognized by proteins in 
close proximity that harbor ubiquitin interacting domains such as the UIM of DNMT1 
(see 3.2). In summary, this study provides a novel aspect of UHRF1 in regulating 
replication block bypass by PAF15 ubiquitination. Our findings indicate an 
additional role of UHRF1 besides in DNA maintenance methylation but in 
replication-dependent DNA damage response.  
Moreover and despite the sequence and domain similarity of UHRF1 and UHRF2, 
we also found specific ubiquitination targets of UHRF2 (Figure 13). Thus, a 
comprehensive follow-up research question will be whether and to what extent 
UHRF1 and UHRF2, two proteins with remarkable domain similarity, exhibit different 
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biological functions and target distinct sets of proteins for ubiquitination. The current 
proteomic approach described in this thesis provides a resource for potential 
ubiquitination targets of UHRF2 for further investigation.  
In summary, my findings suggest new functional aspects for UHRF1 both as a 
reader and writer of epigenetic histone modifications. In consequence, UHRF1 
provides a possible link between different repressive signals, including H3K9 
methylation and H3K18 ubiquitination. 
Finally, proteome analysis showed that both UHRF1 and UHRF2 have distinct 
functions and targets beyond DNA methylation, arguing for non-redundant functions 
and possibly linking different cellular processes.  
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4.2 Abbreviations 
Abbreviation Meaning 
5-aza-dC 5-aza-deoxycidine 
5caC 5-carboxycytosine 
5fC 5-formylcytosine 
5hmC 5-hydroxymethylcytosine 
5mC 5-methylcytosine 
ac acetylated 
ADCA-DN autosomal dominant cerebellar ataxia, 
deafness and narcolepsy 
AML acute myeloid leukemia 
BAH1/2 bromo-adjacent homology 1/2 
BER base excision repair 
CDK2 cyclin-dependent kinase 2 
CGI CpG island 
Ch cherry 
CNS central nervous system 
CTD carboxy-terminal domain 
CXXC zinc finger 
DMAP1 DNA methyltransferase associated protein 
1 
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DNMT1/2/3A/3B/3L DNA methyltransferase 1/2/3A/3B/3L 
DNMT1o oocyte-specific isoform of DNMT1 
DUBs deubiquitinases 
ESC embryonic stem cell 
EZH2 enhancer of zeste homolog 2 
F3H fluorescence three hybrid assay 
FACS fluorescence activated cell sorting 
GADD45B growth arrest and DNA damage-inducible 
protein 45B 
GFP green fluorescent protein 
HAT histone acetyltransferase 
HAUSP herpes virus associated ubiquitin-specific 
protease 
HDAC histone deacetylase 
HMT histone methyltransferase 
HP1 heterochromatin protein 1 
HSAN hereditary sensory and autonomic 
neuropathy 
IAP intracisternal A particle 
ICBP90 inverted CCAAT binding protein of 90 kDa 
ICF Immunodeficiency, Centromeric region 
instability, Facial anomalies 
iPSC induced pluripotent stem cell 
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K lysine 
KG lysine-glycine 
M phase mitosis phase 
me1 monomethylated 
me2 dimethylated 
me3 trimethylated 
MEF mouse embryonic fibroblast 
N-terminal Amino-terminal 
NLS nuclear localization signal 
NPC neuronal progenitor cell 
NSC neuronal stem cell 
NSD1/2/3 nuclear receptor SET domain-containing 
1/2/3 
NTD N-terminal domain 
Oct4 octamer binding transcription factor 4 
PARP1 poly(ADP-ribose) polymerase 1 
PARylation poly(ADP-)ribosylation 
PBD PCNA binding domain 
PBR polybasic region 
PCNA proliferating cell nuclear antigen 
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PCNP PEST-containing nuclear protein 
PGC primordial germ cell 
PH pericentromeric heterochromatin 
PHD plant homeodomain 
PI5P phosphatidylinositol 5-phosphate 
PNS peripheral nervous system 
PRC polycomb group repressor complex  
PTMs posttranslational modifications 
PWWP proline-tryptophan-tryptophan-proline 
RING really interesting new gene 
S phase synthesis phase 
SAH S-adenosyl-L-homocystein 
SAM S-adenosyl-L-methionine 
SETD1A/1B/3 SET domain containing 1A/1B/3 
SRA SET and RING-associated 
SUV39H1/H2 suppressor of variegation 3-9 homolog 1 
and 2 
SUV4-20H1/2 suppressor of variegation 4-20 homolog 
1/2 
SUZ12 suppressor of zeste 12 protein homolog 
SVZ subventricular zone 
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TDG thymine DNA glycosylase 
TET ten eleven translocation 
TIP60 Tat interacting protein of 60 kDa 
TKO triple knockout 
TS targeting sequence 
TSS transcriptional start site 
TTD tandem Tudor domain 
ub ubiquitinated 
Ubl ubiquitin-like 
UHRF1 ubiquitin-like, containing PHD and RING 
finger domains 1 
UIM ubiquitin interacting motif 
USP7 ubiquitin-specific processing protease 7 
ZNF Zinc finger protein 
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4.3 Supplementary Material 
Supplementary Table. Overview of mutations associated with HSAN1E 
and ADCA-DN. Point mutations and one deletion mutation found in the DNMT1 TS 
domain of HSAN1E and ADCA-DN patients. Investigated molecular dysfunctions 
are summarized. 
 
Disease Mutation Molecular dysfunction Reference 
HSAN1E    D490E 
+ P491Y 
Global hypomethylation, site-specific 
hypermethylation, 
DNMT1: misfolding, premature 
degradation, reduced enzymatic 
activity, impaired heterochromatin 
binding during G2  
(Klein et al. 2011, 
2013) 
Y495C 
Y495H 
H569R Not investigated yet (David, John, and 
Emmanuel 2013; 
Yuan et al. 2013) 
P507N Not investigated yet (Moghadam et al. 
2014) 
K521Δ 
T481P DNMT1: Loss of heterochromatin 
binding ability during G2 phase, 
imbalanced protein homeostasis, 
translocation of mutant protein to the 
cytoplasm, aggresome formation and 
autophagy 
(Baets et al. 2015) 
P491L 
Y524D 
I531N 
C353F 
Y495C 
Y495H 
ADCA-
DN 
A570V Not investigated yet (Winkelmann et al. 
2012; Moghadam 
et al. 2014) G605A 
V606F 
C596R Not investigated yet (Pedroso et al. 
2013) 
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